cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,2.8123570354563356
NCI-H522,613000,2.2856040748624347,2.7571735727332753
YAPC,16038120,1.926562361021756,1.1292547932150467
NCI-H292,9935249,3.8808310590786,3.433901080687109
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,-0.7496894670301733
NCI-H522,9908783,5.043768225694569,4.7466406524829425
JM-1,11175137,0.9157477453434189,1.8544253263260861
NCI-H522,5287620,-2.19230412457559,-1.975168885450315
MDA-MB-453,4917,2.8920757434762203,3.0267382487366503
DMS 273,135421197,2.3407622077730035,1.3796262297936255
SNU-449,BRD-K55473186,5.1406225681359174,4.050325733915989
SNU-61,4521392,3.90812104829802,4.25469895436442
G-401,9549297,1.736191202159007,2.075735309305532
NCI-H146,89183176,1.451528120959232,3.525548618906565
LOU-NH91,5287620,-1.52867963951729,-1.6533647497557178
FTC-133,123631,3.8044847524269865,2.3394713380939787
KMRC-1,5291,3.811670367299954,3.485965201736114
A-673,9823820,4.6435125645675095,3.638017644915875
FU-OV-1,168313047,2.3973799381416208,2.4778332816147826
Panc 04.03,44462760,4.978463894781355,3.90629414384809
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,3.0276253237558426
OPM-2,445091,3.996829176942573,4.153058695679872
ONS-76,5746,1.4703359849180313,1.3342295362406835
NCI-H661,3025944,3.908905198351104,4.391266125760515
A4/Fukuda,107970,1.5574682195612295,1.966445506535823
CAL-51,49850262,3.6300011952383584,3.811443357347845
NCI-H460,2858523,3.1665522277325575,2.95864646934669
G-401,6184667,2.5094508901292487,2.6762219987169584
NCI-H661,44607531,1.139733733680255,1.6108697799475502
SNU-81,6917907,-6.2756065511253185,-4.27779105961576
MSTO-211H,54678924,1.5146991125566602,1.938531223552582
FTC-133,10127622,5.496386107928154,3.585083328130669
EFO-27,11977753,-1.8189065225127747,-1.5974078934693727
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,2.3258240079676007
MSTO-211H,19582717,3.17062921236116,4.4411933643276
KMRC-1,53392493,3.2185750963739026,2.65225690187338
OPM-2,2749,1.7313419667612246,1.2110085803556125
NCI-H460,5351362,3.0809857123464037,1.5265914241881149
SNU-449,56949517,4.374997906660537,4.384374839623678
NCI-H146,1716436,1.8968095332546364,2.6819005324699727
MSTO-211H,9884685,-1.5007126123703023,1.0169552064779317
CA46,46926350,-5.311040218420036,-5.039213297165387
BxPC-3,72193861,-0.2425633398981322,1.664668596579052
NCI-H522,24180719,4.104291025168841,3.4634442700219115
NCI-H292,16038120,0.8772093711483475,1.2669532040068978
NCI-H2171,11364421,-5.769988570724398,-3.318080990614417
LOU-NH91,71304818,3.9209078908272703,2.722734561356576
NCI-H2009,71466380,3.950405172838994,4.660623044155215
EFO-27,44607530,2.237032971856772,1.8827383488604914
CAL-51,3136844,4.799885860604426,4.1706166889513385
MSTO-211H,9936388,-4.464575449065994,-0.47783839462206407
A2780,66577038,2.715796351675557,2.8716687500673106
G-401,24779724,6.361263224396382,4.013759440243704
OPM-2,5470400,-0.1217933569770787,-0.48005681181814824
HCC1143,36314,1.6197332159913502,-0.6174085239818613
SW1463,54143018,1.6932952952144893,0.3515482733742341
JM-1,1317464,3.8125649173872938,3.537980151357374
DMS 273,46907787,0.4735517334159472,0.9563315574835055
MDA-MB-453,46843906,1.4379824902109608,2.4932386306058287
YAPC,6252,1.451992868069142,1.1062254260425062
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.8962318755743126
CA46,46943432,1.2105530921386296,0.9182113271846534
NCI-H292,24785538,2.1095024536235374,1.915418603672646
NCI-H292,3038522,3.811290582208577,3.2111218372144528
NCI-H460,54454,2.7807551042334935,2.701764866133085
NCI-H661,9911463,3.595935737335879,3.8395561799120657
BT-549,4261,1.9217340769001163,2.1647040566601863
FTC-133,16013152,4.199465293191842,4.339260379451143
MDA-MB-453,54618305,5.448966988850886,4.05721601087727
LOU-NH91,56946209,-2.032751224257796,-4.008732914556653
KMRC-1,16659841,4.161446951047465,3.9727428322680534
LXF 289,66577038,2.7615792990535937,3.032034377149499
A-673,2871966,-2.1375369153988597,-0.12307492118675903
EFO-27,4788,6.204062284318603,5.770057437861234
FTC-133,5281321,-2.4880366458953196,-1.346172100018003
JM-1,613753,2.4959303189076376,2.6177468718024532
CAL-51,168312962,1.4117577594763937,2.0797346925806433
OPM-2,6450551,0.7106995413225735,1.5147922578541853
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,3.5814859393913343
EFO-27,26596,4.577324640946523,-1.082758919438209
LoVo,656346,0.766025679375412,0.959164693739158
NCI-H522,4477,0.4448521837298123,0.4933817315790504
NCI-H727,9936388,1.6432072244848812,-1.1597794222871043
FTC-133,104842,-5.8581546696404,-2.3532610081961454
EFO-27,7326481,5.957065585898912,3.1462227069928694
NCI-H460,11222830,2.8861636193629323,1.6146162651679203
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,2.823915932084619
NCI-H460,54618771,1.6853262233131374,0.8549385781964031
JM-1,52947716,1.780956269613054,-2.5611353797434573
OPM-2,9444,2.5095115053941557,3.7591155770192217
NCI-H146,60700,-4.723399126949256,-0.9771294079863688
BxPC-3,9911830,2.611582201474507,2.62243020835092
NCI-H146,16038120,1.7989248875403512,0.7942299543219832
LXF 289,51037431,5.679407317259089,3.4482696003017126
HCC1143,44589607,1.260451666530297,3.0617810569108665
CA46,5281321,-3.5082232289526663,-2.9537094127950185
BxPC-3,3815108,3.682439325637505,3.0970400047774223
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,0.6476848989434046
BxPC-3,3552672,2.73628551508051,3.052306053763589
SCC-9,3081361,1.719146178558617,2.448521903112993
SCC-9,135875424,4.9754653396039314,4.013116094516758
LoVo,1716436,2.86184708699294,2.8902922225854946
MDA-MB-157,9884685,1.398372779004129,0.8631623923436803
NCI-H292,9911463,4.207043029649759,4.013050494482569
G-401,54626689,4.421186382617726,4.476734509000714
NCI-H460,6917907,-4.956095121428261,-4.446561512940196
CA46,25062766,1.483751377697603,1.4328921539974702
LXF 289,44241473,4.688676931788039,5.095048498814946
EFO-27,71680916,4.9682795090816185,4.819346408931037
SW1463,11152667,-0.1903484351781526,-0.46720479179140795
NCI-H292,73707398,0.96137499748578,1.403238538215015
NCI-H2009,16725315,3.943728055015544,4.4631453272926045
SNU-61,135440466,2.760100648324382,2.0316806842817545
A2780,451668,4.676838081876032,0.5456027517043358
JM-1,46191454,-0.7072965876905944,0.3617715716722765
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.4880814552906179
SNU-449,2733526,4.280379959685792,3.7032739586055197
JM-1,10302451,3.097435274235228,2.704435044032339
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,-1.6017065517664943
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,3.3330978466520906
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.3949714233135126
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.4166551401033052
OPM-2,52912189,-3.1407059889083424,0.16983050789548368
SCC-9,9549297,5.273243325738832,2.679647332414475
A-673,375860,-0.5094320760358009,-0.27163980665494597
SNU-449,15983966,0.8926749279922188,-0.6231810666493643
SNU-449,135440466,2.7536019754154375,2.380143261713136
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.4960359288590184
NCI-H522,73707398,0.7434005611154502,1.0278464387211108
NCI-H1623,72376,-0.6301176586270604,-1.248289426341464
SCC-9,24901704,4.548877009949327,3.437872311171256
HSC-4,448949,2.25928901468022,2.02811305193256
SCC-9,25102847,2.571358625043281,2.638005854040913
FTC-133,135411,0.6572104898559208,0.6449524424230472
DMS 273,445643,4.452334519038606,3.9507772240842707
HSC-4,24771867,2.9499855440491243,2.687342952803412
BxPC-3,2841722,6.186043735824486,4.340198463437159
MDA-MB-157,52947716,2.709287320485668,-0.5573013994031777
HSC-4,46224516,3.389129888163455,2.2953578095155582
NCI-H146,400769,-1.4971487301951925,-0.6757997246990031
LOU-NH91,387447,-3.4249375140388247,-3.862593083751007
CA46,6610216,4.017162804005507,3.904652221450783
LoVo,375860,-0.1162329718395109,-0.3138266633503136
FU-OV-1,9911830,2.8434321082933773,2.5046933664521047
LoVo,9840324,5.061772266378942,5.801522550315412
MSTO-211H,56649450,2.845391743702004,3.37482631432271
HSC-4,9935249,3.700870290975298,3.309408886988536
BT-549,44486219,4.179253703467884,4.3860687041457185
SNU-449,24901704,3.9093934632949616,3.498585851003513
FTC-133,44589607,3.1305768616958085,2.652446444912543
LOU-NH91,42642645,0.5799169530603235,1.098265104347961
KYSE-70,51037431,6.2873914521382765,3.3785569487001883
KMRC-1,1566236,3.0378094444517645,2.7022847394332734
Panc 04.03,42642645,1.6619965718360328,1.155288855107327
CAL-51,3689413,0.5709426612715743,-0.09112811028047525
NCI-H522,44487872,5.4176039717063915,3.797726301720526
NCI-H2009,16722836,0.9347693241342916,1.6050468045789665
NCI-H522,11222830,1.4433136379668847,1.4874040375473387
CA46,72193861,0.1338517787347367,0.19696286114106537
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,-0.23209020195602442
LoVo,119607,4.4096130331744865,5.35503993595034
MDA-MB-453,1566236,2.5975650319928434,2.2497531257951526
ONS-76,11152667,-0.1692604119623072,-0.22519522635573666
G-401,24748573,1.6686206591324024,1.63747945266537
A2780,176870,3.0464675702719655,2.9348365511455996
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,1.0153878719806038
OPM-2,3385,3.5898560550490837,2.645180855143595
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-0.6829214005400002
NOMO-1,53495165,-0.0338576092201104,-1.0771413269570567
LoVo,46191454,2.275591949439888,1.5183718918870388
A4/Fukuda,4096211,1.2598455852625392,1.5819399082918404
NCI-H522,25126798,3.91575296607237,3.8287614100830982
FU-OV-1,135411,0.8541212220651947,0.6204671103254522
KYSE-70,10113978,1.960067513789881,3.3638433294517465
FU-OV-1,24856436,0.8416503079264269,0.6148833747334026
A-498,10026128,4.231838396167064,4.169633857120122
JM-1,11626560,-0.1801568688824005,0.831616566141866
NCI-H460,9911830,3.1326305509826824,2.731515859899405
A-673,9911830,1.9751375507094395,1.9650817159387186
Panc 04.03,71751553,4.683117627568525,4.545992448507334
LXF 289,6450551,1.9915066986525345,2.933838256732876
NCI-H522,156414,0.937566519659893,1.3321283479657458
MDA-MB-453,6610355,3.820285868995436,4.62327262811071
FU-OV-1,46843906,0.6915308493256752,3.167270500244184
NCI-H522,42642645,1.4297074042386375,0.48216673513830677
SCC-9,4917,3.683292695011318,3.2038797454746177
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9601038407033
SBC-5,54649381,4.189343649803657,3.7871167280216294
NCI-H1623,6918837,-3.3974396350468674,-2.8233733023902867
KMRC-1,10184653,1.755388017214173,0.6777062468223268
LXF 289,9967941,3.6599941581067057,3.9533793052160813
FTC-133,57519531,1.7209799050566308,2.7047158927428385
NCI-H661,19582717,3.3132894226769056,4.324108468537329
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,3.377770531048111
LoVo,71466578,1.8530080227063717,4.851636372597892
NCI-H2009,46907787,0.5680124512944033,2.2043320511404625
DMS 273,49793307,-3.720971975288363,-2.8823202807081003
NCI-H522,135659046,3.4944475458884012,3.520020176171956
FTC-133,5351362,2.946320615286136,1.7799004604228401
JM-1,208908,1.8689748302954872,1.9393107686527735
Panc 04.03,216239,3.3806837686851923,2.5434493016841104
NOMO-1,71466445,1.8310961714544176,2.3581587489029037
NCI-H522,71680916,3.6078643166976896,4.388531499400716
EFO-27,2126,5.846579140474247,4.568202404436167
ONS-76,5284616,3.539643222518188,2.7867097396866827
SCC-9,16736978,3.1048488109971664,1.6170069729962133
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,-3.9573208270178646
A4/Fukuda,23582824,-0.7377224087572002,0.5395924253320561
NCI-H661,53325874,4.390083123893945,4.553629772796647
SNU-61,4096211,1.05462843518756,1.8306500493513547
CAL-51,675434,4.354107922133551,4.350265788718306
NOMO-1,11175137,1.3676050257567425,1.5746928137209613
NCI-H2171,5335621,4.282845813975702,4.063355690947094
SNU-449,11647372,1.9881649315547345,1.2390389781963307
NCI-H522,3503,2.0960599148243557,1.9993855218327605
NCI-H2171,52947716,1.4567314464455066,-1.6998712588262506
NOMO-1,5291,3.5817896511091862,2.6723550360603583
NCI-H522,46843906,2.3044802452603967,2.4722619672299366
OPM-2,11494412,0.3054873199299708,0.6287372363974653
A-673,53495165,-1.305348317827654,-0.5324710638007729
KYSE-70,54618771,1.1170424016733127,0.8876484929150061
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.339395005751454
SCC-9,3062316,1.318086870144001,1.1403997716822956
LoVo,387447,-3.727342469020989,-4.4384892758793315
MSTO-211H,73707386,2.8647689708389943,3.0487802823002266
FTC-133,54613361,1.5430217136639572,0.29250708349512455
SNU-61,12001922,2.043150446887516,1.6805267176553114
DMS 273,374536,2.442253811681885,2.324979792373279
LXF 289,10302451,1.735451917587997,3.2837930896513803
CAL-51,2858523,3.1959449804225524,3.054906930851768
Panc 04.03,23582824,1.118403221753994,0.9972361862821518
KMRC-1,6505803,1.455434702084088,-0.42785028811476666
CAL-51,4261,2.4552246887350417,1.5958424989423228
SCC-9,5746,1.774962232755205,1.15843279864316
NCI-H661,71466578,3.739107690689307,4.682479712124713
ONS-76,54619267,4.0364090976663,4.143327864515663
NCI-H522,100016,6.692385014202011,5.766684007973237
G-401,11719255,3.853695059500007,2.9634600835781395
HSC-4,3815108,3.178044313970192,3.1057396180805035
NCI-H2171,5287620,-0.0573950216422359,-2.3584137214255665
A4/Fukuda,5311,-0.1264358008137528,0.6270978120686372
NCI-H292,387447,-4.003442188855186,-3.862540852385716
OPM-2,148124,-6.3849256320012575,-2.7912366519927314
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,-0.06932209904703157
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,4.752911353271562
CA46,9967941,3.699441503938977,3.0711387046611787
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,0.21820370232534245
LXF 289,387447,-4.093727880786265,-3.8924536392172833
CAL-51,5113032,4.55807021159329,4.717769111690604
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,2.0033276521579118
OPM-2,241158,1.7102591321182437,2.7197271816156534
ONS-76,16741245,1.9308546797770672,3.8158157243846738
Panc 04.03,322968,5.075488138121087,4.028860146299669
BT-549,135875424,3.804392758634582,3.980998295456883
A-673,54626689,4.6393725921997415,4.482572712771304
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,1.5962609233615088
HCC1143,3543504,4.280043771428645,4.449808211269951
BxPC-3,107970,2.2592769610294448,2.25456746666135
ONS-76,51037431,1.0002101292366832,3.3774424656156476
G-401,24785538,-1.0602782345595374,0.8069381688198248
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,-1.6541236510789497
FTC-133,676352,3.9949531967924297,2.0711192738963726
NOMO-1,53232,3.2414615649348772,2.5537861573939717
LoVo,11625818,2.0848313295223844,4.546902851955722
A4/Fukuda,702558,5.147225783500614,4.715917317994731
NOMO-1,11455910,0.2303469505827257,0.2742407482932254
SNU-81,4096211,1.97800800333133,1.6692593743036142
NCI-H522,676352,1.6559488811299496,2.0424588841453497
YAPC,60750,-4.781219880342373,-1.5137505417398784
Panc 04.03,11612883,3.751429287253437,2.9461197903369807
NCI-H661,67156097,-3.370555704228358,-0.6023365168343391
SNU-449,4705,3.898593282840832,3.2210631777236376
MDA-MB-157,9952709,2.6586157499418444,3.210911936770036
NCI-H522,16038120,0.9671280612186928,0.5444915654800135
A4/Fukuda,4259181,-0.5702867723998835,-0.28260581509532656
LoVo,135398744,6.330186357549225,6.335193334996652
OPM-2,637858,0.8070227403937857,1.1334294450281788
SCC-9,3038522,1.9571402343301385,3.1273691894674114
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,-0.6711159162473322
A4/Fukuda,10127622,0.8035335483112384,3.44745153176793
Panc 04.03,4378219,5.53220646065493,2.8713245076190437
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,1.2315406396470154
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,1.9574423813689372
EFO-27,11396600,3.826824277303455,3.9020513292704715
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,1.3047479301041398
NCI-H2171,7251185,0.8673768610035957,2.016464685020762
NCI-H1623,5311281,4.903104817913162,2.5137604407625855
OPM-2,11317348,2.0151792351474755,1.1222695272501886
OPM-2,100016,3.804278037815123,5.325146628979219
LoVo,46224516,4.94892102130723,2.383676896544898
A4/Fukuda,9826308,-1.4955537783248567,-0.17707493431243645
LoVo,15547703,1.4569683263207862,3.215399495924107
LoVo,227681,3.064150517180394,3.4508309872665746
NCI-H727,5460769,4.510942150258337,3.0359142113647875
NCI-H292,6918837,-2.538558148903755,-2.5155059370625734
A2780,132971,2.947129832610188,2.56423247237054
FTC-133,4788,5.605324981437421,5.617565360881581
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,3.419883186537553
A-498,23582824,2.0595934555669886,1.0761939920582428
SNU-61,8515,5.6731171982359365,3.781156109193139
MDA-MB-453,23582824,0.0198148722876335,0.5582633667904663
DMS 273,5329102,2.038563375095403,1.9159019976781306
NCI-H460,72193861,2.1658883750752844,1.5488037997232822
MDA-MB-157,6610355,3.680589360872168,4.66614501985391
Panc 04.03,56649450,4.182465283011193,3.6253695165346045
NCI-H727,124202324,2.79148434895864,2.533003611812782
MSTO-211H,24772860,-3.3585393605141824,-1.5252657564810266
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.1970993272624437
CAL-51,20959075,-3.1196535578382987,-3.116876706364544
OPM-2,322968,0.7466819505545055,2.4812522603995237
CA46,984333,-2.431082434536014,-0.5209199254552069
JM-1,1242560,2.356943306915098,2.7360894358790087
NOMO-1,25126798,3.9519848152055848,3.1127888111260744
MDA-MB-453,5738263,2.9414099779046934,3.0469310222685926
OVISE,10074640,3.3556303567674064,3.191064190929198
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,1.0643473305784135
MSTO-211H,159324,-0.971759723426381,3.029481972254663
Panc 04.03,46191454,2.0071895522726377,1.8530706255670961
SBC-5,9826308,0.1778598819423294,0.6963401031297785
BxPC-3,1641662,3.0109567862503654,3.533009708061865
NCI-H460,2708,4.613368759945332,4.828390136952363
MDA-MB-453,2746,1.6853152695376463,2.646581638590286
NCI-H292,2858523,3.0406792249868633,3.127231652900403
LoVo,52912189,0.3784309245329977,1.8925446242814987
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,-0.8842449309279992
NCI-H460,9936388,2.3098343611543415,-1.1054582263993469
A4/Fukuda,176870,1.9874765150136215,2.631768153588014
LOU-NH91,49793307,0.2442451207819767,-1.7615865087616038
MDA-MB-453,2945648,2.145365576847094,2.853305182065476
SNU-449,54596490,5.440438718305218,4.780179553353284
NCI-H2171,9927531,3.1501077196413783,4.246722235417164
CAL-51,25150857,2.2346870378683934,2.490842485515084
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,1.4548593972644557
NCI-H727,9444,4.415864627267573,4.169772213772268
CA46,71466578,1.7711352492213497,2.7658944451883256
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.2792727261955292
G-401,11507802,0.4930201538787991,0.9878677754114791
OVISE,11214940,-0.1911189695405239,2.17587917084144
MDA-MB-453,135999136,4.2113637134750395,3.7083043883101756
CA46,445455,4.357290874085763,4.0650368081169574
KMRC-1,5335621,6.052276706579308,4.550461496637192
Panc 04.03,36462,3.526332093717117,2.4806319451453165
SBC-5,56963564,-0.838635946263744,0.38170641300056823
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,2.2009068564120935
NCI-H727,46224516,2.477743379244975,2.4875915915660034
NCI-H292,11222830,1.205012148013641,1.7261459719944359
MDA-MB-453,24771867,4.091824937074987,2.1030146863004004
NCI-H460,72376,-0.5460239014371263,-1.978301597252557
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,1.4777429918172678
LXF 289,9911830,2.045852319971143,2.7588120834600276
LoVo,1242560,3.2639930925900305,3.485606518815427
NCI-H292,6918736,3.734181331597608,-1.1794129514494005
G-401,11717001,3.7897150646045863,4.147189333280677
ONS-76,46398810,2.9642978938134004,2.521449381700212
NCI-H522,1242560,4.210520049105227,3.269867447197039
EFO-27,3081361,2.362036241237279,2.556506288289609
SBC-5,11222830,1.4112085967579189,1.6543648123895605
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.1486783477087545
CA46,11213558,2.4131379110887496,1.354062775107864
FU-OV-1,6918837,-4.1157354170673495,-2.401239408631941
A4/Fukuda,56946209,-6.395954164738885,-4.456689934750964
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,-1.3059827660025756
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,1.201635542039468
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,0.8697589434657098
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.5453528691910576
A4/Fukuda,216239,1.5760740052804734,1.8185609455620824
FTC-133,4578,5.173307644971936,4.418962873982488
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,1.3787179158424059
NCI-H460,54618164,4.49670945938676,4.176265526937294
CAL-51,42642645,0.4324607401831485,0.765427111499779
BxPC-3,24771867,1.9124988819938955,2.668799920588282
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,2.075405247283626
NCI-H460,15953870,5.00315267734786,3.671920198968586
A2780,24964624,-0.4628922796959323,1.8664313855630743
CAL-51,654092,0.82886283906252,-0.14203711228837426
G-401,5281321,-2.57337969869382,-1.564954403695985
MDA-MB-157,3634881,2.7842407118999852,3.240900985148358
MDA-MB-453,42642645,1.5292302084545462,0.9354179489520412
BT-549,54618164,4.423974096662665,4.229314186312358
A4/Fukuda,16741245,4.963846947143099,3.492409103243149
BxPC-3,44632017,0.4026385498906549,1.5658011466998576
ONS-76,9911830,2.941904202808556,2.5214910582328565
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,0.7365959762318728
ONS-76,4477,-0.2351585842599584,0.6677779041563278
JM-1,44493528,3.997956862382446,3.848800544855599
NCI-H146,5702613,3.149923076768629,3.044205762650808
NOMO-1,25150857,2.063048355345986,1.8964817451933078
LoVo,24856436,-0.7244956111709783,0.331275745614049
OPM-2,53481919,3.0492738202957206,3.183023763303183
BxPC-3,44507138,1.658490789748868,2.2886432569046944
FU-OV-1,2113511,4.466585490981426,5.533860142568667
NCI-H661,2749,0.7713739826565964,2.102415364269665
NCI-H1623,53495165,-0.5563852526996439,0.9013288773655603
NCI-H522,6610216,4.154510920860766,4.194610881310239
BxPC-3,148198,-2.171424706341701,-3.1138267195465072
MSTO-211H,4788,5.119342350142264,5.767115448627051
A-498,1750826,-1.7479882416802337,-1.2711138851312045
HSC-4,136227924,4.2199200707906845,2.9119316863816938
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,3.0249586609159285
LoVo,54618771,0.7060685526757626,0.911288700809514
DMS 273,10322450,3.6367733537116167,3.6152094165873248
ONS-76,1750826,-1.6505794475434372,-1.6565044134614553
MDA-MB-157,135440466,3.174924928897617,2.1811763141133316
NCI-H727,241158,6.115461447477091,3.7792815208070203
HCC1143,46398810,2.1694021244377333,2.6849118430364878
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,1.6287811069272984
SNU-449,3062316,-1.3612378425924234,1.5852517109979427
SNU-449,11977753,-2.005546044599541,-1.2481621920585446
JM-1,24771867,-4.48997165682624,-1.0486808593153185
NCI-H2009,11507802,1.1556617167312242,2.013240657538373
HSC-4,11964036,1.64347500999081,1.2143414334390004
Panc 04.03,5479543,4.112837907412102,3.628342459838961
ONS-76,439501,-2.2755976390662163,-2.1992043585166208
JM-1,54639126,4.392955654749798,3.4357975115079595
CA46,11167602,1.6890466560929325,1.477424885381967
CA46,135411,0.0331424760277949,-0.3883717257655633
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,2.390328740395414
Panc 04.03,11625818,5.081289492721679,4.628459632012752
NCI-H292,12001922,1.805770236255338,1.983006461284471
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.6627132825938242
MDA-MB-453,5278396,3.602107220771141,3.338232351919379
NCI-H522,6438330,2.681865372615506,1.8127462941221006
A-673,71466445,2.638210082463498,3.4425448116642268
MDA-MB-453,25105715,3.2581724710849778,3.4100599117573376
A2780,17759555,2.3500586644289165,3.492528956630178
YAPC,124202324,3.68667481758741,2.6673571067511634
NCI-H522,25227462,-0.4562280137645088,-0.2544406224317457
KYSE-70,10074640,3.109810551584267,3.170419849221416
HCC1143,5278396,2.995823973274505,3.7788620823725267
HSC-4,5479543,4.052409111099337,3.705097506734705
NCI-H661,446155,0.1985182541705634,2.600078626959819
YAPC,53495165,-1.0203233667221312,0.6074874386549785
FU-OV-1,11719255,3.4823701199113097,3.4444088044321517
NCI-H2171,5278396,3.2627520221828115,3.2234882195562973
MDA-MB-157,9911830,0.0801478348660684,2.259119480107825
OPM-2,9911463,3.091122447781221,3.339582808383487
LoVo,25126798,3.7423562181337338,3.801441469754024
EFO-27,9911463,4.361076045114702,3.9780575820023443
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,-3.5611181320155696
A2780,5280436,2.9198027340920434,2.923395777824555
SCC-9,5311037,3.6943722712183007,3.8277012051518
ONS-76,5978,-2.168221630618191,-2.007788632163346
A-673,44819697,-3.745571155852308,-0.9742703894159288
CA46,24785538,1.2011715151517115,0.5320055446573576
HSC-4,9936388,2.361545024779824,-1.9244938350155991
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.176235619049834
NCI-H460,49793307,0.4479933662320887,-2.9286787061801802
A2780,64971,1.607646338152048,2.8152993915414335
JM-1,72193861,0.5763432020354632,-0.020361339697886595
NOMO-1,11625818,1.7683333213472852,3.7369530028146234
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.4374663210837375
MSTO-211H,11507802,-2.113337212450165,1.6533559036945338
NCI-H661,53232,0.4849867031297817,2.7795127932461803
YAPC,16720766,-1.1916244870670316,0.7736361301530432
NCI-H522,208908,1.8410391152152548,2.0213329137498883
MDA-MB-157,5284616,2.798393493195082,2.292191347449504
MSTO-211H,6505803,-0.0669493563910609,-0.7151932318726371
NOMO-1,56649450,3.0749194455734012,2.5764635149345354
NCI-H727,9967941,3.73486297967426,3.6576887128554163
SW1463,15547703,3.1824451623977312,3.0198621794003815
FTC-133,24951314,1.987520160616717,1.3846878123377726
MDA-MB-157,24772860,-2.2599749907314175,-1.7498123383675241
G-401,2749,1.3663456978729704,1.3778120127527667
BT-549,16065773,1.5788570773866877,2.778535267925643
OPM-2,11955716,-2.9191891869850015,-1.8499479352342465
NCI-H661,176870,2.3474624932942207,3.3206023553606565
NCI-H292,66577038,2.9683700205355765,3.1217449656974026
MSTO-211H,54143018,-0.309857947329572,0.7705618609642026
OPM-2,3634881,2.0291765129520467,2.8135910329412366
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,1.6009235336018404
A-498,44607531,1.7098722083353044,1.6102382456855187
KMRC-1,2749,2.412459730094544,2.2380096281308517
NCI-H292,57519531,1.7489075965122454,2.627864722871297
NCI-H727,11404337,0.8145711342672778,-0.1359309056495588
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,4.541855573424855
SNU-81,107985,-4.076050447844214,-3.5098652658510447
SNU-61,24785538,1.5668080683488936,1.3304584397182608
SNU-449,56946209,-2.472995255165521,-3.614438411455033
KYSE-70,452548,2.3575041584151637,0.28537302612029813
BxPC-3,5280436,3.644569175052812,3.5450836771768706
JM-1,409805,3.649428990507172,4.047979868399768
SNU-81,17755052,-1.02795410661762,1.5736259698076898
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,-1.8250882493511864
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,2.6240570254318953
G-401,54618771,0.8582285882331511,0.5133560990047602
LoVo,4788,4.577300245187766,5.750076436735628
A2780,24771867,-2.9740519428749055,1.3559674596326394
NCI-H292,4261,1.3935441456482582,2.022533322198315
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,1.4367813178315418
NCI-H522,2729026,3.0595997973682043,2.6188287526575595
MSTO-211H,448949,1.6774063902575909,2.160215677044564
BxPC-3,9825149,2.348819386499172,2.1416562682615568
NCI-H522,44607531,1.4505766804532754,1.3777621282658326
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,0.8342865796095178
A-498,1285940,4.242355519484504,3.7741064676607463
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,4.394632179887536
NCI-H661,44543605,4.030509034099432,4.200805228003654
CAL-51,12003241,-1.2189714227076325,-0.7788241581030073
A4/Fukuda,135411,0.1560078623072997,0.1568797668251297
HCC1143,675434,4.285446752444937,4.437878728439935
CA46,11719255,3.04595311036835,2.5326078344176164
BxPC-3,654092,-0.3546902897816355,-0.49647501774582536
NCI-H292,11238147,1.7384499640365698,2.998491777732111
LoVo,285033,-2.045623665035502,-2.1912824298061975
NCI-H1623,136227924,2.959018127447204,3.093508087260344
OPM-2,5329102,0.9197947820907424,1.4880772531363133
OPM-2,208908,1.37961789198716,1.6641894188700073
MSTO-211H,124202324,2.766151060695559,2.6245552780615835
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,1.949335792143142
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,2.805755645189334
SNU-81,55508,3.0035688840672767,3.089231283979587
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.6645688294719228
A-498,24821094,3.8657770123239574,3.0070030260929403
DMS 273,6918736,-3.620580414510608,-1.7925231921857079
JM-1,3062316,-0.5573937765637444,0.7199301698762439
JM-1,56649450,3.7062904943567263,2.707003932762197
SBC-5,24856436,0.2896075356546521,0.10610399981370884
BT-549,285033,-1.3520552126123144,-1.8117393233096244
OPM-2,5746,0.8583790934138843,-0.15623516460999073
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,4.1665524082075045
G-401,6914657,-5.660532663542792,-4.902826109636948
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-1.6832996564176208
HSC-4,2858523,3.1192513569149245,3.025956330546953
NCI-H522,675434,4.236381328267226,4.302198807090857
CAL-51,25183872,-0.1080661998677032,-0.75399356475633
BT-549,4259181,2.4625999028961743,0.34744992281022363
NCI-H522,11455910,0.4156799864056491,0.8757227424390028
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,-0.20096690319800067
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,1.6563182158594494
NCI-H460,3543504,4.388423548450019,4.389232450713719
LOU-NH91,11626560,1.802766880846386,1.8920585049565144
NCI-H522,2871966,1.782445654343025,0.1655548634050369
G-401,135440466,1.822823734742602,2.000766610112746
A-673,10172275,4.325815901444083,3.4427945792040022
LoVo,3385,1.4948122184820352,4.3377660419538975
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,2.810851937378464
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,-0.722742339473514
A-673,637858,0.7164978632133837,1.3948228280878658
OPM-2,4915,5.457147549775398,2.781051004101904
CAL-51,11626560,0.7349282975065881,1.684621227555837
NCI-H661,2729026,2.3445725854556696,2.7168540595173827
KMRC-1,25126798,3.86147373401716,3.7558827193463538
KMRC-1,107970,3.035071998795665,2.3012300425266576
MDA-MB-157,16219061,1.3123257474603047,3.3195616619150248
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,2.3378943631812015
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,3.0352033264217466
NCI-H2009,24964624,2.271229049936602,2.6949204209845874
NCI-H522,7251185,1.2190943442977031,2.377841817279146
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.4853623347585705
G-401,52912189,0.0594470173160698,1.2387955514808187
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,2.216653853775255
OVISE,702558,5.699669356311473,5.25522699005526
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.8498721099108721
EFO-27,54678924,2.818156902929417,1.930372250751938
LOU-NH91,44607530,2.1348137775706646,2.076248916901698
EFO-27,24180125,3.663788732934096,3.271259213823848
NCI-H661,135421197,1.0600684669241136,1.9774171293731755
MDA-MB-157,56963564,-0.5852778857487072,0.5496557552339597
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,-0.4852014447326443
LXF 289,6505803,-2.367756082461904,-0.47901068067765773
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,-1.0525420191353068
A-673,5278396,3.572368012209165,3.3570923762380285
MDA-MB-453,135421197,0.8806711164351635,1.736207257509621
NCI-H661,11396600,4.301216087095742,3.610843801246127
G-401,148124,-6.018913106580182,-2.9439091111850315
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,2.9576684272540206
SNU-61,208908,2.000237947522829,2.031512699027464
NCI-H661,5329102,2.676948448482624,2.0944545305688083
NCI-H146,148124,-0.9007997951548676,-2.140419744009063
HSC-4,446155,4.1145986724492865,2.913572889929404
NCI-H661,3825829,3.711058317012711,3.789635826034277
OPM-2,135411,1.0006691045824918,0.05910250638396925
CAL-51,3815108,3.0623029951861396,2.990257599246449
NCI-H522,2858523,2.9817407099898676,2.97019585478646
YAPC,2708,5.2324194580289065,5.132710503676674
Panc 04.03,4917,3.7974030923782274,3.43182050164541
KMRC-1,51039095,3.0507646213845008,2.687522891556554
MDA-MB-157,44632017,-0.0621812067979977,1.592639616772807
KYSE-70,613753,3.646356391333843,3.175307941660742
OPM-2,11364421,-7.162542415885671,-4.277501749855587
KYSE-70,11964036,0.6479741930424838,1.4311004737281772
EFO-27,9915743,1.432055126276498,1.3235922394200788
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,2.781899849752895
A2780,9935249,1.4583070792637778,2.7486003636242127
NCI-H292,25105715,3.507158893285561,3.566339468785037
JM-1,5566,2.903571956440186,2.6655606222109665
NCI-H460,16722836,2.818869820371906,1.625477177477446
MDA-MB-453,71466380,3.4268898477848784,4.587597018443158
MSTO-211H,24753719,3.2448003358152286,4.215976840376662
JM-1,637858,0.5231851777275447,1.1753634336246113
MDA-MB-453,11152667,-1.4808178636693017,0.38213117376649736
HCC1143,44185566,2.5224843451498273,2.557706382012235
SBC-5,53481919,4.872311947173971,3.8893028668056076
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,2.0239194975478676
LoVo,3038522,4.270533501697307,3.2306897491126265
OPM-2,5280436,1.5288125622159816,2.61706313531085
A-673,71680916,4.0499723530429295,4.435102484590206
LOU-NH91,6610355,5.077923698507978,4.647965309355749
SW1463,10127622,-0.1211197806374188,3.060696768943048
ONS-76,2126,3.999900921085769,4.438820588519427
NCI-H522,53301938,4.938312106360689,2.387259988784142
NCI-H2171,3552672,1.63504499488054,2.250372292206018
SNU-449,375860,2.655390537146391,0.10258063425833829
MDA-MB-157,54626689,4.568687551235484,4.720718884236765
KMRC-1,5746,2.0919022066371484,1.0876494960328822
CAL-51,24964624,1.6704816041215405,2.3181525184540037
EFO-27,46199207,3.7203826311454096,3.3328429846521015
A2780,439501,-2.4090624878410316,-2.4064033843569024
LoVo,89183176,4.107889784939482,3.954138129998138
NCI-H661,24772860,-4.399665014096174,-1.7173823939433799
NOMO-1,46224516,2.27353152393119,1.7667236728084958
NCI-H460,5281672,4.99885948312363,4.525540651842518
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.3447271491387185
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,1.5845428031787483
NCI-H460,9967941,4.030885542149613,3.7272438181910883
NCI-H292,44819697,-0.5623825720804246,0.020788470418414473
OPM-2,216468,0.7655721379939343,1.3214052745397538
ONS-76,60700,0.0915142349819345,0.14564420537927736
YAPC,17755052,3.2330221121257874,1.7555595973746636
EFO-27,444795,5.488221670965637,4.723439697919053
YAPC,24797083,1.6153709299916277,1.6392623892909741
NCI-H661,51039095,3.3700376717556315,2.8048008263440236
MDA-MB-453,25154868,3.2796937080857296,4.344245862058784
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,0.8887866387161155
KMRC-1,9911463,4.4126092990485395,3.750773541835487
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,1.1599700651933482
G-401,107970,2.0352708529532824,2.107077617537605
FU-OV-1,25195348,3.3767609447508846,3.454191856633973
NCI-H1623,11234052,4.315313421055944,4.0732677357272165
MDA-MB-157,151289,0.3130009139891556,1.2567149855461575
EFO-27,56973724,4.318199286965652,3.3573929467261663
NCI-H460,5328940,3.322075361136407,1.8198840068168056
NCI-H2171,11964036,0.8555185627034467,0.8135525455901299
Panc 04.03,24821094,4.144896314615952,3.3064743906851657
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.279026694507863
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,1.9240609115343519
FTC-133,5280436,3.005172717589714,3.4665656787215293
NCI-H292,49766530,5.348764781206105,-0.42920032155555915
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,4.051086619611524
FTC-133,219104,4.114698267906641,4.006504132513033
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,2.8306765404201872
ONS-76,6918736,-1.0728340962982743,-1.3570090818706328
A4/Fukuda,16065773,1.900447949816596,2.129418546710598
FU-OV-1,25126798,3.715640842708804,3.8337455128792204
NCI-H460,6505803,-0.4074860596498978,-0.6466500358375586
ONS-76,44491742,4.314760532803232,4.297245642037586
MSTO-211H,6914657,-1.9341273237470331,-3.0543551280186216
G-401,136227924,2.3105932180874365,2.6798601723170994
Panc 04.03,148198,-3.912302089259141,-2.904036966643364
CAL-51,23725625,3.781531245600544,4.965496240541756
NCI-H1623,7251185,3.63742147878688,2.5961069208899357
A2780,44589607,1.4452328541597397,2.482349555267735
A-673,675434,3.949120496105267,4.331303086489924
KMRC-1,25227462,1.6145893273286742,-0.475175372202939
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,3.3010615611176437
HSC-4,2749,1.8453067540575636,2.0410702198807242
DMS 273,6438330,2.6669951536881182,1.6474445043627903
KMRC-1,44491742,6.09620831621162,4.15650310329687
MDA-MB-453,3465537,1.8912554302439897,2.4665936491723115
SNU-61,156414,1.6812768260110038,0.8740230846113655
YAPC,11625818,4.8006567630911094,4.537650029877746
CAL-51,9911463,4.251278022142156,3.932871259779611
MSTO-211H,68056272,2.8034566103574825,3.5891343565906726
OVISE,9911830,4.830872688345326,2.671145176045888
MDA-MB-453,6917907,3.1299164846836796,-4.365409524821715
SNU-449,9444,4.238096768887569,4.170910767112818
SNU-61,3062316,1.255261088163193,1.3236536280135214
A2780,11178236,-3.658526043242797,-3.81524891537799
MSTO-211H,219104,2.9811404214526136,3.9340986459320546
CA46,11364421,-6.636542851208846,-4.7141574606036585
NCI-H1623,3689413,0.664737487618683,0.2040782586799871
YAPC,9907093,4.959151627500645,4.391191702215566
ONS-76,19582717,4.438276624405871,4.343789754646637
LoVo,446155,3.732759169917468,2.7912106953436178
G-401,5566,2.967754959970698,2.9132342754209577
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,0.3643398571362202
HSC-4,9884685,0.6492053944574516,0.9447575930957384
CA46,4788,4.772802977698259,5.026240865739465
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,2.923973415512421
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.694916638558235
Panc 04.03,6918837,-2.8853122799888085,-2.259322135558097
NCI-H460,71466380,4.4879606530616725,4.578603619608696
CA46,25183872,-1.226882585953409,-2.3619972539135747
NCI-H146,12001922,1.0892970499924846,1.5479850871676242
SBC-5,11625818,4.225517908096314,4.217470056240596
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,0.41810972376630673
LoVo,2708,4.2308362163689415,5.00952818735319
OVISE,72193861,4.281646205908775,1.9417809312108445
NCI-H460,16720766,0.8258921674033131,0.6886186663249476
LoVo,4378219,2.040258922351895,2.355433039370732
MSTO-211H,24901704,1.657456360567008,3.3857578193282314
A4/Fukuda,4477,0.5783674149898913,0.4217245828047693
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,3.20574158118156
CA46,107985,-3.181693098398671,-4.3427499802821306
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,1.1919702160069898
EFO-27,19582717,3.374407024388894,4.51531181716197
NCI-H1623,15953870,1.9962949386047493,3.541856259471777
FU-OV-1,46199207,3.737847668041784,3.3711847653408014
A2780,11213558,0.737897067491707,1.5422386947767124
NCI-H460,9926054,2.081701465030928,1.929469538737149
NCI-H460,11404337,1.7201854837770862,-0.1438155426415002
NCI-H2171,2749,1.9442537074322577,1.2299108712889346
HSC-4,49846579,1.975916395804951,2.1298075807078347
NCI-H2009,56963564,-0.2763231945711286,0.7384784244249993
Panc 04.03,3825829,5.002168928220905,4.268694404841111
HSC-4,5738263,3.918173826320675,3.476302403494027
MDA-MB-157,9926054,2.0716850398098368,2.161822212906303
OPM-2,50905018,4.056598853615348,3.706932948883004
BxPC-3,9915743,0.4274244099837221,0.4832738986922444
HSC-4,16725315,4.164866459292326,4.369201481539853
SCC-9,11175137,3.431057653368815,2.6839869361912077
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,4.190212899480404
NCI-H146,107985,-3.379993708562796,-3.5830417514539175
SNU-61,3689413,-2.128463404187725,-0.23731303440932652
KMRC-1,9903786,4.024109374851969,3.0763264101847927
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,1.351069264420397
SNU-61,73707386,3.625444775073466,2.872420802068949
ONS-76,11238147,3.0900457426442864,3.045837660004163
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,2.7712725237810196
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,1.0386575001145717
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.8560363523459673
OPM-2,44607531,0.9426576866563848,1.1204670849148097
BT-549,409805,3.826135579342285,4.89019831317227
G-401,6505803,-2.085126737120111,-1.3193470987919773
ONS-76,9866186,2.0020907987509657,0.9082252251296851
BT-549,1641662,3.5282995747020514,3.601635457991847
MSTO-211H,3384730,2.0695323326007387,2.963830609704625
NCI-H292,439501,-2.469830491210978,-2.159667706204495
NCI-H2009,11964036,0.3874991337590915,1.7534625344268893
Panc 04.03,9840324,5.85151623174837,5.95571210089147
NCI-H522,5311,1.356899837189567,1.1819964942517178
ONS-76,5311,1.4287655491580966,1.5796548264407562
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,0.1301181914047402
EFO-27,24775005,4.127014722833266,4.138952403926001
NCI-H460,5278396,3.885794996406102,3.7246174515255914
NCI-H2009,23725625,3.8804106674125713,5.31791208823963
NCI-H146,25102847,3.053262776547781,2.1707185840261554
JM-1,11396600,1.6173586604508372,2.758647513574522
SBC-5,168312962,-2.5718885882949896,1.905059143564531
DMS 273,46215462,1.755765775691153,1.780788130628625
YAPC,107985,-3.02393363080246,-3.450560147257633
KYSE-70,5566,3.0340425256076813,2.8941035936997603
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,4.1804646311800475
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.5508645131848726
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,0.19535236800424394
CAL-51,11404337,-1.4033364127444676,-0.43758271569701335
A4/Fukuda,25183872,-2.565081518812491,-1.9568274670924088
SNU-61,3815108,2.973673139417603,2.9675301938556813
KYSE-70,11507802,1.463595053056406,1.8244957552357426
A2780,10296883,3.5268945611299927,3.749649338528897
FTC-133,24797083,1.5806228477994335,1.4944192326160033
MDA-MB-157,122327,5.563359607134461,4.924108070800816
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,0.7593760517159106
NCI-H146,4378219,1.8118272794434884,2.5913225938487034
SNU-81,54143018,-0.9079963072010888,0.31831499014783443
NCI-H2009,49850262,3.4451640543988233,3.95465034405108
KMRC-1,54143018,1.481383467839363,0.7921620662946585
NCI-H522,11507802,0.900021964921284,1.1401090431223606
A2780,6438330,0.9178294762259074,1.7489638081867256
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,2.746459503921264
SW1463,82146,3.98984472956996,3.613787655642335
BxPC-3,135984461,1.8776729747018608,3.8562589333919903
NCI-H2171,56946209,-6.55665845628197,-4.09225224903886
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,2.184308205280732
HCC1143,54619267,5.25191473393144,4.243435743009747
NCI-H2171,46907787,0.7633638606493435,1.45453727961091
NCI-H1623,216468,3.833399887526913,3.0398509371665505
MDA-MB-453,9803433,3.6839578739817935,4.32556647596438
SCC-9,11955716,-2.333323067647372,-1.331288658635686
A4/Fukuda,54619267,3.184419267966046,3.7371774386409853
KYSE-70,387447,-2.8804562370412765,-3.549955954543168
FTC-133,135398744,6.510037604259866,6.472968578369067
CA46,2842253,3.7037662444842696,4.30481103757729
BT-549,12001922,2.460799936977109,1.9941807872700616
LoVo,107970,2.0597080136849795,2.2391448918961045
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.278246320758556
CAL-51,3385,3.064238699960593,4.220660201991997
CAL-51,375860,-0.3577134594482877,-0.07477124983023478
OPM-2,3025944,3.8735985412418943,3.7901226788244786
NCI-H522,53325874,4.347038439567835,4.1502652221034335
MSTO-211H,216239,0.7405720543436254,2.3633161824452515
CAL-51,9868037,3.5441777448678615,3.0628983655170505
A-673,49836020,4.096681472773702,3.001536023958289
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,2.9695983065693485
LoVo,49836020,1.6927786584323,3.2213620983193327
OPM-2,5291,3.3293230980723254,2.896951932983816
LOU-NH91,9884685,4.047485572984955,1.0667013190671324
HSC-4,36462,0.7755986988683452,2.1215938032744934
SNU-61,46907787,2.0753699666277936,1.3387602837277093
NCI-H522,5951923,5.621144710124551,4.688130335754252
SBC-5,445091,4.3721050746953845,4.406891104504809
MSTO-211H,6252,0.7966303392140095,1.4476889237362354
MSTO-211H,6610355,3.5448971464264507,4.747395380536194
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,1.933729343973246
CAL-51,15953870,3.220977372988981,3.658508408404919
NCI-H460,25150857,3.536831166282903,2.4962908009307805
DMS 273,3854666,0.530051590236263,1.3228032599279829
LXF 289,9825149,1.6285560242869113,2.4389454585167014
NCI-H522,67156097,-2.1513446238308656,-1.2486905063021063
MSTO-211H,3062316,0.3213577633457804,1.358352006470634
LXF 289,11485656,2.2610473771175847,2.609025717198979
BT-549,4477,0.6326595549350394,0.4264625532200362
NCI-H2009,54454,1.843451372115344,2.621310307959986
SNU-449,16013152,4.866412327860677,4.284719889773615
SBC-5,16115403,-4.662279180425711,-3.847588143115514
A2780,2842253,3.957240977141399,4.687506643586725
MSTO-211H,135398516,-0.6247457561994184,2.245364021209044
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,-0.6628883893307657
YAPC,702558,5.05880400043124,5.445474094116454
MDA-MB-453,409805,5.496183153122164,4.789936810255263
G-401,25161177,2.410029759496817,3.72322617469609
A4/Fukuda,3025944,3.254701794903189,4.036434785619473
NOMO-1,126941,-2.339513844414448,-3.641147809449417
FU-OV-1,159324,3.7929038817112746,2.774996969514481
MSTO-211H,2113511,3.4014041807223228,5.703891339614201
A4/Fukuda,1242560,1.4412010240031818,2.9299962393477923
OPM-2,327653,2.4944005218311984,2.858010175112732
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,-0.6874913735446725
KYSE-70,46398810,2.5990171625416916,2.4957749448915423
MSTO-211H,44486219,3.5621328730435216,4.447790727526024
MDA-MB-453,6450551,2.407686053683273,2.5412390935202085
A4/Fukuda,24180719,2.900503133545593,3.3405747252519715
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.4952708251548779
A4/Fukuda,11234052,3.83864189929063,3.343062328553317
ONS-76,10231331,-2.145918525616272,2.1148910723760608
JM-1,11656518,1.5501827619920003,0.5330491612179236
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,0.5359045216240916
EFO-27,16741245,5.191473652546265,4.186468926263807
DMS 273,216468,1.1199955960897896,1.7318768703687897
MSTO-211H,3689413,-2.1873545800685865,-0.19331374418579828
NCI-H727,10074640,3.0722260002613697,3.2064570123601492
BxPC-3,66577038,2.7392816080167117,3.024405641895777
OPM-2,44489675,4.196628172603179,3.466115838636286
A-673,1239801,2.654695998337671,3.6635044565076655
G-401,9444,5.739332402240228,3.995262463498216
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,-1.3131324111457514
KYSE-70,71466380,5.08916461895765,4.594713234242611
NCI-H460,3025944,5.476008686130055,4.263222124073339
OPM-2,375860,-0.7230228450862618,-0.4482274893060116
G-401,262093,2.911602765721858,2.2630726288481595
OPM-2,12001922,1.1641343868089369,1.6322925290888641
SCC-9,9903786,2.6448761987997917,3.172730676926057
YAPC,1750826,2.252131937951327,-0.7940056163119315
JM-1,9840324,5.823306366003189,5.361128905529364
SNU-61,4705,2.600761934037586,2.954503539906649
HCC1143,24821094,3.095995819095247,2.810044348240698
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,0.5253908380845028
HSC-4,15983966,0.1445652725334258,-0.626991365669057
MDA-MB-157,9887053,3.277628039368057,4.099324935412661
KYSE-70,969516,2.5944329315988552,2.820480374176501
CAL-51,135421197,1.6266864976107616,1.8637476799533197
LOU-NH91,11175137,1.9157928307161511,2.634835758659424
NCI-H661,168313047,3.0111797961595523,2.4524173617533624
Panc 04.03,16659841,4.736684370351261,4.182395331858811
KYSE-70,16720766,1.38091635176305,0.2855931428096187
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,2.528643924871471
NCI-H2009,9911463,4.220122302208283,3.9855752353013942
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,1.8649150496700484
MDA-MB-157,44491742,3.772080854170876,4.171340906709756
A-673,216239,1.7434495050319987,1.7720456793987323
MSTO-211H,9967941,1.8027522151796112,3.7749273647487693
YAPC,3815108,3.3369752363492315,3.2709699967650465
MSTO-211H,73707398,0.6990065379334892,1.5680979827670032
NCI-H727,4788,5.448581481072406,5.6579661954945335
A2780,9911830,1.8386970616579583,2.348501213313612
JM-1,3038522,1.6953465924304043,2.204173357031242
FTC-133,107985,-2.14591043360211,-3.370819729494224
NCI-H727,3503,3.7902677592538265,2.565783651124517
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,1.9540021623756672
KMRC-1,24771867,5.5206603877823275,2.123795818393206
KYSE-70,3634881,3.4536977245329363,3.327500030388961
SBC-5,119607,3.910029744126627,5.2629927120708855
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,2.2651587604424814
Panc 04.03,5329102,2.9853977590279075,2.2343004656194743
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,1.7959162865647014
A2780,9826308,-0.0101157672837292,-0.0014834843552526422
HSC-4,135440466,2.2202939224472655,2.2207712753160465
NCI-H727,6917907,-5.56846167215282,-3.7122192741663183
MDA-MB-157,123631,3.9412563374531864,2.3251996229633223
MSTO-211H,11640390,2.078497045728262,3.5033901489801713
OVISE,54649381,4.33420809644373,3.834607232641115
MDA-MB-157,9868037,3.2071579521245823,3.376896305421858
A4/Fukuda,67291369,-0.3870993856905487,1.3471687299068997
A4/Fukuda,10113978,1.900139268592958,2.4805583533725497
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,-1.1149900803682469
A2780,46199207,2.4758344041689093,3.055153493571038
NCI-H2009,151289,0.8401149520435854,1.443579356403254
DMS 273,4477,0.2378478748071137,0.4607857154655938
HCC1143,6852167,2.667487538311212,2.853935180812756
NCI-H460,5335621,5.645903220513178,4.640005302887452
NCI-H460,54613361,2.8642714411834502,0.3907744318189733
A2780,6852167,1.374383856311773,2.6604369334254274
SCC-9,11707110,2.5707994933885736,0.5796125421589852
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,2.0059210702702774
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,0.8558978221753086
EFO-27,6610355,3.735872349212987,4.654427910454717
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.9022142083115008
OPM-2,16038120,-1.581922980476964,0.17976643302465545
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,2.101347295273564
HCC1143,10410894,4.771687149558392,3.220056767182539
YAPC,54454,3.200830039856186,2.7880022621646314
DMS 273,6252,1.7538621935564394,0.1720026426481073
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,-0.9224301990427015
G-401,44491742,3.951665256591854,4.121307434587892
DMS 273,11625818,4.382645377089847,3.902909650910446
LOU-NH91,3503,2.9647844947930397,2.421032487468204
G-401,446155,3.2535633304842144,2.2994404143220772
DMS 273,675434,4.24768091674901,4.26554669306928
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,3.1474234221573725
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,0.7122404811029179
Panc 04.03,168313016,6.087789512449841,5.0308024734432415
NCI-H1623,24856436,0.944997546799197,0.43084721602254994
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,0.5818000195670505
LoVo,3025986,-0.1762115912359206,-0.7412198973559343
A-673,10184653,1.446453264453446,1.1996207683026479
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,2.193098511790343
LoVo,66577038,2.852951614414874,3.0385546496941918
NCI-H522,3136844,3.3827652175643577,4.160261948798323
A-673,3676137,4.749608800479587,4.310190153529001
SCC-9,409805,5.497565328609373,4.796859888936677
DMS 273,6918328,-1.955094157059326,-0.8145399216736555
LXF 289,4259181,0.8555931132792622,0.3333493158676748
OVISE,448949,2.233154508177948,1.9855295177424779
JM-1,675434,3.7844228868956296,3.9540178908428594
NCI-H292,5566,3.044146869319611,3.177076918745448
EFO-27,227681,1.958013080406725,3.357146086862027
EFO-27,65064,5.385038331959097,5.143227725973389
A-498,9907093,3.786767310891997,4.353243937295194
SNU-61,676352,2.4274144006766893,2.0859126771618404
MDA-MB-157,135421197,1.265960780615991,2.1173956299291823
NCI-H460,10074640,3.83137833519258,3.2251384771496507
BxPC-3,46199207,2.8626203608628416,3.1651371253782155
CAL-51,387447,-3.720200693098244,-4.25338280150768
NCI-H146,56946209,-6.937271673290349,-4.743793607410558
EFO-27,46907787,4.067144836646944,2.533025324763701
NCI-H292,2729026,2.9142630754738037,2.8084907524798552
LOU-NH91,1716436,1.3649900096390022,3.1074160119125933
KMRC-1,8515,4.713762602344707,3.756007863681516
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,1.9646429482933943
SNU-449,448949,1.5810053045793695,2.1442136339315447
SBC-5,4096211,1.588189246491771,1.9124292293615912
NCI-H661,26596,-0.5563822784391794,-1.43537787847596
A4/Fukuda,51037431,0.9928208538339424,3.0619932121549125
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,-1.0160592727905868
OVISE,5311,2.608797421965248,1.6055671168901273
A2780,11238147,1.47132390494783,2.56439431604884
NCI-H1623,676352,1.987229853680802,2.1991478806767675
Panc 04.03,126941,-1.1535511280443094,-2.510543414824808
NCI-H727,9926054,2.0492739470784445,2.0053491607250216
LoVo,65064,4.389937632551182,4.876159631692864
SNU-449,52947716,1.9936156354056855,0.36423279263643676
Panc 04.03,5351362,1.307383541492636,1.6948138056427846
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.101608413176957
NOMO-1,44493952,3.580250185381126,2.4788414947317845
A-498,676352,1.77005199556574,2.262999318365648
Panc 04.03,5280436,1.6844699655115762,3.545353740063679
CAL-51,16736978,0.375988055286384,1.432504476632845
MDA-MB-157,54618771,3.1146330047846877,1.192627686446183
NOMO-1,6450551,1.2307950565416117,1.2701526021114211
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,4.782313505103914
G-401,25105715,3.9034348367564258,3.1632225263567477
BxPC-3,151289,0.5689607060021993,1.269362396113162
NCI-H727,44543605,4.300237824274415,4.0081249065676845
SNU-81,2907,6.641268536629272,3.426549501890717
SNU-81,613753,2.2388707005796507,2.9502683695311624
JM-1,168312962,1.22629450044224,0.5482387397911777
LOU-NH91,168313200,3.810508485111527,3.0962390718807042
NCI-H146,3854666,1.3221451848305394,1.3938450516832572
KYSE-70,322968,3.381611542483835,3.321327360265063
ONS-76,241158,4.846225597872182,3.6977999175647756
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,3.090635904347025
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,1.0004861954861641
CAL-51,5291,4.8235616489491635,3.8410765407675935
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,-1.8144197194707774
MDA-MB-453,168313016,4.163913885489913,4.5685589483221225
A-498,60700,2.2087582051541257,0.4161899235957803
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,4.946092123339504
HSC-4,6918878,5.2813290465493505,2.783269698815389
MDA-MB-453,9884685,-1.4419247946131482,0.9072204356925201
A2780,2746,1.939184711313242,2.6482964347421545
NCI-H661,148198,-4.235070372495308,-4.106017503216486
HSC-4,54678924,3.092091974621669,2.3224398358873826
A-673,2113511,4.0082027727586,5.253393710003674
A4/Fukuda,5287620,-3.30087759062066,-2.1574006892969995
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,2.5944680263125988
LOU-NH91,6918328,0.1478473020386815,0.13140429554929556
BxPC-3,3385,3.820290029267426,3.972582078207083
MDA-MB-453,44185566,2.487729821066063,2.3735037477709944
LXF 289,46907787,-0.1426698074457199,2.306023687832264
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,1.8785639241296679
EFO-27,9887053,4.025142225668377,4.329550323232873
BxPC-3,4259181,0.1397018777458316,0.42777669806267116
SCC-9,10184653,-0.319006591471168,1.3394207410730998
SNU-449,53232,1.6560937312011326,2.78446293157098
BxPC-3,53232,2.859321527409702,2.7900525598152286
NCI-H460,71304818,2.359856693071434,2.489323630607738
NCI-H2009,11178236,-2.605718631753464,-3.5463329026153945
FU-OV-1,400769,0.1189863997269066,-0.6214970762499463
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,3.5769902129824986
FTC-133,72376,-0.3430893294901544,-1.2697289040312412
LOU-NH91,2858523,2.98680776080117,3.190367460071162
LoVo,6918837,-3.586713596901602,-2.764570742161003
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,3.2702867395366586
CAL-51,6918837,-3.0563476396929703,-2.7818790073396036
NCI-H292,676352,2.616071543582294,2.166679081311804
NCI-H522,11626560,2.464867345362881,1.361087139986352
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,-1.516435074366204
A-673,11167602,2.442600782118551,1.9120094838239161
OPM-2,11222830,0.0961911151739945,1.1530651412114283
A4/Fukuda,7251185,1.076285820033946,2.105925233758344
OPM-2,24978538,1.9225155298388676,-0.7672032622875059
CAL-51,135411,0.595745817277345,0.6096299393256638
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,3.446491681952549
HSC-4,3025986,-1.9523671858491285,-0.7768453339688847
BT-549,54618771,1.4883156908959423,1.2856719909487506
DMS 273,1239801,5.369367906855259,3.7604801453740326
SNU-449,374536,4.370390285639732,2.5196308578819697
MDA-MB-157,168313016,4.249309770188466,4.959777748997509
NCI-H522,446155,3.2752737209903504,2.7323242512270487
BxPC-3,9935249,3.9268263105803727,3.18079632404477
A2780,16725315,3.2354385253964253,3.779238638801954
NCI-H522,11647372,2.460433695225771,0.7475671798168558
MDA-MB-157,3689413,-1.567220624306923,-0.18230902756708478
NOMO-1,36314,1.6795260413615891,-1.8158131040722294
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.2663697800056821
ONS-76,46199207,3.062888044588984,3.2677691360717067
HSC-4,2746,3.845189406581069,3.1849690717860697
A-673,126941,-4.88778992999732,-3.2447827125556086
A4/Fukuda,2874250,4.0164309105299685,4.179808130280304
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,0.9655461544481967
Panc 04.03,3136844,4.698465140769799,4.370221181641383
KYSE-70,53232,3.7067207893488017,2.8420294275234657
CAL-51,24180125,2.8082301472193203,2.9850196438437937
Panc 04.03,9884685,1.6842032304446288,1.2558215377045256
NCI-H460,11626560,2.497647926194901,1.6800240132608368
SNU-449,168312962,3.745202246753347,2.2291684195078014
HCC1143,9935249,3.8757786370374303,3.2428133787373308
SNU-449,613753,3.229445182846538,3.231207847643525
OPM-2,44491742,3.727542800888903,3.9308309519873808
KYSE-70,9936388,-4.915846401119174,-0.7462738019738633
CAL-51,654092,0.82886283906252,-0.14203711228837426
SBC-5,448949,2.9920694717704204,1.9292905220447087
OPM-2,46843906,-0.5330027912440064,1.751046858766473
CAL-51,5566,3.271951139375183,3.170011342046573
KMRC-1,53232,3.79650380515527,2.8568060204406525
CAL-51,11228183,3.6770505489909007,2.0936953153028046
SW1463,24785538,0.6322996420886741,1.1307662462653842
A4/Fukuda,119182,-4.160589878424858,-2.193874057439465
A-498,107970,3.0044685679861054,2.5147730466905474
CAL-51,11612883,1.9359641259018452,2.8374976556218616
A-498,11317348,4.2355090436144875,2.8398739201468874
LoVo,67291369,1.4516021942624118,2.4664933502707744
A2780,11222830,0.6433638933511314,1.2761156978106667
BxPC-3,241158,3.755569293331497,3.8701592525798656
SCC-9,6610216,4.4695629784882795,4.298881932248481
CAL-51,374536,3.1977545561189347,2.363016659873971
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,2.3175167542304655
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,-0.650273283032614
SNU-449,72376,1.1438392823146497,-1.3877910798029098
A-673,4259181,-0.6373852614685119,-0.004679416523506975
DMS 273,168313200,2.725135044490621,2.863464790243003
NCI-H460,9911463,4.421747687015995,3.7447608274265405
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,4.057044593476132
YAPC,119182,-1.6155541294016968,-0.7629341995802325
SBC-5,6184667,2.5027552360756946,2.911749557915813
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.5776887231602106
G-401,2858523,3.0226653633513,2.7604749204676775
MDA-MB-157,10184653,0.5581112583171038,1.3362397936350512
A4/Fukuda,19582717,0.7629696429231957,3.178967739791795
NCI-H460,53392493,4.733063337287369,2.620449530211525
OPM-2,72193861,0.7906161175639799,0.557986599638456
NCI-H146,44491742,2.6808030102351323,3.8108221287569144
NOMO-1,46398810,2.1682472320454504,1.6162474804082243
DMS 273,16736978,0.9096800466601204,1.33537974460321
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,2.095509299633049
CAL-51,16741245,4.222373420591208,4.141716038473168
MDA-MB-157,10074640,3.629475203970288,3.1922784022397956
SNU-449,2828334,6.138780539354761,6.172725158409129
HSC-4,9823820,4.434899642824078,4.081868787061156
A-673,11238147,1.6374380314183412,2.258414042739326
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,3.995701906098785
A4/Fukuda,4915,4.811112690158961,3.1661158391964013
JM-1,42642645,-0.9084434189288264,0.0868228176048685
MDA-MB-157,3854666,0.668628762558335,2.1229789614855594
SBC-5,2841722,4.592516057239796,4.0850613553291915
BxPC-3,2742550,6.208235416241253,3.9741301875843673
NCI-H2171,168313200,1.615164123973231,2.649730671983771
LOU-NH91,46843906,2.60442098689998,3.320616001238047
DMS 273,54619267,3.628421853226673,3.573762360994152
CAL-51,16725315,3.2794500362302,4.144647023966337
MDA-MB-157,10127622,3.2546864424502076,3.8589214952539987
NCI-H2171,16725315,3.053630151756443,3.6758925815403902
SCC-9,9935249,4.690276947265519,3.3827316053218435
NCI-H460,44507138,4.578042897326484,2.9250153234649825
NCI-H1623,5282054,3.865413044747809,3.4875322063231016
HCC1143,984333,-0.0539665216618622,0.8148431837312061
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,2.985816264277545
MDA-MB-453,9840324,6.873328025428986,5.666548798880423
Panc 04.03,176870,4.897846724128431,3.450292292693781
NOMO-1,11640390,1.5691640408186416,2.7210267478052943
Panc 04.03,409805,5.536204895331733,5.1222969777443845
MSTO-211H,71466445,2.2675767772231024,4.337932393652696
NCI-H2171,9915743,0.832341910278816,0.9774562405168412
A4/Fukuda,5281672,3.917758560865086,4.008726915567958
LXF 289,11427553,2.4541082171467368,2.711012154393807
Panc 04.03,7251185,3.2944683029692237,2.744741026673428
NCI-H522,9933475,1.020852520604034,1.8123164855906015
JM-1,24180719,3.5833576580940005,3.0288852233466743
SCC-9,15953870,4.1491811794097995,3.4780550476240366
Panc 04.03,56946209,-4.443392589569815,-4.03737965967132
BT-549,6918837,-1.3661230802503712,-2.330372509213013
ONS-76,56946209,-3.559106939272703,-3.7861422090227053
OVISE,44507138,4.185704551553473,2.5963327427182152
NCI-H292,441298,3.4530013870499037,2.6836124810715547
EFO-27,374536,3.468329704237433,2.5225006208175618
NCI-H292,568763,1.0095796953036382,0.551399949822122
NCI-H522,122327,3.7548997428021904,4.7771888627402666
FTC-133,409805,6.0297974484260655,5.027166828764405
KMRC-1,3384730,3.706671423221143,2.955216945046737
HSC-4,5351362,1.6988999536887646,1.4604681186367607
BT-549,448949,1.6914375683866394,2.1756525815812258
JM-1,753704,3.307600856766594,4.0921565650520115
CAL-51,25195348,5.6667768045179905,3.197913227347061
CAL-51,3025986,-1.0834382414923172,-0.8935573064836082
HCC1143,15547703,3.062266000318877,3.2706455869746636
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,2.2375791895052424
CAL-51,135999136,4.2132345103647015,3.9564771830509726
ONS-76,55283,0.3588409196586273,2.746583280378671
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.1435592512986386
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,2.331410316917618
SW1463,25262965,-1.5690747748042335,-1.4995571869475812
FTC-133,241158,4.091507154193835,4.006986002044208
KMRC-1,23582824,0.9449566223543509,0.9459084639582851
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,0.9228593148334867
FU-OV-1,16013152,4.2048953133679765,4.472267221664481
MDA-MB-453,613000,0.0740651651217389,2.5059270821210697
MDA-MB-157,24797083,0.6098010922803769,1.550785824287101
NCI-H460,10074640,3.83137833519258,3.2251384771496507
CAL-51,16722836,0.8083581946159574,1.4887511033073377
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,1.7354333486049234
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,2.3701596302743213
G-401,10322450,4.220475308231234,3.714695478473004
G-401,15983966,-4.354524639754001,-2.506431230747475
CA46,9887053,1.048475441216289,2.411534392495323
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,4.570593856235884
NCI-H1623,11152667,-0.7587975819891684,-0.3043058620781734
HSC-4,11609586,5.018303752842559,2.897436448076502
OPM-2,67156097,-3.031514601372161,-1.951384503329264
G-401,984333,0.0612358592539302,0.16513059833775062
LXF 289,9908783,5.689655754809611,4.981443182858552
SCC-9,5329102,2.2394800798474677,2.183708601231523
NCI-H661,17759555,2.3282310316349935,3.6241908741863553
LXF 289,24856436,0.8419130403195528,0.4897476912594214
SBC-5,159324,3.4028835437957112,2.197973430753029
JM-1,6184667,1.7187669889057045,2.39396245012837
MDA-MB-157,11396600,3.7386973485738424,3.7073200495082586
BxPC-3,216239,2.4917493719892274,2.390364981760803
MDA-MB-453,72193861,1.6700607918257404,1.3613245505736324
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,2.3512612697305353
KMRC-1,9915743,1.4003501061845525,0.5559151160474936
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.6166950542018201
A-673,12001922,0.9671300191794728,1.6274848293040762
A-673,1323703,5.495685082034704,3.550328346411785
SCC-9,2729026,3.0647326637868573,2.623429939359823
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.8356546608765039
NCI-H2171,3503,1.152076889590999,1.843107191376738
JM-1,252682,6.042634536055517,6.2554445216499355
CA46,44137675,2.206940954689562,2.612767369272076
CAL-51,11152667,-1.203722258692511,-0.6401878678496038
LXF 289,135984461,4.539632657840611,4.034449901067512
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,-3.1500260581386863
SW1463,11507802,1.438199099446833,1.5732244411106473
BxPC-3,25062766,1.590701824067561,2.1984018614917
EFO-27,45279963,4.232301991437958,3.894281565835779
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,2.0053616367296736
NCI-H2009,42642645,0.1491359953679814,1.0964134994440244
FTC-133,53495165,1.6157050027500164,0.8236707589924659
NCI-H292,11640390,3.2514062698758015,3.799684732191356
A-673,135423438,2.29660224903782,1.5480140385082775
SBC-5,9911830,3.21689826570876,2.387129230301929
MDA-MB-157,36314,-4.695989096441824,-0.21327171075822757
NCI-H1623,5328940,1.639592653942716,1.7111373642310483
SNU-61,135999136,5.618921387112628,3.858970163640771
CAL-51,25102847,1.94226811064499,2.177346251693562
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,2.3484247127879927
A2780,68056272,2.2410901197134923,2.909379263978922
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.5601692117217754
KYSE-70,24856436,0.5719980221753466,0.16087320188821694
CAL-51,46398810,2.084696284876613,2.608348354949426
NCI-H661,16720766,3.873672796747104,0.6785629822158568
LXF 289,11234052,4.719623128458786,4.301657936626655
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,3.7359208373423964
MSTO-211H,107970,1.929708493397844,2.3658334232143052
MDA-MB-453,9929138,5.862527790185705,5.292104806881313
G-401,285033,-4.902412101243927,-2.814035587847394
OPM-2,6852167,1.7172653102666242,1.7261119779832732
EFO-27,11228183,3.371245966973651,2.5670035345014326
CAL-51,17759555,3.5733302595078182,3.5629013301281565
SCC-9,24785538,2.4612574042553432,1.7240834962675908
KMRC-1,11364421,1.724167601186248,-1.5288392265658381
MDA-MB-453,24748573,1.9919110400088051,2.003103286395009
EFO-27,5460769,4.47484627366887,3.2279712931631668
HCC1143,49850262,3.2153342375189533,3.8777236540259135
Panc 04.03,66577038,3.1738099516277667,3.0344034136163147
NCI-H661,11238147,3.129195095759777,2.9849707101741836
SNU-61,6623618,1.73773822434396,1.946025574959134
EFO-27,16720766,3.656433318818957,0.8297901011385194
BxPC-3,969516,1.4378873066513898,2.7617999505709667
JM-1,54596558,3.768195826371459,3.9872357328685406
LOU-NH91,5738263,3.7277759973822726,3.471807554431929
JM-1,25183872,-4.29494207596009,-2.324991897642916
NCI-H292,89928392,1.456532385863884,1.6832316070213176
NCI-H460,119607,4.735621464768821,5.42659845741658
NCI-H460,322968,5.369771337760045,4.224224004430472
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,1.6523973479439065
CAL-51,9907093,3.7886359098281783,4.261311921371366
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,4.799953458044123
LoVo,123631,1.2882244486240189,2.1928849538338686
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,2.0475075115069687
MDA-MB-453,15983966,1.8434310309669164,-1.4296287135526837
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,3.513125335199083
HCC1143,135440466,2.588436572703006,2.462124040054675
NCI-H146,9926054,1.7480459470636802,1.7241171317837887
KMRC-1,5278396,3.6212610119500783,3.6083880194558646
A2780,46191454,-1.192769752942619,1.4482750746313633
A4/Fukuda,25062766,1.3929374396347198,1.7825284511572992
NCI-H292,53232,1.814131755875953,2.8619828720468634
ONS-76,24771867,4.286887453999452,2.3837862491945216
FU-OV-1,31703,-1.7023718917237094,-0.5630757955461896
A4/Fukuda,66577038,2.118562328013949,2.697577978761837
NOMO-1,445455,4.303833401854377,3.9619890689182453
NCI-H2009,12003241,-1.6852069192913937,-0.7459629476035592
LXF 289,42642645,0.485507292149712,1.082343347737032
NOMO-1,46199207,2.5514936314753434,2.7252743803162423
NCI-H460,322968,5.369771337760045,4.224224004430472
Panc 04.03,5328940,2.517395347800957,1.7985171648576972
SNU-61,9936388,-6.308071034865157,-1.8129398761460096
LoVo,4261,-0.8211989197292223,1.4363172365492283
A2780,136227924,2.141563547945887,2.6339642675792643
DMS 273,11175137,1.5448586489611442,2.393404536463895
LoVo,44202524,1.5416570481285088,2.347034441840124
HCC1143,9907093,3.794716934303189,4.20612661742956
NCI-H292,6610216,4.846288432835765,4.366244760578743
BxPC-3,11178236,-3.5754762678880567,-3.5431182867616866
MDA-MB-453,5978,-2.563797038396111,-1.8257378229130135
NCI-H146,5460769,1.8747395178404,2.671187322273381
CA46,11238147,1.5462987380530164,1.9409077566255732
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,2.1745786456356275
LoVo,2828334,5.515630519838643,6.17507664091068
KMRC-1,5287969,-1.8174868244268352,-1.6592458475772383
NCI-H460,676352,2.985829219207002,2.1895477134693566
SNU-61,23635314,-2.2430318809352556,-1.3266635550488997
NCI-H460,11612883,2.88158995470921,2.8770692737257195
HCC1143,24951314,0.9489239510798212,1.386949581291532
OVISE,387447,-4.037756707187744,-3.725903693755373
JM-1,568763,-0.4685251193741573,-0.39320760329407456
SNU-449,9907093,4.078651849005814,4.311709858925949
BT-549,53392493,1.9491955503491856,2.82025248050669
MSTO-211H,24180719,1.9210037149309027,3.4903140781806776
NCI-H1623,23635314,-3.504391783968502,-1.4466833973759248
MDA-MB-157,135875424,2.7117106005077276,3.748815392033829
NCI-H661,54678924,1.9600004323573317,2.249420025173548
DMS 273,25105715,3.6490952941772496,3.3298468331671027
NCI-H1623,216345,4.517328735854535,4.049631996128104
SNU-61,5282054,3.0015154117441996,3.5218819194033193
SNU-61,10302451,2.848073588995495,3.0208182442692104
CAL-51,16720766,0.5416929462446769,0.43653398879716193
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,2.5396551110174235
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,1.153257163877485
NCI-H522,46398810,2.2314734558486053,2.4811403182842513
JM-1,67156097,-2.627968736143573,-2.0141349768171506
LXF 289,60700,2.2902498510351528,0.027092361869951766
BxPC-3,2945648,3.219283504871713,2.968038017183646
A4/Fukuda,65064,3.1077716650538707,3.8180438723936705
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,-0.09637571784853456
BxPC-3,10077130,4.243605425717339,3.474625684156334
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,1.7169512606730921
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,1.6182494852889102
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,3.786563249819545
LoVo,168312962,0.7059894109575258,1.911641317665491
G-401,65064,5.209946412003188,4.078874985548731
NCI-H146,148198,-5.323171419653744,-3.7408230478701423
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,-0.37406747392678164
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,0.929008676996282
HCC1143,2746,1.9419289545652112,2.934306082973805
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,3.0757343487236404
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,-0.499694071548173
NCI-H2009,10385095,0.2451756361843044,1.6444808903225876
OPM-2,11167602,1.1745103577473592,1.6364443019428085
CAL-51,26596,-1.4638590943230956,-1.2800413976154477
NCI-H460,1716436,4.318712917611328,3.1192448005348785
ONS-76,71304818,2.469307822454373,2.4443580878320894
BxPC-3,11626560,1.2674200020854305,1.8927154359349345
CAL-51,104842,-3.020036586723177,-2.81842241286564
NCI-H460,49793307,0.4479933662320887,-2.9286787061801802
FTC-133,5284373,3.681008384459256,2.8637907248721506
SBC-5,11455910,0.8715920005264659,0.7816920281967961
MSTO-211H,49850262,3.597717946429448,3.8088743413129125
DMS 273,2871966,0.6484564569530932,0.20728051991034632
OPM-2,2729026,2.502425703285658,2.1735614902815428
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,0.6725779050127096
NCI-H292,9840324,5.8141064790381884,5.8617829557899
NCI-H661,375860,0.2037463104187888,0.022511385794480934
NOMO-1,6918328,-2.206625897840938,-1.3771607244421316
NCI-H522,54143018,0.2801073306793095,0.5326851072011121
OPM-2,23635314,-4.85335222903722,-2.52985677550859
NCI-H1623,1716436,2.729344651836522,2.7607396192863227
CA46,60700,-1.6899904219212585,-2.1864468665508987
SNU-81,10077130,-1.1742608263747976,2.973899605097776
MSTO-211H,9907093,3.5779290533064856,4.373992298249308
CA46,2126,3.4622152695614767,3.712736888632856
CAL-51,49766530,0.4609697007955676,-0.28970166450756824
CAL-51,6438330,3.884194225982375,2.252951110840969
KYSE-70,68056272,3.571583007543391,3.517763156192844
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.0876446399125619
EFO-27,68056272,3.9995237189063784,3.771164708552179
SCC-9,241158,3.962823581088113,4.17470538234819
NOMO-1,5746,1.3002002606442051,-0.6089196863086105
MSTO-211H,44202524,1.4972222665959742,2.441741173211195
NCI-H727,49793307,-2.322611372156632,-2.4552740613372257
NCI-H146,4578,4.154543455900732,4.398615103855462
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,0.6836483966346824
LoVo,107985,-3.583734032756361,-3.3732317471962903
YAPC,984333,0.9591784056691972,0.9147316541528361
SW1463,1750826,-6.63000221324875,-0.8461544232127781
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,2.0317400989450642
HSC-4,9866186,0.7177643600632182,1.0711339815948575
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,-1.0882955795888982
ONS-76,135398516,1.9151603507117831,2.1301392881072716
LoVo,11964036,-0.4950100771581299,1.0817718963260587
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.763544368663541
CAL-51,11964036,0.7531640395115359,1.1339419569640925
SBC-5,5328940,3.016318294707136,1.6884228670223123
SNU-61,9444,4.091366887299019,4.166773933484377
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,2.606011210633274
A2780,676352,1.788840905955693,1.9235628190695482
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,0.8750618968380364
JM-1,7251185,0.7253388444333596,1.6504513364584938
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,1.0246294549349884
NCI-H460,52947716,-4.997624319891589,-0.729086803058269
NCI-H2009,6505803,-0.1719772058921901,-0.5607193056055049
OVISE,25126798,4.262747569123806,3.968796001350208
G-401,54678924,1.6253720221899297,1.5626452863762847
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,3.215589159082936
A2780,135421197,1.3895584306244824,1.7077289115444423
EFO-27,25126798,3.692256603979053,3.9233279088859825
DMS 273,73707398,1.2764695344106731,0.8488717303384119
MSTO-211H,10296883,3.6762481855456985,3.880912058938407
LOU-NH91,60700,-0.2604526525302556,-0.02645488206312714
Panc 04.03,8515,4.900392472396633,3.9748647381091398
A4/Fukuda,216345,2.739557201577506,3.411988086115976
A-673,24978538,2.0217931845087596,-0.693191599974716
SBC-5,11152667,-0.3838978082878119,-0.3443358100576973
NCI-H460,15983966,-0.5601417251503862,-1.2794061885057932
EFO-27,400769,-0.0834796845468066,-0.5452455446722615
YAPC,2858523,3.168058012530131,3.110162061698511
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,1.7022427951508745
NCI-H2171,227681,1.8296199533038344,2.94009919213097
NCI-H460,11455910,1.4134750909778395,1.0418964190018558
G-401,44566777,-0.9568944013200004,0.4279974358359432
NCI-H292,5328940,1.2067364026743148,1.8354027138253135
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,0.9782279632586056
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.567405319817271
JM-1,25154868,2.919888649987432,3.8309053195851703
LoVo,44185566,1.1715497148164364,2.384073532873718
ONS-76,54618164,4.167815792355048,4.228785243286969
NOMO-1,151289,1.0922355572005962,0.34094663057840824
G-401,44493528,4.310857122389352,4.198637833342578
KYSE-70,89928392,5.113782206339635,1.5379702122644374
NCI-H661,89928392,1.5970967591597882,1.5200111155559477
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,-2.8412741835570396
KMRC-1,3503,2.6706031423305845,2.460831173586084
G-401,11455910,1.3171347053017213,0.5223492377947275
SNU-449,208908,2.01293579360495,2.4658581628753966
G-401,57519531,1.5783303012871783,2.127652161895771
MDA-MB-453,11427553,2.8599395215861567,2.63032485747857
LOU-NH91,241158,4.097895358021133,4.029105823446101
G-401,24951314,0.7541386929645643,0.8787609356863249
MDA-MB-453,208908,1.869724740513474,2.052503997648168
YAPC,46398810,3.0625661294812216,2.5385461918565007
LOU-NH91,1750826,-0.8784962447018205,-1.48111079648762
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,0.6395929010828496
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,2.351524849861392
MDA-MB-157,100016,3.517936084480814,6.294302649799159
HCC1143,60750,-4.413462787403808,-1.6004375721056028
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,4.3891549062418695
HCC1143,159324,3.533344711636858,3.022092320333782
JM-1,1750826,-4.271139507623605,-2.801507233984196
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,0.27730660748056785
A-673,11396600,2.723776149104898,3.305527126597281
NCI-H1623,24964624,2.070631930148384,2.4858704212407288
MDA-MB-453,104842,-3.389911854354977,-2.762789409848722
SNU-81,49793307,-4.215972202332142,-2.9563117762305353
A4/Fukuda,54618164,3.3817410387547575,3.7608492820405717
NCI-H2171,26596,-1.7584148860978708,-1.9269739467571108
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,1.7193270677503525
ONS-76,676352,2.5309673509494535,2.21691029057563
SCC-9,4378219,1.9931327421657885,2.867203052073423
CAL-51,613753,3.3238399640193177,3.2379722847476984
Panc 04.03,49867926,4.237506736984018,4.261701954189248
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,5.196136008849335
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,2.0776988544772848
MSTO-211H,3543504,4.118160915221066,4.561045898109219
NCI-H460,6252,1.4342703041264255,0.9082477742148163
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,-0.7876376502393498
NCI-H727,3825829,4.725008182252989,3.976522111175283
OPM-2,119182,-0.8289962289267476,-1.771553520799628
LoVo,54613361,-1.4267659732177436,0.07427198189622776
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,1.9273809517645868
A4/Fukuda,126941,-4.18863393868508,-3.1241434172508837
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,-1.693539666854912
NCI-H460,136227924,3.925006850615035,2.939149345773478
NCI-H727,3136844,6.195563862298742,4.28478445220663
MDA-MB-453,136227924,2.410345496671846,2.5234182603640574
SNU-61,51037431,3.7250627983577513,3.165702938278298
SNU-61,3384730,2.3184170398790154,2.7229360708513126
Panc 04.03,24753719,4.39873379823384,4.336412262390912
SNU-81,5978,-4.726956734092058,-1.929679398873602
SNU-61,9967941,2.1294940171884043,3.490009444386477
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,2.4560262669249444
ONS-76,5470400,1.68546701619173,-0.2051280526156994
JM-1,52912189,-1.1165299764243126,0.48603950631812237
NOMO-1,52947716,-3.339302012338735,-3.0988889973303997
JM-1,26596,-2.491901301923365,-2.3489757587451865
NCI-H661,445455,5.2176896422295025,4.781354397444256
SBC-5,216468,3.330480208625043,2.528227379160046
NCI-H292,5311,1.7806932533505695,1.5818510944957527
Panc 04.03,9935249,3.3873751996630177,3.406065194150118
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,-0.8888970288491865
CA46,25262965,-5.196703638661911,-2.6966491406144772
NCI-H460,11626560,2.497647926194901,1.6800240132608368
CAL-51,54686904,4.850424917483252,3.756315688828634
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,1.3127222579241686
NCI-H2171,6918328,-2.9240080597430813,-0.860235840737667
CAL-51,3825829,3.9510679995615257,4.049416534570776
SNU-61,65064,4.771880102821997,4.661442170448063
CAL-51,124202324,2.033990287468598,2.4246092619449446
NCI-H1623,11494412,1.2552972437851018,2.0558123646386814
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,-0.28665577640981094
JM-1,135398516,1.8505892369708832,1.3089504803421537
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,3.8405393719219827
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,2.734204267027336
LoVo,1641662,3.111662868893329,3.316864337703301
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.1150160891140286
HCC1143,24856436,0.4052757500096688,0.48514406781325126
YAPC,73707398,1.1307339717786768,1.416807684068466
FU-OV-1,24771867,2.3744516407985485,2.336008810273826
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,1.976481454295224
SNU-61,2749,1.958913212534665,1.5481634076032709
CAL-51,20959075,-3.1196535578382987,-3.116876706364544
A-673,6918878,1.2344260030899934,1.3562746244799662
LOU-NH91,73707398,1.1540810865513749,1.4422856091770877
NCI-H2171,107985,-3.896160678794096,-3.7074330614961775
KYSE-70,12003241,-1.4257688129039825,-1.1883127330446346
MDA-MB-453,10296883,4.2989687155614735,3.781369350144887
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,1.9943327321463147
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,0.9565233739694814
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.2503591565101693
NCI-H661,4259181,-1.4326329693308524,0.2839844012965082
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,4.292022708159705
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,0.5564332909119949
SCC-9,25183872,-1.5689686359020558,-0.45192621579691805
NCI-H727,6438394,3.7246032061112553,3.206261970129633
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.9920668897035574
Panc 04.03,9911463,4.4327726522455855,4.039975615518187
ONS-76,2733487,6.718347537986806,6.070477625685657
MDA-MB-453,25062766,1.9156877669914651,2.0967851267657154
NCI-H1623,36314,1.7259264714185265,-0.596305792036372
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,3.6870690082598516
MDA-MB-453,11234052,3.3366002038414493,3.7802172809712857
NCI-H661,54143018,-0.94518686271758,0.339662215750971
NOMO-1,72376,-3.881755374018637,-3.4277775196580063
NCI-H1623,104842,-3.8091356035642434,-2.662403839036381
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.3949714233135126
JM-1,71466445,1.831003524042788,2.297336427287915
EFO-27,49766530,-2.657964166176686,-0.16522639079459578
NCI-H661,753704,5.093119647973415,4.794814939419847
OPM-2,11175137,1.4890519960627426,1.9220952202727528
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,1.8039804815559615
A4/Fukuda,5746,-1.1009867615741116,0.2266220709077751
SNU-449,44489675,3.6193477306301927,4.021726327552839
NCI-H661,12001922,2.629031416850278,1.9805572849247666
DMS 273,11640390,3.3173332454053717,3.1601803922262017
SNU-449,4259181,0.6587440570439733,0.2739770887796295
EFO-27,24964624,2.939505532014586,2.7014193025931514
LoVo,4096211,0.5868958804653562,2.1468760957221904
A2780,2841722,4.258280317113099,4.078965762127445
CAL-51,24771867,-0.5018492111736887,2.019776313532286
G-401,46907787,-0.0293884143124787,0.9681665817087527
JM-1,24772860,-4.004711239665373,-2.8457877415209016
MDA-MB-453,71680916,4.8348560692055695,4.746379124330371
JM-1,11507802,0.223918960474334,0.5756402694371254
A-673,462382,-0.040658639847304,0.24563561510993895
NCI-H661,216345,4.176204855685743,3.7409237178102357
BxPC-3,9907093,4.5613416209155755,4.278861657932041
HSC-4,216468,2.5769925673594227,3.0861543431190976
NOMO-1,60700,-1.0021705320646457,-1.7008824277175825
YAPC,11455910,1.8317787914833017,1.3149507612656963
SNU-449,11175137,3.183352091664916,2.764932662074341
A2780,2113511,4.588817591987419,5.3699030456821895
NCI-H146,613753,2.6314812615131222,2.865013741839892
SNU-81,10231331,-2.370371712203436,0.9030034815549469
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,-4.337642258692624
NCI-H661,168313016,5.326553105852446,5.008082394141148
CAL-51,25126798,3.926975819986009,3.7558652917838002
Panc 04.03,1716436,3.048029385411991,3.0678179864374915
EFO-27,11625818,4.615590718074381,4.752904691070821
A-498,44495899,4.223152889477574,3.6425083906222664
A2780,3825829,2.5427924978442467,3.7682085061660864
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,4.444766965297225
NCI-H1623,2858523,3.2758661507497115,3.1414005037248813
A-673,49793307,-5.444897343264971,-3.4137621166534013
MDA-MB-453,9935249,2.561550169446695,2.2329294931085943
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,-1.851560225212359
LXF 289,3062316,-3.851151802003845,1.1966753669495498
MDA-MB-157,2874250,4.29768331905581,4.334604587460707
HSC-4,4521392,4.744801099229743,4.366141788720077
EFO-27,23725625,5.484413053531449,5.296113196311807
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,0.9824755145617652
NCI-H2009,5460769,1.3316086312624285,2.888102514217168
LOU-NH91,654092,0.641619390442256,-0.14977447281197048
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,3.8148063350366708
SNU-449,9887053,4.621717664819675,4.074819918974068
LOU-NH91,54618164,4.244208934703923,4.232108869119508
MDA-MB-157,24951314,0.2652102931153908,1.315913467930808
SCC-9,4261,1.568262163612179,1.803030253371181
CAL-51,262093,2.862241975448649,2.9068023717790883
DMS 273,100016,5.677769516399485,6.0953742015892685
A2780,44137675,1.3252793631369038,3.2386560949787313
DMS 273,71466578,4.37241227128359,3.716645086956449
A4/Fukuda,1566236,1.4071330472860828,1.6741470669449154
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,-1.3490777819525166
NCI-H2171,25102847,1.8897460049958847,2.2645812282403828
MDA-MB-453,60700,-1.6006047446684224,-0.37607848557131646
A-498,11404337,2.25955984981305,0.32789256611295853
NCI-H2171,10302451,3.986494326049399,3.3753044557657654
YAPC,10184653,0.1561987566095487,1.2648163054250683
NCI-H661,9967941,4.170813203069281,3.6978155801098853
BT-549,24901704,3.7794480452342,3.3764810577043307
A2780,3038522,3.0311112283818864,2.7825659776791434
NCI-H522,67291369,2.1338291538877514,1.894628940303314
HSC-4,753704,4.983094182740762,4.898984288867936
G-401,44607530,1.0217800111575093,1.501929622999933
OPM-2,19582717,1.9960397366001383,2.973972042432604
NCI-H2009,104741,-5.941055510927969,1.5408041984738114
OVISE,9936388,2.6758567859836826,-0.16089394284089664
NCI-H1623,11178236,-2.2917099582879144,-3.190183676358674
CAL-51,5746,-0.6872762444946757,1.1046707817500148
JM-1,3503,1.2397121319894746,1.534724744356003
LoVo,26596,-4.043483931746528,-1.3352629304800596
ONS-76,44486219,4.293725912166159,4.34041612116015
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,0.8080971077919686
NCI-H460,24964624,3.5490884182562565,2.40343075926338
A2780,448949,1.9574027813966313,1.8135053632067724
G-401,6918878,1.5849207586223315,1.6939733298654938
EFO-27,123631,3.2705036111065957,2.5879769318006267
NCI-H460,71466380,4.4879606530616725,4.578603619608696
NCI-H146,126941,0.4535750644224253,-2.650609320624798
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,1.0658177757507559
JM-1,25062766,0.7257031347370316,1.7270127752981643
BxPC-3,44819697,-0.5900667288519075,-0.08231562118093645
DMS 273,49766530,-1.3487399530522592,-1.0642637147964673
G-401,6918837,-4.518653911968971,-3.5687880426320544
FTC-133,25195348,4.144583358862902,3.486902637547138
BT-549,5281321,-3.0037540013163433,-1.1834872374338
Panc 04.03,44241473,4.425072929332434,5.118513525463303
YAPC,5278396,4.010893890545004,3.6548523318561643
ONS-76,5287620,-2.6985711183159573,-2.207352271064662
SBC-5,11612883,3.4240653421197877,2.639085487147869
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,-1.2046027206622891
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.788662374512362
SBC-5,219104,3.745930190487188,3.7098824005618787
SNU-61,176870,2.732721688120773,3.025867363910233
CAL-51,36314,1.3238047725901672,-0.6551402186146486
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,3.255943834887213
DMS 273,71751553,4.31191978803821,4.195640720120806
NCI-H2171,400769,-1.2297634018381476,-0.7078864153353784
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,5.093864268651431
NCI-H727,71304818,2.536891878991305,2.4568281392824853
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.6446401028333588
CA46,135398516,0.7680931483587626,1.4476305635959983
MSTO-211H,100016,4.243846732059744,6.113941233717136
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,2.006640729056845
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,3.079803830636399
SW1463,25183872,-1.2446986167158185,-1.105129293674422
EFO-27,122327,4.8281000238128,4.808095279429607
MDA-MB-157,11222830,0.6776847499576403,1.5635242511707748
NCI-H2009,25150857,2.992056775880064,2.68383769655318
NOMO-1,216468,1.212023833941809,1.220798549811879
JM-1,11152667,-1.617053586455527,-1.861579409987513
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,2.0220305363855027
A-673,25126798,3.569829443135804,3.738818175903049
DMS 273,148198,-4.27913692458833,-3.5045458416673734
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,3.5575087646390298
LXF 289,5329102,1.6667075021580833,2.349585191026774
HSC-4,53495165,1.6708694504220498,0.5654908806511657
CAL-51,969516,2.948027689121256,2.7410136603592514
NCI-H661,5746,2.052034109930783,1.0456390775794895
A4/Fukuda,9967941,2.4411204768161983,3.3973142711976636
MDA-MB-157,89928392,-0.9485630303355488,1.645221871136407
NCI-H460,12001922,2.3574763109101253,1.8940181515101324
SNU-81,327653,3.5323829695882267,2.742706114397646
NCI-H661,124202324,2.0891928025286943,2.6866456246897807
BxPC-3,42642645,0.6313588777440967,0.7871909089802213
NCI-H2009,24772860,-3.0306018162615342,-1.744789823237675
A-673,6610355,3.502413574243847,4.29342327540969
SNU-61,57330099,3.603690788773508,4.371534736606987
NCI-H522,2749,2.969505400884835,1.5275518535588068
NCI-H661,57519531,4.09429699672183,2.347087460225423
MSTO-211H,2126,4.496176254172968,4.740126427691336
KMRC-1,10410894,3.4812991400934585,3.4031936494046615
EFO-27,44237094,3.2066908421034332,3.1412724708335005
LoVo,16725315,3.2447595903434627,4.395944294479581
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,3.6135067869943858
MDA-MB-453,2842253,6.29942483998937,4.999537879347989
A-498,135875424,4.978423270774445,4.276299246053531
Panc 04.03,9903786,4.611047286699123,3.2310485453299322
SCC-9,54639665,4.512228528266098,3.4897750679521424
JM-1,24856436,-2.211637583066154,-0.7322962674395704
A4/Fukuda,5311037,4.577970147235868,3.1751613958803877
NCI-H522,66577038,3.0388231599187017,2.8902187518452673
BT-549,25154868,5.818557590138654,4.476779475303178
KYSE-70,6505803,-1.025033993677824,-0.5968956262430593
LXF 289,11396600,4.152956454399736,3.6122684177337057
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,1.0286097420516669
SBC-5,126941,-0.8684780314881991,-2.697137659193372
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,-0.11182765558223448
OPM-2,9933475,-1.3895511853659537,1.2458325948097773
YAPC,11214940,1.707662344700129,2.059991552600628
EFO-27,4259181,1.8274060730963064,0.5330092407667464
NCI-H460,446155,3.79922347841428,2.827826013709023
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,2.9027980561380895
A4/Fukuda,3634881,2.7004024711225596,2.7452036809838307
NCI-H661,1566236,3.2299922345410006,2.4150776481964704
MDA-MB-157,6450551,1.4635370045174534,2.7043497711152855
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,2.9447172724091017
BT-549,6918328,0.6487197523295809,0.4274104766272597
NCI-H727,11175137,3.085433657363398,2.7117612881022133
NCI-H460,3854666,3.1385110084048065,1.8916943639250383
LoVo,44241473,4.10673515965005,4.86123084900633
G-401,10074640,2.6430496317806957,2.903254702700875
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,0.9466818254594124
SBC-5,2126,4.14698296213378,4.565543851769635
ONS-76,3503,2.5109588721491938,2.351149533609437
SNU-61,5470400,-1.745187092277687,-0.9995328125752949
NCI-H661,36314,-4.592945905020296,-0.2224048308440884
JM-1,451668,-4.255879556837535,-0.6817989439456992
NCI-H1623,5978,-1.0298747552622975,-1.8648329561228403
DMS 273,136227924,2.538513279360657,2.6818773846376036
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.6227696844330308
A4/Fukuda,6918638,-1.9449982869755031,-0.496943359125805
HCC1143,16038120,0.5509172721588973,1.1427273889315983
BxPC-3,44185566,1.4327209520395616,2.5733895471712342
ONS-76,2858523,2.9452513130208975,3.108753167041863
NOMO-1,46191454,0.6880471005756411,0.26257965686705975
NCI-H292,216239,2.858200088172953,2.4285452945467556
DMS 273,11178236,-4.200581603954177,-3.6683053910130865
OPM-2,10074640,2.1693178922200813,2.598207671037144
ONS-76,5566,3.1751487050742804,2.9811607668671396
BxPC-3,10385095,1.8732992891777025,1.4596376328706513
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.4462488745915407
MDA-MB-453,675434,4.221225816741011,4.217922559044838
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,-0.5667052375916196
CA46,9825149,2.310107059064329,1.517904906873038
MDA-MB-453,12003241,-0.9610578830621354,-1.0175390457944744
A-673,613753,2.7839803669097134,2.9872638050998774
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,2.465850173228789
NCI-H460,3062316,3.704520183651484,1.4796203259031002
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,0.7810931944936174
A2780,11427553,1.40474333506403,2.2306358395725123
CAL-51,5287620,-2.338247824560234,-1.8410179806364397
KMRC-1,11640390,3.901360175468555,3.368670391060801
EFO-27,16219061,3.8100949831762296,3.56727635047229
A2780,31703,-4.480868228272363,-1.679967704002174
Panc 04.03,135440466,2.8713092707831116,2.2602383077033306
SCC-9,16065773,3.2014379284662864,2.581402681535553
SNU-449,148198,-4.785889264279132,-3.5708776275105354
OPM-2,2949965,2.476405976050771,2.47674748845813
ONS-76,44489367,4.840464292002439,4.383935706146527
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,0.6508065899356543
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,1.0695774579078252
MDA-MB-453,135411,0.2962177293375728,0.35861558394050264
DMS 273,123631,3.074313122611396,2.1892062511897685
CA46,19582717,2.2741322004032716,2.8539688409782373
A2780,3676137,3.624330330130062,4.302214590273667
BxPC-3,11964036,0.7144816609502266,1.3756082184175487
G-401,71466445,3.182548969694367,3.4312762881980943
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,1.8965936009053441
A-673,49766530,-3.0139632371957705,-1.0341168907972842
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,0.13348861565789674
SNU-449,11609586,3.2368097564340546,3.1102058594022095
G-401,46199207,3.084348249789013,3.037694378699714
A2780,11612883,1.284093973133662,2.5305074049569867
KMRC-1,2708,5.927603665606935,4.682511387862845
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,-1.3778405966736682
DMS 273,135875424,3.231864587804135,3.5377721096422463
Panc 04.03,2749,3.2242301239764184,2.1222557861568405
G-401,675434,4.2282934242266235,4.321559212424429
G-401,72734382,4.843742106159305,4.358726082985083
SNU-81,72376,-4.141271855112041,-2.4034262713788466
LXF 289,208908,1.975389940693236,2.313405986551679
EFO-27,11175137,3.0704812268942296,2.908505381152547
HCC1143,16736978,2.2332113551174415,1.704968048000523
LoVo,24821094,2.523288695365458,2.823791224914658
A4/Fukuda,10322450,2.3588003127389277,3.6382823034988805
EFO-27,11152667,1.7712187839859168,-0.18793410897953827
A2780,6918736,-1.942572837589071,-2.04365290643088
FU-OV-1,285033,0.0377877938075082,-1.9158263877487867
KYSE-70,11626560,2.028097573065789,1.6025034225704475
CAL-51,400769,-0.1641693790968544,-0.7053768552807302
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,0.9572067730251905
CA46,11507802,0.4399982092061076,0.7929318206896451
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,2.6158907958769952
SNU-61,44607531,1.8838139804325664,1.309912791354829
MDA-MB-157,135984461,1.8807242402896556,3.9127625681329006
YAPC,68056272,3.685228443179594,3.7428553066169044
KMRC-1,3025986,0.2913922358554936,-0.7498678291740394
G-401,11656518,0.9589948119457968,1.4397856263311457
CAL-51,25262965,-2.904292987251918,-1.3597141515609974
NCI-H727,31703,0.5895859224805655,-0.4439811199553044
FTC-133,3025986,2.6500554516402515,-0.5406258388696998
OPM-2,11404337,-1.9830798838769188,-1.367435270301701
NOMO-1,54649381,4.1030759428324455,3.34161697156715
OPM-2,45279963,2.6394525890823335,3.16157219098929
G-401,54619267,3.6389956680017495,3.798506744679703
SCC-9,613753,3.4469207135602904,3.151584453260211
FTC-133,3825829,4.910712910753543,4.197140380804363
NCI-H727,6918328,2.020699769993763,0.04308990317866769
JM-1,3384730,1.783412153965406,1.3159427032133288
OPM-2,5335621,3.731372916139424,4.247086136602821
NCI-H727,46199207,3.049846279584177,3.275791818498193
NCI-H2009,100016,6.24887408197215,6.229568310453216
OPM-2,2742550,2.8639715022070713,3.3656001225983965
A-673,56649450,2.339222019664337,3.1434279380489345
LoVo,135928012,4.12079355273469,4.2030440566710965
SNU-449,46215462,1.6240369462021291,2.142130173566573
EFO-27,10385095,0.896347771716858,1.5345321335208169
BT-549,6917907,-5.828237871920148,-4.610587170134637
A-673,262093,2.1198375376891705,2.2827030636707257
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,2.0335619295661003
G-401,2871966,-1.4998546935779766,-0.1171631909816567
NCI-H460,6610355,4.949206869720499,4.509985736277573
NCI-H292,56946209,-3.439063202171596,-3.603473835441311
MDA-MB-453,46907787,-0.524764523127372,1.965708260761754
NCI-H661,9935249,3.279757521015836,3.282171905754536
Panc 04.03,5311281,5.064761813982229,2.5932738263506803
EFO-27,54765302,4.904683382842226,4.2009482643157074
OVISE,24964624,2.347879134584806,2.445863349664225
MSTO-211H,6918878,2.3677965777112653,2.8448610724283636
KMRC-1,1641662,3.91383049133015,3.4051003852004924
NOMO-1,3025944,3.969971169930392,3.967278636858526
MDA-MB-453,10322450,5.853812101119735,3.676635474832845
A-498,675434,6.195396019607132,4.784840847983897
JM-1,16736978,2.465148690257062,0.940148683865745
HCC1143,400769,-0.895432113907658,-0.5966491755527829
JM-1,5328940,0.4457439228433418,0.7440869057320615
NCI-H522,156422,4.012108454967305,3.7539824943046374
DMS 273,135999136,4.8097980755766505,3.3968050667390215
A2780,44607530,1.3884091000724437,1.840118124414183
KMRC-1,10302451,2.629362111325239,2.872248178681694
SNU-61,6918736,-1.624439463390885,-1.3762113915772043
BT-549,135999136,1.9798336492119424,4.163859372862614
NCI-H1623,9926054,1.7409203229588674,1.9288811524930947
JM-1,16722836,0.523497579231149,0.7904163542877083
MSTO-211H,613753,2.697490548990984,3.0012464918659196
NOMO-1,16725315,4.952538276899841,3.9504223569208805
KMRC-1,16736978,2.1404631421072975,1.6447142005996727
A-498,123631,3.2458168084526564,2.511844299411052
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,3.78916853311626
NCI-H1623,24951314,1.0133274480783143,1.5150246309035083
NCI-H661,11228183,4.275001578251326,2.0110248956183856
FTC-133,5479543,4.4305420476204205,3.861127833071186
NCI-H292,136227924,3.1886204590132654,2.974969852605342
A2780,6184667,2.4201329833494705,2.757831727299361
SCC-9,5278396,3.934746070394729,3.701514802721563
OPM-2,5743,-3.6176009576451142,-1.291664635602506
DMS 273,66577038,3.0260629384717443,2.90051881856406
SBC-5,151289,0.3068057764327633,1.1382005551244792
A4/Fukuda,44491742,3.3943913096556444,4.1143768665647675
MDA-MB-453,135928012,3.1518499848728534,4.038055413409534
A-673,2828334,5.945698490544337,5.899082536281396
OVISE,44185566,3.1371413376940724,2.5128441744398673
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,-0.18204041284267003
KYSE-70,5460769,2.831605222646697,2.8444463383317378
EFO-27,60700,0.0275300045157078,-0.08182335473665452
SNU-449,2871966,0.0642629453363792,0.4467710742141219
A-498,135411,0.9450284346401692,1.1137855694877248
CAL-51,151289,0.6583498849401344,0.9222221183989285
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.8445166443714343
NCI-H292,54454,1.5363763322568371,2.7447144364238314
MDA-MB-453,984333,1.2010378495759917,0.46756553616299895
A2780,1242560,2.8030380184252346,3.282425349967198
G-401,11625818,3.256149300060542,3.7179686524377775
EFO-27,2729026,3.178460421270277,2.733909299277251
CAL-51,54454,2.240351559744082,2.9428715809813935
SNU-81,5470400,-5.232383325772668,-1.122583375505273
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,2.143048437944816
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,-0.692364483244567
LoVo,51037431,2.9518330914759043,3.035682378090292
NCI-H1623,57519531,2.253772853853667,2.6351562608348456
BxPC-3,6918837,-2.8801990347910045,-2.504445727041838
SNU-81,452548,-0.1759999006209261,-0.24807955162009943
BT-549,327653,2.9888914918454854,3.41245842234692
CA46,46199207,1.8825158344658808,2.3466444866056717
MDA-MB-157,10410894,1.6628456414259642,3.3262709026257413
SCC-9,66577038,2.999012470787333,2.9580486611406793
NOMO-1,6918878,0.4522523514749809,0.6909491003299418
SNU-61,5281321,-1.743716860572046,-1.3285461343408735
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,1.404139099986461
HCC1143,9840324,5.44269474449066,5.767964338624081
CA46,11234052,2.4794836109026077,2.987077547741416
CA46,11609586,1.0102139081655188,1.4455209007088383
NCI-H460,10385095,2.2920897819597896,1.3208869116726065
BT-549,11625818,5.0921701677816875,4.659322594232698
SW1463,400769,-0.5224692496950973,-0.7091315797893799
Panc 04.03,10113978,5.097338218314276,3.594684736381236
JM-1,9907093,3.962832886035932,3.486018048723717
CAL-51,23582824,1.0413279539794644,0.6478051838540947
Panc 04.03,135398738,4.347297256699442,4.280746251410752
G-401,3038522,2.1905688095022215,2.6320415981199328
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,2.3914825281934573
NCI-H146,4261,-1.8051480987265105,1.0439995479569415
DMS 273,2729026,2.67706862921606,2.3412478520088196
SNU-81,1750826,0.9975547695410114,-1.016307334886902
CA46,168313200,1.9493207867170304,2.5212041950561823
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,3.3876571248924017
A2780,57519531,1.3251208810116586,2.0547318068821294
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,0.534756919177978
A4/Fukuda,11717001,3.8123333180630103,3.9316160231996404
LOU-NH91,3634881,3.4323223488487593,3.350518858474793
JM-1,11485656,1.6613246077420758,1.5913140937723975
SNU-61,107985,-3.1587785808489297,-3.563629130056537
FTC-133,2729026,3.353273516564875,2.6408671224057034
ONS-76,159324,2.5690437216419677,2.920223880352522
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.891105999146491
G-401,9927531,4.9703255494446035,4.510135643731647
LOU-NH91,25105715,3.511519280721543,3.5799946377356413
SNU-61,15953870,3.2687219409332657,3.3633997694759183
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,-1.2830397821450146
EFO-27,24951314,0.9989426715403756,1.479793163774832
MSTO-211H,5311,0.950405781568164,1.5936295706701165
A-673,9444,4.054770941664931,4.020816325534833
MDA-MB-453,6852167,1.219966928776707,2.8606467406848624
DMS 273,3384730,2.794672653243152,2.206978363993167
NCI-H522,24964624,3.0091798278143003,2.319144853090915
DMS 273,6918878,0.6913807013381441,1.7114399987486677
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.123124110549053
CAL-51,5311,1.4183219405835503,1.283762480623017
SNU-449,3136844,4.333259755823753,4.283482197216091
SNU-61,10074640,3.0465009012673923,2.943300470275119
NCI-H292,5738263,3.605646843776872,3.614133042549101
NCI-H2009,135440466,0.1778924686528867,2.1938807804946006
SBC-5,387447,-4.42204631831661,-3.8875691912341774
HSC-4,60700,-2.3901041148359,-0.13354002290104486
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,2.209439976282035
BxPC-3,322968,4.585795478380971,3.739344713665074
CA46,24821094,1.9467424475066963,2.174614996367966
SNU-449,5282054,4.57557530009064,3.6700170875126514
CAL-51,11625818,4.1129054868405905,4.315268079504039
A2780,16038120,0.4203115446628392,0.6999080355871092
MDA-MB-453,44484893,4.218904183145372,3.304831618353319
YAPC,969516,2.7207948170212894,3.0272356215725065
SCC-9,6914657,-2.6898440352771704,-3.5496161790054397
BT-549,156414,4.402880659642667,1.5973533172611654
A2780,10410894,2.69442494781606,2.8893137525501578
HSC-4,1566236,1.9723291328750472,2.5041170906229966
CAL-51,53232,2.8018516258833395,2.998253880749605
NCI-H522,73707371,4.918377506073214,4.378462005187592
FTC-133,2858523,3.137647378022636,2.9492885477058763
NCI-H146,2949965,2.1998257096859235,2.7960820614982307
A2780,5291,3.6974106280730767,3.2053145952120587
A-673,11317348,1.5484644948233677,1.6472922924483955
CA46,5284616,-8.167802056045408,-0.10510272773486769
FU-OV-1,9840324,7.491199941931371,5.787214559820142
NCI-H292,17759555,3.476208496969499,3.7198101490097635
NCI-H2009,6918837,-3.78935135271195,-2.6891756848932435
NCI-H460,216345,3.827300936034388,4.012494471998494
BxPC-3,54143018,-0.804639103071218,0.37082110929537376
SNU-449,11612883,3.957753067546404,3.1051414930860317
DMS 273,49867930,4.404291499076759,4.463659752114031
FTC-133,15953870,4.441911294632587,3.7418241515491952
NCI-H522,11612883,3.3366707819202666,2.6302692545383297
A2780,9444,3.815396075990075,4.050065841488012
NCI-H460,54619267,4.901891634717457,4.064507675079082
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,4.92046059156421
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,-0.8583727037857501
A4/Fukuda,4521392,3.820585335578038,4.07003941423761
CA46,5328940,1.1838617633473132,0.7361461732383577
NCI-H460,452548,0.6919333948360032,0.4077021440789671
YAPC,25126798,3.983335704988987,3.857311058335966
SNU-449,322968,4.603056923598163,3.9334741565962137
SNU-61,54618164,4.021673833793196,4.038362157773828
NCI-H661,400769,-1.492892337104586,-0.6645346755421105
G-401,24964624,1.4880998129973728,1.8284304882914555
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,5.445953805362621
OVISE,2945648,2.8352179600513367,3.003537762788964
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.858120355548156
BxPC-3,984333,0.8836461068661873,1.00990271580388
NCI-H1623,42642645,0.9313727170286358,1.3023614121680955
BxPC-3,71466445,4.819923879864087,4.092604497821906
MSTO-211H,126941,-2.2791548116201987,-2.7556075699620095
MSTO-211H,20959075,-3.222615813929693,-2.959191879339519
BxPC-3,16741245,5.048799679028713,4.041974391040668
OVISE,12001922,2.261742632923514,1.8950182947026408
NCI-H2171,135440466,1.9220793929810305,1.9241231796967755
BT-549,119182,-0.6766164524597643,-0.43820061522172565
KMRC-1,65064,5.386842832596526,4.725112010092621
ONS-76,16725315,4.104726960292652,4.377975008059199
ONS-76,6505803,1.3937943977095182,-0.18974946307408658
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,0.4277698269378704
FU-OV-1,25062766,2.359728819743937,2.2058715126183635
KMRC-1,5566,3.18269246163038,3.1802847205329994
NCI-H460,6438330,3.783082395235063,2.3354097611091493
CAL-51,135440466,2.9511327404143755,2.2205103589504045
DMS 273,23582824,1.3511796414129456,0.6877632776442951
CAL-51,56946209,-4.496983035262223,-3.6909134604485963
OVISE,176870,4.342841287056181,3.4152093973891215
KMRC-1,11494412,2.978505743964039,1.857727265776283
A4/Fukuda,54454,2.014078017992857,2.4671937253600578
MDA-MB-453,2733526,2.894784526555574,3.5258666508806944
HSC-4,11625818,4.485436042124793,4.639082366324943
NCI-H727,2733487,6.440431233061491,6.159978262275814
HSC-4,54618771,2.9865797342969564,0.8097702034653433
CAL-51,12003241,-1.2189714227076325,-0.7788241581030073
A4/Fukuda,52912189,-0.8285591911559074,0.6567731989238973
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.2930541947030665
CAL-51,6610355,4.388066889778601,4.417710283211754
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,-0.1777576789518984
NCI-H1623,56649450,-0.2540238687607088,3.1700210260504376
A4/Fukuda,9444,3.1818692272898423,3.7494895274754065
NCI-H2171,55508,1.786136919471965,3.0180971112112913
NCI-H522,9840324,6.2981118504366735,5.803383994534713
DMS 273,409805,3.6932334728164826,4.514119125250356
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,2.7129616606729443
NCI-H727,16722836,1.5817712487099789,1.7509057847331433
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,3.8009982550400743
G-401,5281672,4.259815588040996,4.313578958478271
FTC-133,4917,3.819256860929221,2.8951459477717094
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,3.07159906184716
JM-1,10113978,2.290370569955518,2.1129859631475427
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,-4.6388375770509676
EFO-27,675434,4.38679148408465,4.655226639637416
SNU-81,5460769,-2.0941921209529575,2.5170626105555236
BxPC-3,5282054,3.885649252328735,3.855071015593635
OVISE,6184667,4.390472676016808,3.4080465570604788
G-401,16659841,2.2879294183156396,3.4953604779867318
HSC-4,19582717,4.479728463380205,4.299591808952343
KYSE-70,1750826,1.0050628158627442,-1.1712845952162905
LOU-NH91,135659046,3.4412725013745336,3.8560115169848768
HSC-4,11396600,3.0766488056466104,3.6451727891229253
KMRC-1,11964036,1.816670768699429,1.4586204733861248
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,2.1637607660300504
HCC1143,54618771,1.714955024233068,1.401308248945454
A2780,8515,1.754639935244518,3.65822419337976
FU-OV-1,36462,2.321134275550796,2.1860870774817434
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,3.3235737265059306
YAPC,216345,4.822006863531136,4.161439704048558
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,2.5151500579473365
LOU-NH91,72193861,1.0473212139197163,1.8540224305586062
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,2.014150337238563
CA46,54618164,3.845436645537388,3.6301150300449763
NCI-H292,446155,1.4424758906582096,2.9137560737375168
HCC1143,9936388,-6.988875343339418,-1.5195935226781223
NCI-H727,9907093,4.262034183201205,4.299332954781386
ONS-76,126941,-2.856353430413947,-2.408149500487858
A2780,11455910,-0.8495199814745813,0.561693189412059
A2780,73707398,0.6651600447827565,0.9091932478314859
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,-0.16366033125249227
MDA-MB-157,24856436,-0.6830375019554852,0.49858676702616456
LoVo,1750826,-1.736017877496402,-0.869443420972658
NCI-H146,49766530,4.81095512251176,-0.4517845910665724
HCC1143,409805,4.31745443409651,4.872551639462959
OVISE,159324,4.206537691518507,2.8840561642528253
SNU-81,10302451,3.60256279960024,2.742472247544816
EFO-27,5282054,3.999430083075576,3.8208695895798384
LOU-NH91,4917,3.4124252266322297,3.2227786704451438
SCC-9,5328940,1.568072217369216,1.6240307527439808
OVISE,637858,1.8122421616924396,2.224854085883113
NCI-H2171,44607531,0.7654225162387793,1.4928236931311005
SBC-5,7326481,1.449700392659346,2.9599400011348043
LXF 289,9907093,2.975231625485398,4.369156542244905
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,-1.9959744276391036
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,0.920855824444352
KYSE-70,159324,1.7590392520862297,2.7422936308899706
NCI-H2009,3025944,4.548991530576528,4.452799584133139
SNU-81,135398516,1.5373988209241822,2.1986649670895693
A-673,9911463,3.7053308577681583,3.455397873093225
CAL-51,9826308,0.5677925602140103,0.4741875775546868
SNU-449,10074640,3.65403010435808,3.2303896779784522
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,2.79216611873559
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,-1.7442966346471758
JM-1,11213558,1.11781575024048,1.2372279736191738
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,0.7427665665052081
DMS 273,11396600,2.9821670224503025,3.471468894347691
CAL-51,2742550,4.689941422286605,3.7999326829154527
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,5.238904753616819
NOMO-1,24856436,-0.4465471145990737,-0.8589529309281587
BxPC-3,54454,2.2110977916594945,2.399993474396013
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,3.902553304814557
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,3.1390650865833267
LoVo,54678924,0.9602640778132784,1.8321634258264168
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,2.232207799545175
NCI-H460,9911463,4.421747687015995,3.7447608274265405
CAL-51,3062316,-2.5625958708444205,1.6280981881994077
G-401,11404337,0.5096427987118028,-0.9290521545014936
A4/Fukuda,107985,-4.34456564276242,-3.9977531551119307
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,-1.288031267771903
SNU-61,9956119,3.7156714580567063,3.3897363917863004
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,-0.9416486053643243
EFO-27,53301938,6.290465616373669,2.5309630697327976
NCI-H727,17759555,3.180616959518291,3.7711020090037284
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,2.3795732722775402
SNU-61,44819697,3.53302657640718,-0.17586560617555744
FTC-133,16065773,0.3113531910395277,2.5533437868750744
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,2.0742632774764385
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,-0.6860260908231376
NCI-H2009,107985,-3.3237358160703843,-3.340864267056743
NCI-H146,3676137,4.978597159303883,4.273331045336044
NCI-H146,16065773,1.505871551892472,2.0723873281232974
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.618273324392844
NCI-H661,60700,0.4833445990508663,-0.1615987805087956
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,2.9591731662892964
MDA-MB-453,44491742,4.088527945953042,4.128715505177615
NCI-H661,2945648,2.4705894827529984,2.891118987588202
FU-OV-1,12001922,2.2107336164209586,1.9879769374629068
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.9321723477465473
FTC-133,168312962,3.97521401805193,2.3290523051957153
NCI-H2009,24951314,0.5822698862930126,1.5507174073545658
Panc 04.03,3552672,4.635312487107652,2.8703301255897897
HCC1143,16725315,4.684699585721338,4.097407205361426
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,1.8062623650875622
A4/Fukuda,67156097,-3.3575882698535526,-1.8380609853102772
NCI-H460,44507138,4.578042897326484,2.9250153234649825
BT-549,262093,3.1295246575488354,2.81758546588284
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,2.17429107004821
LOU-NH91,23635314,-2.2216361010230545,-1.3718765855816486
HSC-4,11485656,2.41592786996926,2.2714762035743696
Panc 04.03,2858523,3.1704472292667245,3.190949255826518
CAL-51,31703,-2.726607914110417,-1.0165853657026258
SCC-9,11485656,3.6663619913543446,2.559721682203878
EFO-27,11234052,4.354926990140025,4.230033965587818
NOMO-1,11977753,-1.9426292333262003,-2.2928018137334707
NCI-H146,5280436,1.6778415991784894,3.1634800189600596
SCC-9,44589607,3.476138487776652,3.0229963516883664
YAPC,1716436,3.308380745751715,3.081681254769687
MSTO-211H,72376,-3.945669301292739,-1.7226557867171162
CA46,6438330,0.8057128440407828,1.339135701333458
SNU-81,46907787,-1.0582449369350613,1.1943005811265985
ONS-76,53232,1.9476307600046912,2.88581325925856
SCC-9,51037431,5.108150298111964,3.5024702960413627
SNU-61,11719255,3.5581483316812275,3.023502074516985
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,2.080302815400167
NCI-H522,8515,4.67214972936148,3.612212919972058
A2780,104842,-8.58016789938804,-3.72650558449208
KYSE-70,56946209,-4.444419695204879,-3.9540715454184534
NCI-H2171,46191454,1.782184086758524,1.0465884436329516
NCI-H292,54618305,4.4370648491662195,4.518875141678078
A-498,16725315,5.296109915632034,4.448740426234241
A-498,11494412,3.741733086313002,2.4040928294967863
JM-1,36314,-7.745176622378906,-2.5965655900441584
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,2.008481002084038
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,1.7697975268191843
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,2.844049646468702
BxPC-3,72734382,5.457836982387995,4.633008276986447
NCI-H2009,72734382,3.739945681050146,4.74889061115856
CAL-51,65064,3.306239750209062,4.742129517751033
A4/Fukuda,6252,-3.645065834912594,-0.38588906844491755
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,-3.240375157550293
A-673,36462,-0.225010248526114,1.0942725789696057
BT-549,25195348,2.629764497852918,3.4331086317585067
ONS-76,3385,3.2517912405561784,4.496933303924172
A-498,73707398,1.745059470984177,1.8028961390129736
A-673,56963564,0.0212663307031236,-0.007547203751590337
NCI-H522,984333,-0.7488997443424653,0.40908613609622757
NCI-H292,452548,1.0483210578903834,0.49660707673245136
NCI-H661,57330099,4.147264508988866,4.3673400741393715
KMRC-1,11167602,5.704956856257104,2.6498766868325334
YAPC,25150857,2.3485140693919178,2.575278258925563
LoVo,6918878,0.5506920931363443,2.614309362054623
LoVo,5282054,3.3404837473565077,3.6422344736941157
G-401,445643,3.8388087856424,3.941670461942489
Panc 04.03,31703,0.9238663549391216,-0.31966591196407257
KMRC-1,25150857,2.932634990579502,2.458611855149963
LXF 289,9903786,1.8485652979864533,3.262816239145313
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,-0.7101500362917003
Panc 04.03,25227462,1.6849134644206611,-0.035651028683453975
LoVo,5328940,0.1711764774474706,1.422961543986831
SNU-81,49850262,-1.5447601433950633,3.46791686346512
CA46,46215462,1.3062506059575565,1.311676605477631
MDA-MB-157,219104,2.454471278072077,4.073730340724905
MSTO-211H,168313047,1.6297190097298295,2.414692715721331
NCI-H522,16722836,1.5816295407965617,1.5039696640936793
OPM-2,54626689,3.88605573030338,3.912358792508441
DMS 273,60700,-0.3389173956036069,-0.6392961634688318
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,1.1259329320182068
SNU-81,9826308,-1.744878476856413,0.10230728448766291
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,3.7713423815744083
NCI-H292,72734382,4.432039940054941,4.613451598399856
NCI-H661,11507802,0.3336368123539006,1.465574632164867
Panc 04.03,676352,2.180457258433582,2.341621517017541
FTC-133,322968,4.798855030018761,4.061797151702751
G-401,16720766,1.0481135004094,0.11859634701434453
G-401,462382,0.38796721763981,0.23306470922605255
MSTO-211H,25062766,2.0532887481804605,1.9029551801814426
A2780,16736978,-0.7643928517553599,1.1909876824987409
NCI-H727,2729026,3.015864992302643,2.8839048864313965
CAL-51,135440466,2.9511327404143755,2.2205103589504045
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,2.3469828096129812
BT-549,72376,-0.6560931555152002,-1.3505567747287919
A-673,9933475,1.583729012108943,1.6398616909638417
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,-1.142392478126687
EFO-27,135875424,4.6207788215281465,3.9427517297531436
A-673,24785538,-1.1944412082957694,0.6866474634441281
CA46,135659046,2.986085914123542,3.320619771507288
CA46,3038522,1.2076902647573031,2.2678152207322633
MSTO-211H,54626689,2.3486455994654767,4.724352526702557
SNU-61,44241473,4.262106100814371,4.785947626552956
MDA-MB-157,25126798,2.9199314308838327,3.601586601482378
SNU-449,10410894,3.985550363358928,3.6055161480073754
LXF 289,53232,1.5859701947912777,2.6844648944946554
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,1.1779292415195632
DMS 273,11234052,4.3748762471871725,3.679964900295511
A2780,107985,-4.859396565896689,-3.6420207433622425
Panc 04.03,44202524,4.489701680422056,2.5536123660365453
LOU-NH91,44185566,3.062522771292805,2.674390411965092
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,2.307436347114582
EFO-27,36462,3.079082429258617,2.2828667883040743
JM-1,24821094,1.723225199642946,2.3517470964255525
KMRC-1,216345,4.164305633353381,3.9409671023953017
NOMO-1,168313047,1.7455342513633885,1.857541749065988
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,3.16904986743334
NCI-H522,5282054,2.516149277526254,3.334567368492267
SNU-81,26596,-2.2143193215677925,-1.29785444147753
LOU-NH91,135875424,2.9424536382603215,3.9662849336129344
HCC1143,446155,3.993343592958968,2.711506851012757
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,3.095018119620501
LXF 289,3081361,2.235375481166719,2.6680429559887746
Panc 04.03,6918638,0.956445062850862,0.9575551667394674
ONS-76,46907787,2.0367347893242247,1.993226650991545
FTC-133,5470400,2.075616738071143,-0.12929243801504692
SNU-449,9884685,0.40134732620175,0.8346123023341774
FTC-133,44566777,0.1715240988601806,0.6930679918519548
KMRC-1,9911830,2.7576147713752532,2.6824012659149306
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,-0.6149794616218056
SNU-61,119607,4.552023022199627,5.261395313833862
FU-OV-1,2945648,2.6612648927829348,3.0100725181188666
CAL-51,5282054,3.552468823116285,3.589694460485228
A-673,1750826,-4.326827801164573,-1.5831665707139104
NCI-H661,23582824,0.4459994130921247,0.7008893359470133
A4/Fukuda,208908,1.6750686900112284,2.012266802697106
LXF 289,24180719,2.719444673565486,3.6527867541868138
MDA-MB-453,11647372,0.3935032395331521,0.9520857019478193
NOMO-1,54454,3.4949720971193083,2.3287691990074144
SBC-5,1750826,-0.5333690682178334,-1.6501958010537872
SNU-449,11234052,5.346874708028275,4.310321063188362
LXF 289,159324,2.685439807189008,3.060409502964639
A-498,11964036,1.806054574855834,2.015455175187915
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,-3.02751458185488
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.9149065282869266
NOMO-1,11178236,-2.492998231075174,-4.208653186315516
BxPC-3,3503,1.5238678808710824,2.4123888904545363
A2780,5281672,4.494440141018236,4.277650003369438
NCI-H460,57519531,1.7606196796007008,2.5134216980941146
NCI-H146,3038522,1.5824622735127496,2.8098580073532484
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,-0.3722379538535324
A2780,7251185,3.0282253021168835,2.077126388847587
NCI-H2009,54143018,-0.2798924220132643,0.76653873092303
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,-0.7513299402779839
A-673,50905018,4.224820228350104,4.108932608792856
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,0.5356839575500626
A2780,11640390,3.511086163886132,3.301588291240518
NOMO-1,984333,-1.7512214516120577,-0.14224056670425902
NCI-H292,3062316,0.0480521305272509,1.0884940286190192
NCI-H1623,25183872,0.2518729007636168,-0.4676499278325619
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,2.158463378561011
DMS 273,11647372,0.2469617170644157,0.5271586211059082
KMRC-1,12001922,2.9414276180440884,1.9582631738432574
A2780,54143018,-1.3409986451592475,0.3569716597494038
YAPC,49793307,-4.348408449857898,-2.789377260211056
CA46,1716436,3.005257864158129,2.567507352288095
HSC-4,676352,2.328446260179327,2.2132308258032567
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,2.8611275849533992
YAPC,12001922,1.7591466639310227,1.9485887153449934
MSTO-211H,5460769,-2.0887143253822615,3.1542289606694323
CA46,3384730,2.283076300956678,1.4248588070097759
JM-1,9911830,1.0886367976495992,1.8131252600307166
BxPC-3,1242560,2.823718248478356,3.66666190686676
G-401,44237094,3.2290132612915325,2.648129844181402
BxPC-3,16736978,1.696086021540879,1.5100280723529997
SNU-61,46191454,1.739312628335972,1.5728463050187513
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,1.859349882901245
NCI-H460,5329102,3.240160570329804,2.086033007235454
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.23436250564089
LXF 289,216468,2.2889797638929683,3.5378546301173386
SCC-9,44819697,0.1293575980749295,-0.09280367210723074
Panc 04.03,675434,5.243078667682196,4.718209848142654
HCC1143,135398516,2.188515967576281,2.3010154986154485
ONS-76,25262965,-0.7369683376858831,-1.287085964786205
A4/Fukuda,53392493,1.8640822641046917,1.8817090841559456
A-673,2130404,3.217416760546526,3.117077457708348
NCI-H661,72193861,0.3965882674238952,1.6103710748541014
CA46,119607,3.9558807366301374,4.447609192120486
CAL-51,24856436,-0.3083697359271743,0.46200682279083866
NCI-H2009,2828334,6.796615650463657,6.248853480639684
JM-1,135398738,1.1596934849395544,2.7233565029685654
CAL-51,49793307,-3.2015156477281193,-2.5037287775408545
HSC-4,10410894,2.7401570440851155,3.348537182473472
KYSE-70,46843906,3.5210263801871498,2.870886305733358
KYSE-70,11178236,-1.2639965798928303,-3.3594844412399194
EFO-27,6610216,4.772563131438148,4.389903557808275
JM-1,135659046,3.550517545140938,3.2975255150892986
A4/Fukuda,3136844,3.333855932915555,3.9021181785158605
KYSE-70,53495165,0.5494520653774981,0.13879849263706218
EFO-27,9926054,1.857839666788878,2.0780915899414403
NCI-H460,16741245,2.175171044948558,3.8714602747926237
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,3.987437546198383
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,-1.4369508184485493
NCI-H661,107970,2.2398777867932473,2.199666854867067
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,3.4236792698563545
SNU-61,51039095,2.128467827492616,2.88521752153398
YAPC,104842,-2.4249346234244302,-2.869484662540808
EFO-27,11364421,0.0539420857608272,-0.9870466575619588
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,2.5289705717045905
HSC-4,5284616,2.67117659303102,3.0586858148220086
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,0.7863834266614517
KMRC-1,100016,6.458679548763862,6.39772746478871
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.1365709236077404
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,1.1860486923694311
LXF 289,10184653,0.2846387514020494,1.4076869688770406
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,-4.218508225363693
ONS-76,73707438,3.6763163562039103,4.201983243782384
CA46,10113978,2.0547387812543425,2.2446556513129208
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,3.995331474742573
MDA-MB-453,9444,3.890114397090033,3.8939336677001415
DMS 273,462382,0.1050500144131629,0.2571214370011719
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,1.8900464984728567
SNU-449,327653,3.836895463512291,3.349337327565438
JM-1,4917,2.618606210388543,2.63103668128333
A-673,7326481,2.3948672158707027,2.735913454992984
LoVo,3543504,4.109477120593384,4.420666226536248
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,-1.8400022344077274
FU-OV-1,322968,2.943455676205593,3.968685486406136
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.664404930605975
NCI-H522,10172275,5.332939953657848,3.4540418623521933
FU-OV-1,11175137,4.687876560675478,2.8069671060501658
NCI-H292,702558,5.809534673466565,5.452985071344554
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,0.14150436915094086
FTC-133,4378219,2.0024564120700874,2.48786395487761
A-673,322968,2.685664332943325,3.236670220249156
A4/Fukuda,11175137,1.0544671313881684,2.1019385516192624
NCI-H522,9907093,4.234502914187168,4.0629707501394
NCI-H460,73707398,3.251551904382877,1.4471334818721542
NCI-H1623,11625818,3.770410958253076,4.323149152588863
NCI-H2171,3384730,2.17478810564445,2.3088665218324693
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,-1.2011027010631077
BxPC-3,135398516,1.0474106677719497,1.965426920189608
YAPC,6852167,3.757016833172803,3.062464526789601
HCC1143,11178236,-3.0622306456236728,-3.625647717249649
LoVo,168313047,1.791039731088859,2.4207202486640087
CA46,9915743,0.7447060154867644,0.5167161973151291
CA46,16065773,1.8844207098737984,1.9813959716258571
DMS 273,2749,1.7681499736943271,1.4254992652248109
OPM-2,9549297,1.1861201303789202,1.3601569280625276
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,3.680162466279299
G-401,3136844,3.887156631896907,3.97970391653505
NCI-H727,24901704,2.771852034083143,3.1380283750716687
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,2.355804233696639
ONS-76,36314,-4.67770988102335,-1.0731307858682566
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,0.8294780400988233
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,-1.0664786855971276
NCI-H146,54618771,0.1782763900918093,1.1625411796547802
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,-0.6124746636334101
BT-549,1750826,-1.15792790160721,-1.4230299011158412
A-673,4521392,3.83212246390289,4.190890459266315
A-498,10127622,2.6897842830613934,4.129373501939337
NCI-H146,24951314,0.0243539025761212,1.0399879078317047
LXF 289,11404337,0.1273620702572638,-0.08255700563725286
CAL-51,72376,-2.938334648898351,-2.2275411574952564
HSC-4,56946209,-4.10163917558625,-3.802126659227804
OPM-2,11719255,1.0053781432887028,2.4634938602925733
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,2.5843137185582328
OPM-2,54765302,3.66991118627716,3.5039470263215957
YAPC,107970,2.510985201601563,2.274757773389952
A4/Fukuda,6505803,0.0348674492980193,-0.9553554230886685
NCI-H146,421610,3.280213272702812,2.9692295113752762
CA46,10427712,3.800630662833656,3.672034309846708
Panc 04.03,42611257,4.903884607697216,3.5408835919620305
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.664365541245447
SBC-5,54618771,0.9612938071948806,0.8216457854726349
NOMO-1,44819697,-3.3724853213010895,-1.1267775925176367
SNU-449,46843906,3.9850337221839074,3.149449737664872
A-673,2733526,4.173930306540303,3.6733341018229715
Panc 04.03,387447,-4.060832381569581,-3.7081214803082014
ONS-76,16038120,1.944596111088229,1.1041395731558021
Panc 04.03,12001922,2.0215480430072588,1.965803528228546
EFO-27,56946209,-4.24663912291577,-3.9366887753371724
A4/Fukuda,15983966,4.102938700353478,-3.7368022596145165
NCI-H522,10322450,3.5945001970925787,3.877552660798232
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.6337496246950152
BT-549,16038120,1.0292862217749383,1.1990916419084985
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,0.2436200183727394
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,2.312104479012454
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,-0.9195792441468851
OPM-2,10302451,3.176323712036339,2.845217321620252
BT-549,5291,3.9626748190842167,3.9447359041144807
A4/Fukuda,54143018,0.5698360241890451,-0.4287200621098585
CAL-51,5113032,4.55807021159329,4.717769111690604
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,1.016720109339726
KMRC-1,15983966,1.4470823508624893,-0.8918204275418781
SBC-5,409805,5.881004535625117,4.69062500400389
MSTO-211H,11717001,4.186640197436745,4.264612036845958
MSTO-211H,5351362,0.1292531164344693,1.5612070172693109
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,1.1644024275766343
A-673,135398738,4.1394757023123505,3.607794457996423
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,-0.6341988419542623
NCI-H2009,12001922,2.0619007134450524,1.8498260602682708
CAL-51,3634881,3.319714226315486,3.260558676299978
SCC-9,5282054,4.577178009511458,3.7905456397319273
SNU-449,6610355,5.42598000328545,4.580539161710046
JM-1,100016,5.094244415703564,4.999593108283736
DMS 273,16720766,1.3424969772091375,0.21431952204086946
MDA-MB-453,82146,5.197355724890258,3.4532415257279787
NCI-H727,219104,4.385991256377306,3.8456274942706354
G-401,387447,-4.890417311710873,-4.435930275549621
SNU-61,445643,4.910443238015828,3.922190122427549
G-401,445091,4.490925944707375,4.3812250673909245
Panc 04.03,10074640,3.644812120140466,3.289333173495616
KYSE-70,3038522,4.319477989558539,2.717197935614605
NCI-H727,5311281,4.417954223041409,2.543955075122655
OPM-2,24889392,2.046562304125139,2.4109208911563726
OPM-2,9866186,1.7779199456036283,0.02606593243516186
NCI-H292,65628,4.3235700442832625,4.429925384008036
JM-1,5284329,3.614100674193798,2.455214434961963
LoVo,49850262,2.4887252685350227,3.766531818612996
BxPC-3,24785538,1.143761767664292,1.6662924651297488
LoVo,176870,1.1282563754131285,3.1474714768829175
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.5347635677733538
EFO-27,73707398,1.1269975883077623,1.442269224825392
CAL-51,49850262,3.6300011952383584,3.811443357347845
NCI-H2009,1750826,0.0733322198534379,-1.0430721860176702
LOU-NH91,9903786,3.184012464559237,3.2018954648235503
NOMO-1,9911463,3.1879476164010243,3.106914301418878
A2780,16722836,0.6661441985838381,1.4431742798564797
MDA-MB-453,11238147,2.2482376857817856,2.680537687690475
NCI-H2009,11626560,0.9059448501577204,1.634959481965525
LoVo,2746,2.3133613771451524,3.236673507887569
NCI-H661,9840324,5.7754199175322825,5.831982721349857
SNU-61,10385095,2.7560205308704044,1.1053778083558712
A4/Fukuda,24771867,-3.7385177445932585,0.4993232670166283
NCI-H727,654092,0.4388886539996767,-0.07926124368519294
NCI-H661,44507138,1.7319125686737762,2.5418832173745307
EFO-27,16013152,4.523705738143722,4.425965470689016
CAL-51,4259181,-0.5132501801478601,0.2577801879384449
A4/Fukuda,2746,1.0000278581130588,2.0448261007205133
NOMO-1,10184653,1.080224838410231,0.8759278969536769
Panc 04.03,135398516,3.776050709281408,2.245478267264536
YAPC,3038522,4.3203914817087234,3.136289118262267
NCI-H292,9926054,1.8794077191249725,2.0579161886555255
NCI-H661,5278396,2.727600530538007,3.5778109355524155
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,1.7660585379566018
A2780,9803433,4.475774001896097,4.303937511251223
MDA-MB-157,11178236,-4.597953573249134,-3.364985048619973
ONS-76,44137675,3.612845962454732,3.6461845746887747
LoVo,51039095,1.8047028032602028,2.750703502662045
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,-1.240517600593517
SNU-61,25183872,0.0265852822027559,-0.8178869469959953
NCI-H661,10410894,2.079430431888453,3.241898355518235
NCI-H1623,11497983,5.112351206162292,3.549823014178952
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,-1.207563152164978
NCI-H522,6184667,2.532079714436212,2.959882782053721
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,2.3948675857099717
NCI-H2009,44589607,3.679148722712513,2.969798141106036
EFO-27,44137675,3.925812188621705,3.743112036196416
FTC-133,5328940,3.204514542529291,1.6179140322803334
FTC-133,2708,3.4116435244290773,4.9737841273715535
NCI-H661,24901704,2.3315866691701395,3.4767191780001045
MSTO-211H,11719255,2.56955632094912,3.330236635968447
OVISE,11626560,2.348997135596899,1.820617134800438
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,0.15636326293161795
CAL-51,9868037,3.5441777448678615,3.0628983655170505
MDA-MB-157,5328940,1.5742504795877947,1.6917261210279542
BxPC-3,19582717,4.685369750995796,4.257699229572642
MSTO-211H,6852167,2.890925130180435,2.8939194217710162
CAL-51,5746,-0.6872762444946757,1.1046707817500148
OVISE,17759555,4.197708618199663,3.5132597551061524
EFO-27,6918638,-0.5643283195590469,0.8373298791116767
JM-1,439501,-5.872076466297635,-2.7291798735176314
NCI-H522,44486219,4.336787525166091,4.039838311214032
SNU-449,11167602,2.762483283064935,2.6919850594524144
NCI-H661,11640390,3.9877189690607993,3.599650682556282
SNU-449,216239,2.7953722371364473,2.243156411701508
NOMO-1,17755052,-0.2814114025249274,1.0963537428249106
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,2.1325197658367063
A-498,54618771,1.1394352833671273,1.312945177111753
CAL-51,176870,2.9999818119422175,3.1787966865733286
NCI-H292,11404337,-1.5117614396305947,-0.1898487926532457
HSC-4,9911463,3.832706037448295,4.0166374240089935
DMS 273,5470400,-1.1243568241206934,-0.5917325943880467
OPM-2,25183872,-4.3499490255982085,-1.798211835269216
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,-1.1653864205127216
LOU-NH91,31703,0.5806868540812907,-0.8182335793854808
NCI-H661,44493528,5.823125515558819,4.310201905965726
SCC-9,10074640,3.673307032160535,3.0952241686727735
A4/Fukuda,11427553,0.0702382308883879,1.8420416903780825
SBC-5,568763,0.2965266090010964,0.6435160527288631
BT-549,25126798,3.990115132251306,3.883929454858121
SNU-449,9933475,1.8242814161965168,2.085503185521727
BT-549,2113511,7.745487386721322,5.558157870827889
SCC-9,969516,2.533129063350548,2.9143394084253145
A-498,11178236,-0.0767055613398424,-3.118051368262079
YAPC,1242560,3.336355906074855,3.5134862324501626
YAPC,54626689,5.597039319211252,4.665455168896021
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,2.6697757242374447
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.609470224910653
HSC-4,6918837,-1.8301723200742368,-2.466079300240723
YAPC,656346,3.528875898488543,1.0102970282264834
LXF 289,5470400,3.745756378340341,0.35126127071998114
NCI-H2171,168312962,2.801787293375821,0.9707137706327988
MDA-MB-453,6918638,-1.2403270134347248,0.3077187645478117
NCI-H522,1566236,1.6835491869847783,2.0780133847896787
NCI-H661,24964624,2.8216778680067836,2.28531979882081
NCI-H2009,5281672,4.642324044569225,4.786551257444019
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,-0.47241129638769
NCI-H1623,16065773,2.4078381094703456,2.3981614386941748
CAL-51,46398810,2.084696284876613,2.608348354949426
OPM-2,54143018,-0.7196855693728514,-0.1691740950040399
SCC-9,15547703,2.91115041464476,3.143537705663107
DMS 273,6914657,-3.971712341208325,-3.800887145051543
OPM-2,3676137,3.169610101166173,4.1221443401856135
OVISE,3025944,5.5857056433387235,4.187377137396302
Panc 04.03,4259181,1.0934261994249337,0.566944772351479
A2780,11683005,3.0394905793504963,3.6805902689983525
HCC1143,5328940,1.7305674649682683,1.7087482925405353
NCI-H2009,72193861,0.2482611586799762,2.01871773000981
NCI-H292,6914657,-3.659053204598075,-3.1052807459697283
NCI-H522,46199207,1.8719788650663136,2.9338973353055797
CA46,53481919,3.755788894439918,3.1866098537972762
LoVo,444795,4.8141558651213145,4.660432297863824
FTC-133,9823820,4.816748988305079,3.977498597221764
KMRC-1,6918837,-1.4377118656295438,-2.5775610115817966
HSC-4,44486219,5.375029781512573,4.4697174793848715
NCI-H292,54613361,2.8419740491204957,0.5336911690620584
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,-0.9423141424710596
CAL-51,11234052,5.18044926966805,4.121492762049893
SNU-449,387447,-3.8386512960067862,-3.955272391773926
SNU-61,53232,3.65751057839411,2.7431620160573504
LoVo,16038120,0.8839921956645777,1.0915991435334633
BxPC-3,219104,3.7528053800812615,3.9184891510700925
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,0.9053935971850029
SNU-81,24748573,1.8214275246808207,2.1062548100652867
MSTO-211H,16725315,3.290115596802182,4.035543790880873
SNU-61,25154868,4.341936394973705,4.340202252067266
MDA-MB-453,1716436,1.6727209102312437,2.5125118361184
G-401,5329102,1.4807949874052762,1.9088509938036131
BxPC-3,6610216,4.298723179439111,4.353911474377447
ONS-76,5738263,4.146346761655981,3.3942956063585727
A2780,51037431,1.9184867581168112,3.2153855905077804
CA46,46398810,1.9636985074186508,1.6770549463200703
BxPC-3,9936388,-5.112429278661846,-1.6079913450539334
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.3642210699818624
MSTO-211H,637858,1.3984482263345202,2.238164587926322
A-673,5284373,2.9730764803314496,2.796024440823928
JM-1,5284616,2.861882362083186,0.1457668125367376
A-673,64971,3.704564654457452,2.3564570993339804
ONS-76,6918289,2.669224964930956,2.660219697977139
HSC-4,11167602,1.6360881716966182,2.389274217531467
NCI-H661,3689413,0.5447440822016135,-0.12237827340662889
A4/Fukuda,12003241,-4.192136354440014,-1.3960582240970911
LoVo,10231331,-0.6826574775964468,1.2128019282299483
NCI-H292,219104,4.068792108053485,4.0096852734297315
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.4027575263651201
NCI-H460,216468,4.763843832635099,2.8939741740049976
SBC-5,322968,4.849411960208385,3.410543859333927
MDA-MB-157,135411,-1.5273896245850724,0.7300676136882349
A-498,6918837,-1.461997313484149,-2.1882710523018085
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,2.251469090697129
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,-0.9134398814781626
FTC-133,36314,-6.239918298117373,-1.1351203523617852
CAL-51,23635314,-2.261837237964324,-1.5273272627057597
NCI-H292,126941,-3.055153146808903,-2.60823808145183
A4/Fukuda,23725625,4.971593284778653,3.9844805989401015
A2780,25105715,3.052833826388835,3.2568269403092063
JM-1,9903786,1.587415218469425,1.9813287554730274
NCI-H460,5566,3.3663694984335533,3.0409950548070794
OVISE,262093,2.7343448368987597,2.915819394120243
CAL-51,25262965,-2.904292987251918,-1.3597141515609974
SNU-61,448949,2.574317813231787,2.0051549994354145
SCC-9,24180125,3.671852734769843,3.2111692051129395
HSC-4,42611257,3.4394582921614933,3.261391656102751
EFO-27,46174525,4.9061854461465435,4.533249834245146
G-401,3384730,2.1525913455039474,2.2823955552658415
G-401,3825829,3.962498358217521,3.6157981872149616
A2780,53232,-0.3956468617212337,2.5406701499271134
YAPC,54618164,4.31457100114165,4.201750763298468
SNU-449,54765302,4.743565917095417,4.211261950130545
NCI-H460,24951314,1.96669984187411,1.353488495114353
FTC-133,11364421,1.174405518858428,-1.1348538927196237
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,2.310075485864395
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,0.9936120526135666
NCI-H2171,24771867,-2.6220866978549444,0.456335604619257
A-498,11427553,3.7697046176741185,2.8637911743251356
MDA-MB-157,5394,4.303334925677516,4.277337724675145
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,2.841725126183842
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.3566813640604392
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,-0.479955519713313
SNU-61,15983966,-2.103596771317332,-1.4186693593112327
A2780,9927531,3.2712332494904226,4.497819022882236
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,2.0212026662366136
NCI-H661,168312962,0.9705864877614524,2.0550267748729656
OPM-2,135440466,0.016624870652288,1.6429927748808246
NCI-H727,44486219,4.75896405378265,4.172027173186258
NOMO-1,637858,1.0893367728071195,1.2882444757025109
NCI-H727,23725625,5.500914308976136,4.928415992768639
NCI-H661,444795,4.831383676329662,4.590090071933235
NCI-H1623,10427712,4.824592613381889,4.458340798739448
CAL-51,11507802,1.2528060552922216,1.3871190484656741
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,-1.8082878215444291
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.6490356093816072
A-673,2949965,2.43157797191215,2.336599038359216
FTC-133,46907787,3.491897677971775,2.299623158977624
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.7897361555060656
JM-1,12003241,0.2073989775302392,-1.79098269869441
DMS 273,72376,-2.307681046282287,-2.4935704606366453
A-673,3025986,-4.4852998426095985,-1.0058646821391977
A2780,9823820,2.6289512031423836,3.7619083390483667
HCC1143,11152667,-1.9901975183751028,-0.3036459497333065
A2780,119607,4.019563194528792,4.960925878365213
MSTO-211H,136227924,2.717505566177341,3.0503390099243775
A-673,3025944,3.970835118137527,3.9644822808286166
NCI-H146,11222830,0.9953145616857674,1.2498932596057666
NCI-H146,1750826,0.7822669653178473,-1.325282416832599
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,2.3492773765501926
BxPC-3,1750826,-1.1292189334445044,-1.005300470077418
CA46,6450551,1.1375422858810305,1.0831936360036787
NCI-H1623,46191454,1.8980276717062192,1.5206772063652922
CAL-51,24797083,1.5666479073716466,1.3140248310624154
CA46,448949,1.4123991312197492,1.3035623521753374
OVISE,135999136,4.426271635938179,4.018142340759335
HSC-4,2742550,4.46855499399167,3.9183294288027595
NCI-H460,168313200,3.91056508525232,3.144866101556272
NCI-H292,1750826,1.4118366921158176,-1.0933251930221362
HCC1143,452548,1.7974899966046338,0.40254702473100323
SCC-9,53325874,4.533787552290022,4.778379756790629
CA46,24771867,-0.8036362931877258,-0.5928301243533378
A2780,72199292,-0.0351373222218005,0.998102526613924
MDA-MB-157,216468,1.0474678727125786,3.2622133100806296
SNU-449,65064,5.2463646910054536,5.004120831669491
NCI-H292,9952709,2.799114874088216,3.175413550135645
LOU-NH91,24964624,2.935669445800335,2.6965851469607
MSTO-211H,5566,3.048712391825719,2.951079864955099
MDA-MB-157,3384730,2.532514051685687,3.135436539408608
BxPC-3,753704,5.46289082133378,4.967051798125022
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,-1.987641672786968
SCC-9,12003241,-1.125345709331217,-0.7674972099697005
HCC1143,285033,-0.1452813325821209,-2.0232864659432797
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.9557791658345667
FTC-133,9956119,4.526890245155382,3.5511412329593686
SNU-61,3854666,2.8565665342705735,1.9249730653231258
G-401,16065773,1.1067048318222386,2.12159997859212
G-401,11214940,0.8244141998238856,1.8422268356401057
HCC1143,54618164,3.885707225557291,4.170388469951564
MDA-MB-453,16013152,4.031304285322853,3.8630008079670324
SBC-5,24951314,1.1707148737631825,0.9974073829800192
FTC-133,135398516,3.4482633492568913,2.4288691353640077
KYSE-70,11625818,4.1356453826336965,4.257614863943447
BT-549,16722836,2.2023880033470893,1.8746251116236048
MDA-MB-157,54678924,0.1283777680712135,2.2011277222797383
SNU-81,10410894,4.450607476297739,3.316924424876624
KYSE-70,9926054,2.326174845830733,1.9754759352929983
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,-1.336647179510116
EFO-27,25102847,3.020723568572887,2.4190110392831774
MDA-MB-453,5351362,1.2969167061447922,1.4505137606256167
LoVo,9926054,1.9069881185353632,1.8995914897733948
NCI-H1623,46926350,-4.300601402935136,-3.8991196869936577
SNU-61,16065773,0.792903808301444,2.3819980586227034
A-673,5287620,-2.2582011832849824,-2.0404721291639745
NCI-H727,9903786,3.725485605999375,2.8776259475346087
KMRC-1,72376,-0.8386976675707333,-1.27918146483393
JM-1,11640390,2.558073354039076,2.596620786641966
A-498,104842,-1.4921326822698753,-1.9937469087116313
LoVo,10127622,2.21220618035224,3.300263798779602
LoVo,11364421,-3.7348040522268624,-1.9158758388079073
FU-OV-1,57519531,3.042184872303348,2.6058416843723564
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,1.9733618303778737
DMS 273,6917907,-5.615473283892677,-5.0282483557764746
MDA-MB-453,2828334,5.6655606940020755,6.018572652657294
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,2.0112083792503332
A2780,3025944,3.330273751246369,4.0936495262436665
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.2222857572058852
Panc 04.03,11152667,-0.1106415062306802,-0.3581067972127853
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,4.2240628848195305
SBC-5,374536,0.1871414147839566,1.8019903306064184
NCI-H661,11222830,1.6760341955617937,1.6520191206632056
BxPC-3,89183176,5.843393871566337,4.089562509442417
JM-1,135999136,3.9281924738089016,2.6219494387460625
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,3.0224886691651527
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.30400882588235
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,1.0057712225967455
SBC-5,56946209,0.800516243447007,-3.8950920626010226
NCI-H2009,5328940,1.7426808664178373,1.7659300713875936
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,-0.7734432729476454
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,2.525473794100239
SNU-449,9911463,3.778924364931394,3.993692580662635
HCC1143,3025944,4.170847171640537,4.368226132619572
JM-1,969516,2.095061675415332,2.263515442888048
NCI-H460,3384730,3.247736649900264,2.6785479501452447
LOU-NH91,135411,2.1671070624345674,0.7917992937093418
FTC-133,44607531,1.7603587928522244,1.3730710158392057
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,1.3158346868433355
MDA-MB-157,445091,2.3343110617588785,4.580368176629191
HSC-4,16013152,3.4985623845199956,4.262784722637674
Panc 04.03,11427553,3.7212087866143433,2.8457908334283077
KMRC-1,10113978,4.2388531684480615,3.342634269344156
A2780,10127622,1.5174517910950884,3.3855227364355436
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,-3.0029270311408403
NCI-H2171,89183176,2.3651641452605747,3.518967686690587
Panc 04.03,54618771,1.7180394725494992,0.9706667823950168
NCI-H292,11485656,2.2579953762585725,2.536710973174504
LXF 289,322968,3.971478433961818,3.7549847638601905
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,3.067316907064878
YAPC,10385095,1.3302689043535871,1.4749120314413051
LOU-NH91,5329102,1.7122787452562382,2.1690074310221696
SNU-61,19582717,4.214212535444011,3.5329439884798943
HSC-4,49850262,4.158516161733518,3.8942758475892973
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,3.3460377726183026
NCI-H661,123631,1.2265867761007856,2.3856649136929264
KMRC-1,3062316,-0.7612421720697753,0.8021987386449954
BT-549,9936388,-4.888200161073446,-0.465879984696752
HSC-4,24951314,1.4348411807415282,1.2221544586638076
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.4027575263651201
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,-0.9636483270026901
SCC-9,9933475,1.8547363245124415,1.9194504012183362
CAL-51,9936388,-5.638746232401389,-2.3480684225462833
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,0.5728719208543318
CA46,72734382,3.577472012209052,3.7586697221309913
NCI-H661,16741245,3.244500107466936,4.035410314392035
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,-3.2335210374483165
HCC1143,11964036,1.1986784595252613,1.3103423720109089
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,3.474775661957391
A2780,126941,-2.3178428604154746,-3.2662824591079076
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,1.3506674356088766
NCI-H661,24753719,3.905315348750775,4.223662703818671
SBC-5,25126798,4.2020115243555285,3.6423678080967483
NCI-H146,6917907,-6.190181636892531,-4.45949497280276
NCI-H661,1750826,-0.2904028146963975,-1.49120324872163
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.59738743885442
ONS-76,613753,4.08215787211526,3.223489331246518
SBC-5,3689413,-0.1482568941323282,-0.1385629992109988
FU-OV-1,446155,2.635089718837861,2.6124671855686876
SNU-449,216345,4.054978999003172,4.019175026109005
CA46,6918328,-3.721989268042841,-1.5343320731985473
CAL-51,5978,-2.6819752982341463,-2.3390755785305095
MDA-MB-157,57519531,1.1252399396652772,2.5189259005523175
NCI-H1623,51037431,4.287686451446288,3.353260039869623
A4/Fukuda,5394,2.6676913787283305,3.7347065799305987
MSTO-211H,151289,1.1545674452198869,1.4566058329804321
HCC1143,3825829,3.893715702367038,3.994341743446243
MSTO-211H,374536,3.2477584475462904,2.341673470791341
NCI-H460,6610216,4.838717363885395,4.3365154077651775
CAL-51,54618771,0.0049145289548569,0.9994597724591153
CA46,1239801,3.4142476342729817,3.3532577120987885
A-673,9956119,3.229119212963112,3.281396667193403
NCI-H460,73707438,4.549718141383013,4.389958514475719
YAPC,9936388,2.1810367621372095,-1.521133056706056
LXF 289,4705,5.10311909598278,3.180265423714338
CAL-51,54454,2.240351559744082,2.9428715809813935
JM-1,4788,5.493172342149484,4.931089617928471
SNU-449,262093,3.0394524195162766,2.9814102611136817
EFO-27,46926350,-4.056205960361391,-4.055196782585612
SNU-61,5566,2.945300560810773,2.896911282322258
Panc 04.03,6610355,5.365295116093154,4.599312485599105
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.8584224515067256
NCI-H1623,56963564,0.7315466561739135,0.7890470953978391
HCC1143,10113978,4.851592729588868,3.2066447082390255
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,2.1220798398863545
LOU-NH91,5311281,1.0411900413843744,2.4762207396834577
KMRC-1,24856436,1.3740575733249207,0.6636115375397926
SBC-5,400769,-0.0932857286492618,-0.6449439758343759
OVISE,11964036,1.5054845636014844,1.4353330448067592
JM-1,1716436,2.291915875842717,2.676907877619972
SW1463,6505803,0.5252870082270547,-0.580929363385662
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,-1.037881952376129
CAL-51,119182,-1.323881847361974,-0.7035449596779477
A4/Fukuda,4788,3.9402862208503753,5.12784329991321
SBC-5,9926054,3.0567796435466628,2.0082491218301817
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.0878168919259366
G-401,3634881,2.5006119442923938,2.9498734100411967
NCI-H727,9911830,2.860892848593743,2.4081502560474597
G-401,9911463,2.712760379614347,3.4429794961585345
NCI-H460,15983966,-0.5601417251503862,-1.2794061885057932
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,2.317587199317509
NCI-H292,31703,-1.868725819699569,-0.7035504768900134
NCI-H292,11175137,3.5103695935197328,2.784446621181543
NCI-H2009,3543504,4.270240870629309,4.637969333111773
EFO-27,702558,4.734643042503988,5.340044679597376
NCI-H292,107985,-2.5053359043606043,-3.3947165728295836
HSC-4,25154868,3.1331848354363063,4.429246353675383
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,-2.9084156505440535
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,-1.194296206583025
MSTO-211H,11364421,-5.484172518994792,-1.6171980521343832
NCI-H460,11238147,4.460003386993959,2.960980523843097
NCI-H2171,60700,-0.3771090207819011,-1.041228629470966
LXF 289,1641662,3.640483694902119,3.559370180666985
MDA-MB-157,49793307,-3.250396628323611,-2.292062170743995
A-673,3503,1.5343061624145853,1.6608932587104663
LoVo,10296883,3.831816674357036,3.8802633778510915
HCC1143,6917907,-6.676374133945339,-4.666093250115333
NCI-H661,44185566,2.810411867420033,2.6051740197869195
NCI-H522,23725625,7.287275637495971,4.431604938189263
BT-549,11175137,0.9532540120968724,2.7635932559861836
BT-549,9840324,5.7680719211185005,5.894150869378693
DMS 273,42642645,-0.2214891751848421,0.6370155897922956
LXF 289,24797083,1.462636821965973,1.341539596836043
A2780,9887053,0.4462184617201571,2.9804691286964053
G-401,3689413,-2.428789331956376,-0.55292398873686
NCI-H460,65064,5.803776096144955,5.091050790440381
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,1.85449207258226
CAL-51,452548,-0.9080095532304931,0.5171371810194947
NCI-H460,54613361,2.8642714411834502,0.3907744318189733
YAPC,675434,4.582728256156342,4.534389136398013
KMRC-1,4578,4.295676817145532,4.323987709037565
BT-549,387447,-4.9509675804959,-4.003325705199999
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.2382740434958717
EFO-27,11719255,3.4932821683662865,3.6075002100843614
OPM-2,219104,1.446566622432128,2.6115421438190056
NCI-H1623,6610216,4.306736710776884,4.3082956688076095
NOMO-1,23582824,0.0799476906959343,0.6794424153171943
NCI-H292,6610355,4.982353204264952,4.492745254037531
NCI-H2009,46191454,2.1369399253900347,1.6827583249803082
NOMO-1,3062316,2.517026306117631,0.005845596624778828
NOMO-1,119182,-3.695250738066314,-2.4064595734906624
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,3.4491416915785913
FU-OV-1,11364421,-3.956792545928709,-1.6065313226019493
OPM-2,17755052,0.9533058757913144,1.1559634335542694
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,-0.6334076500233019
DMS 273,46199207,3.605640907411319,3.0203328830805463
NCI-H522,55508,2.4640988254574356,3.246754026940223
NCI-H292,10385095,1.2562128411100733,1.462035063392059
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.578308641228363
CA46,107970,1.651382626144423,1.9083830619509938
EFO-27,5746,1.7615281276545924,1.3143768042336932
OPM-2,24856436,-0.767009816479034,-0.46369881000252633
CA46,25126798,3.582571225160254,3.463613711236765
YAPC,89928392,2.607647468641453,1.785848623403189
MDA-MB-453,3062316,2.3886014193927285,1.9970520062001487
MDA-MB-453,387447,-4.667010811634082,-4.171959338645269
G-401,107985,-4.394015959361378,-3.5100351721783163
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,2.6304531943200753
SBC-5,135875424,3.947045576812926,3.939093200216379
KYSE-70,24785538,1.5800117539652696,1.5715074827074045
BT-549,25262965,-2.559107571112332,-1.0239565216177302
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,2.926580906061226
BxPC-3,2828334,6.44946379786602,6.135713023401325
NCI-H460,3025986,0.3909368316008428,-0.7698091451842511
DMS 273,11656518,1.6608448179793895,1.4875490569508594
EFO-27,3825829,4.213579429540561,4.155980382204905
NCI-H146,44493528,1.3818057906729433,4.087221625086503
CAL-51,73707398,0.7053044464230985,1.218137864881192
NCI-H292,148198,-2.0841293800573446,-2.7877394538881246
NCI-H460,2828334,6.134119597935603,6.099504101227826
CAL-51,439501,-2.444412450902406,-2.3780948172560343
SNU-449,73707398,1.8238531786702632,1.5418712762767877
A-673,10322450,2.1969870036583323,3.6615019667345843
NCI-H2171,71466380,3.3392440967630797,3.9743356973888093
HSC-4,53392493,2.986961827224748,2.6397880884557208
OPM-2,1239801,3.3443313732590543,3.456157427295411
LoVo,9935249,1.1872155844887071,3.0147400193090936
G-401,1566236,1.5621622205700352,2.064850320897742
HSC-4,9907093,5.592562690426939,4.320792360580148
MDA-MB-453,445091,4.203535883394564,4.341291529717278
EFO-27,24821094,3.745327872256005,3.3000736886398205
KMRC-1,3038522,2.3225128068669676,2.9895801612249127
NCI-H2009,11427553,1.9586555200212517,2.871087222605861
SNU-449,25227462,3.4571199035251565,0.6340978998536173
CAL-51,136227924,2.079284078064279,2.8190144872465113
ONS-76,452548,1.1046001555889895,0.6756769055708207
SNU-449,25105715,3.5056666677867625,3.445809318730497
CA46,156414,1.2808873732328336,0.6558801147094614
SNU-449,400769,-0.6000208096132458,-0.4805372991074044
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,3.1825454800071395
NCI-H146,462382,-0.5302162316770459,0.27929080035077286
NCI-H460,613753,5.368273372553464,3.4244645739041846
MDA-MB-453,3136844,3.6967063162994114,4.274948784534528
A-673,5281672,3.4533278359325323,4.215663202943558
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,4.862785601682302
EFO-27,1716436,3.5844471141038823,3.1470899729629713
SNU-449,3825829,4.613153689576251,4.000045725066535
NOMO-1,73707398,0.2786764614411772,0.3869894062950172
A2780,568763,-1.431759576680003,-0.02672285161134288
HCC1143,6918878,5.533567107436573,2.7690344628797856
LoVo,11455910,2.8170443999319574,0.8165140357900762
EFO-27,23582824,2.0177544133250187,0.9074262076921871
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.6527637816480034
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,2.228568670826302
MDA-MB-453,44819697,-2.6195477020037696,0.055326877359666876
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.1591388128820395
A4/Fukuda,7326481,2.3355820774301206,2.719215445599979
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,0.014035363414434697
DMS 273,5566,3.001039957404815,2.9013412876586226
MDA-MB-157,148124,-6.016678597172854,-1.910891874594322
LoVo,11507802,0.9778049572121082,1.4678992513103004
NCI-H522,9444,4.166279980928258,3.945452654857896
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.7327371086967842
MDA-MB-157,9549297,2.7932032986762008,2.8198795739178064
YAPC,3689413,3.09003195173071,-0.1763960587017474
KYSE-70,10385095,0.9665013844498838,1.5455544035543758
ONS-76,11222830,1.7336224967240552,1.7278995309214873
JM-1,11625818,3.7613008305210727,3.445736470862162
LoVo,16736978,-0.2277330125842315,1.411939308544969
NCI-H2009,10074640,3.329342225437922,3.337413056052879
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,3.0580690154378134
NCI-H460,9866186,0.4176494313944011,0.8782351738481003
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.7064327436497115
A2780,60750,-0.3844759756013921,-3.1028013180896243
MSTO-211H,5329102,1.1990183253858175,2.231549558183169
NCI-H292,60700,-1.1983388185725197,0.2919348907928342
OPM-2,16659841,1.643311806599576,2.882834283805331
NCI-H661,11427553,3.4193847918785782,2.794112250298736
DMS 273,445455,4.9732665628078045,4.2927604124528465
NCI-H460,9967941,4.030885542149613,3.7272438181910883
NCI-H460,5281321,2.142807178276493,-1.1997159164105298
HSC-4,44137675,2.9134227764609735,3.4518525978566292
HCC1143,2729026,2.66692124656069,2.8666348821790213
LoVo,1566236,1.5203890875485482,2.249216961464628
NCI-H146,2842253,3.419228107779433,4.837688481831357
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,2.0922458769341334
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,0.685172691493093
NCI-H522,5311281,2.6748920868920125,2.1511969840768406
NCI-H2171,2945648,2.4840683519833835,2.28930351173932
OVISE,9840324,5.37005208850368,5.917495736345521
NCI-H522,11485656,1.866098793785005,2.060194225945073
LoVo,5280436,3.7935840263164984,3.4096984518497355
SNU-61,11152667,-1.0116802565381595,-0.6897215322870406
NCI-H460,2708,4.613368759945332,4.828390136952363
JM-1,6918328,-3.1408711543116854,-1.5722369982813218
ONS-76,1716436,4.404636467874722,3.0651965896301476
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,2.740441387248089
EFO-27,241158,4.165561573655071,3.983568974812741
A2780,7326481,2.2466116261364215,2.764421403057316
SNU-61,11507802,1.2021022137126776,1.429223184169822
MDA-MB-157,11404337,0.0143481506183785,-0.230876167378691
CA46,71466445,1.6737757590775906,2.3838226693991746
NCI-H727,5329102,2.005304296489746,2.072832450898164
HSC-4,51039095,3.5449735354798,3.0228837472255274
SNU-61,135411,1.4786327368897634,0.5952996008346669
KYSE-70,23635314,-2.258343718513796,-1.4744045848786949
LoVo,54619267,3.1603381625719,4.103619917998617
A4/Fukuda,71751553,4.0599050322296995,4.071152242201526
MSTO-211H,156414,0.8242215144670997,1.8608371734086153
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,4.544448468163527
FTC-133,44185566,3.3632936032593403,2.639443719303835
DMS 273,448949,2.08082767357287,1.9296191552650552
NCI-H2009,71466578,3.1093531088855797,4.689797489979104
G-401,44632017,0.8985354611426208,1.1001502319511132
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,2.913426481102934
HCC1143,107970,2.31840177997234,2.3004854450543424
NCI-H661,156414,0.2928474479064595,1.726357778557854
OVISE,216345,4.54917324344274,3.7054247931357973
SCC-9,25227462,0.3695734481821194,0.38106643686688707
FTC-133,46199207,4.2182762440826576,3.330460765654993
Panc 04.03,9926054,1.9560696374821285,2.055807181743076
G-401,6918736,-2.2327850291733577,-1.750965312684285
SCC-9,44607531,1.3853072214617428,1.3722421058296306
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.9397152976941356
HSC-4,171352865,4.360447231593142,3.01584581428207
OVISE,613753,2.681502253258482,3.2007455235796756
A-673,5282054,2.3452018577417166,3.263951297605664
CAL-51,5328940,1.595278406971918,1.63540738949542
G-401,426756,4.944025345893246,4.165506512846354
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,2.990610200192487
FTC-133,73707398,1.7335394908123083,1.1380881629998993
LoVo,20959075,-3.964629838563966,-3.033031894956326
LoVo,46907787,0.5340804086119918,1.8830470973797528
FU-OV-1,9907093,3.428205270837273,4.214381297572374
NCI-H146,5470400,-3.389889619220011,-0.6273520953315984
FTC-133,60750,-2.331663889988264,-1.151584690736208
NCI-H661,637858,2.3544841299222927,1.859413926662259
NCI-H460,24772860,-0.596461213785507,-1.7616350852680904
FTC-133,135999136,5.800253145127344,4.429576492934761
SNU-61,2945648,3.4316222719918903,2.924429829596187
SBC-5,52947716,-5.148190181120178,-0.7287225864310397
G-401,5311,0.6627378317361174,0.8665157095627781
SNU-449,25183872,-0.2769192593247403,-0.7888567228787124
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.0396402610124578
A2780,444795,1.1255727490438436,4.255639868678034
HCC1143,11404337,-0.7051632820466462,-0.13356511951316563
LOU-NH91,23582824,0.7266398713670753,0.9965885904094249
JM-1,24964624,1.3785887120991174,1.4211768376092306
SCC-9,6918328,0.8244293983868239,0.27933383411385376
SBC-5,44507138,1.9527307391432291,2.124203960980083
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,-0.29193412521701706
HSC-4,3081361,1.976322212956416,2.1976711530370547
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.6296510610775692
A4/Fukuda,73707398,-0.4328093310020208,0.5814724358234522
NCI-H146,2130404,3.7873290414593983,3.2427228470713074
NCI-H522,11656518,2.6059049947054533,1.332506294695661
A-498,11626560,2.3564203123568648,2.1140268846935464
A2780,17755052,-1.4995675278651837,1.5164672892801816
HSC-4,2841722,4.578140166849417,4.346381643338379
JM-1,44462760,2.3346005220819785,2.080733922279904
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.2720680420435497
FTC-133,4261,1.6400921135700228,1.6451909519450294
LOU-NH91,54618771,2.8270991446030593,1.2580246095028573
NCI-H1623,16720766,0.9555863303424396,0.812186401849584
BT-549,44632017,1.021144372127497,1.5846581638003285
NCI-H292,107970,2.31632347859771,2.3900825639078667
SCC-9,24753719,4.411411644196846,4.273889829495154
KMRC-1,4917,3.6746853329943248,3.0198551377098943
NCI-H661,72734382,5.266471995298585,4.714558556892282
SNU-449,4578,4.5704959764236675,4.2724840724085515
KYSE-70,9887053,4.5630363901990565,3.979068514937456
NCI-H460,81146,4.483282466350705,4.6819297346638065
G-401,637858,0.5800115670130345,1.4375970462239351
BT-549,5280436,2.325988989460079,3.4632633301791396
HSC-4,107970,2.304506496588027,2.224866508207474
NCI-H292,421610,4.310067764922952,3.1802037853145784
MSTO-211H,11175137,1.4320314455831638,2.553065504213436
BxPC-3,11175137,2.81920931641519,2.779963100007025
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,0.49474245753033846
NCI-H292,11625818,5.668815438823822,4.780009707748506
BxPC-3,3025986,-1.3024282207469429,-1.0705412770713238
NCI-H460,11364421,0.3566052665939138,-2.5729977121496947
MDA-MB-157,3385,-0.6145392702282009,4.507289457747382
DMS 273,44589607,2.105355871894398,2.461282530465823
SCC-9,107970,3.0149180037966095,2.258085683407667
Panc 04.03,17755052,3.2992451395509503,2.1745483675301207
LoVo,10427712,4.119455144779727,4.298414055083316
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,0.6470959162675115
OVISE,9825149,2.776616936788869,2.290547906522031
DMS 273,44185566,2.401025824688418,1.969663446973308
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,2.174903230514886
EFO-27,5329102,3.2209933806874926,2.337861138745059
NCI-H2009,3503,2.6223022737526085,2.4422652525425477
SNU-449,66577038,3.1506640300230075,3.075923636230479
SNU-449,135999136,4.264029635041134,4.057147507370013
MDA-MB-453,16725315,3.1590887754383847,4.070183378559221
SNU-61,6505803,-0.8091898598550518,-0.8844769851353433
Panc 04.03,6438330,3.1739512088269968,2.596633988489485
SNU-81,124202324,-1.5604837877349913,2.073771452349102
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,2.054509435467209
FU-OV-1,49850262,3.0107305406398206,3.8366378470538045
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,2.4709270695813843
ONS-76,54618771,0.5276024038238057,1.1195588018726468
SNU-61,5311,1.5459052759872411,1.2510247164248958
CA46,11612883,1.866301185217262,1.8569648705266875
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.6451708637857398
A-673,11960529,3.1772019850221054,3.8519217276101925
YAPC,400769,-0.4056066486406303,-0.40616711527482946
KYSE-70,107970,2.5727619321994353,2.2040765994229012
JM-1,5291,3.241129374385646,2.6723848844496207
KMRC-1,9444,4.31479767249553,4.186452416090932
NCI-H727,44819697,-0.26094531007839,0.1532719371882832
NCI-H2009,5351362,1.2372754831617516,1.717092984900958
LXF 289,53495165,1.0389398894889437,0.48463099176725416
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,3.1926495029487945
NCI-H727,123631,2.758434269009812,2.539814318589936
NCI-H2009,5311,0.3641463076187463,1.501714948676834
MDA-MB-157,241158,1.407364121620741,3.8495955946020657
LXF 289,24785538,0.6202102990423739,1.866181008729827
BxPC-3,10074640,2.675443562621253,3.1993897561340527
G-401,4378219,4.593157039926137,2.343560886631114
CAL-51,445643,4.334473435217703,4.0898398949300905
OPM-2,2858523,3.124441680057984,2.662070761861138
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,2.133689162902025
HSC-4,11175137,3.5997845208099797,2.5907953787932625
MDA-MB-453,25126798,3.9955340419002057,3.7710248401428
SNU-81,159324,-2.5700546068481502,1.9207756184697502
SNU-61,3552672,2.025857953798933,2.6187399849304853
FTC-133,246676,4.92384525208296,4.632182980325383
MDA-MB-453,11364421,-1.677319267600166,-1.4114638971362299
CA46,122327,3.963727711050333,4.141796328338843
LXF 289,262093,3.4150141342974605,2.2474823139699045
NCI-H292,6918289,2.42392533304279,2.905645023936587
NCI-H661,25154868,3.681430006213129,4.539591496180245
NCI-H522,327653,3.011425661783578,2.815318740027288
KYSE-70,44202524,1.884457998669868,2.5902290569158772
A-673,8515,3.2253171108003023,3.7484812949577004
SNU-449,6505803,1.2866498789511422,-0.32265583043441126
FTC-133,10074640,3.79174067417729,3.1719941359503734
NCI-H522,72734382,6.037966635177564,4.494642382690547
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-1.6832996564176208
NOMO-1,46943432,0.592792127892358,0.8268375829436514
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,6.19203302303005
MSTO-211H,15953870,2.3250629767102273,3.741968760224411
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,-0.7669150900147623
NOMO-1,24951314,-0.0494287054100275,0.631686641436142
NCI-H292,6918328,0.4467511585294103,0.4025937531502495
SNU-81,72193861,-0.4444993909438327,0.8081177732332994
SCC-9,9956119,4.352516606884389,3.7751154322550864
CAL-51,66577038,4.134711160885491,2.9193599166718207
MSTO-211H,44489675,3.600660518296678,3.8556014115643804
SNU-449,11494412,2.814472666417892,1.897619626242531
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,0.4648494234444575
NCI-H522,11364421,-6.31463288554187,-2.6930502085481356
OVISE,11222830,0.6942836946088363,1.7168321972428497
LoVo,135398516,0.8347424818537327,2.106248733951828
MSTO-211H,409805,4.793476239157615,5.246959898031417
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,3.297961629536884
MSTO-211H,9926054,1.9546831701161536,2.0765975210616556
NCI-H292,2749,1.484796478537434,2.0787401531672463
OPM-2,702558,4.8466631372101725,4.458908641514582
LoVo,71466445,2.646256567071358,3.8559496846884143
BT-549,16659841,4.205377629414311,4.05147901583004
KYSE-70,3025986,-0.3454993097331295,-0.758064868684696
NCI-H2171,15953870,3.344319567560605,3.1679540408955624
Panc 04.03,11640390,3.824707626147026,3.651627791830561
NCI-H292,5278396,3.8202006656128735,3.7241461214369025
NCI-H460,5311,2.161812802665503,1.5811973360498663
CA46,54596558,4.227379600712383,3.888251331657435
NCI-H522,50905018,5.2003053075185734,4.172337506708575
JM-1,54596490,4.858476490911798,4.024695462642977
KMRC-1,5281672,4.43646792139098,4.577424738173324
SBC-5,46199207,3.436092011920994,3.10059786329701
NCI-H661,46907787,3.1119891404607083,2.0396195382219697
NCI-H1623,11222830,2.056201659978474,1.6140870302648542
SBC-5,3038522,3.9213361824350024,2.8667976189445064
NCI-H661,9926054,1.7811448977738318,2.1140751757222866
LOU-NH91,969516,2.9922565120136944,2.855547447636098
MDA-MB-157,5329102,3.39801486229995,2.19189670959864
SNU-449,445643,4.11461116511151,3.960398218285014
NCI-H522,9887053,3.177768808520637,3.420726993682739
NOMO-1,16065773,2.6012917178973405,2.0484735681624473
G-401,67291369,1.7656191364648908,2.0975700401063384
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,2.0441326716128145
MSTO-211H,11609586,2.648073114002603,3.066436108677467
A4/Fukuda,25195348,0.8993846970771071,2.4540342490608964
NCI-H2009,54649381,3.659944396907473,3.9851702252136905
CAL-51,3025986,-1.0834382414923172,-0.8935573064836082
EFO-27,52912189,5.780518526906142,2.3108052488536153
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,-2.5252223643191045
A-673,123631,1.860693828866879,2.188024506031206
A2780,44632017,0.0856486258730489,1.1276717905263285
A-673,24901704,3.0162186042420966,2.4732585687872928
OPM-2,168312962,0.8773607091058507,0.15434706779294943
NCI-H292,46398810,2.6001901820453166,2.7013554721386672
SNU-449,53495165,1.8844225218094013,0.8393423304931455
YAPC,2749,2.2394739682848512,2.0322954137126765
NCI-H460,4788,5.894567383019075,5.633241415357146
LOU-NH91,637858,2.168731257760998,2.295561525903738
NCI-H727,11427553,2.8726920198872397,2.852665789584934
NCI-H2171,5978,-3.1305615418900468,-2.969612764130013
EFO-27,969516,2.57565712333896,2.9081543028168686
SNU-81,11152667,-1.3658791794225291,-0.4749205869295874
LoVo,2858523,2.923658201852042,2.970549707611317
FU-OV-1,56946209,-4.492733112758285,-3.637287168177217
CA46,9549297,1.0960598621603344,1.323378959381521
ONS-76,6917907,-5.751164378556486,-4.376247296847955
NCI-H460,51037431,2.104101453867928,2.9339604533959567
CA46,68056272,3.136594245199668,2.650551961583872
CAL-51,54143018,-0.6388505972102335,0.6392255937314926
SNU-449,5284329,2.300938885216567,3.722006287365642
A4/Fukuda,11609586,0.4485915276425587,1.8997376045454315
NCI-H146,9933475,1.6402256772331771,1.7052345852559168
NOMO-1,9927531,5.049638663441057,3.961213142742875
A-673,148198,-7.755828732328633,-4.421331771808341
SNU-449,2113511,6.338115821615388,5.609593369130788
NCI-H522,49793307,-5.2014711504438,-2.908783865780433
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,6.360321065005231
FU-OV-1,44493952,2.9850522959236883,3.5674197532297365
NCI-H661,5328940,0.9675290055268168,1.6882129832075246
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,4.26018228379982
NCI-H727,60700,1.7894131654495464,-0.21142111865258706
MDA-MB-157,10385095,0.7848337329764868,1.3617551501549756
DMS 273,46224516,2.6849968878024297,2.2319427867261044
G-401,1641662,3.2482177517563766,3.108634027637092
NCI-H292,448949,2.3471350598248795,2.217028073522803
ONS-76,3038522,3.87205505246704,3.046929903745431
G-401,216468,0.7704979015554879,1.9305370620737916
NCI-H727,10127622,-2.4732053445147333,4.158358140987593
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,2.6926376073365477
LXF 289,16722836,0.8079280065417594,1.620461412651824
FTC-133,11167602,2.051836472120041,2.804835021072608
LXF 289,3825829,3.6707575370566534,4.0235396713132126
CA46,25150857,1.719157108492683,1.7384965570755582
NCI-H727,3025986,0.1020219293656271,-0.6578199069815461
MDA-MB-453,107985,-4.386344018126506,-3.493849490494071
NCI-H1623,72193861,2.1993190803521423,1.8251310981533384
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.641815299829709
ONS-76,12001922,1.7268373273866384,1.899631361606264
LXF 289,5460769,3.06478422280727,3.0140025504305408
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,-1.0384687244621338
LoVo,9967941,3.621110602900207,3.713698778555587
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,1.0695837139123312
NCI-H727,5113032,6.018394893069797,4.802834257553088
MDA-MB-157,5351362,0.7984725267524495,1.4766416780485014
JM-1,1641662,2.861679408031504,2.736392842945481
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,0.1721807752403699
MSTO-211H,445091,2.4700472101717312,4.533426022493911
NCI-H146,11404337,-1.5914515878545687,-0.5618863009499395
CAL-51,11364421,-3.809863778172731,-2.4261028009463432
A2780,4096211,0.5297517602102724,1.4483590233072068
SW1463,23635314,0.7077124425294024,-1.4136460821084518
EFO-27,9933475,2.2279721994416364,1.9906640200259091
CAL-51,135875424,4.33643967165441,3.7223284241784205
NCI-H1623,15983966,2.013058792543676,-0.8393043563187237
SNU-449,3038522,2.1807259662851735,2.9730452011442647
SNU-81,969516,2.098687325749346,2.53819489876996
SNU-449,9935249,2.650976699885872,3.4108072882056804
LoVo,10385095,1.3603816893768768,1.290796206779379
ONS-76,322968,4.979501026393853,4.139536985652135
DMS 273,9933475,2.0005654751864865,1.7362807560609632
CAL-51,71466578,5.340961831553399,4.339807731518852
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,3.105427974504952
MDA-MB-157,1750826,-3.091616753079083,-1.5418776651500203
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,4.626911906191956
NOMO-1,702558,2.777027807122979,4.297259416569646
YAPC,60700,-0.2763967023007928,-0.22614156524682258
CA46,5287969,-2.5448622649608925,-2.6057311335276436
CA46,15953870,3.0438117584706164,2.6077693495209138
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,3.113619616747248
YAPC,6610355,5.243598963135711,4.539903421562076
SNU-449,4477,0.3396527753410003,0.710474146879613
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,1.9366365163824637
SCC-9,168312962,1.0708744032070256,2.0874095948712865
SNU-449,119607,5.345576432951938,5.404667056035906
LoVo,135999136,5.7154474843469565,4.204430374569746
NCI-H146,984333,-0.904410626141992,0.4769286752587389
KMRC-1,54619267,4.117989845600413,3.869599102878324
A4/Fukuda,11485656,1.5130746228374388,1.9454882255585213
BxPC-3,5311,1.3160685062040935,1.4719419559851434
NCI-H522,3038522,2.4524519125835473,2.947570547016947
SNU-61,89928392,1.2163192063780537,1.3761225840768185
FTC-133,5287969,-0.5047683720981219,-1.7129137602287614
ONS-76,25062766,2.430053801867403,2.1046227108257782
NCI-H2009,44486219,4.368704582532332,4.407789081471934
NCI-H522,637858,0.9732265340904396,1.6702071207248685
NCI-H522,44632017,0.530418286591973,1.0977827137043854
SW1463,11485656,1.9271812519349985,2.0835658013767304
SCC-9,46843906,3.309522412048413,3.197020891997295
A4/Fukuda,6914657,-5.308594861321554,-4.182986762408993
LOU-NH91,36462,3.2256365983613677,2.2831041444985156
NCI-H1623,3825829,4.488518875119825,4.164670414142704
MSTO-211H,56946209,-4.75779739938848,-4.04441851722689
YAPC,11427553,3.397606686380644,2.692873110203933
JM-1,426756,3.661156723786521,3.903022497607063
JM-1,10184653,1.3269176228991806,0.5269840323785945
NOMO-1,11497983,-3.443590431300748,0.5204513305865289
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,0.574350867005105
A2780,9952709,2.339079626269582,2.9284850212083664
MDA-MB-157,9866186,-1.7048510464532898,1.2866099892920666
CA46,216239,1.3191761483145148,1.7530750471782586
MSTO-211H,176870,1.3974668510804569,3.502931459981686
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,1.1605058670525963
OPM-2,135928012,2.8826672527394956,3.387977339100171
BT-549,9915743,2.34179420613382,1.2695902043447107
LXF 289,71304818,2.1201305139291033,2.694540511240145
HCC1143,11214940,2.1301365232114144,2.3617275483860114
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,0.3134829248320559
KYSE-70,11404337,0.2060464556058333,-0.5706313617871261
NCI-H2171,11152667,-0.915095731247344,-0.7051333165450399
HCC1143,46191454,1.52291312584366,1.8223711864162868
SNU-449,71680916,5.959793136995753,4.72987533223208
YAPC,219104,4.027438046449075,4.0736846308761265
JM-1,446155,2.7706022090916793,1.9471096897030091
BxPC-3,46398810,2.2883583084835126,2.5683754688378064
OPM-2,2828334,5.82639787583413,5.909156028150744
A-673,44137675,3.4578104481213905,3.1702205548705806
FTC-133,7251185,3.0292037228467628,2.557828254948397
KMRC-1,676352,1.883475825529446,2.098663516688209
EFO-27,1641662,3.8267974599371417,3.537688555903309
G-401,168312962,3.2015141434031547,1.4322592243834178
CAL-51,2945648,2.7250935788350064,2.9811543711389263
CAL-51,71466445,4.7818956768695715,4.109128178500797
JM-1,5113032,4.766616079684312,4.643451009561003
SCC-9,24821094,2.906183993814488,2.8121102738366632
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,1.7561228935483835
NCI-H292,216345,3.474677020151061,4.019519197600411
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.8556042184182113
SBC-5,9549297,3.510799485826288,2.2121782583251357
CA46,156422,3.7635879578153126,3.169722979428913
MDA-MB-453,71466445,1.9167870178623896,3.5472826022670194
A-673,54596558,3.847043372257958,4.264343646319237
OPM-2,10231331,0.6444733525039235,0.705115092216548
HSC-4,5335621,5.235604448739508,4.694299389961642
CAL-51,11719255,2.5837610433465588,3.2655685176602316
Panc 04.03,44493528,4.362737332857046,4.402128676767468
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,2.7358307445882493
NCI-H522,24821094,2.425713290484283,2.7026913538960735
CAL-51,6610355,4.388066889778601,4.417710283211754
MDA-MB-453,6438330,2.0150251794967655,2.338132787879848
Panc 04.03,46199207,3.759856924739056,3.378168592604373
SNU-61,9866186,1.5207851909017442,0.7477165029438823
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,4.4018733407173345
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.6489431315456884
Panc 04.03,71466578,5.726073349824824,4.634573353587721
NCI-H727,107970,3.133468251114326,2.263088343942404
BT-549,60700,-0.4810674620852896,-0.14201353741293965
OPM-2,51037431,4.229346700902662,2.8177677788069873
MDA-MB-453,56946209,-4.730570165381635,-4.021884982479352
NCI-H460,72376,-0.5460239014371263,-1.978301597252557
BT-549,44241473,4.976602861760902,5.152234537811812
A2780,24748573,1.2286507677110594,1.934312605837699
NOMO-1,5311,-0.031303965270056,0.47567602807746057
A-673,9927531,4.216692000672551,4.47128959208778
NCI-H1623,46199207,3.747077477678168,3.1838655332208172
NCI-H292,71304818,2.830949431838268,2.627268061488769
NCI-H1623,9911463,3.95788841498078,3.8987838325169544
SBC-5,9825149,2.9056064620320896,2.188993936715944
NCI-H460,11612883,2.88158995470921,2.8770692737257195
OVISE,6918878,5.066606594706477,2.71021382586427
FTC-133,5278396,3.726623182659884,3.6129605084151626
Panc 04.03,24775005,4.54660450697204,4.11773477948295
CA46,1641662,3.144498035259472,2.865835107398289
MDA-MB-453,16722836,1.2443221263797826,1.4090146014836602
CA46,54618771,1.203400154931592,-0.09603926667239544
HCC1143,613753,3.4353326628352714,3.1995878936586437
A-673,60750,-4.61356677624384,-3.4394728236977654
A4/Fukuda,1641662,2.3667755294261297,2.8280937569297824
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.9694811073551781
MSTO-211H,375860,0.0606650448750636,-0.18244077139706757
BxPC-3,6184667,3.26727461265582,3.2159838709240036
CA46,227681,1.829365253324193,2.4768424135453033
SW1463,11964036,0.627645429671571,1.123376820862781
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.1494351078730263
FTC-133,49766530,-1.1381086002707512,-1.0808798288289743
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,4.183536260351484
NCI-H292,11364421,1.76762986564817,-1.081874642656581
KMRC-1,44819697,1.235264283084374,0.14417784392671373
NCI-H661,9907093,3.834837743900246,4.272374581615371
DMS 273,17755052,0.9609599247674856,1.7141889558179404
SCC-9,11364421,-0.952029021799848,-1.212626554494918
FTC-133,135984461,4.350998124633342,3.934633522400985
JM-1,11497983,-3.7280544169699192,0.5787207757392282
MDA-MB-453,24753719,4.38597739181452,4.1253308044686
ONS-76,168313047,2.901208476511606,2.3456182706472934
NCI-H460,67156097,3.7191617083219097,-0.4165875877309654
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,2.7662700073719764
A2780,9866186,0.3046354439957303,0.5011654439733645
HSC-4,219104,4.150323587810277,4.040838234925203
SBC-5,168313047,3.954131669958023,2.4450892995693105
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,4.215537435107544
NCI-H292,15953870,3.631273190289841,3.7326511561668805
SNU-449,5281321,-2.557888043471457,-0.8371649854638723
HCC1143,702558,5.703077608026742,5.119156576674703
EFO-27,644241,3.241988529302909,2.4624027466518954
Panc 04.03,9911830,2.4999304852863404,2.6293814610467927
NCI-H522,9967941,3.44539283334302,3.1888170104845255
BT-549,44607531,1.5480457992975702,1.5751284954900067
BxPC-3,44607531,1.3275313586220698,1.3460113929107438
KMRC-1,24951314,2.7376925539969927,1.5427432305892124
JM-1,10231331,5.343116821873739,0.5100265961714097
A-673,25262965,-3.9892118887375303,-1.6360243451770506
FTC-133,1716436,3.3698315146098015,2.88211076882315
OPM-2,2733526,4.066729211955922,3.4730502412519413
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,1.8437997692268078
DMS 273,3825829,3.788583241717048,3.683069548884845
KYSE-70,3825829,3.6022414485207452,3.9942124793317224
BxPC-3,5351362,0.9304368738373464,1.4562850176968494
NOMO-1,6918736,-3.755126975181922,-2.084472188645588
A4/Fukuda,11977753,-3.131569873612884,-2.0563126671279606
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,-0.6558454556885002
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,2.0333209242015275
A2780,73707386,2.710080958425795,2.60134201038994
SW1463,44819697,-0.8614164905769626,-0.3716087167959642
YAPC,24180125,3.806846010722946,3.013152661974299
NCI-H727,54649381,3.660865770056845,3.8441064834368035
SNU-449,2708,5.735631765174737,5.0076490257855655
CAL-51,54143018,-0.6388505972102335,0.6392255937314926
LXF 289,753704,4.962227230589067,4.86940202198262
NCI-H2009,9907093,4.391694288558607,4.364086814074775
EFO-27,387447,-3.111228692284437,-3.9230348320345296
NCI-H661,65064,3.46809117241053,4.6468938026867015
SNU-61,5278396,3.627128978826316,3.403846127303833
NCI-H727,452548,3.7056139041011034,0.5686333726738991
NCI-H292,16720766,0.3451831901206211,0.800193401973985
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,2.144094985000211
A4/Fukuda,100016,4.8831896191852096,5.0943364053358895
G-401,25126798,3.708942608188802,3.423320353778576
SNU-61,24951314,1.416243399270427,1.2983010180630838
CA46,89183176,2.547561715641907,3.201509486451442
Panc 04.03,2746,3.3610494767062513,3.350433396664168
FTC-133,107970,3.2744864550719126,2.2885681180260296
NCI-H661,6918878,1.4921814323330362,2.526127204947275
YAPC,24951314,2.2257819926279243,1.5926221581761602
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,2.2205643670426456
LXF 289,216345,3.67485776854348,4.068659577513711
G-401,5287969,-2.352936827953192,-2.0480781230221656
LXF 289,5566,2.9960878643930218,3.0169394407998764
JM-1,71680916,3.747509118270568,3.902733495546384
LoVo,16741245,3.141864677583783,4.169267884383652
NCI-H661,54649381,3.920223147571483,3.785993611804471
EFO-27,25154868,5.200143123549252,4.5706087928847605
SCC-9,25126798,4.663845786250664,3.958741500786856
A4/Fukuda,24964624,-0.76967256635286,1.366344288196251
A-673,11178236,-6.344930978772708,-3.68353533369897
SNU-81,3825829,3.873341985908314,3.70346941287246
KMRC-1,36462,3.0698954920529324,2.104029331854582
NCI-H661,262093,3.4983141095274126,2.8848972268739197
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,0.8262821596623504
G-401,676352,1.5550652369933835,2.0259789182480863
SNU-81,11228183,0.0397441918833689,1.5137842146053677
MDA-MB-453,10385095,0.8735195901829151,1.1506670724952914
KMRC-1,16065773,3.457331493974802,2.6388603431593576
CAL-51,5328940,1.595278406971918,1.63540738949542
CAL-51,56946209,-4.496983035262223,-3.6909134604485963
FU-OV-1,5329102,1.609553320034118,2.096978541266875
YAPC,3062316,1.4892918633711576,0.9814097084412629
NCI-H661,11609586,3.2377833862635206,2.9261261114326618
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,2.1495222887239174
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,2.0272379105177363
JM-1,36462,-2.702351282209385,0.24836502197674026
EFO-27,55508,5.431657737658487,3.7362166925128286
CAL-51,10296883,4.0377332681132305,3.797271541277573
CAL-51,123631,2.4616591372530605,2.3390310985584675
A-673,53481919,3.7180877845578073,3.6052604804766486
JM-1,107970,1.4704012549786991,1.810871733795492
CAL-51,5278396,3.885366261927898,3.505272086201306
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,-0.27147314061113625
KYSE-70,4096211,2.254549645630953,1.8557255134083113
DMS 273,11609586,1.9163652577621844,2.4335014444883685
EFO-27,9903786,4.039986452778869,3.178468708269368
CAL-51,6917907,-8.395782425589301,-5.18202003907973
A-498,54454,2.893611310147977,2.859753393386813
A4/Fukuda,49793307,-5.572580515048152,-3.826932065801271
NOMO-1,4259181,0.2459758371125145,-0.5609039645296848
SNU-449,107985,-3.1392486992039235,-3.2134716651476545
FU-OV-1,5278396,3.713343254157872,3.72495932500069
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,3.511416664763286
A-673,5460769,1.3883868162718005,2.1644534297843228
SCC-9,568763,0.9120329628896908,0.7654679818388301
CAL-51,72199292,1.0008292341873897,1.6737309528655828
MDA-MB-157,8515,2.4995790404865983,4.00590548295641
NCI-H661,374536,3.546483103952357,2.454179307650121
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,1.5346574270240163
FTC-133,53392493,3.195209876090235,2.703981217743696
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,3.0694859490858595
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,3.0323989578027226
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,1.868361952245252
NCI-H2009,3825829,4.333180881174198,4.145315424807253
A-673,6610216,4.190818336865809,4.149154707572435
LXF 289,1750826,-0.5305094201812034,-1.1577070211389984
MDA-MB-453,44543605,3.7347256504274418,3.7480427066052413
BT-549,24964624,2.3327253679943696,2.67908961271507
DMS 273,24797083,1.0969779553781829,1.100911560116255
NCI-H2009,24856436,-1.037334288977755,0.8369606715039649
ONS-76,73707440,4.1934861569389845,3.982744023962167
NCI-H2009,1242560,3.090706196906407,3.496647578535828
NCI-H2009,6610355,3.511475006316147,4.657420483604422
CAL-51,51039095,2.1842093640891416,2.80843530681421
CA46,11404337,-2.4021967063511434,-1.9579044295465826
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,0.42156695120704774
NCI-H292,11152667,0.5464898224488388,-0.1768574443045545
CAL-51,25154868,4.656760297450745,4.389898429947447
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,-0.6439683830394577
HSC-4,66577038,3.591157601556467,3.04819213414405
LoVo,11175137,1.7419612548831422,2.6459417400968177
Panc 04.03,46215462,2.9027075063139804,2.0871759681341233
G-401,1750826,-3.031444880989549,-1.550662987392835
SCC-9,462382,0.912003027061621,0.6805841222049088
NCI-H2171,71304818,1.9125624841179896,2.174369288829746
NCI-H2171,6252,2.1051572182795,0.003978622341114369
G-401,51037431,3.9974576184013726,3.1235322893754516
SNU-61,219104,3.1068483513637033,3.2774038070462073
SBC-5,60750,-3.858196401702703,-2.2088533331569056
JM-1,72734382,2.7239851923699443,3.727104876360136
EFO-27,2733526,4.707486415914075,3.845091470160853
A4/Fukuda,71466445,1.4546499284121797,2.565422192930859
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,2.4987558940971786
NCI-H460,24797083,0.9153025805785596,1.398217441971918
A4/Fukuda,54596558,4.022693113590735,4.143931026282726
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,-0.2046554764033785
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,2.190267600548317
HSC-4,44202524,5.184990397771561,2.3102062629071907
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,2.9617764963922
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,2.374679964653646
OPM-2,9915743,0.7579871544404475,0.7152300518463557
CA46,56949517,4.303265452215328,3.3885930122500407
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,-0.5151862047091403
CAL-51,24785538,0.7720267524795773,1.5454097429124658
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,2.113639913834122
CAL-51,10322450,3.881825194853649,3.8650217297966116
A2780,241158,1.61479428578643,3.4717379374058446
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,0.1342783251164541
LXF 289,10074640,2.806214579062189,3.131821310329004
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,-0.5418243525063868
NCI-H522,119607,5.115168095819997,5.170004608500789
A-498,6918638,1.620608219340894,0.8193521179382582
CA46,10302451,0.2515382956842912,2.5622960097295056
NCI-H727,11152667,-1.354343634557878,-0.1600024924581388
NCI-H292,135999136,4.360218039072087,4.337626471253241
NCI-H292,322968,4.489137987914782,4.117418073966489
KMRC-1,11238147,2.6910045327617422,2.726796479275288
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,0.9171678532331287
NCI-H522,9911463,3.273817127322074,3.608922085971855
A4/Fukuda,26596,-3.7061252239164553,-1.8532440537746038
CAL-51,2945648,2.7250935788350064,2.9811543711389263
FTC-133,10113978,5.149340897630058,3.4266315944128523
G-401,25227462,-4.354739504605027,-0.4095558767298155
CAL-51,3634881,3.319714226315486,3.260558676299978
NCI-H522,5280436,1.9285860105900432,3.2446020313761075
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,2.3031518139825606
A-673,285033,-3.783680268063714,-2.9161997458554665
KYSE-70,11497983,4.3699696445826035,2.928187536534555
EFO-27,135423438,3.7049046399150134,2.5408519895774306
CA46,26596,-3.5845712744961324,-2.2824671827655765
A2780,24785538,0.5365701421591345,0.7906197234538564
NCI-H2009,8515,4.894015987740437,4.037302288607072
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,2.072822756033772
JM-1,387447,-6.033292615187937,-4.994505170450069
DMS 273,9956119,4.190734481617164,3.4228497378704037
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.1335596446622858
NCI-H146,36462,-0.9223549938225544,1.2769751611414386
NCI-H1623,11485656,1.644044907667622,2.3702744896494714
NCI-H1623,24821094,-0.2323488781711246,2.9160184837774885
HSC-4,53301938,4.738168418112686,2.7781134019244815
LOU-NH91,676352,2.464978676736505,2.097662885123533
NCI-H146,46926350,-6.324766796143129,-4.534680171598222
ONS-76,16722836,1.7132123007700326,1.6811592841178247
YAPC,327653,3.117178905090827,3.415131221520823
OVISE,24901704,4.2849421736627615,3.171579987341342
JM-1,54618164,3.458143614246244,3.6262780782153685
A-673,445091,4.1466370846962075,4.277082826795206
OVISE,5329102,2.956482132219437,2.292599053046414
HCC1143,5470400,2.3870928447001867,-0.7462709824187277
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,4.9492681860884655
SNU-61,3503,2.986460298481687,2.219455988410859
DMS 273,11455910,0.4737958394902512,0.7053109572462278
NCI-H460,46907787,4.3372157131836255,2.390426398434677
CAL-51,216345,2.9520334452605637,3.9198824943093458
A2780,6450551,0.1349302943593443,2.0544465798378004
LoVo,46398810,1.578557668618055,2.425390173271429
SNU-81,15953870,1.3050219745867302,3.171267618460001
A-673,54613361,-0.6759826855411176,-0.3100407000064294
SBC-5,11234052,4.136817608168693,3.9692886356192143
NCI-H460,36462,3.103581216464206,2.143747409134056
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.7978333899873151
A-673,168313200,1.7801049656035806,2.585690323638404
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,2.503731617076964
A2780,100016,4.757543521992015,5.760195394385965
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,3.4835654801148466
CA46,25105715,3.628482142858773,3.1004692013825053
HCC1143,9911463,3.749174224015704,3.972286208253924
LOU-NH91,4477,1.3512747052000795,0.8077711881578178
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.2825027525353867
FU-OV-1,25154868,3.6525772823030502,4.42152751163863
A2780,168313016,3.896841135664639,4.682172997623827
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,1.4622792845458201
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,3.2900914484936448
NCI-H292,15547703,3.23498204624142,3.270235652034655
JM-1,5329102,1.4301495534996294,1.5177078954082104
NCI-H522,3384730,2.8239588226941104,2.6668654964574214
A2780,9911463,2.7303797257759235,3.4899649497500285
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.2176782734331644
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,3.1801990525585264
YAPC,9887053,4.707664045043398,4.081725323813065
HCC1143,10074640,2.8253679093766104,3.234297644627597
LXF 289,11178236,-2.9660816129263297,-3.572502587749922
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,0.45891448115049543
KYSE-70,135398516,2.3739819683449697,2.3882704560331174
A-498,57519531,4.461574036812888,3.070814935449748
NOMO-1,9840324,6.741383080584752,5.489723670105372
BxPC-3,10427712,4.346184062898943,4.4043466018128665
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,3.5215003340120767
LoVo,25062766,1.8850615394111836,2.0681862853190016
FTC-133,262093,3.024825063724614,2.986525161072578
HCC1143,44819697,-2.8669414823386115,-0.10333838650314671
BT-549,5351362,2.1022372489581227,1.6547870710326098
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,1.6010744655894502
MSTO-211H,53325874,5.432400358349695,4.715393626384732
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.23436250564089
DMS 273,7326481,3.48743847164077,2.7510942975839274
JM-1,11955716,-2.692308040243548,-1.9980479929566766
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,0.4803392168961716
MDA-MB-157,2842253,6.170125707570699,5.46164778242348
SNU-61,54454,3.789888893365768,2.512626955793922
NOMO-1,5460769,4.769752092364765,1.5577450650917493
A2780,285033,-3.502152061737446,-3.0422949307018827
HCC1143,44495899,4.517503920361928,3.831280044946043
NCI-H661,31703,-1.814857416200904,-1.1052857495458328
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,2.203474591974075
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,-0.6902549551906914
A2780,2729026,1.9590477988732768,2.454159981387161
JM-1,89928392,-1.0810313065311572,0.2959660220467414
JM-1,10410894,1.2527004533251185,2.315876185537966
NCI-H661,16038120,1.553795977052523,0.9322508407817925
LoVo,135421197,2.0078610802467307,1.8285966520853612
HSC-4,24901704,4.088081803824046,3.5530519838177965
HSC-4,135411,-0.261300177061483,0.6617979260872967
NCI-H522,4917,2.9130794248329392,3.0273748507440614
JM-1,11364421,-7.32386861469755,-5.081048322979856
NCI-H2009,10127622,-1.471627480680591,3.9705695403424013
DMS 273,4917,3.103248515982538,2.8597337281139152
OPM-2,44462760,2.3304413416808463,2.1578955472323385
YAPC,9956119,3.92905072911681,3.725455316858172
A4/Fukuda,5113032,4.450145517718883,4.370163536190302
NCI-H1623,49793307,-1.4788317062169576,-2.290399908140933
BxPC-3,637858,2.219072546092823,2.3302775865257566
NCI-H1623,1566236,4.077529389730835,2.458747188610674
G-401,23725625,4.115882586635449,4.3127961163002775
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.60636283763911
DMS 273,252682,6.321322886147215,6.318450492675698
KYSE-70,135411,1.9014599224142343,0.5311251445596007
NCI-H2171,49867930,3.814749813399888,4.368388481705434
SW1463,10302451,2.197754569420114,3.286679312841995
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,5.0783469715172425
NCI-H522,71466445,4.480637973076106,3.493191318189673
NCI-H727,6610355,5.167779637611195,4.517772558352234
A4/Fukuda,613753,2.966875582154842,2.9146429319682436
ONS-76,4261,2.2909626551681757,1.596067743775861
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,2.2557271743680034
KMRC-1,31703,0.3325905755235477,-0.9273252486784388
SNU-449,445455,4.484776409201516,4.652795832516369
A-498,6918878,4.306638073301365,2.9707056268042775
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,3.7576359613132064
OPM-2,1750826,-5.079410714013139,-2.6036231301151416
NCI-H1623,9915743,-1.6977137550638366,0.6963691154566913
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,1.891105999146491
SNU-449,7251185,2.777592648573664,2.5796569847342568
NCI-H522,2733526,4.089503686239825,3.782350096488415
LoVo,24180719,2.381979820549913,3.5922424921341705
A-498,49793307,2.582548635431232,-1.971675254811859
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,3.4211464396645823
NCI-H522,4788,5.8756804910396925,5.257990601096325
G-401,374536,1.448879337840406,1.6940413326613515
SBC-5,135440466,3.787084066930897,2.34509110380043
BxPC-3,36314,4.043064497836865,-0.9020463406346502
SBC-5,11626560,2.9533832336239985,1.644301001044012
OPM-2,613753,2.6904302784099845,2.896035489422987
G-401,71466380,4.3225707153388,4.217566343790827
G-401,45279963,3.527434868311602,3.4987588952668074
MDA-MB-453,1239801,4.069717893467032,3.836992560002336
A2780,11719255,1.8256962189728296,2.9104418119675897
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,-1.2177772344044702
HSC-4,11404337,-0.2351979780524762,-0.35083383467019713
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.6501951136600723
JM-1,5978,-5.097158196512326,-3.4764241753276894
BxPC-3,6917907,-5.822397614063261,-4.987625287168137
NCI-H2009,52912189,1.2519346625881922,2.4944253899399973
KMRC-1,6917907,2.5901706443444477,-3.623663241885529
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.1581677320641588
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,3.920492910017025
KYSE-70,2746,2.8005709054024224,3.0673159520793094
BxPC-3,638278,3.0042450495358923,3.4559601916663136
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.7249408569195495
HSC-4,31703,-2.446577735650292,-1.3132946647273969
NCI-H661,11152667,-1.7022631730770723,-0.5232331127786939
SCC-9,73707398,1.5896934234406246,1.3002337091683527
FU-OV-1,148198,-3.302287500778492,-3.6294869893825124
MDA-MB-157,5287969,-2.775456728988527,-1.5215417216577578
OVISE,6918289,3.317561176891493,2.9144481995164995
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.6645688294719228
HCC1143,10296883,4.463772522749199,3.830349463995313
FU-OV-1,25150857,2.264135178575504,2.5591554851854053
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,0.7215539553283195
BxPC-3,16725315,4.1100247270568815,4.290829450136561
EFO-27,11707110,4.483747329636401,0.6823389459964601
A-673,2858523,3.068752318729834,2.9601065678677827
OVISE,5280436,4.204860612632051,3.593220640845442
NCI-H727,122327,5.896927010318378,4.576917597580942
CAL-51,448949,2.479839067238928,2.053403918136817
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,1.7281382480407463
HSC-4,72199292,2.0552941548988506,1.4940744156409065
NCI-H2009,36462,0.0033291412741449,2.132379707434589
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,1.2048514561615369
JM-1,71466578,1.9829041072742877,2.8310112760778856
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,0.7096554801248527
LXF 289,67291369,3.4412292386368746,2.533691230919519
NOMO-1,5281321,-2.1390969134868656,-1.9764004296371658
NCI-H661,387447,-3.746079371333459,-4.126357039187821
NCI-H460,10385095,2.2920897819597896,1.3208869116726065
EFO-27,3543504,5.270070957864149,4.466074816259274
NCI-H2009,11497983,-2.437134563400756,4.1065238219401765
NCI-H2171,4917,1.7834364774656617,2.7312590221444513
MDA-MB-157,4578,4.4846224734546025,4.59916978825968
A-673,9935249,0.595201632659186,2.469848662481155
NCI-H146,4096211,2.4692816884948856,1.587061333091391
NOMO-1,60750,-2.6028640292275567,-3.866744546741391
NOMO-1,676352,2.3647709516043336,1.8227534894271498
SNU-81,168312962,1.078666024421789,1.2722113090014364
A-673,3081361,1.7117642477526505,2.417981189674403
NCI-H460,46398810,3.30325787352206,2.5349090150020728
FTC-133,24771867,3.849205905915908,2.3433003098611525
KMRC-1,409805,5.852991634240623,4.958590010485565
LXF 289,2708,6.094251503540483,4.922769402690825
A4/Fukuda,11647372,-0.68075141177871,0.48611544711445065
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,3.39750840375399
NCI-H522,3025944,4.039653719751215,4.181866025158893
HSC-4,6918289,2.856015155241233,3.079544667350404
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,3.090537882482691
MDA-MB-453,67291369,1.3466484853812946,2.4240190914120494
A4/Fukuda,11178236,-5.149024442366163,-4.157687906319508
NCI-H661,168313200,3.81404568417466,2.8429391638634507
EFO-27,219104,4.121088157278177,4.096327808989889
KYSE-70,46191454,2.1451937437577575,1.905194638162849
SCC-9,9927531,5.254709651648818,4.646527029364238
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,0.6456587831811349
CAL-51,16038120,-0.248771562775031,0.7922144436763561
JM-1,3634881,1.559410928505107,2.5861237709063123
SCC-9,5113032,4.570528604758655,4.906985080246297
CAL-51,68056272,3.9955701948507247,3.6862689919967626
CAL-51,4521392,4.667802355757324,4.263408649048383
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,2.068565347311217
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,2.7638413099138486
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.7890887839135794
SNU-61,9887053,4.377899885829067,3.55870236982746
NCI-H2009,25102847,2.121570289721804,2.519035870633574
NCI-H661,54454,0.5886754914082402,2.70022790064013
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,3.1886375827760842
MDA-MB-157,46174525,4.215722898807237,4.473284095932355
LoVo,5978,-0.9838296745754056,-1.9444828476472005
NOMO-1,44137675,1.7607667559168472,2.7291105534094946
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,-0.09987129193845767
FTC-133,216468,3.7386330008080018,3.2008562788689914
NCI-H522,5284616,3.1429047752915036,2.0982888604331444
A-673,6450551,1.2504532759531255,1.8128539831031427
MDA-MB-453,2126,4.599537631708682,4.435027463280287
FTC-133,12001922,3.1425787892022656,1.932934539895588
BxPC-3,6610355,3.939463034432562,4.5276737492160075
Panc 04.03,72193861,4.339971647759762,1.9827137520765543
DMS 273,984333,0.9143511576606916,0.2931784319768596
NCI-H460,126941,-2.220790788147435,-2.7834971650454237
SBC-5,11178236,-5.106449128542812,-3.574527217039203
A2780,11497983,-3.587231584220661,2.3776328825724167
EFO-27,5278396,3.98166727080577,3.720721268855409
NCI-H460,40482356,5.06381124686115,3.4653507104288126
OVISE,51039095,3.497583622307714,2.9238178801948407
HCC1143,56946209,-4.25120546555742,-4.061908997425366
NCI-H2009,3025986,-0.6988289053859157,-0.7739661473148394
DMS 273,44543605,5.15097132829554,3.8726114199627024
HSC-4,23635314,4.118860430098142,-1.5184347661503237
FU-OV-1,107970,2.0514231206369686,2.3639971155492843
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.8291122818001873
A-498,5284329,4.906845392884974,3.8819596156370375
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,2.9240180868167447
A-673,11612883,1.6900414301434703,2.2055609228633046
DMS 273,11507802,0.7884214749573938,1.143698977438054
NCI-H661,44486219,4.876697308801278,4.475956194680593
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,3.2590738136138864
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,3.140341194437945
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,0.687189050186841
SNU-449,135875424,4.841371934548395,3.9722129077368438
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,2.8663570481477785
NCI-H292,72376,-2.1951743702669573,-1.5887461202698514
CA46,36462,0.0715644321871689,-0.26623748423636795
A2780,54678924,1.3135335490837166,1.5844969942371718
JM-1,9926054,1.6867956204893688,1.6172261576951086
LOU-NH91,4788,5.956614254075031,5.747529210507866
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,0.9319183610420929
YAPC,9929138,5.651296587688524,5.610671018183878
CA46,613753,2.777360120502711,2.7148889806191674
BxPC-3,159324,1.5239234886257875,2.8748861889913253
DMS 273,9911830,2.0619640796568848,2.3545098028568243
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,2.215449212374635
ONS-76,17755052,2.9613727126940126,2.0312696195758426
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,1.3895262063738856
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.9880263474708457
BT-549,56963564,0.7590937126260752,0.7021074687469955
A4/Fukuda,135398738,0.2588260022635366,2.9392649654868994
FU-OV-1,6918328,-0.3184221939986219,0.22135692108561433
NCI-H2171,119182,5.854927706564024,-1.04373562575026
LXF 289,46224516,3.632609368126253,2.475429536213761
BT-549,66577038,3.347380186099457,3.0692821420216205
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,1.1385549156229644
NCI-H460,25183872,2.110783783288614,-0.7672163816110459
CAL-51,17759555,3.5733302595078182,3.5629013301281565
HCC1143,4788,5.8180322078124265,5.541938001740244
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,3.4925316468176213
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,1.8094914128463222
A-673,11656518,-0.6930464248114873,1.2284196245143064
NCI-H522,12003241,-1.5672925136718587,-0.9376454810214591
NCI-H2009,19582717,2.816304614086765,4.322284073627667
LXF 289,9911463,2.935801973679381,3.9989178406578367
NCI-H1623,44202524,1.6623127043604982,2.542846575609812
NCI-H522,9952709,3.5153076410238477,3.013102405172853
EFO-27,4378219,5.419366677908557,2.695192467119385
FU-OV-1,11404337,-0.2130364442314083,-0.3211020842512887
FU-OV-1,119607,4.651010364988691,5.268579956536246
NCI-H146,135875424,2.9115600315347057,3.4310670904282845
LOU-NH91,11152667,-0.304989451834292,-0.466256736304009
SW1463,439501,-0.3046644173954531,-1.834495329256948
LoVo,25022340,4.929882293123705,3.1105433405049268
NCI-H1623,23725625,5.633484297207613,5.236576443865321
KMRC-1,439501,-2.7889227637684773,-2.1423633635290145
A4/Fukuda,9907093,3.513986602103764,3.7562520387755463
A2780,969516,2.2684147801302155,2.6182012406680344
HCC1143,24753719,5.247680835091332,4.395000656634442
DMS 273,25183872,-1.4455230978287994,-1.1325858951802825
SNU-81,3854666,0.9917295007006844,1.9803698624576795
NCI-H522,57330099,4.380671698756577,4.181470515271115
A-673,135421197,0.3124298336996849,1.53971911715093
NCI-H460,46398810,3.30325787352206,2.5349090150020728
NCI-H661,52947716,-6.022145864838143,0.17617414368212267
CAL-51,9907093,3.7886359098281783,4.261311921371366
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,2.9515638902133134
SCC-9,11640390,4.170413196512925,3.5636320035132916
SW1463,56973724,0.8689023909239705,2.600126513417149
HCC1143,24180719,4.266131781804432,3.6300090932474585
KMRC-1,135398738,5.381791034510906,3.9141154930112054
BxPC-3,36462,3.4182720226712457,1.8285840926993868
MDA-MB-157,4261,1.9483424687424111,1.715345093676018
NOMO-1,2708,4.2098167660909525,3.493256027887759
A4/Fukuda,10410894,1.64506751408979,2.8201799074397593
A2780,3384730,1.1479192192658911,2.2544719576800802
SNU-449,439501,-4.772752939359215,-2.1578455002636407
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,-1.2548442140903442
DMS 273,51037431,4.4079331684726775,2.987603995366811
A2780,16741245,2.3123767413084786,3.9396154750421344
SNU-81,42642645,1.3921275935464503,0.5811614561754916
CA46,44632017,0.5480853683486498,0.4914632971883067
A-673,71304818,1.350808371963784,2.169000783889047
SNU-449,6914657,-4.967870149056919,-3.878270330850508
MSTO-211H,25150857,2.632878402859221,2.6150107160356186
MDA-MB-157,26596,-2.8480155125253623,-1.1399471446115468
LXF 289,9929138,7.38651684018349,5.696910767686676
G-401,25183872,-1.5190566583165497,-1.2747547441053044
A-673,241158,1.6738540084680422,3.60591352858981
SNU-61,25195348,2.878615726844662,3.1368872597528576
MDA-MB-157,53392493,1.7008245883035995,2.527346650312652
LoVo,68056272,4.365145786196869,3.6574862733400524
NCI-H2171,6918837,-5.273009588122425,-3.7876517864902586
NCI-H460,168312962,-1.8333752522095308,1.5109049331905382
CAL-51,44259,0.1826439745217317,1.062741797857689
HSC-4,285033,-0.8602386046724618,-2.0064881272955977
EFO-27,25105715,3.778793980481446,3.5029734485237984
A-673,1641662,3.2069303925294625,3.139037937686108
KMRC-1,3854666,2.659759078644905,2.470695382832907
DMS 273,375860,-0.4468381354972334,-0.14322484344045236
NCI-H661,10231331,4.850159308010921,2.147420121473355
DMS 273,16725315,5.248612259787856,3.97694340232198
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,2.053342183398085
NCI-H661,73707398,1.1965083244926786,1.3187179739340809
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,-0.2214907513597279
NCI-H1623,135421197,3.7764453326534855,1.9835637645692124
BxPC-3,24951314,1.2340413323146109,1.3620809355082337
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.058836758824655
NCI-H146,119182,2.1823445512420308,-0.7591525292896171
G-401,4578,4.054730999265937,4.273012114508827
MDA-MB-157,6918837,-2.759774975538005,-2.4409175571135457
EFO-27,9907093,4.474758252228614,4.362222286755175
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,-0.7751116796308277
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,1.2371804317444737
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,2.816016300906748
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,-0.5379431597358796
NCI-H460,3025944,5.476008686130055,4.263222124073339
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.5290059704795718
NCI-H292,9915743,-0.4817131806939655,1.1576139526671623
LXF 289,44202524,1.498501439362416,2.589183682205004
OVISE,135411,0.7729741022965545,0.7465751574280367
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,4.474138237997099
NCI-H2009,5746,1.7505534195957702,1.3219769926249487
A4/Fukuda,10184653,1.3612642262853822,0.8420627998529043
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,2.036296244891271
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,0.6868356584854451
JM-1,375860,-0.4977027167273706,-0.3293422687733694
SNU-61,46943432,3.2717403410494397,1.974302537346385
NCI-H146,168313200,1.5894074456272884,2.6537180185266775
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,2.0080912195769427
NCI-H2171,6184667,1.4164127707768046,2.5805752525298318
DMS 273,10184653,1.3805891581139824,1.3224243471888506
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,0.9195197783846131
SNU-81,24856436,-0.0712468901893707,-0.027649282932758357
LXF 289,71680916,5.339150924844951,4.797732380288485
CA46,5291,2.960224941202677,2.893203800506547
NCI-H2009,5329102,2.1297157842750756,2.2094880057049835
HCC1143,49793307,-2.279288310815399,-2.1377865076691847
HCC1143,15953870,6.0969880807250085,3.6750486593340708
BxPC-3,2749,2.8971498792709784,1.941999820539949
SNU-449,12003241,0.2005365129445947,-0.625511428339161
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,2.122458596083885
MDA-MB-157,2733487,0.3711294020076626,5.936131983162948
NCI-H292,3025944,4.3344233170115185,4.366467909361607
FTC-133,637858,3.731185140297224,2.2416257062419978
NCI-H1623,387447,-3.670338978810225,-3.980972554197764
JM-1,5394,4.3191880254190425,3.492390864721196
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,0.6957318025175471
MDA-MB-453,24964624,0.7400526464517642,2.298920570222175
SBC-5,637858,3.033148612268187,2.1010395972595926
HSC-4,3825829,4.330540788358233,4.200094189350942
LOU-NH91,26596,-0.8372049149458933,-0.9142427882002616
Panc 04.03,24180719,4.502790622897018,3.591256720687806
MDA-MB-453,44486219,3.97168660448306,4.260004704202612
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,3.865175397748305
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,1.0137936049987073
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,1.1136267665097803
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,3.216851901768702
A2780,46398810,1.6945681809511193,2.244993992611913
ONS-76,44493528,4.396938069944904,4.513823370071413
HSC-4,3854666,2.969420021692798,2.0997807457418456
SNU-449,5291,3.951163668523845,3.819620617038236
MDA-MB-453,216345,3.4613524333124337,3.558357874416386
NCI-H727,71680916,5.541731669631066,4.648654721010069
NCI-H460,4261,3.676509117184606,1.7347447125988007
NCI-H2171,10184653,0.99528741531969,1.0419492290486627
FTC-133,54626689,4.834884112239084,4.667892872347598
A2780,55283,0.78738067747292,2.4242170900952646
OPM-2,753704,3.6202062566191984,4.0718985357142685
NCI-H522,53392493,1.8355339375888644,2.3207530433398227
DMS 273,10127622,5.766745520319409,3.5968745026515467
ONS-76,BRD-K58730230,4.314454311755605,0.7109820582527422
MDA-MB-453,49766530,3.3081056054922064,0.011127128357462782
A2780,16065773,0.67384212990199,2.200088025426194
JM-1,241158,1.7269305863155773,2.5177686080020583
A4/Fukuda,71466380,2.851115718652883,3.8938837788946667
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,3.546553088392364
MDA-MB-157,16722836,1.792866712111087,1.8932117647692026
NCI-H460,6852167,4.590065962834362,3.1779088109783427
SCC-9,375860,0.1694000381305893,-0.3213607991613502
CAL-51,54649381,3.902782783768603,3.8747401587585686
EFO-27,2708,5.128228617584202,5.0270945830440645
G-401,6450551,1.2745400494425214,1.9789619605791091
SNU-449,168313016,5.914877518762689,4.91756735723272
NCI-H661,654092,0.3537062860674825,-0.2119467200436236
SNU-61,5284616,3.808934677012338,1.6164768318160376
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,1.1312214525669946
KYSE-70,25195348,5.534160735777195,3.2698802007839927
NCI-H2171,135421197,2.0026019926205185,1.3297264991023265
NCI-H460,4261,3.676509117184606,1.7347447125988007
DMS 273,1641662,3.247845954250749,3.1932233770166305
BxPC-3,6914657,-4.023901786471393,-3.397487623760868
CAL-51,9936388,-5.638746232401389,-2.3480684225462833
A4/Fukuda,25161177,3.5710974046751804,3.8820003665215226
NOMO-1,24821094,3.1222382635594967,2.470616597452783
A4/Fukuda,53232,1.4709221708336295,2.6107530454559917
A-673,9840324,5.96119566119886,5.690474185101297
LoVo,613753,3.444351424595812,3.2324530470255466
FTC-133,4477,0.2258553638980791,0.6628144859427383
MDA-MB-453,11214940,4.455338804672604,2.4401971219554945
A2780,56649450,-0.3009304069219352,3.105671576964109
HCC1143,89928392,0.2924123173203115,1.5720599931875057
BT-549,6852167,2.654575121453327,3.0744750392579805
G-401,375860,-0.2910974790080222,-0.44298690157544174
NCI-H661,613753,3.3170674343428708,3.1646057901554197
YAPC,71304818,2.728620236586343,2.649719866301586
NCI-H292,3503,2.756562172316919,2.4010959849240456
OPM-2,44819697,-1.6539436611429392,-1.3004251533746864
HCC1143,60700,1.3373007617879429,-0.29247993327439226
MSTO-211H,446155,-0.2868964860821164,2.8974688305729486
A4/Fukuda,2708,3.0461577581065007,3.7260698586518286
SNU-61,126941,2.173772773827979,-2.6921306785386965
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,2.981705650453325
HCC1143,444795,4.803024181226615,4.692523371160303
JM-1,441298,2.4952150007247393,2.225226349242125
DMS 273,44507138,4.08877163590395,2.1159304962167793
Panc 04.03,5291,3.9842309161066063,3.855791568163869
BxPC-3,3062316,-1.891072672499,1.0128983912361536
KYSE-70,15983966,-0.1847866067827735,-0.4176565078852945
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,-0.8216983173159494
DMS 273,44607531,1.5313743675110545,1.30644005895666
NCI-H292,5746,0.9253562515034884,1.1747577714654074
NCI-H146,6914657,-5.6838858588772245,-4.376081262539095
EFO-27,25150857,3.1416161415552173,2.72764107214506
SNU-61,54618771,-0.470226071786205,0.858824599161286
BT-549,1716436,2.964006130486385,2.928621284868895
BxPC-3,4521392,4.6952932183187,4.359683938512536
BxPC-3,5328940,0.9544734009845622,1.357162841772729
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,3.315550555147865
Panc 04.03,16013152,4.359497957481629,4.282492115454348
A4/Fukuda,3062316,0.4248767517614322,0.803557661130975
A-673,11609586,1.032418246609784,2.328999824840202
SW1463,322968,1.9625017896764745,3.423408550578265
JM-1,11427553,0.2949480151387566,1.3099057854261102
CAL-51,11497983,2.6322425573174213,3.2695555318522964
Panc 04.03,12003241,0.3752932920389255,-0.6219811702360661
FU-OV-1,216345,4.02478525181321,4.052168704343053
NCI-H522,89928392,1.1479343378844449,1.3370752748343258
NCI-H460,11485656,2.6212830818798065,2.3818942504146587
LOU-NH91,6438330,3.480541802748286,2.580178135186237
MDA-MB-157,11228183,0.9797898244038654,2.1234529749340765
A4/Fukuda,10385095,0.4549399411675465,0.8200924251446796
G-401,241158,1.9889661714459972,3.4674435971644737
MDA-MB-157,5282054,1.4096594950320644,3.601076130068121
NCI-H522,11404337,-1.4542746262182442,-0.5289574647656196
NCI-H661,322968,4.732962604670861,3.697778637331422
NOMO-1,65064,5.083490310509571,4.056327031747848
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,-0.4501408345517737
BxPC-3,1716436,3.6064873492654943,2.9526926732108585
NCI-H2009,24753719,4.192950544032197,4.363269970532065
BxPC-3,136227924,2.62858882862477,2.8818923988625924
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,-1.2011401088303761
SBC-5,3854666,0.5257720708282073,1.9048031015093188
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,0.29210046072231094
NCI-H460,1750826,3.3189287492303197,-1.3087859701448306
A4/Fukuda,4705,2.104501352907832,2.768958619993131
BT-549,24821094,3.680768028115557,3.2935813910220393
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,3.2175606773479517
A4/Fukuda,46398810,1.5683404384737003,2.027784220176749
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,0.9413889963114846
MDA-MB-157,3062316,3.257879214731084,1.128400634383253
NCI-H727,71466380,5.170266193783112,4.54339743517215
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,1.8645688865196035
HSC-4,16038120,1.7232268235274473,0.9226787238146187
FU-OV-1,53392493,2.412509849766808,2.492456667011973
NCI-H2171,3634881,2.317126021520602,2.9216808917266324
DMS 273,54618305,4.272082763698834,3.7885859832287547
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,-3.7870082148974884
SNU-61,9926054,1.8929452670989917,1.7733575335874163
MDA-MB-453,216239,1.9202357593604051,1.7643494448872172
A4/Fukuda,252682,6.117343290485243,6.023858157448816
Panc 04.03,11455910,2.454958233695195,1.1516066687729116
MSTO-211H,24951314,-1.1401244239295247,1.2505331142296585
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.1359028269617217
NCI-H146,67156097,-2.3396756899377595,-0.7512836135524843
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,0.5449024753928355
FTC-133,25150857,3.5794152247995004,2.625723342947067
KMRC-1,24797083,0.8876318381449373,1.6520458836040033
KMRC-1,5282054,4.624285853166485,3.8931678099998117
MDA-MB-157,36462,0.1516360669313773,1.973832114432264
SNU-61,11609586,2.423992088951442,2.7431809690212763
MDA-MB-157,4378219,2.6716514190617104,2.8715785437688197
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,0.9047310836867157
A4/Fukuda,57519531,1.5811593813701257,1.6226095634217015
EFO-27,136227331,4.702115323060179,4.348494767879583
MDA-MB-453,9952709,3.2945084007394616,2.949451059650427
G-401,54143018,0.971383874427432,0.04320790769558841
EFO-27,9927531,5.387402639259967,4.924064816833439
DMS 273,3025986,-1.574939205922683,-0.9731687253615903
NCI-H522,26596,-2.5500947066960276,-1.5360168277428228
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,2.218194519297237
CAL-51,5280436,3.749440064194485,3.2983886301345704
SNU-449,25150857,3.008716268425874,2.686980874661927
KYSE-70,23582824,2.6933165956875964,0.8626079167249934
OVISE,54454,2.25285494204451,2.8825899007091165
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,2.533251897335815
MSTO-211H,5282054,2.057664237493602,3.6933692271919547
CAL-51,16720766,0.5416929462446769,0.43653398879716193
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.442095617045205
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,-0.44937082098831604
SNU-449,446155,0.8119451390236352,2.5683813666166544
NCI-H146,375860,0.4213004900992469,-0.023584600099076498
CAL-51,5281321,-0.4656602142962174,-1.4335792765038502
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,1.6227281721487776
NCI-H2171,44462760,3.915746717375186,3.2687910114818903
SNU-61,151289,1.0402759766313254,1.0258168100208176
DMS 273,24856436,0.3584417497554937,0.09842304715143292
CAL-51,71466578,5.340961831553399,4.339807731518852
HCC1143,44607530,2.3193328073886628,1.8480878526361255
SCC-9,3136844,4.895725881728452,4.370348316967926
CAL-51,148198,-3.728190383000159,-4.122151723101926
DMS 273,25126798,4.049346019168164,3.6319332220176386
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,0.0699322363036276
A2780,9825149,2.396834344892177,2.334950513081094
CAL-51,104842,-3.020036586723177,-2.81842241286564
A-673,676352,1.522059533133182,1.928034204337433
FTC-133,9967941,5.123707260677636,3.879791753621481
NCI-H2171,56963564,-0.0417490265139498,0.008605371627545872
DMS 273,753704,5.000496745911757,4.681068368897793
JM-1,6918837,-6.173851145057706,-4.838767791724997
KMRC-1,285033,-1.948983558292048,-2.023201651791928
FU-OV-1,54454,4.96368280899624,2.941014062706037
LoVo,11152667,-3.1828514843907967,-0.19788106710296824
A2780,3081361,2.3669572433114663,2.123284076330847
CA46,11497983,3.715862022418827,0.3558086230973088
EFO-27,9952709,3.7128554087131658,3.1671020333774687
SCC-9,3503,2.580691900576731,2.313873519133134
CAL-51,42642645,0.4324607401831485,0.765427111499779
NCI-H522,462382,-0.0152056919239,0.2882211466535142
NCI-H661,44632017,0.8459474985730225,1.7431252951204
LXF 289,44137675,2.0502885463252665,3.7872530314582873
SNU-61,11404337,-0.7844361329588494,-0.44335942587963023
FTC-133,15983966,2.5675405254421113,-0.7221469802494676
KMRC-1,56946209,-5.003023698532595,-4.086604479790671
CA46,9866186,-0.3275085520058725,0.06447727974283653
DMS 273,23635314,-4.293922540672693,-2.174816399433271
LOU-NH91,4259181,1.0248896787271708,0.2890650473135424
SCC-9,46224516,2.803045033456012,2.4884328880740063
SCC-9,6918837,-2.658799999554452,-2.4699589943794265
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,-0.7242875027694851
LOU-NH91,15983966,2.104720476479653,-0.22257618391601666
NCI-H661,285033,-2.1039671806681985,-1.9421746676207767
G-401,16722836,1.0452487365316014,1.5188568526027495
SNU-61,11964036,1.5202881054490238,1.0840258643912941
MDA-MB-157,374536,-0.5698586384338129,2.639910365283311
OVISE,168313047,2.139797955827927,2.565392526849363
LXF 289,400769,-1.8947060859446272,-0.48898475316063367
BxPC-3,10302451,2.105262518783424,3.278487616461928
KMRC-1,446155,2.327207673229407,2.854504903498876
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,3.221394428048632
MDA-MB-453,421610,2.7771188964172664,3.0355076254763547
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,-1.577587844325535
OPM-2,2113511,3.5660346238413565,4.81866207499662
ONS-76,31703,-1.5971524717515937,-0.6010188007046635
CA46,100016,3.773189878640827,5.045064195887765
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,3.195672624610929
EFO-27,11167602,3.5204241483481686,2.800661584187673
SNU-81,6505803,-0.5044882096333503,-0.9761309016858154
NCI-H727,1716436,2.7605133955676178,3.067317631260397
OVISE,10302451,2.747913318530857,2.960621778581088
NCI-H292,24772860,-1.7688616980402292,-1.6383825133181358
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,2.1969111356569044
Panc 04.03,702558,5.6133476434957,5.552980883704908
NCI-H727,24964624,2.2819429425827984,2.657511643356728
MDA-MB-157,2828334,5.757584300180036,6.093378429749873
NCI-H2009,67291369,0.975633217461442,2.769012602030045
EFO-27,421610,3.836140121936173,3.296922744940146
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,2.976140438400068
LXF 289,11626560,1.452143156792952,1.8828524315057422
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,2.793140220156264
NOMO-1,9444,3.521396869825756,3.723483598478931
KYSE-70,24821094,5.190593902676824,2.8490130874054977
NCI-H292,104842,-3.713576042756873,-2.5734337116340824
CAL-51,23725625,3.781531245600544,4.965496240541756
MDA-MB-453,11175137,2.676203543730399,2.3773620513372635
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,-1.0549165361616095
OPM-2,3038522,1.4393753112244685,2.4813852291596743
KMRC-1,107985,-3.501321688193531,-3.496939246170306
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,2.2898072663237796
FTC-133,9549297,5.410509835078823,2.5000702584294876
HCC1143,66577038,3.1905565845946993,3.0419635679356913
A-673,73707438,5.240927680887528,3.754514705933364
LoVo,44137675,-1.419079349485425,3.6611309433073633
SNU-449,3503,2.7484718807665396,2.275970574644523
JM-1,11960529,4.3881984442046384,3.3606907365721206
FTC-133,5460769,4.281031552964228,3.1339064058603
LoVo,3025944,2.9449078290251256,4.170924827831835
A2780,613753,3.052273906836147,3.0319831888564432
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,0.9108440185524533
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,0.40957904931711353
NCI-H727,119607,4.980733327072692,5.3363781022708165
A2780,15983966,-5.363621110890126,-2.5960886282048947
LOU-NH91,52912189,2.021653283813576,2.3140921915423327
NCI-H2171,46926350,-4.867098709680934,-4.526528632344317
JM-1,11222830,1.159649219525665,1.202915491572805
Panc 04.03,9887053,4.247469701197239,4.406082638885744
MDA-MB-157,6918878,0.7604288199483474,2.743220722442544
DMS 273,25150857,2.151062266440261,2.301875858861813
NCI-H2009,637858,2.463099291034241,2.2826172207685826
A-673,89928392,0.0772153864579325,0.7634820478595958
OPM-2,56646779,4.429673228200906,2.905401757844407
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,1.3366447740349852
MDA-MB-157,104842,-7.463907387011825,-2.856559917900737
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,-0.2452392002041979
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,2.0220305363855027
SBC-5,23725625,4.5493880465204235,4.740723807519137
CA46,16736978,0.453820731366511,0.6463345626208521
SNU-81,5287620,-3.371703836172312,-1.7861198532678693
OPM-2,9929138,4.40255967212205,4.899976682264424
CAL-51,107985,-4.126908547019261,-3.419908643894641
SNU-61,4261,1.9153687598051303,1.4006918200259966
KYSE-70,5311,1.3049127753558711,1.3666410615862414
A2780,2874250,4.6617329815359545,4.39330364708386
A2780,46843906,2.4977538844634637,2.5183934150523877
FTC-133,11234052,5.0298463189452445,3.9339852620164084
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,2.3219207539682363
OVISE,5282054,4.4060399380094415,3.527853652668305
HCC1143,4096211,1.556998125169598,2.1156864298521376
NCI-H661,11364421,-5.690348879388773,-2.5634830599011775
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,-3.6697641368695586
A-673,11427553,0.6536689467636717,2.0376389833868567
JM-1,6917907,-6.147483124234289,-5.12502296937225
A4/Fukuda,9926054,1.7963505717751411,1.762610068466743
Panc 04.03,65064,5.203402541242721,5.14963959037978
MDA-MB-157,25154868,5.338832763625219,4.52757949097492
A2780,3689413,0.5219259729031659,-1.0866219860284603
NOMO-1,2828334,5.727397129817869,5.839365075353315
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,3.4480652850611673
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,0.6533984792464095
A-498,10385095,3.0502652475567347,1.6815359196859987
NCI-H460,5280436,4.847067650781305,3.4862323230071577
NCI-H146,71304818,1.6140243095299662,2.193581034224556
SNU-61,135398516,5.118120351018792,1.9275124926932872
HCC1143,9967941,5.23006520077408,3.6099495856619286
SBC-5,51039095,3.807088636542375,2.3853539812052573
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.567405319817271
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,1.121429085424607
HCC1143,44137675,2.963488174732173,3.6270655835345202
EFO-27,15983966,2.453959425588555,-0.6094175953746495
NCI-H1623,10184653,-1.536462891864862,1.042791682103687
JM-1,216468,0.5768131010636649,0.8825965524689152
KYSE-70,5278396,3.1929088159597656,3.413954575364693
SW1463,216345,4.078496637973622,3.94004044108834
MDA-MB-157,54619267,4.18775168816921,3.956153151028717
LXF 289,16065773,1.584092119185821,2.7424448954156015
Panc 04.03,107985,-4.416167995938274,-3.6311577333087457
SNU-449,11238147,4.105269625362408,2.9837936434603636
ONS-76,66577038,3.2799369572038977,3.039979129134071
NCI-H1623,156414,-2.396664487331107,1.1524307589060816
DMS 273,4578,4.680938801431088,4.24259254953261
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,3.3600948067435956
OVISE,73707398,1.6715872061037895,1.6575325223563069
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,2.2134667398271795
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,2.2750305847984222
G-401,2945648,2.835527608429738,2.4682715886460005
BT-549,89928392,1.2423762488932544,1.5872958800309158
NCI-H146,107970,1.621489555747201,2.0484052215947197
OPM-2,71466380,2.758760560312852,3.6754315847195183
HSC-4,15547703,3.6362413258054063,3.057393068652529
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,1.1997393520616886
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.7027984702484844
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,1.091741605969052
HSC-4,17759555,2.4253306074953978,3.633936120093838
FTC-133,2945648,3.116487231281591,2.9483776167649425
BxPC-3,3825829,3.4267099071969738,4.035184136096944
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,3.834125331062054
NCI-H1623,3025986,-1.391492623029173,-0.736930518270743
BT-549,3025986,-1.1986125704978905,-0.8008195545454458
JM-1,25227462,-4.63830716322272,-2.585112457300829
EFO-27,4477,1.1283660363220671,0.5490141986863984
LOU-NH91,52947716,2.984350097195249,0.8192320034902368
CAL-51,44489367,4.725330666921359,4.424140148086142
DMS 273,2949965,2.5486766063035056,2.73900146543183
MSTO-211H,36462,1.134601353001676,2.1301916837136248
BxPC-3,4917,2.980696163243889,3.2271887283175347
CA46,9903786,1.650432742323398,1.8631831562383354
CAL-51,156414,1.13799157004995,1.5790408906129902
OPM-2,6610355,3.590135914900994,3.877022389631676
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,-0.7864816444696732
NCI-H661,439501,-2.903837615768139,-2.22774201775638
Panc 04.03,9952709,3.610885547265169,3.3566133243540555
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,2.010581161322905
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.618273324392844
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.5987786492492
OPM-2,2708,4.148168261065231,3.8602354878923877
NCI-H661,10385095,0.8549868667974337,1.2871576344134732
JM-1,24785538,-0.4888535449792195,0.38170611277066874
FTC-133,6610216,5.488595178062795,4.310656429027334
MSTO-211H,216468,0.7149646325927866,3.2830447200029043
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.7297383272356475
NOMO-1,5978,-2.430694050184869,-3.247022706227399
DMS 273,216345,4.389361768667068,3.8428584960020915
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,2.3177781588142436
LoVo,676352,2.5317553470156646,2.2023899034353143
Panc 04.03,107970,2.70125557955606,2.4522274536975597
HCC1143,11427553,3.376761154443363,2.4233878323401807
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,1.790701221330888
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,4.720607736509995
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,0.4713675119232883
NCI-H292,11626560,1.446983052748098,1.9798020151893214
EFO-27,3062316,-1.351094232476051,1.5114143782463578
MDA-MB-157,2746,2.873003215594031,3.1640158513618344
LOU-NH91,24180125,2.532676427085935,3.274342121161877
JM-1,135411,-1.048960589681706,0.032801314442497
NCI-H146,644241,1.2089846023639548,2.0604214001744108
A4/Fukuda,72199292,-0.4044306818473915,0.84864310574909
SBC-5,135421197,2.079587314097717,1.9320409087626869
SNU-81,6918837,-2.735310336273069,-2.9723724637828655
JM-1,7326481,2.606242200480973,2.3238457541825714
LXF 289,67156097,-1.7104573080698593,-0.5845583862223942
CAL-51,89928392,1.068329558331595,1.4784426809628934
A-673,6505803,0.2745970276233078,-0.8424365380649224
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,3.2056166718873413
SNU-61,15547703,3.101064478021952,3.1506697772111663
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,1.969413189107992
SNU-449,16065773,2.84526561612217,2.535849085616839
MDA-MB-453,53392493,1.7017875748321412,2.2492130554439327
SW1463,11317348,3.510696959395443,2.247466977253869
MDA-MB-157,11214940,-0.245291289631715,2.5551011421469276
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,-0.6173543148676718
OVISE,44202524,4.183655897410181,2.415664559280204
A-673,11964036,0.9382905451812168,0.8450998445078726
LXF 289,3503,2.5386473527097837,2.498920669690013
MDA-MB-453,54678924,1.5140521677167769,2.0518566836749788
SCC-9,2749,3.600343159035071,2.15694726858754
CA46,9840324,5.575806842573594,5.448859900283351
DMS 273,54143018,0.522600880214995,0.2467223014196344
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,3.5077395817061343
FU-OV-1,25102847,2.696211974787464,2.42376937813343
KMRC-1,73707398,1.5458693028147192,1.2581914136128303
A2780,5287620,-3.13264442622338,-1.8357166499912132
NCI-H460,54619267,4.901891634717457,4.064507675079082
EFO-27,2945648,3.241602940948522,3.1646781514673665
NCI-H522,25105715,3.4847863866008755,3.354826418110597
SBC-5,638278,3.4285441526954687,3.467779954962313
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.9307460671559673
CAL-51,6918328,0.3807555589851347,0.1992774693049676
NCI-H727,11497983,4.370504456176288,3.599428657605019
NCI-H460,4259181,-0.2054535095090753,0.33576814402451904
FU-OV-1,16741245,4.362196150231273,3.9758715203599353
SNU-449,9911830,2.1326623866395487,2.634536585815257
NCI-H727,5278396,3.8599732465447247,3.6578848655105896
MDA-MB-157,44566777,-1.1276584651283623,0.6109546536875506
LXF 289,656346,1.157307128170796,0.9345617758571269
CAL-51,176870,2.9999818119422175,3.1787966865733286
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.1267163233423867
SNU-61,10184653,-0.5580603125211917,0.8666454440504847
OPM-2,25126798,3.830489811395835,3.444226703857791
SNU-449,49793307,-2.0136733678876335,-2.1729509756494134
NCI-H2009,60750,0.952457111724262,-1.9793954831961957
MDA-MB-157,60750,-2.031758614917575,-1.7318511777235666
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,2.889627445188612
MDA-MB-453,44137675,2.41330993625909,3.471816225198072
DMS 273,5287969,-2.213452126148289,-1.9656141531374376
LOU-NH91,11609586,3.3390226168587716,3.227801520736695
NCI-H661,24951314,0.8780582238506052,1.1359074785548888
A4/Fukuda,6852167,0.513003696591474,2.0883093935121253
CA46,5311281,1.0891225881142432,1.5186042000750835
A2780,11625818,1.819164792403796,3.9521137190494966
LOU-NH91,51039095,2.9779244840652295,2.9232852122177597
NCI-H661,4096211,1.4698398043308702,2.2095711381772394
LoVo,4705,1.5085236639058903,3.0413595352267073
MDA-MB-453,46926350,-4.337117227146235,-4.260214798747226
SCC-9,5738263,4.330654025732234,3.4292417123833796
YAPC,46199207,3.321634350680955,3.2439832454722946
A-673,71466578,4.1904953682389,3.704886643608713
G-401,10127622,3.1466102465201793,3.8185308879954163
A-673,5311281,0.6354511881397967,1.7410661940568002
Panc 04.03,6917907,-5.49357619863333,-4.594462211029667
OPM-2,216239,1.2934585013066655,1.6593057292136248
KYSE-70,1716436,3.404085131889099,2.848992843845449
NCI-H727,9887053,6.41036176282966,3.6685466202905004
NCI-H460,11404337,1.7201854837770862,-0.1438155426415002
CA46,24901704,2.114836921018661,1.8990463029909435
NCI-H292,9903786,2.498172259524573,3.2464180010990775
A4/Fukuda,9927531,3.7257201794253776,4.223620818264897
CAL-51,2113511,6.39897875596168,5.559631111018233
OVISE,409805,6.403340651497087,5.280101752852735
HCC1143,11626560,1.5863706836040057,1.8724360595566296
CAL-51,26596,-1.4638590943230956,-1.2800413976154477
A-673,23725625,2.0065405091728272,4.515402406017253
DMS 273,6610355,5.006954006570411,4.197561347703796
A2780,24901704,1.9524214470888757,2.808373898799866
SCC-9,11494412,1.4365999648395638,1.842329391780772
DMS 273,4788,5.897035505528926,5.526190519157901
NOMO-1,46907787,-1.215006340822028,-0.2291652081068106
EFO-27,676352,2.5978940444924703,2.1773640817430504
A-673,44607530,1.766367479354274,1.6546053815604909
SW1463,9887053,1.032433665952219,3.699033406494499
EFO-27,54619267,4.322845534804342,4.149578696172353
G-401,9907093,3.2734126555601506,3.9121848156978416
NCI-H460,24772860,-0.596461213785507,-1.7616350852680904
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,1.1553135444481466
FTC-133,119607,5.542629368531396,5.293889466340293
SBC-5,11364421,-4.061592659681506,-2.095938095558593
Panc 04.03,5566,3.3462548914340204,3.033290024761841
NOMO-1,6505803,0.1224616163714439,-0.6411285347935851
NCI-H146,24772860,-4.237473750878659,-1.9394468416158506
NCI-H1623,11609586,3.053283731487635,3.0329975705950245
CA46,208908,1.4900061271350116,1.825529854215474
BxPC-3,9956119,3.6276214672042975,3.428773194754866
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,2.4812754035029534
CAL-51,10410894,3.3356149928792513,3.302351099571203
JM-1,9927531,4.0230036766634125,3.8005867480741706
FTC-133,9866186,-0.0573555179634338,0.9693753139554373
OPM-2,3136844,3.3377711403827783,3.6531564870578443
FU-OV-1,3815108,2.287889788505342,3.0816485339263675
CAL-51,10410894,3.3356149928792513,3.302351099571203
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,3.38411736761969
LoVo,5329102,1.3429054297502294,2.0719900422468807
A2780,168313047,2.060680306449853,2.277347446657564
HCC1143,104842,-3.076711821193911,-2.7067915702087317
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,0.9576278044286062
LOU-NH91,6918736,-0.749268328982244,-1.0541590433462698
LXF 289,11625818,3.3628594045115805,4.638135638840137
LXF 289,5311281,0.8902308213691446,2.089277618170556
SNU-449,5351362,1.2849200933546208,1.847136753426866
NCI-H522,135875424,3.5456342124976445,3.6379645343158677
MSTO-211H,44185566,1.3875680654995235,2.682106621065651
BxPC-3,24964624,2.317613094015834,2.3928284121456924
HSC-4,6852167,2.6632521076475446,2.6843883257598127
NCI-H661,409805,4.01937565581764,4.80782995397345
NCI-H2009,16038120,-1.1539994385349277,1.0815599349463365
NCI-H2009,5978,-2.257242885332271,-1.8639680260185367
EFO-27,56649450,4.209581770525167,3.4382855801137344
DMS 273,5287620,-2.166812480100597,-2.304459469208149
LOU-NH91,613753,3.2819891552194327,3.301157742474191
NCI-H460,73707438,4.549718141383013,4.389958514475719
LOU-NH91,24785538,0.7950573935003075,1.6770315111193022
KMRC-1,71304818,3.217910603872335,2.612109654071909
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,3.0554579584038906
LOU-NH91,15953870,3.547895487506012,3.66444306361582
SNU-81,3384730,-0.4505726212948157,2.146291603516829
SNU-61,1750826,-4.373387519590766,-1.3187726654071077
MDA-MB-453,753704,5.23059705064669,4.874708799004474
A-673,119607,5.020937738944074,4.892762744425727
KMRC-1,9907093,4.272059047954712,4.158937100675717
CA46,11640390,3.3312213559791397,2.4976294736297233
SCC-9,24771867,5.065268858490301,2.771652369038585
ONS-76,5280436,3.697781558026248,3.452554914146964
JM-1,10427712,3.737784417116883,3.7860418196017283
FTC-133,3081361,3.8958462184451697,2.539642364886551
KMRC-1,56649450,3.8757723452520136,3.19822745744588
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,-2.6367881509376927
LoVo,159324,-0.9516179858777442,2.5516122865036284
ONS-76,2841722,4.548555296080543,4.197938132244979
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,-2.916740117423599
SNU-449,5460769,0.9117409452183444,2.697952476498043
NCI-H460,6852167,4.590065962834362,3.1779088109783427
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,-2.5896784495719998
KYSE-70,176870,5.518340217914711,2.9794395597445265
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,0.7618047067743017
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,2.2302774094868485
FU-OV-1,15953870,3.743404981829692,3.8087471306668292
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,1.0157803447439324
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,1.1754492424517793
LXF 289,654092,-0.8888310934038361,-0.0913943657517236
BxPC-3,9826308,0.5055656835854033,0.6415898522075476
LOU-NH91,25150857,3.1116403082593096,2.690784766864892
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,1.1625746920968338
A2780,375860,-0.912616297645574,-0.23048804424086408
LOU-NH91,6852167,3.2671273023515934,2.9814469467622917
CA46,24753719,4.040239779097469,3.294334376593176
HCC1143,135999136,4.602247958833588,4.130363251183069
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.353832082129277
CAL-51,11960529,3.662834723962616,3.8427854939755495
SNU-81,20959075,-6.025577396301825,-3.0607028223907013
NCI-H522,57519531,3.3673050119485555,2.1242855901902216
HCC1143,135421197,0.8918606552263807,1.695727462738888
SW1463,24978538,1.1634359901262634,0.04858330788535547
HSC-4,445091,4.370395830414555,4.333927324249515
SNU-61,5329102,2.445912447276521,1.902592754465897
G-401,23582824,-0.1091259215243222,0.5631523962471149
MDA-MB-157,11485656,1.3019788320898549,2.272957940248005
NCI-H1623,11964036,0.5644570453188236,1.265948083632177
MSTO-211H,1242560,2.686361074048806,3.6782009448492197
A-673,65064,3.1048319417370775,4.520387921644121
KYSE-70,208908,2.5295165235288004,1.8616693853401216
SBC-5,2733526,3.427490731511537,3.6924975942062654
ONS-76,6184667,3.7303112000686256,3.133294226342965
A2780,23939,3.9158411595028046,4.139654360389815
JM-1,1566236,0.6280103536338946,1.5109987572272419
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.6315257149840274
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,0.6529718764437706
CA46,11396600,2.515122226404857,2.662122524368357
BxPC-3,262093,3.443903516481154,2.942509234592215
CAL-51,1566236,2.769525954778687,2.372995131917477
JM-1,3025944,3.553601432401545,3.8221517407265897
CA46,31703,-2.2435350155349023,-2.9208238348851943
FTC-133,25105715,3.757366730830659,3.447958169515397
LOU-NH91,54649381,2.7277802519486514,4.056715310546031
A4/Fukuda,11364421,-5.769651092108399,-4.216523532916615
A4/Fukuda,5978,-3.163562671527086,-3.535302996031094
NCI-H1623,969516,3.836806795163693,3.074286418651789
NCI-H2009,5113032,6.328717344861362,4.838174314222854
HSC-4,7326481,1.9301811465772087,3.045537583056417
DMS 273,54639665,4.46621146803559,3.117978657570729
YAPC,9926054,1.8358643335634888,1.8590779178397008
NCI-H460,11238147,4.460003386993959,2.960980523843097
OPM-2,9887053,1.8393709016316329,2.763484754944242
JM-1,168313016,3.8541200519849017,4.228968068572945
NCI-H1623,285033,-2.516722374910668,-1.8312209253501814
KYSE-70,5351362,2.601126509135012,1.7265542799011582
NOMO-1,10113978,3.435868796737405,2.282585396594641
HCC1143,17759555,3.749709067386792,3.6659226000812493
NCI-H292,11964036,1.1514824488888922,1.5096507058956024
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,4.124686388267698
FU-OV-1,46943432,0.7627718951481175,2.240277312444099
NCI-H292,4917,3.248446822462735,3.1939691194521793
FU-OV-1,452548,0.3745426606957432,0.5117299500730431
A2780,24180125,2.723679145549484,3.0519362300269073
SNU-61,9911830,2.7749851076050187,2.3591391853883836
DMS 273,6918837,-4.776469138555483,-3.5844567288507
NCI-H460,54454,2.7807551042334935,2.701764866133085
SNU-61,5978,-3.491631614089224,-2.1147433282141233
G-401,5287620,-2.7219963273379766,-1.7551624030513173
ONS-76,9884685,2.079600161824297,1.1278654169797275
NCI-H460,6610216,4.838717363885395,4.3365154077651775
CAL-51,51039095,2.1842093640891416,2.80843530681421
MDA-MB-157,2871966,-0.7905554969861216,0.5960578755432787
G-401,46926350,-4.213486210672068,-4.396090201893595
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,2.1619157238294737
OVISE,10184653,1.818458167845024,1.1341538030109015
A-498,6918328,1.134294475717993,0.6427304825828386
A-498,10302451,3.720340150939392,3.4501959065012375
CAL-51,9935249,3.84795648434564,3.2179893239000688
NCI-H292,24856436,1.0729923244387796,0.7866278460772996
A-498,409805,6.12415200666612,5.164620312822954
EFO-27,24889392,4.405449300162506,4.275002520743594
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.7102597683162983
NCI-H460,159324,4.0462841352482855,3.1666653998775423
LXF 289,16720766,0.4842655504206017,0.8087145029199669
LXF 289,54649381,3.6309892426510406,3.8562832811411183
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,0.5330114319566932
JM-1,71751553,4.311473922741218,3.942337087759861
MDA-MB-157,2945648,2.730573332542116,3.0094219549820362
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.3682905828360825
SNU-449,67156097,3.7845495552330024,-0.10433900504084961
NCI-H2171,24951314,0.4758147687646419,0.9796908361874533
A2780,24180719,2.9021439553303026,3.589087653240568
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,-0.5116949263073308
A2780,54454,-0.2144211598876236,2.4050162559681185
A4/Fukuda,16659841,2.2699989015311437,3.073407314118268
Panc 04.03,44137675,4.02019355498934,4.012456645168502
HCC1143,25150857,2.69660437037969,2.6150003430103914
BT-549,104842,-3.414515083122074,-2.5010495578265495
NCI-H146,11960529,3.5646000180725146,3.7672405270416585
MDA-MB-157,11238147,1.748896698587814,3.1190451163091377
SCC-9,72376,-1.0275629780171365,-1.612342355165212
MSTO-211H,57330099,2.804758704858228,4.339862947512164
MSTO-211H,135999136,4.2061059176098645,4.234809938660764
LOU-NH91,46907787,1.567116016960845,2.555649223157691
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,0.5533354020563047
NCI-H2009,71466445,2.5164920571758036,4.18466889878719
OPM-2,54618771,0.7318105179081044,0.10664538859612559
A-673,1716436,1.8403672814357532,2.860931947691974
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.7559345465446878
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,3.764467783360243
FU-OV-1,327653,2.5930307991109784,3.1181461870720835
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.1611899278845375
NCI-H522,56973724,3.7409361942384183,2.6166076069620825
NCI-H146,25262965,-1.0264838155868825,-1.6121789052414213
CAL-51,2749,1.4482754145936665,2.0875802941266137
MSTO-211H,4477,1.290064962685197,0.5786081957999547
NCI-H292,637858,2.5198155256882813,2.3013434456060136
DMS 273,3136844,4.133948633698644,4.08679801443402
HCC1143,654092,-0.1725481204081408,-0.2113369852629318
NCI-H727,72734382,4.575159301501077,4.387713406569485
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,0.788120253811692
NCI-H522,6918837,-4.666914399076351,-3.1130566564582365
HSC-4,11228183,2.0585180361700313,2.5584304396916098
NCI-H1623,107970,2.966658693868389,2.0725552786581147
A4/Fukuda,5278396,2.678829799859676,3.0539493424833917
SNU-61,25062766,2.174077685737065,2.0913571501566164
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.0388210321684226
ONS-76,5460769,1.8809234095271896,3.03324946084245
BxPC-3,448949,1.967823553768285,2.018783862059371
FTC-133,42642645,4.559192948180462,1.1416856729311553
MDA-MB-453,4705,2.8938913201458583,3.033703679160667
NCI-H727,54454,4.237398664855094,2.7557158735042515
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,2.4652838345085435
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,-1.5676846988767037
NOMO-1,19582717,2.563142509513499,3.228279865494805
A2780,445643,3.2119323974162786,3.849434929451365
MDA-MB-453,6918837,-5.413037386455184,-3.5711920085771136
BT-549,72193861,1.0619418160757952,1.8005148486569
HSC-4,44607530,1.7156299328297433,1.762324713635154
A-673,11455910,-0.0977898825280259,0.7564522798429654
SCC-9,262093,3.396257832039873,2.915664106733067
JM-1,148198,-6.864264453079388,-4.829560621052976
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,0.8876414127597877
CAL-51,8515,3.5852991976047863,3.978322847947786
NCI-H292,49793307,-2.523289852336332,-2.402917852846983
NCI-H1623,2708,5.67986318014104,5.042787604746133
SCC-9,3025944,4.376039606027409,4.429833276951035
LXF 289,24772860,-1.828128181459349,-1.5610756661193192
NCI-H1623,5287969,-1.6741359655835943,-1.670828618178615
A-673,54454,2.1191092291244877,2.6774619031935543
HCC1143,10302451,1.8641137803790455,3.2950285355282047
NCI-H292,54649381,3.811841265663476,4.073842808006165
FU-OV-1,44607530,1.1358438423183184,1.9385513412686988
OPM-2,5702613,2.283159730657738,2.3445136418297277
LOU-NH91,11612883,2.793800542696417,3.004969765382015
DMS 273,11214940,1.0513565801549722,1.619877923930815
FU-OV-1,65064,4.9743661807936235,4.896846411774541
A4/Fukuda,23635314,-5.004930640559638,-2.7348797413576142
NCI-H146,44137675,3.928890295501361,3.4416350879710196
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,3.4157571941722518
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,-0.991854254927402
SCC-9,25105715,3.642638215460893,3.4614378333546694
HCC1143,219104,3.69834662828724,3.9365255012841844
CAL-51,46215462,0.9657515518660452,2.0612531886778447
FU-OV-1,9936388,1.7648084748519457,-0.9069967406342883
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,4.086999745286908
A2780,65628,0.1843862993724733,3.956602638725444
SNU-81,11647372,-4.046967337474091,0.34103913475249475
NCI-H460,44589607,4.73035444754351,3.021707849796042
SNU-449,9549297,4.8793656902716345,2.5716438878440933
SCC-9,11625818,5.698343618019975,4.555120025847035
LOU-NH91,54619267,4.2625648850210665,4.18643767017752
SNU-81,676352,1.7899908822518449,2.0386905025931843
CA46,4096211,0.9281979530192106,0.8451194557197788
FTC-133,6918638,0.7173410835371117,0.9417345685925538
A-673,10074640,2.0498537136670696,2.8745561897312
FTC-133,9907093,5.562055210260789,4.466482958775965
HSC-4,24775005,4.677905847548428,3.7527432604484483
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,3.465727745978755
CAL-51,11964036,0.7531640395115359,1.1339419569640925
NCI-H146,16736978,0.7510083752799234,1.577109273672029
YAPC,15547703,3.1542356669454055,3.275928215130765
NCI-H1623,25195348,2.589072393428722,3.4213935136782707
JM-1,5311281,0.5908340552261697,1.602117359511913
SNU-61,9840324,5.730394861191507,5.72352770180704
CAL-51,322968,3.332930006684798,3.8895914777844065
BxPC-3,613753,3.1887459622848935,3.2435860633222706
A4/Fukuda,9887053,3.945623871756388,2.6895322396473658
ONS-76,119607,5.207716304164231,5.230465265607432
G-401,11955716,-2.313708507563708,-1.7406052582474223
EFO-27,9840324,6.098788849131883,5.9373245743051575
Panc 04.03,219104,4.644038290885272,4.081547883093259
HCC1143,25262965,-0.487374364701845,-0.5912517654340642
EFO-27,25227462,1.7048102531951876,0.5642144142136946
HSC-4,10074640,3.187745953835862,3.0799935559773686
SNU-449,5287969,-1.7501228923890362,-1.6633263363973725
BT-549,49836020,-1.94641857460656,3.94365663602313
BT-549,36462,2.0708174288882075,2.32215998305414
SNU-449,135421197,1.7191553190938056,1.820111727199743
EFO-27,49867926,4.359647239344765,4.295105263802921
NCI-H727,568763,0.1873556014231215,0.6151543746456055
SCC-9,5287620,-3.0509576220001953,-2.096167722477346
SNU-449,3543504,4.913571994290616,4.499529528248905
BxPC-3,12001922,2.0478076671218317,1.677774415095258
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,2.148328727735945
NCI-H661,54618164,4.023349318575714,4.228267266887574
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.593124331906841
OPM-2,5287620,-2.918074250075414,-2.268733332153948
SBC-5,71304818,1.011143162310159,2.3738736873366237
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.319132381430554
CAL-51,216468,1.370586512271769,3.0324019646626605
MDA-MB-157,25150857,3.068531629493821,2.727069105144872
ONS-76,10074640,3.173150149140259,3.0755431389054193
NCI-H2009,5470400,0.3791383114910072,-0.08780330266976512
CAL-51,54619267,4.1828818787298765,4.004953109874965
A4/Fukuda,5738263,2.3624425097256676,2.719482572191036
SCC-9,1239801,5.7667211168431205,4.025457197496187
CA46,11152667,-1.1506421067609531,-2.0539954241420246
LXF 289,9444,4.020808033871241,4.179995752443247
Panc 04.03,25062766,2.3535958479396166,2.1939330418384877
MDA-MB-157,71466445,-0.8161407888171323,4.191089145930018
NCI-H661,10302451,1.6315200392387812,3.374158264621967
NCI-H522,10385095,0.7404415633977295,1.1551048228372767
LoVo,53495165,-1.2075385636979648,0.058723566821630824
NCI-H1623,613753,3.253043904005535,3.261971660868769
SNU-81,49836020,-3.195484765979539,2.657152663592533
A-673,73707371,5.345141037142936,4.187829525839049
JM-1,71466380,3.0146886034862885,3.783868890777829
MDA-MB-453,135659046,3.699316020945489,3.492514676378842
LXF 289,72193861,1.9781400147016948,1.690685842262315
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,2.4985010781468198
Panc 04.03,46843906,4.199928797005276,3.1692854815020133
NCI-H460,16725315,5.407057101640495,4.303404073440773
SNU-61,375860,-0.3575080218905608,0.10534478531316203
SNU-61,216345,4.373705885149758,3.8287624705801675
CAL-51,25154868,4.656760297450745,4.389898429947447
NCI-H146,10172275,4.247153556222009,3.4828069721051373
SBC-5,122327,4.539216274618647,4.749134130670091
A4/Fukuda,24785538,-4.18833617701787,0.9210599962972637
NCI-H727,54618305,5.896457883643312,4.458949871542384
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.8350780298309635
NCI-H727,6918736,5.488213607701973,-1.0291285174682638
NCI-H522,168313200,1.7984937800694238,2.8618226674859892
OVISE,11396600,4.241731433198166,3.6120075528069693
ONS-76,25154868,3.0856348617246048,4.490134359981637
LXF 289,135398516,1.6034740470130215,2.296643380866547
G-401,9967941,2.755238424074781,3.3358926279557437
NCI-H2171,44493528,3.677120674941258,4.057632410737057
DMS 273,135398516,0.9081791710880508,1.9736152800809987
CAL-51,219104,3.260140555917495,3.8042168150609736
SNU-449,9927531,4.924705078398161,4.860198009525156
A4/Fukuda,9840324,5.782088483619631,5.484408145989643
DMS 273,11404337,-1.7233190830375906,-0.956762605526622
MDA-MB-157,24964624,3.531877357122639,2.517707996968661
CAL-51,44486219,4.943814728636009,4.2627517862385504
LOU-NH91,216345,4.715464564049095,4.155168662300548
LXF 289,124202324,2.1762748500922657,2.6354780086773775
HSC-4,23582824,-0.585849233367442,0.778818804711078
LXF 289,25126798,3.2757893610597923,3.899910439824115
SBC-5,4788,5.245695847909484,5.576211545758429
ONS-76,24856436,1.9295271968291927,0.39251939750051323
SNU-61,24753719,3.71513491278392,3.9069970169836203
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,3.2741225073587907
LXF 289,54618305,4.64176895308047,4.081656226424361
CAL-51,9926054,2.2227862000004577,1.9507968272541154
DMS 273,11427553,3.72076353850383,2.342230191741331
NCI-H460,25126798,4.092385726400508,3.8341945499819015
SNU-81,1716436,3.163180638308135,2.876706530024163
SW1463,426756,2.2352578961733967,4.398365232525268
NCI-H1623,6918638,-0.0742651507067239,0.7197196599568474
NCI-H522,46191454,1.7170402718959707,1.3040373492031125
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.6803142097369794
MSTO-211H,49766530,-4.866552298919663,-1.0770377175943195
NCI-H2171,11228183,-0.0614644470988351,1.0725757269659142
HCC1143,5311281,1.3434544130633397,2.436163852284025
ONS-76,10410894,3.505250871213463,3.3428096340714832
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.7284234482752063
SCC-9,46398810,2.8303032541075455,2.699143114299803
OVISE,5351362,2.5456705040985708,1.8272418372818393
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,0.15566821632794126
NCI-H522,5287969,-0.7039868347543177,-1.9165963051168498
KYSE-70,9840324,6.215387239369238,5.699209314545768
G-401,2708,4.061322582720861,4.171177713302529
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,3.3865459811541516
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,1.0545308550386907
A2780,9868037,1.6123332444026346,2.83303983730417
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,2.6869059620581317
NCI-H292,2708,4.789540620747355,4.990355214285328
HSC-4,11238147,3.6589845000918504,2.8138270962118894
NCI-H2009,168313047,3.1000323585702083,2.553650362980861
OVISE,3689413,-2.3316050545360136,0.3769911628939383
NCI-H522,71751553,5.137300136027492,4.228634584174219
NCI-H661,9444,4.500292949687679,4.036250062507044
BxPC-3,54649381,3.6406106092590007,3.9182437252023776
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,3.1686065417690235
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,0.6837579829614242
KMRC-1,10427712,4.418169957842134,4.387494346827641
FTC-133,9935249,4.194644265855045,3.1830367358187943
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,0.8339577113586087
SBC-5,5280436,3.662085558148715,3.14934211711129
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,0.38951622505661376
BT-549,462382,0.0307570083617302,0.4555959032830018
Panc 04.03,445091,5.978315194185719,4.403771116442444
A4/Fukuda,3011155,4.269088750580724,2.933625108001116
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,2.723651273196357
A-673,57519531,1.198988142705803,1.8466849261632299
SNU-61,3025944,3.777150750907422,4.06097406352465
CAL-51,11497983,2.6322425573174213,3.2695555318522964
JM-1,12001922,1.1772658700026328,1.4792689038965599
A4/Fukuda,375860,-1.1918610484687095,-0.441784311464768
LXF 289,5978,0.6093029371771528,-1.5711691558704535
FTC-133,5329102,4.217502606235289,2.156716955173942
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,3.0283431525078464
OPM-2,10296883,2.7550650350156474,3.322308066873099
FU-OV-1,4259181,1.2776952629591818,0.308731120982988
BxPC-3,100016,6.453363473458683,6.157856729057778
YAPC,168313047,2.3481335437424957,2.545152707684492
NCI-H460,10184653,3.574651577310896,1.0831655507961038
OPM-2,3062316,1.3077504545650411,0.780326501463047
NCI-H460,9956119,4.485375019847723,3.511248303287181
ONS-76,3815108,3.0019527232257555,2.941757385441336
NCI-H2009,6918878,-0.4863456687538305,2.915910787433305
NCI-H727,10302451,3.178772538514987,3.268812788504413
NCI-H727,2945648,2.622160220955332,2.953009984386925
SCC-9,71751553,4.89059631642312,4.455873653782814
SBC-5,36462,0.3494520767872783,2.119273207776283
G-401,4477,0.236688812816839,0.3029620299821072
DMS 273,9926054,1.8030373867492464,1.8195867287236944
MSTO-211H,2828334,5.714930690846282,6.191642248457023
A2780,24797083,0.8113195258872324,1.1064045592396345
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,1.109664204960915
FTC-133,44486219,4.933137185021197,4.3427592682913705
CAL-51,6918736,-2.0480142356294637,-1.1827393915000268
NCI-H522,72193861,-0.7243330419144597,0.8906368220244688
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,0.7498792648786542
ONS-76,25102847,3.483061373005376,2.694963881676065
NCI-H727,168313016,5.705554517808247,4.889416260228873
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,1.4685205592933144
OPM-2,25161177,3.2493247866394497,3.6526592417678527
NCI-H292,374536,1.098561227965989,2.4405082330865415
NCI-H522,54618771,1.252244709003548,0.5674184171627217
KYSE-70,44486219,3.9722791166403657,4.279688331379515
FU-OV-1,72193861,4.196952295232924,1.8702671565945779
CA46,56973724,2.349278499068081,1.8936311733373512
A4/Fukuda,2729026,2.569130626356953,2.322693240050884
YAPC,148198,-3.117185181322903,-3.3954783149821988
A-673,24753719,3.397650756866718,4.042313310447353
NCI-H1623,16659841,4.138965758514941,3.931036301114718
NCI-H727,637858,2.2360670355510086,2.0756039223136282
NOMO-1,31703,-1.8429032714500968,-2.4633101829932813
LoVo,65628,4.171555925906434,4.33728162090438
EFO-27,322968,2.5694057659070264,4.043954748193496
NCI-H2009,216345,4.438201480917741,4.026884746060288
BT-549,5282054,2.5925054001589976,3.750652903467474
FTC-133,6918837,-2.2077574090678307,-2.627976008720682
DMS 273,54626689,4.997985813086497,4.441060558473955
HSC-4,16741245,1.7716610997683242,4.044731299910217
SNU-61,6438330,3.4216884605560085,2.2274342021264055
FTC-133,9936388,3.0046059879710363,-0.18063052798697907
OVISE,3815108,2.0996140723315913,2.8490575262043563
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.1262046736654237
NCI-H292,5281321,-0.9498489394799606,-0.9488330298838626
BxPC-3,25126798,3.172026591671247,3.88618339031301
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,4.260048608445206
BxPC-3,11213558,1.5061777503093252,2.1035386568375336
BT-549,3503,1.5652779265398058,2.464857863838691
FU-OV-1,1716436,3.524722071533676,3.0320525840343944
MSTO-211H,15547703,3.049193057044517,3.2911781854049655
KMRC-1,11427553,3.2258060185151343,2.469270731863092
NCI-H292,46191454,0.9903655583180804,1.7214655442829363
CAL-51,135928012,4.192641653546412,4.039980571236853
NCI-H2009,44202524,1.444691297679544,2.4370635528082634
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,2.9002565221548093
SCC-9,2858523,3.190510944053216,3.136816417964311
BxPC-3,15953870,2.831569416015373,3.545016010642783
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,-2.385745066782676
SNU-449,135398516,1.5851782119809552,2.4083580772796096
SNU-81,9843750,-0.6437789188002867,3.8298734612195857
SNU-449,11427553,2.8197595076352564,2.921994513846723
OPM-2,11656518,2.629079922396914,0.6509901162419856
BT-549,135398516,2.1186047788766085,2.3841472375906934
OPM-2,176870,3.9257377377060383,2.4017388099295287
OPM-2,46926350,-5.934740852723627,-4.585378575939152
HSC-4,2729026,2.4603123985812276,2.7334577088219847
KYSE-70,9444,4.1582482593031145,3.985239983194687
FTC-133,9933475,4.176811369298493,2.0132030302535706
MDA-MB-157,51037431,2.1321019948022046,3.2310714860034517
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,3.4633095323185343
FTC-133,44493528,6.31419839504633,4.340023451901494
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,-0.0449380958292412
KMRC-1,11507802,3.5140789318254426,1.9072542462347628
KMRC-1,25183872,-1.331773303463366,-1.087961696570877
OPM-2,16219061,1.6139038412518538,2.5233541572635048
LoVo,25183872,-1.0423877479811554,-0.7019756842696779
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.5987786492492
FU-OV-1,6623618,4.441105176868704,2.418229883953427
DMS 273,4259181,0.4383145170351891,-0.28271455632885634
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,-4.419515066144751
KMRC-1,89183176,5.996613867274686,3.950670055147409
MDA-MB-453,9825149,2.3540085594050204,2.046811341516266
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,2.2718913902490514
G-401,4788,4.978954455161412,5.244886098361839
MDA-MB-453,52947716,-7.0217551266009375,-1.6766028359778995
SBC-5,6918328,-0.0891350348900322,-0.174050710745203
HCC1143,49836020,2.702530837822698,3.616870183868126
MDA-MB-453,9956119,4.182542041452956,3.4562693375881963
A-673,136227924,1.815433973878695,2.7117207274299626
HCC1143,9956119,3.9159046092458785,3.6603252664898283
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,0.8314539306852318
BxPC-3,11234052,5.706263551465742,4.061018104665636
NCI-H727,44259,1.5490626006331412,1.2498829455636025
SNU-449,24964624,2.993830455857875,2.772050253409451
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,0.909453781015489
LXF 289,3025944,3.4981276099044134,4.416659073024743
A-498,24964624,2.395732501339878,2.59916847987109
DMS 273,4096211,1.7794100041919845,1.7912820048596536
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,-1.4869296589609216
SCC-9,16722836,2.261290441734353,1.7629452666846412
LOU-NH91,452548,2.191181432305291,0.26882493038006716
KYSE-70,2828334,5.886367586734188,6.081318447589865
EFO-27,6450551,4.042476340029328,3.055648586568547
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,2.91635602270561
SCC-9,1716436,3.7585685406918783,3.090245653484934
NCI-H2009,409805,3.859994247591149,5.226965980752584
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,-1.2749858067058129
SCC-9,54618164,4.4493976732458576,4.24213743504771
OVISE,5470400,-1.924229347102114,-0.43391802752967257
EFO-27,44607531,1.7985046151445,1.3647069300542563
KYSE-70,439501,-1.7979650249976522,-2.07090421055356
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,0.815788347481013
NCI-H460,11175137,3.7005840280640374,2.6238976939793694
ONS-76,71680916,4.956248935312428,4.694075623600647
NCI-H1623,10410894,1.736668634267143,3.2514838789007428
KMRC-1,6918736,4.048742051120841,-1.4227081740602148
CA46,25161177,3.91788686206549,3.6182167995861647
MDA-MB-157,6852167,3.8998726158787007,2.769561065928808
HSC-4,11364421,-0.0916399418549534,-2.114467867877215
CAL-51,2746,3.539110169106334,3.0162450780859076
SNU-449,24748573,1.9316038598597545,2.15660580614744
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.886597976370518
KMRC-1,9926054,1.768451409600443,2.1395429511432758
SNU-61,4917,3.0491510397841015,3.1194526822509876
FU-OV-1,5335621,4.183078950789895,4.727393112958691
LXF 289,44607531,1.6515112206427849,1.403702528307073
A-673,11640390,1.6795118149646189,3.1334511719035714
DMS 273,51039095,3.4577395537233526,2.5210939380713318
NCI-H460,126941,-2.220790788147435,-2.7834971650454237
NOMO-1,5281672,5.39154363605107,3.925630850028371
SW1463,11214940,-1.9875595606860448,2.0521973961772475
SW1463,72376,-4.419423024557842,-1.975992612593897
OPM-2,613000,1.2483941007528057,2.1319816331731527
NCI-H292,445091,4.263425815338472,4.368529215647118
MDA-MB-157,46926350,-4.132103643787292,-4.076799544027707
Panc 04.03,10296883,4.422301293811254,4.074581070675404
SCC-9,11964036,1.807051006133268,1.2735091772945317
YAPC,11626560,1.7222365359336271,1.8713387391460998
LOU-NH91,375860,-0.2088041582630222,-0.11485486595112292
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.2715398185394102
A2780,374536,0.6453837370733745,1.8165277749478759
LoVo,5351362,1.2957137522113673,1.3506702722127861
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,1.1128757120822557
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,-0.5481725860419153
LOU-NH91,322968,3.304915281144932,4.188606871212901
OPM-2,54596558,4.064764759335406,3.971899467333206
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.684294539438519
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,2.034514318511322
MSTO-211H,44137675,1.9879298255329003,3.8563464408181005
NCI-H2171,42642645,-0.8345775302937554,0.18294974679399295
A-673,5287969,-3.109107778120567,-2.013014825249659
HSC-4,5566,3.1631957469062684,2.9683421298982138
NCI-H146,5284616,1.616711114994892,1.5368080323015627
FTC-133,10184653,4.443025626482117,1.3620453864961024
BT-549,241158,3.5488750117076484,4.09953932357784
CA46,25195348,1.4184238486273535,2.3315665646823605
BxPC-3,11497983,5.307904838671978,3.2034029576922696
MSTO-211H,4096211,1.4030307395810702,2.337943497093929
CA46,11175137,1.918070959510412,1.5731478088905715
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-0.6829214005400002
NCI-H1623,5566,3.3003894636357565,2.954557582687986
SNU-449,25262965,-2.560427276701697,-1.3530411997722334
FU-OV-1,16038120,1.1817724128349547,0.9238299902517272
NCI-H460,6438330,3.783082395235063,2.3354097611091493
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,2.023907914530882
LOU-NH91,12003241,-1.4006618643370652,-0.9549851600133846
NCI-H2009,89928392,1.462956527326012,1.7231924385513457
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.4250384009607437
NCI-H661,53495165,0.322884771008066,0.5578527730118995
FTC-133,16659841,4.779782303247626,3.902245004569897
FU-OV-1,176870,2.993075468358777,3.6443773187484925
MDA-MB-157,24771867,-2.9284017086321197,2.413373550379664
MSTO-211H,5328940,-0.7344582610548551,1.7391267718506203
A-498,25126798,4.108305960475203,3.944405974834603
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,1.84166836152992
HSC-4,5460769,1.9290612526481368,2.4803780916063034
JM-1,9826308,-1.254578223347674,-0.2688433996946638
ONS-76,124202324,3.376244033970937,2.551394999058401
YAPC,135984461,4.395865755985396,3.8990774046741823
DMS 273,5746,-0.0149388723107023,0.6510020284568209
FU-OV-1,4917,3.642085139957623,3.187099110405796
LXF 289,49793307,-1.960491877422628,-2.4814149424342618
OVISE,107970,3.0608588072726444,2.4725733581398956
BxPC-3,446155,2.3080345350315015,3.0065472193096467
OPM-2,65064,2.528451354351822,4.0556060822479365
SNU-81,5278396,1.9031243607798085,3.4935062016631435
NOMO-1,5351362,2.08054014163225,1.0597150124956314
A4/Fukuda,675434,3.712142385749843,3.943561881788838
ONS-76,44241473,4.684511997660941,4.871837130177952
NCI-H292,54619267,4.1033140795833445,4.1381199231872525
NOMO-1,5470400,0.2862684612003833,-0.15150323625457346
LXF 289,1716436,2.59582131383783,3.0953045195047406
OPM-2,71680916,3.9051822114426025,4.030693805596647
YAPC,72193861,3.178335780336401,1.773216662209005
HSC-4,148198,-2.795908666323494,-3.4069271762335624
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,1.9900565323627961
A-673,25161177,3.4603475867806788,3.9417900366144614
NCI-H522,9866186,0.2313673592680447,0.5864358372163191
CAL-51,24772860,-2.425084956958233,-1.8798340559495543
KYSE-70,72734382,4.428008981499565,4.631060092682585
EFO-27,44491742,4.311239061696844,4.291352954359484
CAL-51,322968,3.332930006684798,3.8895914777844065
OPM-2,68056272,3.036834126647856,2.4262232496561134
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,3.182880579358882
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,3.0731964855959903
LoVo,11485656,1.8604760547282393,2.192859850349098
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,2.5399755933431702
CAL-51,10074640,3.192334769578339,3.2703613608042144
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,0.9774102705452025
SNU-61,452548,0.6134547199912214,0.27347475601209165
MDA-MB-453,5311,-0.5257883568365231,1.298069825299172
HCC1143,23582824,-0.3689859010226292,0.8126531248218717
SBC-5,7251185,3.120445126947185,2.4100782617586307
NCI-H292,24901704,3.391496569820259,3.512852822284964
NCI-H522,10410894,2.9293088965189553,3.1142682537595117
SNU-61,23582824,2.5643180100002225,0.7200574817597217
HCC1143,16065773,2.712611567173667,2.4013232142939405
MSTO-211H,46191454,1.2859626841233986,1.661909031661143
DMS 273,72199292,5.337691921623293,1.3800730842467213
LOU-NH91,46398810,3.045211454343731,2.637691664463152
HSC-4,135928012,4.241462346184107,4.105013035591707
NCI-H727,3384730,3.6794289647639737,2.5271774000011358
SNU-61,4788,5.909414847709577,5.579006661338781
A2780,5329102,1.3737092942346336,1.7960701756053774
MDA-MB-453,444795,4.759998515464953,4.237837955424399
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.278246320758556
BxPC-3,11507802,0.9945684314547258,1.5312202488699471
Panc 04.03,24889392,4.270107644861146,3.99063552741377
MSTO-211H,46215462,0.9168806818627014,2.0594446048725765
MDA-MB-453,11167602,2.244240898320102,2.3968561555885772
A2780,400769,-2.1774855243121425,-0.7527175088266607
ONS-76,52912189,4.881284158574923,1.906491450730517
BxPC-3,44137675,2.990010873447489,3.6741160634408248
HCC1143,753704,4.831564496260181,4.944339083493057
SNU-61,9915743,-0.5579526190142376,1.0037569515950653
OVISE,1242560,3.5076159129293956,3.6579128807972343
CAL-51,6914657,-5.067352950634086,-4.458420760775479
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,2.737272945941591
NCI-H292,9907093,4.58058164849987,4.329084289088828
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,0.6868505421555698
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.3494724427119835
EFO-27,6852167,4.289895730200754,2.938855955194543
A4/Fukuda,148124,-6.6912736941139865,-3.6467403825908913
MSTO-211H,24785538,0.8010437121318222,1.9392320626751913
NCI-H661,49850262,3.557667726590132,3.716930918292826
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,1.929276597634637
EFO-27,4521392,4.521895501485345,4.37716472488803
A-673,65628,3.827084992759042,4.004008799820573
SCC-9,11427553,3.060791645335887,2.825294034538341
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.7349677627106204
NCI-H661,36462,2.012090600363037,1.8993096382022392
CAL-51,11625818,4.1129054868405905,4.315268079504039
SNU-449,252682,6.455952915446744,6.586474222470847
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.4745120503172902
HSC-4,2828334,6.111197262680893,6.210620208527695
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,2.2186471642596337
A-673,753704,3.1138845387287657,4.560110877612121
NCI-H292,409805,3.708436738901026,4.8671306000629
NCI-H2009,72376,-1.9106633783650309,-1.4644718379720953
OPM-2,24753719,4.370940438199297,3.7473976532750277
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,3.2073170208397226
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,3.1801663890934577
LoVo,9915743,-0.8819018227786422,0.9578633828742718
BT-549,4788,5.920199401047736,5.807423849597432
CAL-51,2858523,3.1959449804225524,3.054906930851768
OVISE,2742550,5.280611289386831,3.992537769159668
HSC-4,5470400,-1.775367561967962,0.2786563969030277
FTC-133,3503,1.9089172693495084,2.3442652710184637
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,0.6880372669773337
MDA-MB-453,4578,4.4862028800041545,4.152681432734485
EFO-27,16038120,2.346094356536249,1.1840746668995727
SNU-61,66577038,2.989851386241242,2.910027357098949
CAL-51,4259181,-0.5132501801478601,0.2577801879384449
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,0.5737584028302678
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,-1.7930458295832767
SNU-449,3552672,3.5064135830435563,2.6581745754863455
SNU-61,44589607,2.748444545219875,2.5988688846081773
ONS-76,2945648,2.901632251679741,3.032810057149092
ONS-76,44607531,1.762572438348297,1.3520743327348899
DMS 273,2874250,4.3291006423311025,4.542084280861572
SNU-449,9840324,5.822936489993131,5.9316310526263205
NCI-H460,6610355,4.949206869720499,4.509985736277573
HSC-4,11612883,3.5946567658341197,2.997467424126465
NCI-H522,11175137,2.853962760117135,2.239114425992021
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,2.9681080838298173
A-498,5281321,-0.4472251536664238,-1.0135839210990045
OVISE,25154868,4.508600245054991,4.624454285545251
Panc 04.03,44185566,3.115745823738928,2.7794778681542476
SNU-61,49793307,-2.3504304765085573,-2.9940074340384735
CA46,44607530,1.320133740199814,1.2352779930660922
SCC-9,10385095,1.4052834583911455,1.4639827632729487
HSC-4,675434,4.235689784331333,4.579392144473595
NCI-H522,16725315,3.2253372097194752,4.0177012778874
FU-OV-1,1750826,-4.024957616345245,-1.2355154105003048
HSC-4,57519531,1.2769425534379089,2.5122840461146096
NCI-H292,9868037,4.01216306257403,3.320806666648862
G-401,52947716,-7.497954818853376,-1.6403791040770535
EFO-27,5280436,2.3763113561475997,3.7357834526472367
SNU-449,11625818,4.573588862325648,4.63602004568504
CAL-51,135999136,4.2132345103647015,3.9564771830509726
NCI-H146,19582717,2.457603508665216,3.5300797113368994
HCC1143,1716436,2.8430583337953284,2.9355137616401685
DMS 273,9911463,3.7655644930376257,3.5433616185458003
NCI-H460,54649381,4.173104904963283,3.847518467664959
NCI-H727,6918837,-1.02939028052569,-2.5958628554156316
BxPC-3,6852167,2.5268139587107754,2.7854329678593155
MSTO-211H,168312962,-1.9489367550084584,2.117972277587146
CA46,17755052,1.7120394846678155,1.2554577962223787
ONS-76,3676137,5.654292431942107,4.548286205168157
A2780,11175137,0.1901581111291173,2.396865538569233
NCI-H727,10427712,4.338841626329874,4.281304784491156
LoVo,241158,4.012317425862525,4.0234123266370885
Panc 04.03,3062316,3.5966054915380647,1.5752045447345298
SNU-81,54454,2.7601348658589,2.581589514839329
SBC-5,3136844,4.085952663076754,4.350928190339558
BxPC-3,4261,1.8613797726144792,1.718485926871116
YAPC,11364421,2.3126725462898508,-1.1521013406212741
NCI-H727,387447,-3.6268426938273457,-3.942006277292429
A-673,11955716,-2.8120675934907107,-1.6252038399756594
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,3.046972784310805
FU-OV-1,135440466,0.9480137026796296,2.3093176452230955
NCI-H146,25150857,0.3973439930915976,2.0790340977606525
SNU-449,46926350,-1.1609870247475182,-4.0505097570379505
MSTO-211H,9840324,5.369584805162093,5.861841321251806
G-401,5460769,-1.872739736028161,2.403216293871609
CAL-51,568763,0.0917223714484538,0.6289395286559539
MDA-MB-453,5951923,4.303369563038856,4.625798262835943
KYSE-70,66577038,3.0162273972396005,2.9098912816313405
LOU-NH91,16722836,1.148829534310261,1.6799636437678194
FU-OV-1,613753,3.071481920375854,3.1640091677336915
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,-1.1014698314379525
CA46,49766530,-5.499020578204802,-1.9829464955573304
SNU-61,11175137,3.4257878627613505,2.5099352131542947
HSC-4,969516,2.6364274978390703,2.8475341460586487
A2780,10074640,2.580771204793581,2.803118357558786
EFO-27,10410894,3.5790791622635907,3.616996873873731
SNU-81,8515,4.116210915577815,3.656356997643458
KMRC-1,322968,4.639571189041566,3.996266816959287
EFO-27,54626689,4.866384531477491,4.795911173262296
LOU-NH91,9911830,2.650870613913377,2.553727618125424
OPM-2,135659046,2.7260896342727396,3.3897029689758456
OPM-2,6917907,-6.048813777211379,-5.407859299278328
SCC-9,151289,2.789872420286255,1.299668901068801
NCI-H661,4705,2.5155315968978127,3.2806989262890123
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,3.6234067077029573
LOU-NH91,25154868,5.6992218929630205,4.596273389882985
NCI-H522,54619267,4.072629967998864,3.709778834481717
BT-549,11222830,1.721965279957128,1.6854006984119934
NCI-H146,53301938,3.7804038583893504,2.418657832316394
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,1.6146323410990786
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,2.304409903268623
MDA-MB-453,7326481,2.376694251985227,2.932550702188305
HSC-4,6914657,-3.070952064512468,-3.735507490764361
MDA-MB-453,72376,-2.4391350280385033,-1.3492072016956724
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.5023509498344436
CA46,2130404,5.640885888744477,2.4453607830449315
G-401,216345,1.83916726924219,3.3126439833585333
LXF 289,54143018,0.7636513295056184,0.5555774224357541
MDA-MB-453,246676,1.942789144720036,4.326451274456355
A-498,19582717,5.689025629434131,4.525761457271267
MSTO-211H,11964036,1.836732040985672,1.8009232777501307
A-673,3552672,1.3462933778606576,2.503597279110467
CAL-51,11152667,-1.203722258692511,-0.6401878678496038
CAL-51,67156097,-2.385254348530768,-0.8665341171217982
CAL-51,65064,3.306239750209062,4.742129517751033
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.418579541762286
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,-0.6068481318688149
MDA-MB-157,6917907,-6.62909111977728,-3.949627615430033
HSC-4,64971,1.7199562834608897,2.7304779877880416
NCI-H460,135440466,3.295247648571462,2.2131158495023975
MSTO-211H,57519531,1.3086690033484818,2.604992360016935
G-401,9926054,1.744192331951833,1.809911439864905
OPM-2,24821094,1.5161257655930716,2.4645824220402583
NCI-H727,1641662,3.969866081416476,3.399179247238072
YAPC,66577038,3.3954554117120224,3.0781081471816942
A4/Fukuda,36462,-0.7730347482869518,0.3331595321472096
DMS 273,135440466,3.3485559592244214,2.0255785921532814
FTC-133,445455,5.178470647326205,4.5503078342354915
Panc 04.03,72376,-2.048199615123948,-1.414885101210607
CAL-51,10302451,1.350542324147247,3.1413239225797587
JM-1,11214940,0.7147440273172748,1.240261321029065
A-498,25183872,-0.6220750954527926,-0.4194568427564355
OVISE,44607531,3.0758971794813093,1.4400902247595777
A-673,53392493,1.8369213613876785,1.8609286321214225
LoVo,11719255,3.552916809155198,3.3926243149447664
SNU-61,439501,-1.3808373898758073,-1.950154587930111
NCI-H460,104842,-2.7771726159534773,-2.4765943107454422
CAL-51,11364421,-3.809863778172731,-2.4261028009463432
BxPC-3,71466578,5.509660254732227,4.657557614317409
NCI-H522,12001922,1.5621076115514363,1.7955542511189824
KMRC-1,11626560,2.283484204530191,1.5673394274880497
MDA-MB-453,5329102,2.150481946774112,2.0413373447768794
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,-2.4168007840453987
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-1.0268786715472125
ONS-76,16720766,0.8880370259188662,0.694702584700787
EFO-27,56949517,4.565823410262603,4.302745711797499
DMS 273,11222830,1.4389641717758948,1.476955602524942
LoVo,36462,0.97058855741136,2.1202055825735258
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,-0.7227934539191787
Panc 04.03,16038120,1.7157321990683845,1.24450977504042
LOU-NH91,3062316,-1.7568876367320156,1.1520612325520108
A2780,9903786,1.372407357095215,2.507459532308439
OVISE,49766530,-2.0570642495309004,-0.4600328601757097
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,-1.874745979243791
SNU-61,11427553,3.286064968901604,2.6736548517867926
A-673,72193861,0.2228627716233472,0.6861242569885406
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,-0.22430583930031445
NCI-H2009,3815108,3.061482559784255,3.0740652704699802
A-673,2126,5.190382873813306,4.236556095359611
ONS-76,10302451,3.399700001459874,3.4371852804328675
G-401,9825149,1.4427851681991832,2.0199492131976
NCI-H522,44202524,1.1337498661514331,2.1623352370793616
SNU-61,52947716,-2.831948664567002,-0.12519477059874473
A4/Fukuda,2945648,2.3216808345706035,2.4579421331257176
A-673,25105715,3.2161270828318207,3.290260177113169
NCI-H522,11178236,-5.864645603629742,-3.7237187626960657
JM-1,216239,1.5816975151035817,1.8047662202799566
CAL-51,9903786,2.1849161121493847,2.898755827777664
SNU-449,9936388,0.4589950900054629,-0.4851264772226056
NCI-H292,9927531,4.942242070848643,4.843395831494799
NCI-H2171,25262965,-0.9052216234257174,-1.2328603113826053
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,2.329122647144236
JM-1,24901704,1.786623485766962,2.3072992734188293
SBC-5,656346,0.6270929807498155,0.7550837059320533
KMRC-1,89928392,3.173061856078121,1.520057528587416
NCI-H292,156414,1.4083938325335852,1.4550163840032106
LXF 289,135875424,3.2815298243266553,4.1491037823839125
A-673,11494412,0.2373053627626316,0.9531887824213663
A-673,5746,-2.085801833901771,0.04493153444150078
DMS 273,9935249,1.448801275140577,2.4470079183388704
FTC-133,11404337,1.1811341910019733,-0.5922364716836893
MDA-MB-453,57519531,4.708696705883037,2.6639671214708125
FU-OV-1,11152667,-0.9879051128837576,-0.17193200313152154
A-673,44493528,4.641329710074662,4.123488254398306
NCI-H460,2828334,6.134119597935603,6.099504101227826
NCI-H2171,16659841,2.989016667138281,3.3229909644284255
FU-OV-1,73707386,2.8924737769549633,3.353711097257298
FU-OV-1,24901704,3.02942514713799,3.393257097748953
NCI-H727,4259181,-0.7375001764594127,0.2716078115750783
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,3.062454479350826
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.9219467474654177
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,0.0255407856968781
MDA-MB-453,17755052,-0.3952702915340721,1.7952514825276398
DMS 273,46398810,2.5474695176149527,2.3223601624886947
G-401,5278396,3.0023073980849424,3.279106805509021
NCI-H661,24821094,2.278259467148376,3.0950612699005107
NCI-H146,11364421,-6.559818289293388,-3.018284189658899
JM-1,24797083,0.8026470280931975,0.9237027652753028
NCI-H522,168312962,3.69802370811012,1.8355182357285662
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,0.6706173588438418
BT-549,16736978,2.673955173636492,1.7165310822989657
A4/Fukuda,46907787,-1.6446005772830188,0.0877270405858005
ONS-76,654092,-0.1261556450149646,-0.2655874274246303
NCI-H661,6610355,4.759868911507443,4.556408552685696
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.697072217485957
G-401,25154868,3.6071608181606063,4.132020981680531
MDA-MB-453,4788,3.7423511350995255,5.252360983034668
MDA-MB-157,11960529,3.789984251684095,4.140305756371127
SCC-9,16720766,1.7269628893506093,0.45995310817335044
NOMO-1,753704,4.4431191000277375,4.199796971103221
A4/Fukuda,6450551,1.0528971846899622,1.8814319704556166
YAPC,24964624,2.625771283300636,2.5638108277043115
A2780,82146,3.1377115486631273,3.633135823945363
MDA-MB-157,1566236,1.4232096904008935,2.6069188168577573
LXF 289,25183872,-1.882522005728347,-0.5806567828378499
KMRC-1,24753719,4.192591897270876,4.273372568180374
LoVo,44607530,0.9946707755477716,1.5202328322801253
SBC-5,44632017,0.6241642112624288,1.3507951526425257
SBC-5,23635314,-2.6646956028329223,-1.629874634407861
LXF 289,54619267,4.7435335143288935,4.069217999634837
BT-549,46199207,3.7007120058669623,3.2450363883532627
KYSE-70,6914657,-2.943523310206574,-3.352275792684426
A2780,89928392,-0.8241966309638568,1.0027521414301852
MDA-MB-453,54618164,4.967166731196573,3.7810990747271687
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,2.8285913135897873
NCI-H460,4788,5.894567383019075,5.633241415357146
DMS 273,24951314,0.5391494064850418,1.0144718280201448
NCI-H460,1750826,3.3189287492303197,-1.3087859701448306
CAL-51,2749,1.4482754145936665,2.0875802941266137
OPM-2,1566236,0.7571858740606694,1.720282809982059
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,1.9341990465288723
EFO-27,11626560,3.0674086659258646,1.9862933406892995
BT-549,216345,4.357029009920563,4.165012980437882
KYSE-70,3081361,2.4267899196210982,2.319521633276308
NCI-H146,156414,1.153076826996135,0.9665696568257401
NCI-H522,135411,0.5669945497970937,0.3972230909423856
BxPC-3,6438330,1.9774707221451924,2.415641405695927
MDA-MB-453,9903786,4.505035222499518,3.0094101343859507
YAPC,5281321,0.2366473375234088,-0.882982831802702
MDA-MB-157,71304818,1.9463509570918949,2.5809632484167846
BxPC-3,56946209,-3.950691768305054,-3.84679115922638
LOU-NH91,6450551,3.4853298595759687,3.064552124848283
G-401,1242560,3.581659075050411,3.1382337306158474
MSTO-211H,3854666,2.1662920246080963,2.34894654662052
NCI-H522,25062766,2.616535601519866,2.120664919935778
Panc 04.03,3038522,3.0958365698912154,3.220851974823489
NCI-H460,25183872,2.110783783288614,-0.7672163816110459
SCC-9,71304818,2.8421374335972653,2.465366447398344
SCC-9,65064,5.356580923551092,4.948606964089977
NCI-H727,25183872,0.4102957812787974,-0.8230347833996183
NCI-H460,81146,4.483282466350705,4.6819297346638065
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,0.36216161129638896
MDA-MB-453,54765302,2.0573663082868405,3.98866112225728
KYSE-70,10302451,3.1884398798129525,3.0692260911408056
LoVo,49793307,-4.412709808216002,-2.6671772670643255
SNU-81,36314,-5.848392982376778,-2.0636291956723083
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,0.6822009506070177
Panc 04.03,2733526,4.292486036611722,3.9299279350693355
CA46,9926054,1.6892727173627182,1.5170103593230766
NCI-H522,2746,2.8917767436803414,2.6943356474887796
LOU-NH91,67156097,-3.1227398262817587,-0.7961809263330114
NCI-H146,5284329,3.6277290639514455,3.0018062106129793
KMRC-1,644241,4.9037113640465035,2.0030527036653427
A4/Fukuda,60700,-1.3381290141173086,-1.1968934578336685
NOMO-1,24753719,4.496099764979975,3.7673716687896444
NOMO-1,9903786,1.612481289648159,1.8075989315957668
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,2.4365299757113705
JM-1,54618771,-0.5043757930015165,0.04824949288978957
G-401,3854666,0.6606077023561356,1.520362731323905
EFO-27,24978538,3.143555245211511,0.9647008259138836
OVISE,322968,2.654176014952692,3.6181665273893704
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,0.7768972783147313
FU-OV-1,637858,1.762395691671764,2.2146144747300234
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.5804321038040257
ONS-76,11626560,1.9844806011562912,1.8502674956146226
LoVo,216345,1.1599721320761718,3.8434714633955935
SNU-449,9926054,1.9385314164963827,2.158929197347505
HCC1143,568763,-0.6390257750571487,0.7949323371302838
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,2.2697826543516784
NCI-H292,72193870,4.439424680926146,3.3973776152380397
NCI-H522,11228183,3.862798460505377,1.334464263608178
CAL-51,4788,6.061217822513647,5.520846344796992
LoVo,4521392,4.145025799048703,4.245491159333337
HSC-4,11626560,2.5873766751252436,1.6679091615076163
NCI-H460,60750,-0.8382921927225392,-2.317909985129624
JM-1,44137675,3.718094845766921,2.67043394384755
HSC-4,71304818,1.898043557267106,2.5633458454148546
CAL-51,25150857,2.2346870378683934,2.490842485515084
CA46,2871966,-1.7971239931694716,-0.8743244244818638
DMS 273,54454,3.225049529812471,2.371740721747664
ONS-76,25183872,-0.170903852827654,-0.5994083495117295
SNU-61,984333,6.216581141210495,0.6760501511124275
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0723546181605244
A2780,71466578,2.665399831677294,4.050559055528907
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,-3.29484241597141
CA46,24797083,-0.1839530161688024,0.9868101675904921
CAL-51,135875424,4.33643967165441,3.7223284241784205
NCI-H2171,3689413,-2.7117222930063867,-0.7474393904419423
A2780,11396600,2.9320615716687564,3.3550130316592335
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,2.213660081186081
G-401,56963564,0.504836775176006,0.32433493509975714
LOU-NH91,44632017,2.871860814691948,1.6562269280401158
CA46,11214940,-0.2735426892992921,1.0730870537842163
NOMO-1,67156097,-2.629595584457773,-2.0249159435427373
NOMO-1,26596,-2.074766602044621,-2.2066339900519965
JM-1,50905018,4.16446369685189,3.652411344068063
NCI-H2171,445455,3.811797523558628,4.305298280896227
EFO-27,16736978,1.8793599511128067,1.4494572627271602
JM-1,54678924,1.2599632015511184,1.1053707291070707
NCI-H460,5281321,2.142807178276493,-1.1997159164105298
SNU-449,5738263,4.026622535351311,3.5977602529996
SCC-9,216239,3.331867398285969,2.3739721699668603
G-401,10410894,3.279247022117546,3.0635366995740236
SNU-61,11222830,1.6415416447740467,1.4817802937726616
CA46,2113511,3.5674790523720317,4.286839953946283
NCI-H146,72734382,2.9399655016804114,4.164524567494224
NCI-H522,613753,2.504960527289346,2.9023894107985813
G-401,156414,1.0662464633968871,1.3102019519431776
BxPC-3,5470400,-0.5134005920596514,-0.4751655713602988
KMRC-1,1242560,3.860865345198952,3.5883491399307035
BT-549,1242560,4.319126066576065,3.672913469055432
OPM-2,66577038,2.8274271292709536,2.6159043067227685
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,3.2038672066684613
DMS 273,16013152,3.9042510131977353,4.007201292709217
NCI-H522,448949,1.6947060599097594,1.855457052708563
MDA-MB-157,5566,3.489209385839125,3.079051132179373
Panc 04.03,53392493,3.71782736184095,2.7023395352520008
BxPC-3,55508,4.124435576281598,3.536498804215276
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,3.63460571782927
NCI-H661,4521392,4.344795346058825,4.379056082359914
JM-1,119607,3.9456515069078,4.546857186169691
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,-1.1750951988421603
NCI-H460,3385,3.2657114863965573,4.647240408916707
A2780,327653,2.026169684275287,2.8371020151913338
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,1.1982362303161331
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,2.0845848171660104
JM-1,4261,-0.3533034531676731,0.28924372174682017
HSC-4,135875424,3.4627713632233537,4.010860309826312
A2780,44491742,3.4077888459991774,4.064472277562769
Panc 04.03,135999136,5.549073334475873,4.187442812245286
SCC-9,57519531,3.918058558817349,2.7628800403334317
LoVo,3815108,2.2685826541267615,3.023363862674773
DMS 273,71466445,2.157471967137961,3.3389528712995182
NCI-H661,44241473,4.80522256986357,5.177942327922554
ONS-76,6438330,3.0471678199579206,2.40653959643023
Panc 04.03,2949965,2.626604824548014,2.939969384436393
OPM-2,676352,1.691725548140899,1.8922696321356858
SNU-449,16722836,2.5551835494173325,1.7663185753385076
A-673,11152667,-2.304412849002376,-1.204477084406181
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,2.8331452181376773
G-401,151289,0.7906130786084481,0.7684823863857687
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.4907662255714467
LoVo,25195348,3.880726101323461,3.3908004956541875
NCI-H1623,11404337,1.3417738865788873,-0.07676390225724877
BT-549,3062316,0.532185160328145,1.4260815804149596
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,-0.8604429652755108
EFO-27,44185566,3.1194970070950276,2.7137585529026302
A4/Fukuda,16725315,3.095723533871789,3.9600563930126302
LOU-NH91,3854666,2.9087049696787544,2.4513767452089934
NCI-H460,676352,2.985829219207002,2.1895477134693566
MSTO-211H,23725625,2.234746785874409,5.041602149109912
SCC-9,5351362,1.6846115382104403,1.4386258966317795
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,-0.9121096439589692
NCI-H522,241158,3.3210308536521156,3.611583381634272
A-673,10127622,5.418104152685571,3.77928767146891
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,2.210632058350735
G-401,53232,3.5991410971239866,2.5769464623219913
OPM-2,5287969,-2.4106191892149185,-2.1264011685268054
SCC-9,637858,3.7694424070181127,2.2754096815175124
NCI-H2171,5282054,2.409902559914623,2.982089429849811
NCI-H292,1242560,3.487131794973456,3.67169367539268
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.487172974270956
CAL-51,3503,3.2899889427654245,2.157960932048516
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,3.675451868506325
Panc 04.03,51039095,3.732934843851844,2.864441496546322
NOMO-1,5329102,1.5937414073922636,1.0621228343057136
ONS-76,1242560,3.484199229378892,3.6373011591297217
G-401,24180719,3.4290114124184568,3.2653900893376333
A-673,11485656,1.6006257465541904,1.9739893551022263
NCI-H460,5278396,3.885794996406102,3.7246174515255914
ONS-76,4788,5.851184911612036,5.676435626577234
NCI-H661,11234052,4.193192571907383,4.115242693549815
LoVo,46174525,4.300656487428364,4.448732766242463
CA46,135875424,2.985562686352135,3.136142024629965
SNU-81,6610355,3.7225360861185592,4.413606416495953
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.8477962498639924
A-673,1566236,1.6605846703776754,2.037963948479615
LXF 289,55283,4.7983814176360715,2.84684191918624
DMS 273,1566236,1.8001113918747356,1.9648228672971502
SCC-9,4477,0.0462068475019735,0.7004710874653931
BxPC-3,439501,-2.27553783948146,-2.0908922804558614
G-401,3503,1.5245243202568906,1.9215891436883172
SNU-449,5280436,2.098309971831213,3.490245514061055
LOU-NH91,119607,5.561970464467383,5.451310892728245
MSTO-211H,6918328,-0.4462053694736546,0.2199825898307263
A2780,10231331,0.3686619766312378,1.4824328007833614
SNU-449,44137675,3.6126407514409378,3.79549897738378
Panc 04.03,9866186,0.4755964236535121,0.9424697872087158
JM-1,40482356,5.622716652052393,2.623535342794605
CAL-51,49766530,0.4609697007955676,-0.28970166450756824
G-401,11960529,4.93979495553103,3.7606685062007004
HCC1143,6505803,-0.5233928936461414,-0.4919282227143267
KYSE-70,676352,2.557270596786296,2.0897527315039737
A2780,135398516,-0.3122960179418635,1.9201282147380896
NCI-H292,23635314,4.8326715815763395,-1.4896007595020293
SNU-449,15547703,3.400796461378631,3.4216830006155394
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,0.39520516020208135
LXF 289,46843906,2.101940493524925,3.136614225361766
DMS 273,46174525,4.164871991455526,3.989233012936721
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,3.40060770499701
SNU-449,6917907,-5.317414756413243,-4.568167715606629
A2780,4705,2.567744201920244,3.0487791015152963
KYSE-70,73707438,4.323396479680616,4.14558082452051
NCI-H460,5329102,3.240160570329804,2.086033007235454
NCI-H661,5282054,3.5253080606128133,3.7038221661094592
NCI-H1623,119607,5.952206355872506,5.20423721615697
NCI-H522,64971,2.9291780846019413,2.480202918576847
CAL-51,11222830,1.6762547521470548,1.5629625565612728
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,2.9091774766417013
SCC-9,25062766,2.812414712404745,2.165844544281018
YAPC,31703,-0.7401868256368748,-0.6000040207286268
KYSE-70,2858523,3.054228167220651,2.9894310313775274
MDA-MB-453,1242560,3.902800159671119,3.317743022051508
MSTO-211H,71466380,4.302501611697816,4.712453403866717
NCI-H2009,3689413,0.5343246791806224,0.06703475183125125
G-401,15547703,3.220896426279267,3.010101434958719
NCI-H522,11719255,2.5592835843852337,3.089606325299576
LXF 289,46191454,2.351463869671111,1.9349480236171197
LoVo,71304818,2.0724805960279027,2.407029178398004
A-673,5311,0.6764453858481513,0.7793303575502066
KMRC-1,11175137,2.246406512349146,2.460991443967939
MDA-MB-157,568763,-0.4149964884485024,0.7158340882701028
LOU-NH91,11213558,0.661761515775888,2.0268503022371958
CAL-51,2733487,8.211583338705053,5.899962001425714
LXF 289,16741245,5.010251526780332,4.381261794548053
SNU-61,24797083,1.0556452382424049,1.352720765167377
BT-549,44137675,4.586830027774197,3.7025097135668776
CAL-51,15547703,3.503799403292956,3.0992363403741017
JM-1,3136844,3.4340507925237307,3.7114044890883933
NCI-H460,46191454,1.6495265120274705,2.168376949786075
CAL-51,16722836,0.8083581946159574,1.4887511033073377
FTC-133,25227462,2.318225674680384,0.47455972354689047
A2780,51039095,0.059669762784491,2.446068200962138
OPM-2,54613361,-1.307423897840743,-0.5538090221151792
LOU-NH91,5328940,1.6284519107294106,1.8046329686695861
HSC-4,11640390,4.10313790521596,3.397063823541909
LoVo,11222830,1.6500045227885836,1.6515957087513704
NCI-H2171,53495165,-2.473385034422452,-0.5244210381847595
MDA-MB-453,5281321,-0.6344069396712416,-1.256186853322091
FU-OV-1,9926054,2.079351745951841,1.9930746282080045
G-401,36462,-0.1566510321668276,1.1021530605945016
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.2696049517497556
NCI-H1623,11427553,2.6307082318350132,2.59275069447249
A-673,6918638,-0.1443248090306654,0.010503703858828586
OPM-2,54596490,4.128803973627264,3.946612080060664
G-401,24753719,3.1602445998928186,4.1038264738806
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,2.1812646759716303
DMS 273,637858,1.5802330029013405,1.5265663150157283
OPM-2,72199292,0.0645754970830883,0.8125037008752771
SNU-449,5328940,1.97588831229785,1.921737179800058
OVISE,49793307,0.0210083556696064,-2.2809565070050604
A-673,11647372,1.3285775791052634,0.5708934030488091
OVISE,6918328,1.4244682512544402,0.19941166608600613
Panc 04.03,25154868,5.1819399857498025,4.495443906606842
EFO-27,17755052,1.748867275877649,2.2635956431790225
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,2.123977869006256
SBC-5,375860,-0.6399303579455221,-0.298252717233885
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,3.381309162161606
MDA-MB-157,451668,4.959725465812671,1.7079726431132176
YAPC,54619267,5.29132207947154,3.9880338670871525
OPM-2,36462,1.377546018006998,0.015262086532470045
BxPC-3,3081361,1.7902484572067556,2.2912899840647554
SNU-449,11455910,0.8938620280411973,1.2945905826889614
NCI-H1623,25022340,5.5347014016683875,3.4992615381197805
NCI-H522,409805,3.737006742854017,4.497494152887353
CAL-51,568763,0.0917223714484538,0.6289395286559539
HSC-4,12001922,2.169357927696289,1.9212676704103722
CA46,2742550,3.5037926309603944,2.9415849036571062
LOU-NH91,11507802,2.1124947170440533,1.9032256532897152
LXF 289,6852167,2.2044562779321635,2.7335569354345512
ONS-76,26596,0.1332187247782509,-1.2492548654598032
KYSE-70,9903786,2.353212274658888,3.093617614354266
DMS 273,10385095,0.5027476993233067,0.9713119810019331
ONS-76,3025986,-0.4351415981508911,-0.759540471762608
MDA-MB-453,89928392,1.7795585771799345,1.0955601933427976
LXF 289,676352,2.537691956872654,2.182349830632436
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,-2.9484232569805675
HSC-4,135659046,3.804399419736421,3.8074551267069934
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,0.6687140110454479
SNU-81,6623618,-2.7236989498385733,2.1688804123894547
HSC-4,5282054,3.7951129778884822,3.7338404023227985
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,0.6623008921764793
A-673,16219061,2.4523595679466954,2.8561467483992287
SCC-9,123631,1.8109604294388877,2.6325992722939002
A-673,11364421,-5.84995188170368,-3.867459529996429
A-673,216345,3.678855080389337,3.419913645422399
A-673,439501,-3.092013019617277,-2.509564613410035
NCI-H460,1566236,4.3513012021592505,2.471947752325243
LOU-NH91,25195348,3.759766884877561,3.555600574683873
DMS 273,23725625,4.676663171220921,4.574988526398993
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,2.4493786807087305
CAL-51,6852167,2.546662292056567,2.976702952588149
OPM-2,5738263,2.0935625564909737,2.58184737620036
SCC-9,5311,1.75647433259966,1.5727444946662628
SNU-81,5291,3.232691727920098,3.425051903110093
FU-OV-1,262093,2.4810055989466018,2.9850318506866773
LoVo,56949517,2.258326270055845,4.255931332637511
A4/Fukuda,9825149,-2.050748608979426,1.7621723227626866
CAL-51,53392493,1.8808489153668793,2.5046311320630306
NCI-H522,4521392,3.962796694444569,4.32310704247712
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,-0.30789887966557467
NCI-H2009,11612883,2.3268324416241777,2.9115873645346952
NCI-H292,65064,3.148033598452649,5.057087856127772
NCI-H292,44589607,3.354505508461316,3.068460055022637
KMRC-1,462382,0.2791911345900462,0.6939557710952488
A4/Fukuda,5291,3.6218734753047226,3.0922985668917624
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.5009855751469605
A-673,135440466,1.1776565801361647,1.7463627678229614
Panc 04.03,60700,0.3719609401953118,0.13564837569488236
LOU-NH91,66577038,3.4622279905398052,3.1315748288125205
A2780,24856436,-0.502193855863573,-0.035683296638578096
CAL-51,6852167,2.546662292056567,2.976702952588149
JM-1,5311037,4.072371281952103,2.5605576905113354
NCI-H460,374536,2.933441634270558,2.1634062897903403
NCI-H460,216468,4.763843832635099,2.8939741740049976
SW1463,421610,3.2195561799423804,2.9667833457941173
NCI-H460,439501,-2.362377537788676,-2.0784926671765334
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,-0.02069089920860292
MDA-MB-157,24978538,3.306703195844951,0.49494889838214035
MDA-MB-453,54618795,1.052632381834858,3.3018007917772976
EFO-27,6914657,-5.685084863882177,-3.764509957066255
NCI-H661,9866186,1.9017456959186525,0.8330577462047799
CAL-51,6623618,2.223133904662847,2.3942708550664094
OPM-2,5281672,3.1701528707347015,3.946403804406511
CAL-51,1716436,3.275997904874087,3.0250883022713397
NOMO-1,25183872,-0.6960845434284378,-1.787089368200121
EFO-27,216239,3.3875560857040887,2.2776160941296495
NOMO-1,54619267,3.207870909981956,3.299182389975711
NCI-H460,400769,-0.4007490431715684,-0.5687632648304863
SNU-61,6610355,3.885584601382451,4.275470294247259
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,3.494000525693914
JM-1,10077130,2.0136903876831993,2.7501797783091853
NCI-H661,81146,4.823771143587,4.4974068859355425
LoVo,56946209,-4.467950537911531,-3.7992945503589777
NCI-H522,5460769,0.5614535105182378,2.5652393888615395
CA46,9927531,3.0223750820915978,3.67913061680104
CAL-51,11612883,1.9359641259018452,2.8374976556218616
CAL-51,11427553,2.069280384014222,2.771007342132648
NCI-H727,5746,2.1304383256196293,1.349223463156467
MDA-MB-453,16219061,1.5030881414961583,3.0924953825214176
MDA-MB-453,68056272,3.261695748545246,3.1564214330345832
A4/Fukuda,6610216,3.4719570509087445,3.955643436875478
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.8445166443714343
SCC-9,107985,-2.37702169012632,-3.5070465514196987
MDA-MB-157,23939,3.513284021833553,4.261447464335757
OPM-2,262093,0.5720462757198622,1.9901835961816332
NCI-H661,5351362,2.412641003608378,1.584198238299232
BT-549,53495165,-2.465962418573161,0.5834795240275724
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,2.8171787965788924
HSC-4,1716436,3.018983829466311,2.95216927439051
A4/Fukuda,10231331,-0.0070700765814584,0.9825833838154604
OPM-2,25105715,2.7306053213312027,3.0872019583121193
CAL-51,3384730,2.4775948365465905,2.8254567032393454
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,0.9608310307464598
KMRC-1,262093,3.6313310555506817,2.5987281577425114
KYSE-70,5311281,3.780874632943925,2.6203564284007923
Panc 04.03,135659046,3.760242578723066,3.8604393219635864
NCI-H460,46199207,3.5033257005335163,3.4346953195919956
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,0.004556149974520835
NCI-H522,285033,-5.015646919007219,-2.423265709532921
NCI-H1623,31703,-1.093718795909536,-0.759446785527939
CA46,8515,3.648186715161825,3.180833381184198
A-673,54618164,3.9765209939943857,3.9426310914527245
MDA-MB-453,71304818,1.4463301677266325,2.323009104826877
SNU-81,656346,0.6811147423088999,0.6197924493278706
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,0.07691142866808054
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,0.7949652517014587
OVISE,71680916,3.981894618274443,4.832312552644447
LOU-NH91,56963564,0.9665729866263152,0.733733386602832
NCI-H661,23635314,-2.0342629068452056,-1.5275649201876182
LOU-NH91,12001922,2.55699926148122,1.8054950843063955
JM-1,31703,-4.919166892515249,-2.294909706996339
EFO-27,16065773,2.8503557299543063,2.418309116109577
DMS 273,107970,2.226748766743483,2.0415997792986724
MDA-MB-157,67156097,-2.087594374926874,-0.536805508614576
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.262695481176371
LOU-NH91,46199207,3.3608515659177147,3.416930532962143
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,0.5743860726778629
BT-549,2871966,1.6191257261573118,0.4186767424023681
BT-549,46926350,-4.493585638609818,-4.06767632799021
OVISE,54626689,4.712933516379989,4.84211993161435
NCI-H460,119182,0.2489341964189734,-0.6981141563537198
MDA-MB-453,7251185,1.8406187352582624,2.3000904562065823
JM-1,4521392,4.181937683636394,4.127840205202995
LoVo,44589607,1.625549992230134,2.6623627012478206
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.0962076810276533
A-673,24951314,0.6400096482448101,1.0299142875691707
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.363559374418038
A2780,11152667,-1.0749204847082217,-1.0537798356266532
BT-549,5329102,2.9790267437316285,2.293229802165274
G-401,17755052,0.028133790527295,1.5304396151172
CAL-51,11238147,2.100409816322544,2.975395421640248
FTC-133,16725315,5.918216987208106,4.401216575924375
HSC-4,10127622,4.548794444843462,4.057350792575891
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,2.2017938587802615
HSC-4,72376,-2.108784759313747,-1.6948624725337682
HCC1143,11455910,1.411815978618001,0.9242050677424384
G-401,6610216,3.9425308150709,4.156173177288901
OPM-2,73707398,-1.391957592490296,0.32822167986406525
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,1.943821297036684
MSTO-211H,11396600,3.2938939565791765,3.73946750473099
NCI-H2171,15983966,-6.379176066325201,-1.807012210706355
HCC1143,9903786,3.3387804215378885,2.814266038516651
JM-1,3385,1.6679469335870958,2.9429317993594872
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.2930541947030665
JM-1,44487872,4.651129481786086,3.072990891527922
NOMO-1,439501,-2.35226533453039,-2.7311791989153504
Panc 04.03,568763,0.8595160951448656,0.6849111152093719
A-673,15953870,2.6171812575314757,3.2447352200509236
CA46,6917907,-5.812984110767001,-5.592543762508603
A4/Fukuda,11404337,-2.650657466190433,-1.072728315660749
MDA-MB-157,6184667,1.80494393962058,3.020266327814897
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.2751468934144274
NCI-H522,25102847,2.0692872541383784,2.4713240913810886
EFO-27,2113511,5.820212709586459,5.8453310674320536
Panc 04.03,2729026,3.1546590032208948,2.662723440787437
MDA-MB-453,9866186,-0.0857862406385878,1.0285165705778423
CA46,44491742,3.801952242992866,3.667575193368705
MDA-MB-157,16720766,-3.610201854539628,0.5751571873554289
NCI-H522,168313016,4.366007701234683,4.710230954380201
JM-1,53232,3.389128909220105,2.8199518522103544
ONS-76,24901704,3.4855009095109435,3.130233534399883
FTC-133,3136844,4.271719807093853,4.494210970086118
CAL-51,54619267,4.1828818787298765,4.004953109874965
NCI-H146,17755052,1.2442303799433287,1.8144904378357192
FU-OV-1,2858523,3.1344850445874752,3.049420179053544
NCI-H292,5280436,4.014624366310106,3.6610076950146957
BT-549,15547703,2.0718927663287703,3.3465265684677172
A2780,25126798,3.236047242798602,3.7020093083278662
Panc 04.03,2945648,3.066534391812563,3.2152565587300335
SCC-9,56963564,0.633234370730304,0.5793604316727685
A4/Fukuda,11507802,0.3746235533355334,1.0451804950989931
Panc 04.03,3025944,4.694936485248253,4.361420766143669
SBC-5,46398810,3.6562963267762183,2.599104059216791
JM-1,49793307,-5.3555461291239075,-4.340209605694159
SNU-81,67156097,-1.5845934662844448,-1.098489613528336
A2780,72376,-3.651935268939024,-2.872645496444527
CAL-51,25195348,5.6667768045179905,3.197913227347061
NOMO-1,10074640,3.0496099519927435,2.4800026239049164
FTC-133,46174525,5.692041239325808,4.541026905644227
YAPC,409805,4.253424942012428,5.025414209199204
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,1.9392857179308598
SNU-61,11626560,1.823906724750755,1.6301528485086738
A-498,16736978,3.6467697702535182,1.9436942444643261
JM-1,9967941,2.969647244173239,2.967651856013808
MSTO-211H,3815108,2.5678993468563913,3.3135657459787513
KYSE-70,637858,2.812350468450961,2.1162671959163357
A-673,16013152,4.069813049540754,4.04282251828191
A2780,4521392,3.924686212385386,4.257529903222835
A2780,23635314,-2.3171748001501635,-1.5651646518673992
JM-1,3689413,-3.612287026066889,-1.4525273807098498
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,0.11258216155238031
OPM-2,64971,2.0053510879561296,2.3539183601448768
LXF 289,9935249,3.315625346230847,3.2432663622747593
Panc 04.03,984333,1.398892433045171,1.0581764852462157
DMS 273,676352,1.7083859345894283,2.146873610837734
MDA-MB-453,4096211,1.6956492567589403,1.800657483809732
DMS 273,9903786,1.811418424711566,2.6349314531935564
BxPC-3,3634881,3.024771766376516,3.3752152796881787
ONS-76,54618305,5.4771970245541866,4.515299761208301
Panc 04.03,44491742,4.30815140156182,4.233923121717463
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,4.316216376956315
MDA-MB-453,123631,2.1950816453081545,2.2292558743123094
A4/Fukuda,426756,4.168045276817785,4.103306815440528
CA46,252682,5.8821335535914905,6.184334909218245
Panc 04.03,2828334,6.268769524950107,6.214962495517349
EFO-27,135411,0.9008731550993504,0.7672619088333519
LXF 289,15983966,-1.3187435990338214,-0.5015744067511729
A4/Fukuda,3384730,1.825152720179272,1.8321902471780243
SCC-9,11404337,-1.771041191231111,-0.40914135058696244
SNU-61,6610216,4.086517799339023,4.205170683564865
LOU-NH91,446155,1.33101507486467,2.787916511977325
KMRC-1,71466380,4.698779777562497,4.557104333966347
SNU-61,46398810,2.7474251169458346,2.3020651709207156
NCI-H2009,9826308,-0.026532071259288,0.7230761076021197
NCI-H2009,56946209,-2.630012103472263,-3.9454026847625143
HCC1143,46843906,3.1964507186723305,3.1004402542590204
A-673,2742550,4.033526638201744,3.4891481077128517
SNU-81,11507802,0.99367607100598,1.27502390701877
KMRC-1,11485656,3.5314695534539045,2.3644694781645343
SBC-5,57330099,2.8388792643726295,4.078004044699842
LXF 289,219104,4.555444774518925,3.993198977696904
Panc 04.03,9907093,4.451330392346362,4.4635311437072716
DMS 273,19582717,4.273838780275844,3.6360814461639466
SBC-5,3815108,2.9831729144642956,2.9768652570201306
OPM-2,168313016,3.5498730155612863,4.145493174041831
ONS-76,10427712,4.642311539672088,4.292268281151488
NCI-H522,54765302,4.051221649365855,3.8131142174754302
JM-1,44620216,4.114569245447781,2.635474412125424
MDA-MB-453,9887053,5.45770037243801,3.52137676094212
A4/Fukuda,72193861,-0.8043632874402014,0.4013263741310532
G-401,25102847,1.393287045797279,1.9150252965691634
SBC-5,11507802,0.0977610232609949,1.4921974388709034
JM-1,168313200,1.89690041567587,2.625631832984479
FTC-133,3634881,3.4388146515237468,3.5295440900094923
NOMO-1,10427712,4.067466468396052,3.6646036457076563
SNU-61,6918328,0.4046547109968232,0.04065201773585274
NCI-H2171,23635314,-3.6505205606038382,-1.9139082081758785
SNU-449,6438330,2.777557669825017,2.273456596609299
JM-1,25161177,3.865095276574429,3.6428528649476766
LOU-NH91,3025986,-0.3413799803632848,-0.7947054069031299
HCC1143,53232,5.137172207040132,2.916191536077725
LOU-NH91,53232,2.5403477328432933,2.923346702785606
NCI-H1623,24797083,2.165751455730843,1.4595290945853554
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,3.1924739290318143
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,1.9591762452582093
SNU-449,3025986,4.266276949739511,-0.7431097403779026
NOMO-1,2858523,2.9127751570608136,2.7296191751465524
A-673,6918736,-0.9753951922870552,-1.878422820607107
A2780,44202524,1.0300821380640774,1.7103802447697247
DMS 273,25154868,4.488535380180048,4.174531476277363
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,-1.5621129731516472
BT-549,100016,6.139281322747303,6.320098189305868
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,2.915191637785288
SCC-9,148124,-0.9222891029936632,-1.2130012115134818
DMS 273,11494412,0.2734180035919979,0.8895464763360903
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,0.3192746931513432
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,1.3408599162776869
EFO-27,16725315,5.151426492732951,4.548094459696639
KYSE-70,3689413,0.9447440025313596,0.1978679289434934
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,0.6704476785197825
NCI-H460,285033,-0.7054560098467199,-1.9968855942321664
KMRC-1,5311,2.4483949186029794,1.5087770867062864
Panc 04.03,54618164,4.2869772681873695,4.2403706049850145
NCI-H727,676352,2.629502567411482,2.4556441753363116
HSC-4,24779724,5.454925638847944,4.071902155030659
A2780,23725625,2.4195603562256873,4.526833723706822
CA46,56946209,-5.9555571874685755,-4.835689121767344
NCI-H146,6252,-1.7817409080320272,0.38094646401085924
SNU-449,44589607,3.7188226068257872,2.9459659585752735
LoVo,969516,2.402995535890804,2.7766763032920636
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,3.331141565199313
CAL-51,9935249,3.84795648434564,3.2179893239000688
NCI-H1623,53392493,3.831222645051568,2.8136053339116827
MDA-MB-453,54596490,5.641262539800198,4.493363705667766
A-498,42642645,1.5845020846141176,1.3502165389774776
FU-OV-1,4788,6.1006518616017615,5.607622839466327
DMS 273,6852167,2.1769146352356707,2.62467255697245
LoVo,11612883,2.4190290931093954,2.8769816831793316
A4/Fukuda,54618305,3.964460418875751,3.5794880495315557
NCI-H2009,17755052,1.0629457660851225,2.1289324044141535
EFO-27,5113032,5.5462842201226925,4.853096425680049
LoVo,9907093,0.4604974674369004,4.10814040787532
SCC-9,44491742,4.764074483400304,4.247471254080425
NOMO-1,53392493,1.775943290565707,1.8122286070418492
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,2.190208531008697
SNU-449,16725315,5.255161508937853,4.433151413179516
SNU-81,9825149,1.815233140933264,1.9117280055107977
NCI-H522,60700,-0.5552110519793028,-0.6508172848786721
NCI-H2009,375860,-0.9754800160336818,0.08922132494503948
OPM-2,44607530,0.8834373674969361,1.5338014457940283
MSTO-211H,2708,3.2234156242084073,4.9410491419326075
OPM-2,15953870,2.653227585048534,2.892563651607282
DMS 273,11238147,3.12717198165546,2.4809532201912194
OVISE,3062316,1.3579552700407893,1.0979500250673013
NCI-H522,11955716,-2.355417617820864,-1.510707074445242
LXF 289,44486219,3.8558224358877298,4.374296422810827
NCI-H522,4261,1.255814980012561,1.2728278869356613
SBC-5,11396600,3.6683316442381617,3.2818306823490584
NCI-H727,448949,2.521247711014773,2.335579909711843
CAL-51,126941,-2.448006630223804,-3.0877980458708794
MDA-MB-157,156414,1.5733069512528617,1.441058567213133
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,3.7901595328682305
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,3.8901358276498015
FTC-133,2871966,2.512715884905784,0.3988503460232329
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-1.0268786715472125
KYSE-70,168313047,2.1859183661660624,2.432148372974959
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,2.248273124174513
LoVo,54454,2.7172548619434025,2.4395788275517196
SNU-61,73707398,0.7144154314829279,1.1826072053472156
MSTO-211H,9866186,-1.5986440722967756,0.9437456714397264
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,1.0136868255847569
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,2.6203891587339654
NCI-H2171,57519531,1.5586354952126105,1.6952312769494489
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.0723546181605244
NOMO-1,451668,-1.632426084818391,-0.6348742792308621
CA46,5282054,2.3254868404716755,2.9387598776421187
MDA-MB-157,54618795,2.0481333451118204,3.2384997226905874
OPM-2,11707110,-2.1571352516283113,-1.039756834864743
CA46,3136844,3.7113001526336338,3.5013284513353553
NCI-H2171,984333,-0.9596445260901963,-0.034822666759065146
NCI-H1623,11507802,3.5238050648518136,1.6216903691845044
NCI-H460,46191454,1.6495265120274705,2.168376949786075
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,2.887934542920487
MDA-MB-157,7326481,2.299098205794017,3.135255144959853
EFO-27,1239801,4.748117996702423,4.299334541041199
NCI-H460,969516,4.1763077592827225,3.047592944064034
G-401,44202524,1.447982360696086,1.89643759415979
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,0.7992108368172195
NCI-H460,2749,2.5004778765083695,2.054968987797279
DMS 273,119607,5.531574360726778,5.093609138790766
FU-OV-1,10074640,3.835416148861087,3.257976770605985
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,0.5607731763021782
MSTO-211H,9911830,2.3480580098381747,2.5855828647140418
SBC-5,135411,0.301348299555382,0.3030183116738196
MDA-MB-453,6610216,3.7821562137745217,3.9610056599428303
SBC-5,2708,2.061546130614232,4.789122212479704
KYSE-70,11396600,3.829938839575827,3.3598288722863874
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,0.21798220462938808
A4/Fukuda,11152667,-2.4230854517211977,-1.731384753304861
SBC-5,36314,-4.885811702708602,-0.9124855930545331
DMS 273,9884685,-1.1971048738595964,0.5545412671541721
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,0.8350081798717318
NCI-H2009,439501,-2.087429471182781,-1.9089603205362429
MDA-MB-157,1716436,1.1718034720311097,2.837142901364445
ONS-76,216239,1.6729885995968985,2.3304383326652265
NCI-H460,9911830,3.1326305509826824,2.731515859899405
A-498,2858523,3.0988346297597293,3.1225346238444764
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,2.885702849937755
OVISE,969516,2.883429877122848,3.065087268152269
SBC-5,3825829,3.3495967392740953,4.034164846939521
LOU-NH91,5278396,3.7974378044691495,3.639327620877122
MSTO-211H,9935249,0.534197831206919,3.387879519793279
JM-1,9911463,2.675259516581914,3.2261775742896868
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,3.192318486725039
SCC-9,60750,4.9910553033212866,-1.4534891519724067
SCC-9,387447,-4.584813930042193,-3.9195987798436294
SNU-81,25062766,1.4859068805404914,2.1269107974236747
NCI-H661,2708,6.321788786635088,4.712912275816061
NCI-H460,57519531,1.7606196796007008,2.5134216980941146
KMRC-1,613753,3.207263348750723,3.025634734674491
KYSE-70,67156097,-2.3379446798215127,-0.2875905159639841
OPM-2,10127622,2.4771662101119194,2.7406510342258565
LOU-NH91,5291,3.971687681340124,3.753583336826326
DMS 273,6918638,-0.6329393875591668,0.22222214471825347
A4/Fukuda,16722836,0.6102638619225811,0.9471807135804202
NCI-H1623,11175137,3.026300100874371,2.746492080503833
SCC-9,122327,5.629849115039079,4.953955741348854
CA46,11625818,3.63093624941088,2.807248481711359
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,1.4483014418412161
Panc 04.03,156422,4.828457411788627,4.4261448249427735
DMS 273,5278396,3.2906012116635694,3.4520277393168546
HCC1143,53495165,-2.177337144630303,0.6393486347872517
OPM-2,1641662,3.0681099569104653,2.9938282560562466
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,2.159233436908134
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,-0.9699439572484788
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,1.1451064106796367
A-498,6917907,2.9475757171512575,-3.943005314584933
G-401,10385095,0.8697787767816428,0.9744228079755314
MDA-MB-453,702558,3.1332940697725435,4.721313592460685
BxPC-3,15547703,0.9056764589340796,3.132436433669635
A-673,44632017,0.706241354368095,0.9248562359466408
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,0.6364394341040144
NCI-H661,11626560,1.806538061239003,1.8933621304940993
SBC-5,9840324,4.760330511699364,5.88072923906571
NCI-H727,46398810,3.032466795061864,2.487852148006181
HSC-4,654092,0.2566378579351391,-0.2543316759395675
G-401,5978,-3.1887203575088727,-2.884451634740895
A4/Fukuda,11238147,1.0973923844128086,2.2481095186784774
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,0.8876003083117199
NOMO-1,54678924,1.1055951494804663,1.047708019114519
JM-1,135421197,0.410328587733175,1.1183793452191273
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,-2.141697019449792
BT-549,216468,4.5222519285579885,3.4824735585380124
NCI-H2009,136227924,2.9896301065010933,3.1690430279550954
SCC-9,2828334,6.128266495621781,6.274850580963568
LOU-NH91,3025944,4.356407657994756,4.332087305526276
ONS-76,5329102,2.3644433253395545,2.263638159924386
DMS 273,53495165,-0.9870251488119351,0.008357416676121443
NCI-H1623,3634881,3.389178636612412,3.440842942398516
NCI-H1623,446155,4.270765867841268,2.954128682986221
ONS-76,984333,0.6472143254241693,0.9096691826768586
SBC-5,3081361,3.306292226806483,2.358554453225878
NCI-H2009,11625818,4.7000574258268255,4.647286798729024
CA46,24775005,3.732581966598925,3.0802428694700397
SCC-9,11222830,1.8600220042192213,1.8147056962751464
KMRC-1,12003241,-1.418239320082467,-1.3857436290124339
SNU-61,613753,3.0121134483838037,3.1409096231464178
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,0.8195856862497192
SBC-5,4261,2.0931810634834105,1.6264922986004229
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,2.092508087128059
JM-1,445091,4.048660068158945,3.890379941192057
NCI-H292,44185566,2.325959343920572,2.7048888659914767
SNU-81,6918328,0.0758058419703895,0.006790327294447141
A-498,16659841,6.0591016575330325,4.031799481847807
NCI-H460,51037431,2.104101453867928,2.9339604533959567
MSTO-211H,5978,-2.861470631068365,-1.3938296256644744
SBC-5,6918736,-1.7962623830849138,-1.2824216676210372
NCI-H2171,11178236,-6.134942659978268,-3.70782079194334
ONS-76,11427553,2.8550216000544695,2.666676527026323
JM-1,11234052,3.3092904099829115,3.018417240426103
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,0.5994377130511264
MDA-MB-453,11719255,3.0016884563631057,3.5115151183939166
HSC-4,241158,3.797905223062241,3.9352961342810455
SNU-61,49766530,-2.178873950286192,-0.31975331156783215
ONS-76,54454,1.5364254879481318,2.9184879465331677
NCI-H2009,54618164,4.160237516111787,4.224534478955938
CAL-51,3136844,4.799885860604426,4.1706166889513385
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,1.4018914776441647
SCC-9,46926350,-4.135183666473923,-4.1627080766784985
YAPC,5460769,2.316930709954587,3.0108196722211944
YAPC,135411,0.9254838530178896,0.7416984122963511
A-673,11228183,1.918128583172148,1.0146527359513144
MSTO-211H,24856436,-1.8779899697418416,0.630092878557923
LXF 289,44185566,2.4809324153017265,2.7795361112566948
OVISE,654092,-1.3076939787912127,-0.3028569410867544
A2780,6918328,-1.1386748973241003,-0.06296285297951487
FU-OV-1,44819697,-2.23904448126328,-0.5810965630150602
BT-549,42642645,1.6219324424635808,1.1739888856397163
JM-1,216345,2.231105973795255,2.725706891976709
G-401,73707398,0.5507155331982622,0.7884595279525292
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.8693208987915382
KMRC-1,16722836,1.9243244677044424,1.6244754076198544
NCI-H1623,135875424,3.67415188779786,3.9584715757460485
NCI-H2009,638278,3.464543124143687,3.6692678677528785
NCI-H727,168313047,2.9561297907786717,2.48911724025537
SNU-81,439501,-1.707157001292212,-1.8811582743029434
MDA-MB-157,11234052,1.0821323764870938,4.213058531977945
NCI-H727,11364421,1.2179988120980565,-1.7204279313453026
BxPC-3,2729026,2.140647578797141,2.703787023116851
NCI-H292,46224516,2.488403107417036,2.5846385808897794
MSTO-211H,5746,0.1838030897357816,1.3097763298555676
NCI-H727,5280436,4.172163827724594,3.3545800429425103
NCI-H727,9911463,4.409308573364914,3.8367013300795403
LOU-NH91,9907093,4.908801109640004,4.342572830634321
HSC-4,24772860,-3.179601965562413,-1.9459164084020355
MDA-MB-453,10302451,3.3014196832790628,3.447093921171565
A-673,2945648,0.1856393110329161,2.4625335686215313
G-401,56946209,-5.714614119541748,-4.23976893291903
MSTO-211H,452548,-2.0931551112296742,0.324556645710325
NCI-H2009,5280436,3.59103147994178,3.6843385965529682
CAL-51,241158,3.781489879449518,3.8470477516542845
FU-OV-1,24772860,-2.86759244210788,-1.4312023931107545
DMS 273,54596558,4.317274835352231,4.282865470479415
DMS 273,71466380,4.5698020131067745,4.248284340752374
ONS-76,11175137,2.2807611594224975,2.4953381765779823
NCI-H522,136227331,5.948504593030567,4.231945090010985
KYSE-70,262093,3.701785722517592,2.840262648524925
KMRC-1,119607,5.885636542486439,5.2384084064305565
CA46,16722836,1.2778374610309875,0.5545984687916062
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,2.7787546948227897
SNU-61,24772860,-2.9174361907600592,-1.6618857968202239
LoVo,322968,3.2361743048313536,3.8106735255505804
NCI-H460,168313047,3.736921155938788,2.374126585613204
LOU-NH91,123631,3.064358892537756,2.3736882685779634
NCI-H146,10410894,2.10877812565835,3.086810408210021
OPM-2,107985,-4.911691484457119,-3.9251109861720384
HSC-4,4917,3.66079963002401,3.1651511250459783
SBC-5,72376,-1.1693945126287038,-1.981983111697299
KYSE-70,11238147,3.36128873589197,2.7788054867691523
CA46,9935249,0.2545497442771542,1.8455810449292036
SCC-9,135421197,2.7056920215811293,1.928381818874968
FU-OV-1,123631,2.446979601054181,2.28709529282345
MSTO-211H,12001922,2.4775669078904397,2.037051769994103
NCI-H661,3543504,4.269759852401949,4.329495503016383
FU-OV-1,53495165,2.0201630022514263,0.4902405980061323
NCI-H2009,448949,2.535639173937985,2.2221743319128415
EFO-27,285033,-1.172211692399995,-1.7605457538371252
YAPC,5978,3.3733616775717716,-1.629247769323201
BT-549,9911463,4.268645247281358,4.111554250417002
NCI-H522,2113511,5.298827483301359,5.284203721977394
SNU-61,1242560,3.7603648536411622,3.3690817397436486
A2780,3503,2.123197367997407,1.8758527901061322
JM-1,262093,0.3077511100871351,1.7638206050542464
DMS 273,11612883,3.047294051558191,2.5832871088857288
A-673,156414,1.4246196000990916,1.279139780009778
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.6760447890541499
SNU-81,3385,3.194341332216005,3.568145846366828
SNU-449,44486219,4.185988120780244,4.483546036439586
SCC-9,25262965,-0.8228501050995407,-1.497397793393675
NCI-H146,9967941,1.5373910611842192,3.3208727950756236
HCC1143,969516,2.4763079586135546,2.847833925576259
ONS-76,12003241,-1.3579895274230906,-0.9499708337628249
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,2.224906578240772
OPM-2,26596,-3.75281027154887,-2.106821693751694
KMRC-1,11955716,1.3700469468180672,-1.0247760963616686
ONS-76,445091,4.207927105180806,4.470500936510297
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.6884244658497193
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.4305482822567
JM-1,11964036,0.6346833811859819,0.7391794230631308
MDA-MB-453,24180719,3.640576555720147,3.6295224136082846
NCI-H146,3689413,0.5626872136369616,-0.4746213036428156
A-673,5335621,4.03269099593382,4.496326537588119
FTC-133,44491742,4.538470926749077,4.161260802418905
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.4714798931303275
LXF 289,23725625,4.938564251049365,5.180335932508467
OPM-2,11612883,1.2708799210561326,1.9725563428417863
CA46,11485656,1.2289823963881294,1.6840291143001265
SNU-61,227681,2.9666568152307993,3.248638257973432
NOMO-1,135421197,1.2386186938920458,1.3044920009428602
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,3.358334945911149
BxPC-3,135421197,1.4419000032460958,1.9956911521048817
CAL-51,66577038,4.134711160885491,2.9193599166718207
BxPC-3,11485656,2.0481416814216375,2.174007339221822
LOU-NH91,3689413,0.742189593443008,-0.3287702503133779
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,1.9676413843931104
JM-1,49766530,-3.0151701370453794,-1.7344249419064157
NOMO-1,15983966,-5.011559396504552,-3.0300066488977806
HSC-4,24856436,1.7831446753384608,0.7916776298462987
OPM-2,387447,-6.258797979541162,-4.851921550987027
A-673,54765302,3.022220101838166,3.836495267504157
A-673,5479543,3.2499245267113928,3.089295285887125
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,-3.3055034897603575
A2780,441298,1.2276441630256645,2.505285337368898
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,0.4632095875965061
HSC-4,65064,5.180183799352401,5.033920204994854
OPM-2,3384730,1.6721258053175836,1.5684600653707323
NCI-H522,387447,-5.403881314975521,-4.085468285705888
MDA-MB-157,11640390,1.4666591993417384,3.440166334470049
CA46,9911463,2.565133854881976,3.2081890277179035
FTC-133,227681,2.0408407851095416,3.288307022717254
JM-1,285033,-4.464347137363986,-4.016266185848034
KYSE-70,16736978,1.1213704825993671,1.2649027132767028
MSTO-211H,2729026,1.9618514095460544,2.7749138997291927
NCI-H661,24180719,3.917772031076744,3.5419704371648892
NCI-H1623,400769,-1.0076663191396935,-0.5291409895997581
YAPC,9840324,5.782457936566159,5.993360445163375
Panc 04.03,57330099,4.388225142481581,4.385945120317163
G-401,135659046,3.5574575455214608,3.501893955390171
A4/Fukuda,148198,-4.99238512913244,-3.834749642178158
CA46,126941,-4.174426911659592,-3.3810018105686277
SCC-9,6610355,5.330005746360321,4.631675031255233
KYSE-70,44185566,2.2395157674699875,2.283814467226189
NCI-H1623,462382,1.1150663609789129,0.6090938466496055
CAL-51,6914657,-5.067352950634086,-4.458420760775479
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,3.7692519108311835
EFO-27,54618164,4.628305371415217,4.1596562514049875
JM-1,23582824,0.2805180690676545,0.3998090444971254
NCI-H460,44185566,3.2105564381381035,2.5465408641181644
CA46,52912189,-0.9978651387823436,0.14263756299931007
NCI-H2009,9935249,4.414461781647313,3.28058399061636
NCI-H2009,135928012,4.098076343567735,4.4110185472386885
CAL-51,60750,-3.4379358682898973,-2.4002982200825387
MSTO-211H,8515,1.6806311840995682,3.995362267126599
ONS-76,15983966,-3.1712265481751243,-0.32803897237238594
NOMO-1,56946209,-4.862706213909506,-4.712394739046456
NOMO-1,24772860,-3.4546209155075687,-2.9795758921590805
FU-OV-1,44185566,3.182046500186311,2.660597093848637
NCI-H2171,11977753,0.3036523614034643,-1.641534141578516
FTC-133,31703,-0.768913830642622,-0.5795784221856352
EFO-27,984333,0.9554706085777084,0.9814764546335684
NCI-H292,5329102,1.7855476735914897,2.198336717594282
CA46,409805,3.3808362620175187,3.8100398692644184
MSTO-211H,25183872,0.3972499543283658,-0.9087938430558176
LOU-NH91,24180719,4.451607655435679,3.5661185960937205
A2780,44185566,1.1999498835751436,2.102572362657608
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,1.1899089998247445
NCI-H2171,6505803,-0.0596794204500112,-0.30251759397494327
CA46,66577038,2.896384523521911,2.489283749942478
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,2.255924831683379
CA46,12003241,-2.799565618947511,-2.2416948910656846
NCI-H661,10427712,3.832896992750264,4.117809996996118
SNU-449,107970,2.557902386411369,2.330934359870728
Panc 04.03,2874250,5.078270927101478,4.674733907542776
NCI-H292,54626689,4.661071465435288,4.837452555356818
NCI-H460,23725625,5.666756485817308,5.264822921025353
CAL-51,53232,2.8018516258833395,2.998253880749605
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,1.9000883801759947
EFO-27,53495165,0.9078503906950024,1.2147304179289606
SNU-81,65064,4.179756271690876,4.1410144890674765
BT-549,3689413,-0.9397914335397376,-0.5527298661781341
NCI-H2009,66577038,3.427367822074961,3.03633109582981
LOU-NH91,10302451,4.426232341068122,3.4879413457561106
CAL-51,168313047,1.9592520089902103,2.4264068425419545
NCI-H292,135411,0.5538002090667975,0.8404252472744731
LXF 289,2874250,5.409057432200043,3.951537502752138
EFO-27,4261,1.4655103146060633,1.9601371035186959
ONS-76,25150857,2.480326692853007,2.39342638376943
G-401,11175137,1.9335599830838224,2.2376099727944854
OPM-2,5460769,4.223891374112808,1.6026496280742344
NOMO-1,10385095,1.0593467546243338,0.8194274067051336
LOU-NH91,2126,5.273491801207327,4.579065338121043
MDA-MB-453,11625818,5.002273286989784,4.141271374720403
OPM-2,44632017,0.7121474472673729,0.8882744145169998
LoVo,135411,-0.4629764704945864,0.5899974936765473
EFO-27,16722836,2.503686118945589,1.7332951238933543
LOU-NH91,10074640,3.3386477352477715,3.340215345107369
DMS 273,11719255,4.586791904076426,2.884021460959882
OPM-2,136227924,1.7425170628423947,2.319242813952038
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.138256278342772
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,3.3333989117809653
NCI-H522,2828334,6.021027928266713,5.835074018715846
KYSE-70,72193861,1.5917149982909504,1.5880199565012487
MSTO-211H,9911463,2.6842905920893108,3.921032593699526
MDA-MB-453,969516,2.9001694226946153,2.8205639223689025
CAL-51,44632017,0.9975947899898204,1.195828165602503
LXF 289,10231331,2.4249622135671824,2.0567387654601763
A2780,25195348,2.1109786238814943,3.125529188863155
NCI-H2171,44202524,1.9759332673432517,1.86953896984252
Panc 04.03,1641662,4.251343925322988,3.590857017478019
NCI-H292,54686904,5.52345614596139,3.9692609697441474
DMS 273,7251185,2.13119393000196,1.9855095715500568
LoVo,9956119,3.291456775833892,3.632615565151704
BxPC-3,11404337,-0.6361724208993981,-0.5311173145351822
NCI-H2009,119182,-1.1305543955582442,-0.43104958308122654
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.1097652163585616
NCI-H2009,5278396,3.446569775137936,3.748203925738643
SNU-61,327653,2.3439595497702985,2.956494800059127
Panc 04.03,11238147,2.6863632300229936,2.957264308761731
LOU-NH91,9926054,3.1176474597994908,1.9018571772346238
NCI-H727,5566,3.3170373665309416,3.020870762417126
SBC-5,25150857,3.1636616713903893,2.4507360255574437
A4/Fukuda,11719255,2.014724282446697,2.7021550527965115
NCI-H460,374536,2.933441634270558,2.1634062897903403
Panc 04.03,135875424,4.739147054003967,4.278061608853228
NCI-H522,9825149,2.538976142931882,2.0046893631877554
NCI-H522,11964036,1.1738559849313974,1.092752983914507
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,-2.936857094754727
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5199297940942892
SCC-9,5566,3.224791432055543,2.928135935068349
NCI-H460,9936388,2.3098343611543415,-1.1054582263993469
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,4.635519182034133
NCI-H460,16720766,0.8258921674033131,0.6886186663249476
FTC-133,54618164,4.149608396421597,4.203731857677678
NCI-H727,5281321,2.7498034475542803,-1.3280263890517379
BT-549,31703,-0.610163723442028,-1.1374027649292828
JM-1,11609586,0.7887510712984062,1.8059359589275552
MSTO-211H,65628,3.7458295220001,4.418079865808131
NCI-H661,9887053,5.171148908960024,3.8576169401139775
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,3.241591274615048
G-401,9887053,1.7608751069117703,3.173488762841784
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,0.6583994017807524
A-673,7251185,1.3487938120123666,1.884415953316591
ONS-76,4259181,0.68334491499701,0.19218783198147005
NCI-H292,613753,2.7114183475644857,3.2602236504025246
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,1.4227671053520976
JM-1,25126798,3.029145333632086,3.4033371572732234
CAL-51,3815108,3.0623029951861396,2.990257599246449
SCC-9,16725315,5.212889946477865,4.393606420744812
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,0.7926681974821662
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,1.8695473133711618
LoVo,16722836,0.1488668556579147,1.8382243111454366
A4/Fukuda,25262965,-4.823082336145625,-2.249268374711255
OPM-2,53392493,1.6243275023991692,1.5679524974551935
HSC-4,9926054,2.0278633205902468,2.054717159076736
SNU-81,9936388,-6.314751034125396,-3.5698705591461333
G-401,9823820,1.4384887897470693,3.6625977881726404
YAPC,24753719,5.0641073859888,4.336319652532078
OPM-2,24772860,-2.8738620885527153,-2.69501063610018
MDA-MB-157,10427712,3.542893078297904,4.370673586069113
A-498,4259181,1.547873530266754,0.5029657130486133
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,-0.43200545090583803
SBC-5,9927531,4.452264212548339,4.6810159833377325
LXF 289,119607,4.549732560104057,5.39126792861667
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,1.7782029229769882
NCI-H2009,11396600,4.054693544346837,3.7547094048592893
SNU-81,15983966,-3.5187473914136738,-1.8760351370745354
Panc 04.03,11494412,3.764008563191269,2.347978052365837
OPM-2,216345,2.3930113976289364,3.0655601159926884
JM-1,66577038,2.266129645862272,2.4102163157407195
SNU-449,15953870,3.8419288275174326,3.7861181580878656
BT-549,9903786,2.513972936103366,3.1038499888659787
OPM-2,44202524,1.1830318509158162,1.4249786050460054
OVISE,6623618,2.0550481440983153,2.2417716016703384
SNU-449,11657048,5.413893492178721,4.4840686213964815
NCI-H2171,67291369,-0.2342814323553679,1.881167815575433
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,1.6916867022068092
NCI-H522,11238147,3.4337502548923404,2.7816352504182067
MDA-MB-453,16065773,1.7584918793826552,2.263903744807464
LoVo,136227924,4.6796674015936075,2.72929171598504
LXF 289,3854666,2.0847029854583377,2.0953843305457793
OVISE,984333,-1.5189255907846522,0.820290275386295
A2780,159324,-2.166969557176003,2.1541307183643363
SCC-9,17755052,1.3521912896367647,1.8851344808705361
OPM-2,9823820,1.0965123517529505,3.2336331317002482
DMS 273,12001922,1.9670879212293255,1.7691762444496488
KMRC-1,24180719,3.956198558970242,3.6033331269361084
KMRC-1,637858,3.0556928718558707,2.2701558017004606
NCI-H2009,6917907,-5.363195379340594,-4.75227403479897
SBC-5,24748573,1.8248605513332548,2.057662809816168
CAL-51,452548,-0.9080095532304931,0.5171371810194947
BT-549,2858523,3.192172893232417,3.0626854065454734
KMRC-1,219104,4.439460794922528,3.7836911636251505
LXF 289,2858523,3.038787864461457,2.8816834334907657
NCI-H1623,9907093,3.838952634819664,4.375515531029539
NCI-H460,168313047,3.736921155938788,2.374126585613204
JM-1,5287969,-2.2665073107333997,-2.1105844808271983
NCI-H1623,2828334,5.745033734102683,6.074226353713653
NCI-H522,53232,3.4340993190045763,2.6972282294932146
MDA-MB-157,24180719,1.846017762198611,3.48717805738582
NCI-H727,2858523,2.9690043699309094,3.0579412299859547
HSC-4,3384730,1.6775009570022803,3.1615007100059547
MDA-MB-453,66577038,2.2210808109899687,2.804236102459033
CA46,54619267,3.4754479185856604,3.4100161776210727
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,2.7566569027116157
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,4.28634155253568
DMS 273,89183176,4.012998903778193,4.280424955420699
LXF 289,89183176,5.264029999533809,4.457012571229059
HCC1143,25154868,3.6479876335061863,4.529840402455495
NCI-H460,5566,3.3663694984335533,3.0409950548070794
EFO-27,3384730,3.632582575012134,3.1548269525723907
YAPC,3854666,3.60977300269674,2.309361307371048
CAL-51,11960529,3.662834723962616,3.8427854939755495
NCI-H522,4096211,1.7167000910654833,1.7793817905303557
LXF 289,46199207,3.0446562724495676,3.2569059603212724
MSTO-211H,44507138,3.561974329612715,2.716434804455106
BxPC-3,10127622,0.1850831315580212,3.6058998836637866
SNU-81,57519531,3.6375637578947098,2.264584937057123
NCI-H522,46926350,-4.757002390021422,-4.283823111570152
LXF 289,675434,4.434927450149955,4.597638572493435
SBC-5,2858523,3.0625939376722147,2.9771957787207612
YAPC,3025986,-1.0818355674515514,-0.7963947946897824
G-401,753704,3.840031862409327,4.68557969240535
NCI-H2171,9933475,1.8341202855706125,1.607231129057629
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,2.953880567300843
BT-549,5746,2.744550621458616,1.4988718459226698
MSTO-211H,2733487,6.00734552009151,6.183094331047872
LoVo,9908783,4.437010992006648,4.823426073616969
NCI-H2009,46398810,2.5614683956162554,2.566826419069989
NCI-H292,15983966,2.054572304908195,0.10314672270090754
G-401,46943432,1.6295589064479152,1.402260547902685
LXF 289,54618771,-0.5375230222620658,1.03388305119908
NCI-H2009,4261,0.1994590765469732,2.0552494710353537
NCI-H292,119182,-1.3574963176080912,-0.5187465141939943
LoVo,675434,4.114717976727459,4.4501730418445415
CAL-51,613753,3.3238399640193177,3.2379722847476984
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,-0.29215472300885165
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,3.6931781564938633
MDA-MB-157,7251185,1.2275966709755557,2.5806176933865386
LOU-NH91,168313047,3.5347026371928565,2.478511868583554
Panc 04.03,11175137,3.811547013287204,3.065390216358566
YAPC,46191454,1.528991916080322,1.600110682405246
Panc 04.03,246676,4.5210437514033615,4.478779947749666
LOU-NH91,107985,-2.204555775629559,-3.2326013550666444
JM-1,9884685,0.5602575931973728,-0.06627315731051224
KYSE-70,26596,-1.4453873864890578,-1.2135763704869185
SBC-5,11238147,3.923057921789592,2.7759075694378743
CAL-51,5351362,1.1872361858703535,1.3407051315654481
CAL-51,148198,-3.728190383000159,-4.122151723101926
MSTO-211H,10074640,2.8901374693183848,3.150092269144231
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,-3.383109312856857
Panc 04.03,54618305,4.994656380487723,4.5388695192885535
HSC-4,9444,4.231424733159592,4.218113945086272
ONS-76,136227924,2.542073211711186,2.7991005504416138
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,-0.03095221152621765
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,0.4853119268908012
A-498,4705,4.1964696083385595,3.348486835157889
NCI-H292,4788,6.000922818610643,5.812832362341198
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,1.3664370966775254
A4/Fukuda,168312962,0.589698091471745,0.5865826389371808
MSTO-211H,135421197,0.8053711662366769,2.027934707310131
G-401,9826308,0.736562536874994,0.15677704806684653
JM-1,44202524,1.2333959484520816,1.3721698827267428
SNU-449,135984461,4.468051833024593,4.196829325900127
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,1.9564382240349105
HSC-4,135999136,1.7584955345229645,4.270212068106502
HCC1143,6918328,-0.4969866258783406,0.18108611094073687
A4/Fukuda,2871966,-1.2628046939905593,-0.5063732270978001
HSC-4,89928392,1.9678897287961257,1.5709820631543736
CA46,7251185,0.9564015595877396,1.5307096510070173
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.7355375991300916
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,3.4959628150639066
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,-0.654058976197765
YAPC,9967941,3.379913520192136,3.740737416441471
Panc 04.03,119607,5.706581209982884,5.655635019264021
KMRC-1,46926350,-4.153095302049271,-4.2323357963678525
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,-0.09379451166538909
OVISE,5287620,-0.8119274098935182,-2.0274620945378086
NOMO-1,135440466,1.6123042261647436,1.3305058921332047
A-673,11507802,0.3878845266361032,0.8793770766216003
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,-1.7485020155488997
NCI-H2009,3854666,0.912328636385412,2.2140087753719815
SNU-81,2749,0.983670801340458,1.8480752322102532
A4/Fukuda,25105715,3.290295740743095,3.0038574486695904
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,2.7100824820040765
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,4.99860216832296
CAL-51,9903786,2.1849161121493847,2.898755827777664
LXF 289,5113032,5.558232749512156,4.70379414548879
NCI-H522,46224516,2.9506377913569244,2.0745653043905894
FU-OV-1,56649450,4.970206677695459,3.5104896827945775
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,2.3135192690834887
MSTO-211H,9887053,4.1066593545259975,4.082445843260772
CA46,6610355,3.575030613446337,3.7977139038108
NCI-H522,445643,3.9693726836499863,4.068398135247408
A-673,46224516,0.8314688808424526,2.1926024595027114
NCI-H661,6918736,-3.5059805921507823,-1.388188835779313
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,3.561115984344351
A-673,3825829,3.830298825271896,3.765365807330343
ONS-76,11396600,3.887590392789339,3.7044856092250775
LXF 289,5282054,3.512278681739004,3.837806724024543
A-673,54618771,0.7910545462175201,0.5107077916655645
KMRC-1,25062766,1.7411663615582824,2.0730542556811873
EFO-27,71751553,4.378478985868248,4.67700234308876
EFO-27,10074640,3.872803440374816,3.340794902769693
ONS-76,24964624,2.710261416606334,2.4269653840597805
LOU-NH91,53392493,2.3846272258457737,2.625438590320888
CAL-51,46199207,3.548155956826357,3.2450782174229453
DMS 273,227681,4.814934070367145,3.123443414473893
HSC-4,9908783,6.127900398037499,4.94752321677721
HSC-4,10184653,-0.7296444895073179,0.9587066808728418
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,2.568913164242486
NCI-H1623,44185566,3.0587688781610667,2.6238911259883464
KYSE-70,6918328,0.2213620303324437,0.24031248721117077
MDA-MB-453,327653,2.9444810987281533,2.8765158322772946
FTC-133,4259181,2.1331002918337925,0.21657568392121868
NCI-H292,60750,-3.187051343712646,-1.9233687676119622
KYSE-70,60700,2.818490002790748,-0.311847722721291
MDA-MB-453,24821094,0.7464785951288041,2.4783172431108564
NCI-H2009,656346,1.3969032628362248,0.9983180379310752
SNU-61,24964624,2.494415785344137,1.8593162923346003
NCI-H661,4261,1.9569329914003135,1.604084491104807
SNU-449,54618305,4.668068655096509,4.278412185917389
LoVo,135875424,3.182508442374063,3.836035459995586
LoVo,6623618,1.7195113979524326,2.150321307469134
A-498,135398516,3.177268179593805,2.5303082775168733
BxPC-3,26596,-1.629746525957504,-1.0974494632370455
NCI-H460,2749,2.5004778765083695,2.054968987797279
KMRC-1,46398810,3.012918063271682,2.580290354005828
NCI-H522,5291,3.860595721411624,3.3695756657457965
SNU-449,36462,4.301758862194218,2.564012112438762
SNU-449,6918837,-1.494845192804234,-2.394006364146181
CA46,11955716,-2.7152267118714204,-1.9219312791523708
NCI-H1623,168313200,4.911870039242249,2.858517934510086
NCI-H2171,10427712,3.6918148562663937,3.8962046662881376
NCI-H522,262093,3.0660845932794656,2.7197456936942626
BT-549,168312962,3.315695506914068,2.1875330036397695
MDA-MB-157,15953870,0.7968689532543627,3.6821355371497395
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,3.1487313286350656
SNU-61,11364421,-2.983927558247801,-2.2411786116569714
SNU-61,3101542,4.3555934573063695,3.4298569371286387
NCI-H460,52947716,-4.997624319891589,-0.729086803058269
CAL-51,44543605,3.919885801001582,4.1059119814129375
NCI-H292,12003241,-1.027467238096921,-0.8909564850111262
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,0.8946137681992414
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,1.9038982736586294
NCI-H292,25154868,5.001413217408079,4.4567992647669215
NCI-H292,36462,2.4286801987130486,2.2029080090549673
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,-0.9719444875358307
NCI-H292,159324,3.210621191245253,3.126192475569084
SNU-81,24978538,1.1236702452048486,-0.4633902357725325
A2780,9929138,3.988043631552867,5.366690453345464
HSC-4,16065773,3.311693132411482,2.559204811047148
A4/Fukuda,400769,-1.555916482707746,-1.3955202536308309
A2780,11977753,-3.718954593203518,-1.7527921885080542
FU-OV-1,60700,0.8482129777629449,-0.0881074123532317
DMS 273,168312962,2.633531304827929,1.2580706908148473
SCC-9,8515,4.77911141452934,4.16969887802122
A2780,71680916,3.658218554445846,4.453185722481352
FU-OV-1,5328940,2.1307155577669143,1.7508366063167617
NCI-H661,42642645,1.2812432760018797,1.0594748898452309
A4/Fukuda,2113511,3.845432548996496,4.829890442991875
SBC-5,19582717,5.27972019168548,3.9408588955948027
HSC-4,11222830,1.068056053085511,1.7041942444105675
CAL-51,10427712,4.2973287072996085,4.262980995399781
A4/Fukuda,44185566,1.3030950937163224,1.6964602975194447
ONS-76,5278396,3.742938248744769,3.7225785682692494
MDA-MB-453,46943432,1.9398007817238585,2.32716835889554
NCI-H727,984333,1.9308701128060968,0.7896557944454156
MDA-MB-157,24889392,2.1225906954298535,3.8461329985713495
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,0.7524764300273915
A4/Fukuda,46843906,1.071626560517578,2.037297416168521
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.448777718411779
HCC1143,44241473,5.874360916813842,4.906618984191786
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.4166551401033052
EFO-27,6918878,4.955152670116511,2.998840913158482
CAL-51,5281672,3.9430830045045857,4.586831180900338
NCI-H146,9915743,-0.2957101551438801,0.8858659005686232
G-401,89928392,0.7343580800154272,0.8888238016816552
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.8384782817618754
EFO-27,6184667,5.467001643500489,3.26004980085648
NCI-H727,3854666,3.6466691501950512,2.2911759033051498
LOU-NH91,9825149,6.244850491409518,2.2253598537064225
NCI-H146,11178236,-6.140205122942071,-4.2612938100910345
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.5870238304639008
ONS-76,448949,2.486443038536461,2.0592257834911885
BT-549,57330099,4.335540938726609,4.495776659920923
CAL-51,44819697,-1.9765663783606575,-0.7481277796994551
SNU-449,5278396,3.499051739077657,3.7230408425984978
LXF 289,9956119,3.057634534881657,3.698356689163971
A-498,9933475,2.3013420942123655,1.9589339580384197
DMS 273,10074640,2.948045052381196,2.9675442334553805
LOU-NH91,25102847,2.3579155704363206,2.5413632340502526
G-401,5311281,1.6046025374895514,2.0320159476886968
A-673,219104,2.2996165619151507,3.1135553505392095
FU-OV-1,42642645,1.0692746742635495,1.153099709990765
NCI-H460,135411,0.3374737909082799,0.7627961125666617
CAL-51,6252,-0.2076922850947726,1.0187953558583271
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.5395161052495336
LXF 289,10296883,3.609856485747645,3.9548875985604797
KMRC-1,54626689,4.972873475873264,4.686427231238984
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,0.7999907789628611
HCC1143,1750826,-1.2654463091368686,-0.925973068649833
SNU-449,24785538,2.8069089427026346,1.925979485682469
LOU-NH91,53495165,1.612116489462364,0.7392661125881811
EFO-27,11609586,3.640431752283184,2.813585317299338
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,-0.9685761442028407
Panc 04.03,104842,-1.0125052126256155,-2.220562677302467
NCI-H522,6610355,5.34603712705315,4.4103616240773515
NCI-H661,11656518,2.215339329496845,2.2368224684676314
NCI-H661,6505803,-0.5859050253944337,-0.6701571225018256
NCI-H292,5351362,1.0382380370911135,1.563609792323269
EFO-27,11612883,3.4595212211892377,2.97486972425681
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,3.370618925230444
HSC-4,10302451,2.384078053411002,3.052390875831579
NCI-H292,46199207,3.366381535989616,3.3528607864572053
LoVo,262093,2.370412929490009,2.965933117348247
BxPC-3,445643,4.432772060189362,4.000374607537771
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,3.293551707722683
A4/Fukuda,46224516,1.3171235816864948,2.10277867880364
JM-1,3854666,0.4999957819555636,0.8052107965832258
NCI-H292,124202324,2.857386903129287,2.569200269603669
BT-549,1566236,1.7296376770428397,2.5225650502654795
LXF 289,11364421,-2.6687395721676577,-1.4915143194736127
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,1.1235385902443644
FTC-133,148198,-1.6568063805549866,-3.2131706189850013
LXF 289,11640390,5.398484732926136,3.6938197938386157
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,1.544595045377539
LXF 289,2749,2.818144236178911,2.081938349605803
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,0.7772215604326808
JM-1,135875424,2.019666731209586,2.90267262166469
SCC-9,4705,2.492131143046821,3.0777134778536066
NCI-H2171,151289,1.4157771037164255,0.7346454368891302
NCI-H522,644241,2.1349742590503427,2.0717975882250177
A-673,445643,4.040507929851862,3.947001265662923
JM-1,6252,-5.0324479776154885,-1.401140980762992
NCI-H292,208908,4.322795663590344,2.1720705160113813
A-498,2871966,1.0686849145956876,0.8212987117566941
G-401,12001922,1.3873374697674952,1.6694083608523567
DMS 273,44491742,3.7307306463602545,4.0589850680274955
A4/Fukuda,11396600,-8.215434514364686,3.3128885764285743
HSC-4,3689413,2.5472025828962055,-0.03004114127394405
MDA-MB-453,4378219,1.7417226469020404,2.5023340477733744
ONS-76,387447,-4.115404850127739,-4.023102382497839
LOU-NH91,656346,1.0077735762311986,1.074075243516747
A4/Fukuda,3081361,1.810117399969756,2.1229123624644863
NCI-H460,6505803,-0.4074860596498978,-0.6466500358375586
NCI-H146,45279963,2.8359939324557706,3.267329165140776
OPM-2,6184667,1.6391974127027074,2.280857910449849
HCC1143,148198,-3.881060339055355,-3.618001084437146
A-673,421610,1.6759942643549426,2.8490578773731734
SNU-61,4259181,0.2985440005718957,0.2839139833950777
LXF 289,44819697,0.5606163889857397,-0.3200534632448683
KYSE-70,168312962,-0.2970816131627225,1.3783717898856926
NCI-H146,11494412,-1.136229477240518,1.0663273394996302
OPM-2,2746,0.9082445461467812,1.911083309310915
MDA-MB-157,6918736,-2.3678025624565175,-0.9825131567895505
DMS 273,135659046,3.477426326571923,3.487649083683505
HSC-4,126941,-2.3076253927529127,-2.7264876235400806
CAL-51,57519531,1.893237876741888,2.4553757370779303
MDA-MB-157,3038522,4.043799431595376,3.012430792957772
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,-1.202746337110701
BxPC-3,54613361,-0.6294380958983512,0.2202349283532647
CA46,25102847,1.8345278315547784,1.8089349593581168
FTC-133,5746,0.3858378554684238,1.2535636877527054
BT-549,10113978,3.95693770646699,3.296824972204025
A2780,54618771,-0.248592168161829,0.4545623091452275
SNU-61,6917907,-7.995083965311066,-5.000618766123573
ONS-76,3384730,2.185678697527176,3.0009219685685133
LOU-NH91,11228183,0.5456186750940368,2.746688000545065
MDA-MB-157,25227462,1.286146426910961,0.2877786299572663
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,0.9363423617512932
BT-549,439501,-3.1266914034371567,-2.2138968229828384
LXF 289,409805,5.2068809837223435,4.890002156336135
OVISE,148198,-3.4121309130102055,-3.3387201922924943
YAPC,262093,3.6115167721531343,3.0764488022372674
NCI-H727,5738263,3.354715168796171,3.4733197315205295
A-673,6918328,-0.9424380212903694,-0.3698975732261476
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,2.0163024813274273
JM-1,445643,3.755930816022248,3.5159402196837526
A2780,25154868,3.617715738937927,4.168818488116076
Panc 04.03,81146,4.4293645850092735,4.707011971638146
MDA-MB-453,4521392,4.261545411784443,4.25632797963225
CAL-51,5460769,1.3780575552768597,2.5483904719721377
SNU-81,9926054,1.3093723678717843,1.6912952807327528
CAL-51,2113511,6.39897875596168,5.559631111018233
NCI-H460,136227924,3.925006850615035,2.939149345773478
NCI-H522,24856436,0.0798065953372803,0.2925306270550462
SBC-5,9967941,3.629642521259923,3.6027161270799
A4/Fukuda,462382,-0.2406989279082468,0.354545192959373
OVISE,11640390,4.491956307789174,3.467652148493378
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,2.1726765924439904
CAL-51,24180125,2.8082301472193203,2.9850196438437937
LXF 289,25262965,-2.558275633709226,-0.8245199235484926
NCI-H2009,9903786,1.8298580590992315,3.058549386517369
SNU-61,54678924,1.5881868934361725,1.3715772606931198
YAPC,24785538,1.575520805381804,1.7195298497378726
NCI-H2171,676352,1.591250217642193,1.9989554861007834
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,3.613006030341996
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,3.150059205916457
NOMO-1,3689413,-2.5325178418163174,-1.2755707869993138
OPM-2,5284373,2.335601496737994,1.9891877843398362
NCI-H661,10127622,4.958480333722226,4.313010462656371
ONS-76,44185566,2.3053400119978735,2.5544408802632104
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,2.7098719927342425
HCC1143,11485656,1.8564802256291268,2.335155251076359
G-401,613753,2.8041503953296187,2.8855894051210482
MDA-MB-157,11657048,4.26764748298064,4.293517314768578
ONS-76,24951314,1.2212354664419371,1.3310333991794252
A2780,36462,-2.0824592368546893,1.1775811695956286
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,3.105998692989815
OPM-2,72376,-3.1510357921092376,-3.2011116591997997
OPM-2,6918328,-2.875264730320658,-1.517048077003087
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,1.011397948853241
EFO-27,168312962,3.0506772104926343,2.3506266758275234
NCI-H1623,107985,-2.7226564689550488,-3.2486016565109748
MDA-MB-453,46398810,2.51328952557295,2.4517285358325904
SNU-449,49766530,-0.9876450445747244,-0.3316194809764849
OPM-2,25102847,1.4573873057147737,1.7881438807877084
G-401,3081361,2.1638535645332664,2.2892141408323856
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,4.031367231180591
A2780,24951314,0.3580646626980762,0.797690711229163
SCC-9,2871966,2.1501352130214695,0.44078059112245505
EFO-27,53232,3.845715413797161,2.776129503986839
A2780,5460769,-5.6757466443406575,2.125872012888659
Panc 04.03,10322450,4.721553837851545,4.390785172979492
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.6375833740366579
SNU-449,23582824,0.6769149785817056,0.7409928539949364
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,3.248555170728776
ONS-76,3854666,0.984876663182433,2.1495638252717675
MDA-MB-453,71466578,1.854784458712459,4.084240808873849
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,1.7781898782542243
MDA-MB-453,15547703,3.861172408325267,3.104428793565244
MDA-MB-157,252682,6.150103454129247,6.482525755974629
G-401,46398810,1.5664917458517695,2.202374860173778
NCI-H1623,327653,3.600793829240414,3.204027334855947
SBC-5,6610355,5.221010400785003,4.409524313500041
A4/Fukuda,6918878,-0.3411937140873722,0.7619166842760271
SNU-81,3062316,2.330723232319837,1.325659913258854
OPM-2,9903786,2.6412283094975657,2.036397400171576
HSC-4,15953870,4.269670192757531,3.653677534700159
JM-1,984333,-1.6115401451915106,-0.3021601042628657
Panc 04.03,46174525,5.826098059849913,4.6935245192653605
NCI-H292,5460769,0.0770188109309223,2.878390201174669
FTC-133,216345,4.490711794352075,4.00841319986133
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,0.6277088654120923
FU-OV-1,5311,1.028726852721831,1.6323737375051106
LoVo,9911830,1.9062113768292104,2.54580160318926
CA46,23582824,0.075225101675958,0.53316171290902
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,-1.8476482926765292
EFO-27,24797083,1.960036113572856,1.6312030177720716
NCI-H1623,5460769,3.63452416726077,2.862962661222385
NCI-H661,5311,1.0541651051557333,1.3727879089029114
G-401,119182,-0.7625552993148171,-1.7308786333861332
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,1.0524731008370303
ONS-76,11507802,1.2556507557201144,1.840019138430893
KYSE-70,6918736,-3.61435843984592,-1.249727971588768
NCI-H2009,4788,5.716428228211685,5.750176925438441
ONS-76,54686904,4.527599605979478,3.7814021566956653
CAL-51,2729026,2.5757432896171517,2.7158647412435717
ONS-76,3689413,-0.2845128895134612,0.197461897649033
JM-1,676352,1.381688063426603,1.7413755276260305
NCI-H2171,11238147,2.9150011478889795,2.5413467036328536
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,2.2989594459436953
Panc 04.03,5738263,4.451939152518209,3.7416015052574014
HCC1143,71304818,2.928848735179534,2.5417788999385182
OPM-2,9826308,-1.153894104617258,-0.07633101704791206
OVISE,73707438,4.551111956107329,3.9393517772678566
KMRC-1,448949,2.0346247593103257,2.131195026253381
NCI-H661,44589607,2.97822499860898,2.9302372798262466
YAPC,3503,2.818608145608573,2.4555824861608637
NCI-H522,3825829,3.960912701697082,3.843560761475632
NCI-H661,5738263,2.7657344337958687,3.4258496862021817
CAL-51,168312962,1.4117577594763937,2.0797346925806433
CA46,4261,-0.8863355705331979,-0.07222733351749092
CAL-51,241158,3.781489879449518,3.8470477516542845
A-673,2874250,4.616954738528679,4.303814060337218
BT-549,46191454,1.72486803708685,1.7722184589303043
JM-1,6918878,0.0294179493888284,0.5757617763507525
CAL-51,4521392,4.667802355757324,4.263408649048383
CAL-51,9915743,1.1260994347217144,0.6387051658033669
NCI-H146,46943432,1.2283557348915184,2.048363903347277
YAPC,168312962,3.6522382892319185,2.333455287376914
NCI-H522,44493528,4.173254194812623,4.173085544793911
BT-549,10296883,4.161421407524775,3.8623452951050576
OVISE,11152667,1.81896217810704,-0.3229653268059095
G-401,6852167,1.9492633511801831,2.373151649495551
NCI-H292,168313047,2.7678931286458974,2.478550649547228
A-673,5329102,0.93841525470917,1.8325612403443252
A-673,11404337,-2.7698937773977033,-0.742614514734514
BxPC-3,11222830,1.6538054387944447,1.6335826503739117
KMRC-1,25102847,3.2500467863275735,2.7555631890791377
MDA-MB-453,400769,-1.402270827463697,-0.6283601964192053
OVISE,89928392,2.0483381338479907,1.6064457551704885
MDA-MB-157,136227924,3.402219650297347,2.8860732890939245
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,1.6067328015344073
BxPC-3,5738263,3.0337675506106576,3.435202803988272
NCI-H292,16741245,5.797273118380107,4.221513844467654
Panc 04.03,11404337,1.3784278741672673,0.020438822041204494
HSC-4,2130404,3.512147769522711,3.631889242272212
SBC-5,5329102,3.79532117952851,2.151995536876973
SNU-449,57519531,5.8010509150022145,2.742851898383029
KMRC-1,1750826,-1.909836969824086,-2.0030411433318225
DMS 273,53245473,3.723579099176344,3.337335050956402
A4/Fukuda,44137675,1.307300702935143,2.980401705688077
LoVo,72734382,4.052668353480041,4.548970089503947
SW1463,57519531,1.6287135351441295,2.2813252296680493
SNU-61,16038120,1.3103584397228891,0.7376644239381309
CAL-51,9926054,2.2227862000004577,1.9507968272541154
KMRC-1,15953870,4.40931040558564,3.577351777542579
A4/Fukuda,46191454,-2.2780561859524457,0.5130967876955557
EFO-27,6505803,0.9411407576336728,-0.16834186960799805
A4/Fukuda,24951314,0.2081517019188384,0.591825139335717
A-498,10184653,1.9377607214538883,1.533061266715141
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,-1.3352283732660069
NCI-H522,9911830,2.121034111225194,2.2353098365437947
YAPC,53392493,3.0834263437199705,2.6332223581919423
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,2.0129963890744227
FTC-133,15547703,3.427766539334031,3.2751449260803924
SBC-5,11404337,1.1992857421773124,-0.29258032561155894
NOMO-1,654092,-2.6158486127541343,-1.0178369019661004
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,0.5407498857506414
OPM-2,49793307,-4.879066461483742,-4.087651606350848
JM-1,11717001,4.327873015149225,3.5857431036353233
MSTO-211H,969516,2.440842922513423,2.9150892193474953
NCI-H460,9926054,2.081701465030928,1.929469538737149
LXF 289,9936388,-5.793518221083613,-1.089811207261148
LoVo,10184653,-0.0525672628767589,0.9930282849591724
G-401,9866186,0.2347893748246883,0.468782262299252
ONS-76,BRD-K99584050,5.369990310930208,3.052949759770785
KMRC-1,168312962,3.867746451267385,1.6637263609974742
YAPC,452548,0.3485834104810916,0.1768928224139695
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,1.509201807409926
FU-OV-1,6450551,4.626381712180732,3.0230448859529906
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,3.0448701566527685
SNU-449,5978,1.8233754703073703,-1.7355655803609573
LOU-NH91,44589607,2.878199319266369,3.1384600514436807
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,4.799953458044123
A4/Fukuda,65628,3.8428022223998366,3.5326565552759384
A2780,42611257,2.862805810765337,2.9992452293038183
FTC-133,49867930,5.271360985380777,4.610003878248598
SNU-61,56946209,-2.5026309203687314,-3.658740641511889
FU-OV-1,3062316,-5.013660753129892,1.3872812491797761
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,1.1578823167898336
NCI-H522,123631,2.114949756755372,2.4051116294060213
NOMO-1,52912189,-0.5265680930430634,0.17781390603284614
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,3.6820251383791702
CA46,2733526,4.193969711090682,3.53232563435728
G-401,44819697,-1.6952135460319926,-1.164283835141643
MDA-MB-453,44507138,1.496822662467132,2.143942235150768
NCI-H2171,9825149,1.181898582623386,2.098137065629658
OPM-2,8515,3.0418796641091226,3.4238815321264577
Panc 04.03,4096211,3.5665133346619684,2.345118151324227
KMRC-1,6610216,4.1544949822147,4.24278598334715
NCI-H460,25150857,3.536831166282903,2.4962908009307805
OPM-2,11977753,-4.6820583055789,-2.43495804864699
G-401,49793307,-5.199300209786212,-3.1810134055311745
A2780,1239801,3.465676691044825,3.7038547187301294
Panc 04.03,46398810,3.688960594211219,2.720053347473082
G-401,65628,4.0909837295628275,4.074707168461387
BT-549,53232,2.511840395622571,2.880091226624083
NCI-H727,104842,-0.3454800108905812,-2.503408171527987
NCI-H292,6852167,2.409220580223775,2.994218941226443
KMRC-1,15547703,4.785371110425684,3.436338607841958
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,3.3024447322877326
BxPC-3,16722836,0.8866010617403134,1.6048371889161444
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,1.4060456594995245
LXF 289,168312962,1.364587801939814,2.4413046135302925
G-401,11626560,1.1843690178322546,1.4155877729150208
YAPC,3825829,4.484241364021175,4.071563835388476
NCI-H2009,46943432,2.8478796444115835,2.436372833594576
SNU-449,16038120,1.104181711259477,1.2625261401485164
MDA-MB-157,72193861,0.2105280638919307,1.8507647506990559
ONS-76,46191454,1.5088295462826262,1.68564626240137
LXF 289,439501,-1.653941874457911,-2.2927703875824226
MDA-MB-453,54649381,4.094182376460235,3.6926744383548815
EFO-27,11507802,4.116687062031661,1.7701697520380981
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.9633644857885317
SNU-81,11427553,2.1196099795437733,2.0031804886827604
SNU-61,54143018,-0.3273600933762652,0.39325596712649236
HSC-4,17755052,1.8179922614483863,1.960138736725464
EFO-27,2130404,3.4270754566369748,3.5917605943312236
FTC-133,24821094,3.776872089794721,2.757479646245668
SNU-449,44607531,1.5485785292308227,1.7585729159208523
KYSE-70,24772860,-1.2328668610311222,-1.6091952780515748
NCI-H522,11214940,1.077396173859641,1.6859374358670285
SNU-449,1474550,4.524224948734458,3.964834722192646
LXF 289,44589607,3.4320685896186585,3.019194916495368
OPM-2,31703,-1.5109362720248076,-2.0686784579719983
A4/Fukuda,445455,4.756694709293823,4.058445068383813
LoVo,71680916,4.224958300762603,4.824598891152497
KMRC-1,25262965,-3.4791684180939,-0.8828903225269523
NCI-H1623,54613361,0.8976129642368637,0.2517188486658952
DMS 273,15547703,2.68216153568037,2.7741323105618005
HCC1143,5311,1.090656828429124,1.6002669265598644
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,0.10152456696648476
MSTO-211H,11977753,-3.756718801235006,-1.4862627566466855
NCI-H661,51037431,4.262261435001038,3.3484974847784077
EFO-27,25183872,0.6822597295955183,-0.6320196531082517
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,-3.1573333223940643
MDA-MB-453,16659841,4.43927192393091,3.519641255328876
SNU-449,3854666,3.254678167809475,2.3616650259842125
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,0.5519393682339654
HSC-4,46174525,4.818915916273074,4.525272175874713
NCI-H727,25062766,3.0095924827905813,2.2293842094096514
EFO-27,9823820,4.474335567240953,4.153112056065018
CAL-51,4917,3.122174268556499,3.020486362290577
SCC-9,676352,2.0394457592349093,2.064015658876492
MSTO-211H,4259181,-0.7585521679245923,0.6363485956540805
Panc 04.03,3854666,3.6180263181428622,2.67154953800646
A2780,11214940,1.8716907673631955,1.639445987208047
Panc 04.03,445455,5.108054343544362,4.7594429637516305
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,-1.37036240488794
DMS 273,3081361,3.0365977955778805,2.364295644676544
BxPC-3,126941,-2.8667568441276083,-2.602439759045394
EFO-27,6918837,-4.778560341054376,-2.636843341640333
JM-1,9956119,1.3894298966841814,2.4052525948696863
CAL-51,60750,-3.4379358682898973,-2.4002982200825387
SNU-449,12001922,2.031450773900583,1.9970198316350816
SNU-81,119182,-3.3799134284972614,-1.179795661760021
CAL-51,6918878,3.0110486558166274,2.5704462504340793
CA46,44819697,-3.819793103454841,-1.9265524625524018
OPM-2,46199207,2.048842595102616,2.521676322002639
JM-1,11977753,-2.0561747941195674,-2.17933947568431
MDA-MB-453,16038120,1.4822204990084098,0.8773182551802223
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,3.694183625181073
G-401,135928012,4.758772301459146,3.8350780940882623
LoVo,445455,4.556737788306169,4.746057023892585
FU-OV-1,11964036,-0.3048537688067435,1.4905352546804904
CAL-51,3825829,3.9510679995615257,4.049416534570776
NOMO-1,66577038,2.985459327680272,2.579092574749548
YAPC,4259181,0.8211273757017798,0.5645233597873852
BT-549,2708,5.415828272287544,5.0390896371762395
OPM-2,4477,0.1075725295912922,0.47644733377213205
ONS-76,23635314,-1.3572631369234491,-1.9856800442009968
Panc 04.03,168313200,2.993774278353398,3.141090909827511
A2780,25262965,-4.532154518345387,-1.5407476476833486
LoVo,24951314,0.8531724175888866,1.4422051287244173
SNU-61,6918837,-2.02709157063253,-3.0538438601889157
LOU-NH91,6918878,5.623996708869271,2.749361295244477
LOU-NH91,16725315,5.120050781978422,4.327144872809849
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,1.2389709184562845
NCI-H661,16722836,1.177222753188902,1.7102591576234338
A-498,9935249,3.347418171794467,3.3769113723514717
NCI-H2009,44185566,3.0429431135599607,2.560244268375442
Panc 04.03,25126798,3.7756614801897377,3.987535568581956
LOU-NH91,24771867,3.0978851297923895,2.982910957412869
Panc 04.03,10231331,4.944041434313903,2.008355986000576
Panc 04.03,9967941,5.787601223768576,4.042480233161405
HCC1143,11497983,5.345504804401821,3.474997007505961
MDA-MB-453,6505803,-3.8322805026755806,-0.6337320102106581
LXF 289,285033,-1.4335563326434544,-1.728141486520464
NCI-H292,3689413,1.7536313837601494,0.1696085564209022
OVISE,54618771,1.319775250733869,1.02463735701733
SNU-81,135411,1.0381613293566891,0.4750773942756718
NCI-H2009,451668,5.323035746604961,1.564572187065718
SNU-81,3689413,1.1974270464491454,-0.35622716173826063
FTC-133,5738263,4.07617232189308,3.50025557921628
NCI-H1623,5291,3.880629558524794,3.7291325707130536
NCI-H727,51039095,2.7124063556691267,2.6129379643807193
DMS 273,262093,2.141936221481062,2.405269059221796
CAL-51,6918328,0.3807555589851347,0.1992774693049676
A-498,24951314,2.536702379510054,1.7066931952926412
OVISE,135440466,-0.9475229728449716,2.3294936335688643
A2780,11404337,-0.8981705286722745,-0.6067213814093197
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,2.065906229461803
Panc 04.03,24951314,1.470760951451068,1.5728967990538991
NOMO-1,4705,2.5023829157060926,2.650791462748624
BxPC-3,176870,2.768163283404042,3.139082230391855
G-401,11609586,0.8694160359503889,2.359244513029958
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,-0.8817678810444842
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,-0.9884921839537592
NCI-H2009,15983966,-3.9047819028388178,-0.8429994098634268
JM-1,16659841,2.088291676862089,3.0189686726694385
NCI-H146,5311,-0.0389435386139853,1.1221416655746963
A2780,72734382,3.371521062177298,4.30654731378552
A-673,2708,2.956024737310482,3.934251686771458
NCI-H460,11152667,1.2005763717636435,-0.31084114860852874
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,3.977024419438647
G-401,60700,-0.931594906554522,-1.1442739503553134
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,-0.8713290682154067
NCI-H146,31703,-2.278385754586821,-0.6346018106232597
KMRC-1,445643,4.4248475697731005,3.99452262318196
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,-1.3034072716528227
KYSE-70,54613361,0.0645626216296427,0.3047353409385525
CAL-51,444795,5.053001195278548,4.531106295650337
KYSE-70,54619267,5.587983352589812,3.9822945509595518
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,2.627883512541447
NCI-H522,135984461,5.248212763135773,3.4949192873827304
CA46,10385095,0.6992054873225039,0.6720685391714473
G-401,16038120,0.8239725572719159,0.6568262971345318
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,3.153411188589345
NCI-H1623,6918328,0.1782181011891448,-0.08777447440889509
G-401,31703,-2.7567506026552904,-1.7957198112364237
OPM-2,11497983,4.2316824511311,0.3487895600421316
NCI-H522,46215462,1.6065433434555243,1.8197996767281006
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,2.2641937697259467
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,4.0351202200078955
A-673,16741245,3.6856166817392393,3.825463476609691
DMS 273,44486219,3.889102530118227,4.388247716146037
ONS-76,3062316,0.3527292351029743,1.4185253204231012
NCI-H1623,4521392,4.396491619301915,4.298817751105254
SBC-5,3062316,3.347274022566764,1.3547453070200055
OPM-2,374536,1.7033153768622478,1.2413640050080397
NCI-H292,5291,3.74340966649761,3.870415870684245
G-401,123631,2.330078370852269,2.302092250399718
HSC-4,135423438,1.814117839489682,2.704167387218701
CAL-51,25126798,3.926975819986009,3.7558652917838002
NCI-H727,409805,5.9670224431598875,4.8602660794771495
A-673,4917,1.8117239982797952,2.8439444060302503
DMS 273,57519531,1.9430749026869305,1.9048279201146396
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,3.3982376104095704
HSC-4,25262965,-0.4495508061813805,-1.268486961948033
OVISE,327653,2.506626214633075,3.0456797930330968
A4/Fukuda,71680916,4.641498651595925,4.212650922498478
EFO-27,104842,-1.4311942194738418,-2.5791176275202745
A-673,11626560,-0.097195247735582,0.9664901415882179
NCI-H146,3384730,2.6214971804948908,2.4134344663735425
MSTO-211H,26596,-0.5653018529577997,-1.315073627175112
JM-1,445455,3.9843646189648863,4.236711471473369
CAL-51,11427553,2.069280384014222,2.771007342132648
SNU-61,20959075,-3.60077638491687,-2.975535250255277
LXF 289,25062766,1.8533275351899623,2.1591952103804193
LOU-NH91,24797083,1.602297413523094,1.4785605541676607
CAL-51,24771867,-0.5018492111736887,2.019776313532286
NOMO-1,44632017,0.9405041708842384,0.5787158767106573
NCI-H146,25195348,0.0229507172684141,2.86758341560446
A-673,151289,0.5990139557366498,0.7714395870529077
JM-1,72376,-3.929922218649067,-3.9978797253010616
NCI-H727,12003241,-0.657143782776601,-0.5491771707353608
JM-1,24180125,1.1035620934920058,2.402823520660301
LoVo,24964624,-0.96112559187181,2.377223100146303
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,0.30690750094307745
OVISE,6610216,4.867128617935935,4.168826859179195
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,4.755633858290733
CAL-51,11507802,1.2528060552922216,1.3871190484656741
A4/Fukuda,25227462,-5.883792654516593,-2.0013956171405964
BxPC-3,5566,2.8001360517565628,3.064633880644064
DMS 273,119182,1.6620070398785467,-0.9441904231307542
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,1.3924116499816859
NOMO-1,168313200,3.152434526133537,2.6549759536582385
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,0.8865378066838459
NCI-H727,24856436,1.7647429516878397,0.6210280867576463
KMRC-1,72734382,5.690666345136703,4.307928460947497
A-673,56949517,4.212065281653062,4.150291355321915
BT-549,135421197,3.4062158650675265,2.141565192675208
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,3.0156524211406035
NCI-H1623,10074640,3.727129107489099,3.1089132978226828
YAPC,5329102,2.676937714502371,2.2171996820909525
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,-3.261820709618026
NCI-H2009,4917,2.9963488408029417,3.09517974242829
NCI-H727,44589607,2.894616632949603,2.966674156987559
G-401,5328940,1.7098947779411977,1.1058722833399022
FTC-133,10410894,5.920528547603018,3.4610559757390957
CAL-51,216468,1.370586512271769,3.0324019646626605
MDA-MB-453,227681,3.97271964535407,3.0552999347847765
A4/Fukuda,5284616,3.229953451024844,0.8516766718228089
NCI-H460,753704,5.635234970240753,4.932309589067166
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,3.3265722350109748
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,1.8653555026536914
NCI-H1623,25150857,2.7146098705885127,2.4981223165947597
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,1.1925805425846419
LOU-NH91,2729026,2.877851429076431,2.7506901260449594
CA46,46191454,-0.333651418813281,0.08584543242265408
FTC-133,65628,4.302527639906617,4.32287149423667
A2780,72193861,-0.1120033238626439,0.9321632344498704
SCC-9,49793307,-2.052824266331224,-2.6146545325904267
BxPC-3,135440466,1.2091890795281053,2.072275883127737
NCI-H146,11455910,-0.4209962248823531,1.0305584761795652
A-673,46398810,1.6125076634642133,2.183762086154005
SNU-81,11626927,-0.7774954189098839,2.904675311448054
JM-1,45279963,2.536030346276664,2.9269784269382706
MDA-MB-157,5746,1.4435337882328911,1.3743476565155226
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,4.549816548347854
ONS-76,2874250,6.058821088556036,4.714905847292835
A2780,5284329,2.502098244540034,3.2829226648008527
LoVo,53232,3.084407514553567,2.9283036915609113
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,2.2849206986517165
OPM-2,9927531,3.0625153090482757,3.950544215528094
SNU-449,44202524,4.173676721592596,2.715626913630495
SNU-61,124202324,2.5924607447988643,2.2922282620208025
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,-2.7248546151299915
CAL-51,44819697,-1.9765663783606575,-0.7481277796994551
FU-OV-1,2708,5.501261259949465,4.737583285764129
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,1.8384086442332892
SNU-81,16722836,0.5712028725805488,1.5311776518212863
SNU-61,1716436,2.6740680266491763,2.9530667498720775
OPM-2,3854666,0.6659331794855328,0.9895937916272995
DMS 273,71304818,2.423766397759693,2.2161013859727547
OPM-2,44185566,1.967847411757682,1.6312089265419356
SNU-449,25154868,5.089625763576692,4.563874543820734
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.1536890547648353
NCI-H661,5281321,0.7671093512543088,-1.0626146065194488
SCC-9,44185566,3.0958673753547785,2.517135669477282
MDA-MB-453,16736978,1.2653262263884038,1.2953083314538218
KYSE-70,9935249,3.427959003246725,3.1667771811078236
MDA-MB-453,11178236,-5.341922221503707,-3.669226376250165
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,4.96211456897932
EFO-27,24180719,4.15462806748021,3.664452650994981
NCI-H727,44607531,2.33451518290986,1.3944808382114433
NCI-H292,10410894,3.620691172443616,3.4028771580130552
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,-2.653170026936891
MDA-MB-453,10184653,1.4947310227918462,0.37132630119960686
MDA-MB-453,11228183,3.436796326739784,2.173651020731696
DMS 273,67291369,1.8884432049214537,1.8697283360598078
NCI-H2171,54619267,3.4799425585632204,3.8672003800207797
MDA-MB-453,448949,2.258073743229602,2.143451553391347
A2780,135440466,1.248320725279374,2.1841272268792555
NCI-H146,9866186,0.8123633746782326,0.6917747077278615
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.4506288757128833
A4/Fukuda,10074640,2.009206402328629,2.82576339819867
KYSE-70,31703,-0.0860185315527888,-0.8592443356157505
A-673,11497983,-0.3979292238924095,1.9790711308291247
A2780,12003241,-2.743381978251489,-1.3921062010847338
A4/Fukuda,25102847,0.4372365282678318,2.009788986208728
KMRC-1,11717001,4.773123606238519,3.912011738166049
FTC-133,36462,0.6793689394766376,2.229265512634614
SCC-9,23582824,0.351039434592286,0.7161986491116135
BT-549,2729026,3.014205222238777,2.743609572536185
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,3.3006261596434014
LXF 289,46943432,1.4312531154305732,2.4796344967130493
NCI-H727,11625818,5.425399240643101,4.25223480087092
HSC-4,44507138,3.308450875381542,2.546948669859428
A-673,969516,1.3043572294505754,2.48146548776272
FTC-133,969516,2.842702479050133,2.856825515823335
HCC1143,11609586,3.6708937391840206,3.1745098955428457
DMS 273,2733487,6.43119993607997,5.913883810845784
LoVo,10302451,1.0215583424111876,3.0550531132876815
KYSE-70,46174525,4.613744209458669,4.4483125967837776
SBC-5,65628,3.417870630997437,4.24622352300812
DMS 273,24180125,3.0640550148835812,2.885796108073738
OVISE,452548,1.282500130328104,0.5566706097904928
BxPC-3,71304818,2.4465042326182247,2.5315947820179963
ONS-76,54143018,0.4309751541382265,0.5527891346594609
OVISE,24856436,2.006053298804951,0.2626014087227413
MDA-MB-453,71729975,-0.0804754192781109,2.255437078446642
NCI-H1623,65628,4.265717950525356,4.430727742868361
DMS 273,9927531,4.953960158421894,4.33755967714281
BxPC-3,426756,6.38858222821808,4.622990916344882
NCI-H2009,49766530,0.9767616789625324,0.05226237861871983
JM-1,2858523,2.95851246958296,2.70420512030738
YAPC,9935249,3.6850704434892823,3.1796860249698216
A2780,654092,-1.3080416104753447,-0.7940148324224561
OPM-2,6918638,-1.573449675489913,-0.3897249016610169
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,0.6066647760817269
SBC-5,25105715,3.9151038194938352,3.398766777555852
SNU-61,168313047,1.9617236271133212,2.3690065414462094
A4/Fukuda,11317348,1.1392337694005448,1.6432279288815104
NCI-H522,25262965,-1.3157493467877637,-1.6909947757543697
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,0.7495339506810952
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,-3.1966387774241216
MSTO-211H,44607530,1.4093785076150551,1.8379194602155686
HSC-4,984333,1.2474358256824072,0.9991062826053846
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.2663697800056821
ONS-76,9967941,2.912852232249919,3.6193042885872813
DMS 273,24753719,4.257561408038297,4.041017170298083
CAL-51,24772860,-2.425084956958233,-1.8798340559495543
MSTO-211H,44632017,1.2059374560785627,1.4379918732932024
NCI-H146,5978,-4.422435519224839,-2.0594842307449266
G-401,2746,2.560873344661061,2.567375921285684
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,2.0336776892667014
NCI-H2009,11152667,-0.3244172236423036,-0.4442751519794822
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,2.986287005976539
MDA-MB-453,219104,3.605347452429255,3.546277764299943
KMRC-1,5280436,0.1724698964633139,3.241269180813569
A-673,25154868,2.9619598302203176,4.255272870227324
A-673,135999136,4.231524255529223,3.1636341815268714
FU-OV-1,9884685,-0.2158788705773567,0.8616205155261298
NCI-H727,11626560,1.656358651993978,1.8354432202974054
CAL-51,9866186,1.45916914556855,0.7068343624199872
HCC1143,44507138,1.5952303095871043,2.3789218834131645
CA46,9823820,1.6053302041689723,2.8511019274176403
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,-3.782234911582798
CAL-51,12001922,2.008779489179369,1.8965426011618067
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,2.8750859201329892
NCI-H292,19582717,5.466560288208149,4.371542835613596
A4/Fukuda,374536,-1.0311095755670416,1.5329392512638542
OPM-2,10113978,1.3298356496360293,2.3759219375298097
SNU-449,9903786,3.696408358539977,3.249319017763108
JM-1,25195348,3.46638875562813,2.433161608974599
NCI-H1623,5746,-0.5390712999232294,1.11606008545205
KYSE-70,71466445,4.079477869375345,3.8752920102264756
NCI-H460,44185566,3.2105564381381035,2.5465408641181644
MSTO-211H,6918837,-2.204195063499652,-2.533068117123139
CAL-51,54613361,0.2180057854442524,0.23737953451435984
A2780,216345,1.0708930445758365,3.3296455307539325
HCC1143,100016,7.122041956726765,6.154727092178357
NCI-H522,5278396,4.518604091155278,3.5708257870340288
SNU-61,54619267,4.677926252875765,3.8893328692746705
OPM-2,135421197,1.341685947169011,1.2835999301590877
G-401,72193861,1.057396802085585,0.6052530252665842
NCI-H727,15547703,3.504014494953252,3.335713655017402
NCI-H292,11178236,-4.939590057195551,-3.1306305571989426
MDA-MB-453,44241473,4.685974466458818,4.538847316672061
MSTO-211H,60700,-2.4521642225491065,-0.29308803441340725
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,-1.8135561248396428
NCI-H2171,4096211,1.8093642806404184,1.5654100423175379
NCI-H146,68056272,3.3997347898500063,2.8732496943832357
A2780,984333,-1.5561630492039429,0.07600583698490368
NCI-H2171,5479543,3.509510962528721,2.9109695619205325
ONS-76,6610355,5.379398654611739,4.58574413492627
G-401,2742550,4.179048555325354,3.63272301833142
OPM-2,44137675,3.238695939616315,2.8964046020853504
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,1.6736981683062246
FU-OV-1,387447,-1.63105242136749,-3.988362776565552
LoVo,3825829,3.571391318080427,3.9451491767806703
JM-1,11404337,-2.1014875230304315,-1.6394319719653043
FU-OV-1,9929138,5.415072941349914,5.660055137235437
SBC-5,5738263,3.46908634421933,3.3096612621171273
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.888200231830468
G-401,4917,3.172752348635073,2.8356213867641435
A-673,44589607,3.5509265356046305,2.2884203896566264
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.4722829756914604
CAL-51,2828334,6.190580852669228,6.06779687985793
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,2.59280216318481
SNU-61,67156097,-2.2274361546113854,-0.7052246819573392
OPM-2,65628,4.597670741376445,3.4120558879438687
MDA-MB-453,3038522,2.334816038150176,2.7153560553658243
HSC-4,2708,2.9878251305615477,5.117672145283979
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,1.5900149635747738
CA46,54678924,0.940253932332064,1.2580166790464105
SNU-449,11964036,1.3997299371502423,1.5695573288224978
DMS 273,54613361,-0.0987092047967699,-0.26971144027777405
SW1463,2749,1.5016847157281326,1.772251217873849
A2780,4477,0.2147996237825641,0.23112679429075345
NOMO-1,9907093,3.6530797436282434,3.5721873119750063
A-673,54618305,4.212251300263772,3.145819034756023
LOU-NH91,65064,5.187256751294022,4.8654682382378995
NCI-H2171,72376,-3.3432588050758296,-2.4416303862621573
MDA-MB-453,72199292,1.3092335372039157,1.4928212222006696
NCI-H522,107970,1.611650854248594,2.22255054607443
A-673,444795,4.685959151928419,4.179174734890682
HSC-4,6505803,0.688410933428746,-0.7713693069784763
CA46,11455910,-0.2967360934235351,0.114601229423449
NCI-H460,6252,1.4342703041264255,0.9082477742148163
BT-549,49793307,-0.000238716840207,-2.2598571165847368
CAL-51,68056272,3.9955701948507247,3.6862689919967626
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.2303592846256808
A-673,227681,3.19347186106623,2.938916756739454
BxPC-3,54618771,0.182098153600537,0.9693599296846328
A4/Fukuda,3385,2.3595203579832553,3.0409891287236746
LoVo,36314,1.7018910931264415,-0.743482981837459
BxPC-3,11152667,-1.4400195695513092,-0.6596307503766622
SCC-9,3025986,-0.0492814979551807,-0.9206206078061292
MDA-MB-453,4259181,0.7923345004369465,0.2541036550852655
Panc 04.03,9927531,5.313421559596226,4.861207688185495
LoVo,448949,1.89047161937067,2.1590234249036335
KMRC-1,5978,0.0310598033875183,-1.4771290517398408
NCI-H292,262093,2.9868554632365556,3.020642614199387
CAL-51,9884685,-0.2528326244590672,0.5598065932660156
KMRC-1,135421197,2.781168744821282,2.2258307009198752
A2780,56973724,1.317874340119369,2.5821113824150888
A4/Fukuda,46943432,-0.0927442133672991,1.0005428519702022
HSC-4,50905018,4.462883747891921,4.60292893429791
JM-1,448949,0.7740790697885386,1.3643746137492712
EFO-27,11964036,1.3211691780165964,1.654993976598857
A4/Fukuda,637858,0.8198578842358093,1.3560113331790546
OPM-2,5282054,2.4375164125334217,3.016730064603022
ONS-76,637858,2.646425044184718,2.231360993570992
HSC-4,439501,-1.7709622187792924,-2.094823937502924
KYSE-70,24964624,1.4483005111507754,2.420150399350905
LOU-NH91,5282054,3.3765969574471315,3.988334016377921
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,3.162000071983032
SNU-81,5281321,-4.892530389502709,-1.8004812238287977
HCC1143,168312962,3.1559735288767468,2.1358551385780267
JM-1,126941,-4.3883192692313955,-3.456726437417394
SCC-9,54143018,0.8755026739061308,0.6963490231614948
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,2.190292559700067
SNU-449,1641662,3.672188762237013,3.522157192460169
NCI-H146,54765302,2.77091239654666,3.662165950706312
NCI-H146,11427553,2.364557310661393,2.3037365027522756
CAL-51,159324,3.1794720270506307,2.7575778862841434
YAPC,71466445,6.285156806731666,4.339453957501037
ONS-76,5351362,1.281569720069414,1.7390785242821716
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,-0.8251514861086844
BxPC-3,6505803,-3.0514917868960767,-0.6467467264481505
A-673,45279963,3.7593508340409287,3.3437640727801075
CA46,3465537,3.345448990020783,2.2016786249087543
HCC1143,168313016,5.718985268806146,4.9738373984474435
A-498,400769,-1.6101267353788036,-0.16601061478229956
NCI-H2009,10184653,1.0890186290305244,1.4024212260742255
NCI-H522,426756,6.015863149473534,4.325428938386985
NCI-H2171,44819697,-4.1780638649943675,-1.26375025444545
DMS 273,24785538,0.640909019865508,0.861661228929954
NCI-H146,6918638,-1.4860665745363582,-0.10738694290820922
NOMO-1,3543504,4.095340640265792,3.8224886797773223
NCI-H661,151289,0.3755226510544496,1.1775743442379436
G-401,53495165,-2.4189675718778516,-0.8816236210682653
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,2.110974637533808
YAPC,6918837,-0.3723714565085887,-2.6858781053316547
BT-549,219104,4.096633484715141,4.069242715643756
LXF 289,24753719,4.56569970094865,4.349109877823242
CAL-51,25102847,1.94226811064499,2.177346251693562
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,-1.7537286617282613
OPM-2,54618164,3.637238343412542,3.759521566617606
MDA-MB-157,2733526,3.146610844933737,3.7421354351193123
KMRC-1,54618164,3.981312375484732,4.126340278395827
CA46,375860,-0.5712781411665353,-0.663374646352025
G-401,24772860,-1.622851891505981,-2.079145871794129
NCI-H1623,119182,-1.1196330586869003,-0.7249047269138896
A-673,984333,-2.7710011035310074,0.013554062632202678
KMRC-1,49793307,-2.5218593870176793,-2.4808460777581463
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,0.6021289460456809
DMS 273,11152667,-1.0918930552191226,-0.5517988640106192
NCI-H460,44620216,3.8133491956675902,3.415627305268606
MDA-MB-453,19582717,2.5916230237173696,3.839393502688435
SNU-61,53495165,-0.6572534585269733,-0.16725248996012276
JM-1,6505803,0.12933264701109,-0.9695241577099152
SNU-449,60700,1.1315850608054705,0.012799100159089648
CAL-51,676352,2.3367523995253454,1.947484348887964
LXF 289,89928392,2.4967474535679623,1.7400879501915847
LOU-NH91,11625818,5.704636625331963,4.768658137853468
MDA-MB-453,156414,0.9469838239648454,0.5504510362262185
OPM-2,462382,-0.5185214646773461,0.004142246956942788
A2780,53392493,1.4842280461046395,2.131160666060366
DMS 273,9823820,3.9764583445605006,3.7490996127556775
ONS-76,24772860,-0.9083480450936676,-1.9220378400471951
KYSE-70,11612883,2.3570058511886396,2.817165748496146
SCC-9,3854666,1.6335835525169635,2.280411068407926
KMRC-1,375860,0.0373834100132385,-0.31292548754276345
SBC-5,9866186,-0.1944977114504531,0.8761205131049377
NOMO-1,11719255,2.6566855899212944,2.5972120783660078
CAL-51,702558,3.5144984342436563,5.231888159967111
ONS-76,51039095,3.253449307143194,2.8941597358529374
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.6337496246950152
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,3.0286545033221914
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,2.2303256341709696
BxPC-3,216468,3.632186197150132,3.322480587846732
SBC-5,2742550,4.323082293816951,3.8404658669602947
HSC-4,24797083,0.9836127584085878,1.6679936147954373
OVISE,4788,6.030976207458705,5.6441679244886
LXF 289,11455910,1.909862916296106,1.1637465499062045
SCC-9,16659841,4.917362195715636,4.160890024819891
G-401,49766530,-2.7444300270308113,-1.0174932172331133
HSC-4,6450551,4.030000721690881,2.710132016860899
CAL-51,6918736,-2.0480142356294637,-1.1827393915000268
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,-0.7582622700041205
SCC-9,4096211,2.914802879806832,2.1495452546715255
EFO-27,168313200,3.5651936579716277,3.3253554597570214
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,6.255199357683153
SCC-9,448949,2.996737074861378,2.268323886632357
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,4.59658743783829
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.4305482822567
NCI-H661,15953870,2.9876041506010003,3.683597452595765
KMRC-1,6918638,1.621172594092556,0.48699246846780914
Panc 04.03,44489675,4.301555650291772,4.001549577112758
HSC-4,54143018,5.46718478704898,0.30769178785934687
NCI-H661,11175137,2.5272908163527745,2.604403172951798
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,1.8668997060702779
NCI-H292,24753719,4.2962074219620225,4.311063031886269
NCI-H146,11228183,-2.941805953111262,1.2807589357813833
MDA-MB-157,65064,3.084719541991811,4.873156012957556
HSC-4,44491742,4.173988284907792,4.277883285944078
CA46,9933475,1.582522184359856,1.3242412875815075
JM-1,53245473,3.7598021769733414,2.8311920715789944
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.6408005637398504
KMRC-1,702558,5.7321455674333475,5.472698854710845
EFO-27,262093,3.0007323703470896,3.1104019089041515
A4/Fukuda,72734382,2.815137004147321,3.775588188006251
NCI-H727,44185566,2.6786881549102626,2.391492720392174
OVISE,25062766,3.2029018764111896,2.1590402198447536
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,2.3507058853990377
CA46,3825829,3.8503527939376583,3.129205384092352
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,0.9390375544156302
BxPC-3,60750,-2.6920891843690273,-1.4267437276979513
EFO-27,1566236,1.9834366009012432,2.8661959555565284
LXF 289,53392493,2.5437082258312804,2.6875820243167414
NCI-H460,135421197,3.2510260026522233,1.919990859222552
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,-3.3062761436340535
Panc 04.03,44607531,1.8924568500741572,1.5657671120759793
ONS-76,15547703,3.220128707821482,3.254310560743628
BxPC-3,123631,1.9141625570683185,2.2811498091201456
NCI-H2009,24180125,3.399696031265864,3.3055145995419752
A-673,19582717,3.777631654850071,3.4531145982279394
FU-OV-1,12003241,-1.039273875540509,-0.8294940328731011
SNU-61,409805,4.743067556302579,4.84939274077886
DMS 273,11364421,-1.741561290091182,-3.47682456725337
Panc 04.03,11214940,1.7867172186781857,2.1378525624327422
NCI-H522,31703,-1.0005486569838078,-1.1777963920046974
KYSE-70,5287620,-1.7159794680358271,-2.017457365224468
A2780,11507802,0.380240885087182,1.0186580012544666
ONS-76,54613361,0.8570205233962582,0.38269097869399077
KMRC-1,2729026,3.101959850286169,2.6471108629335665
NCI-H522,136227924,2.2034936459857506,2.8572116787241186
NCI-H661,52912189,3.763222756257729,1.9541954584320136
ONS-76,262093,3.354802573562099,2.835903710197581
A2780,675434,3.840840752716624,4.406047410185282
EFO-27,24771867,3.839082818590537,2.5671647125814054
BT-549,44185566,3.1570730526396407,2.732530560155359
NCI-H2009,89183176,3.352860584382055,3.993462252627403
A2780,2949965,2.158264003903123,2.788611435476123
MDA-MB-157,119182,-3.4496410534325093,-0.57363682794773
MDA-MB-453,2949965,2.588847266095094,2.733450971771477
MDA-MB-453,71576739,4.365206221166654,3.5599216711742114
A-498,11455910,2.747308138802023,1.3983041059371175
A4/Fukuda,448949,1.1686862984883333,1.600996990934847
OPM-2,10385095,0.6586756349946576,0.8287286812776804
BxPC-3,52912189,1.4214477046132656,2.253536844630329
JM-1,46907787,-1.9243382261841309,-0.23627201600085865
G-401,3385,1.38862488630676,3.535360779217835
LOU-NH91,24978538,-2.307670841327046,0.9276926242034104
BxPC-3,25262965,-1.1326145626109247,-1.2078909753915967
KYSE-70,9915743,1.2522553618909642,0.6672786169591131
A4/Fukuda,42642645,-1.373677794386147,0.475989400724907
A-673,44202524,1.1944686936342714,1.734968478940197
FU-OV-1,66577038,3.5319441468561648,3.040929057175008
SBC-5,BRD-K99584050,5.772271611565925,2.901989892326016
MSTO-211H,2749,1.2029234831790616,2.0794133873676546
EFO-27,2858523,3.4178086224101527,3.0718762816580574
NCI-H2009,54613361,-1.6701870677586086,0.4960569158079652
CAL-51,11626560,0.7349282975065881,1.684621227555837
YAPC,446155,3.8433351119798695,2.908244535864909
KYSE-70,3854666,1.6457032232411275,2.2210220412463877
MDA-MB-157,49836020,-4.4611089332084335,3.2149168423796883
Panc 04.03,10385095,1.3607276101908192,1.4417187817380892
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.5873145922355412
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.5163120479719694
NCI-H460,31703,-0.6563705559837907,-0.6495689038173424
HSC-4,135421197,2.1482643592466495,2.096846257577691
KYSE-70,216345,3.953496119268799,3.833867329497987
NCI-H2009,44259,0.1981246725332563,1.1427440653710335
NCI-H661,24771867,2.8989054210712784,2.3278836250766233
LOU-NH91,89928392,1.577129115434841,1.6840751155179305
SBC-5,44819697,-0.6119786373907494,-0.4741373098943503
CAL-51,135398738,4.757337519270393,4.340080474666886
A2780,11234052,1.762226904306368,3.7111512841996674
EFO-27,5287969,-2.249416082595734,-1.6232074426652676
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,1.1084188581804943
EFO-27,72734382,4.838814549837177,4.750621719941599
A2780,2126,3.67742533530732,4.328026031823033
NOMO-1,656346,0.9377734591624955,0.5080237506997234
NCI-H522,439501,-5.784929410118117,-2.3222809156795465
NOMO-1,4521392,4.093982124965485,4.007569851301257
NCI-H2009,452548,-0.9979896146805513,0.41732410090272576
NOMO-1,327653,2.81345515165661,2.6243192994253453
A-673,46191454,-1.7005324627981964,1.320467485189121
A2780,168312962,0.1167104942518841,1.2488188580593218
HSC-4,11214940,4.953530718305131,2.1411302718781973
KYSE-70,44507138,1.8487883665285316,2.73946224399129
MDA-MB-453,5566,2.956907653722259,2.836560877935376
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,2.763399310083389
SNU-449,24753719,4.452712705797618,4.314021038165239
HSC-4,6184667,2.683776581109496,3.1577300564604207
Panc 04.03,4477,1.027037586587599,0.7984083954560964
CA46,24951314,-0.0442972386064399,0.5642602382892534
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,1.1712521544116181
NCI-H460,637858,3.384702960830197,2.3169785344123848
MSTO-211H,54618164,3.0389284404004795,4.078239808022713
BxPC-3,135875424,4.118804534986376,4.009125149645637
LoVo,374536,3.1459286411718055,2.1682518001466473
SBC-5,65064,5.87027592575748,4.747922778505552
A2780,2708,1.6817262399506028,4.068736809815055
NCI-H292,11427553,2.7677841547579347,2.906107550645294
EFO-27,10184653,2.474041422726229,1.435146928333345
LXF 289,16038120,0.5250135720403194,0.8547026931057033
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.8444170758250709
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.7050736285527837
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.5094254144166634
BxPC-3,10184653,-0.596247884950306,1.1129747951562525
KMRC-1,54618771,0.2036698487849761,0.9644596955123518
FTC-133,4705,5.547028107549284,3.1179899680032683
A2780,107970,2.1177540249197246,2.036059195966751
DMS 273,15983966,-4.308041598319055,-2.0630490997088184
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,1.00630581038111
HCC1143,637858,1.5767538824178036,2.0591413323890384
OVISE,753704,5.218614122812972,4.995464466758554
NCI-H1623,148124,4.04127286799143,-0.8978836364613005
NCI-H661,1716436,2.7606212382296205,2.8442949550734657
A2780,5328940,1.6938804432156576,1.5854729452771443
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,-0.2604801513390481
A-673,52947716,2.7267743407084333,-1.4577004384911019
LXF 289,51039095,1.6878089310027404,3.0113319302744426
LoVo,24753719,4.853832341629896,4.172038293431243
FU-OV-1,16065773,3.3464590574422424,2.5943404216522747
Panc 04.03,439501,0.3022334331499904,-1.768878117302692
NCI-H2009,44137675,2.9238442509206606,3.7322824080831443
SCC-9,24964624,2.350052808289582,2.6192632798254127
BT-549,56946209,-4.178729112607428,-3.9269274638931004
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,2.9905843622275654
NCI-H460,1716436,4.318712917611328,3.1192448005348785
MSTO-211H,4917,2.9904400598930088,3.165737678914465
NCI-H2009,5282054,3.436101167626708,3.8991485091587608
FU-OV-1,53232,3.5510277872612903,2.9451631901911384
NCI-H460,3503,2.4668231300278154,2.331171229245756
CAL-51,6252,-0.2076922850947726,1.0187953558583271
CA46,44607531,1.0933116261411373,1.037718358079876
NCI-H2171,44589607,1.1207968177639505,1.9897177039543203
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,3.2930041178938603
BT-549,5311,2.3943998607281314,1.6073370020158584
SNU-61,44491742,3.859456688826312,4.049998866631269
JM-1,46943432,-0.1491870155181681,1.071284866061397
HSC-4,156414,0.4374127066870092,1.2376383207474646
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,3.258329042885646
OPM-2,42611257,3.2957467857000404,2.4704950643272094
A2780,136227331,3.7351205807719863,4.247653013283735
MDA-MB-157,71751553,2.589623955944651,4.660589144988629
HCC1143,262093,2.740628946324062,2.8546489355512574
NCI-H522,56946209,-5.885513086137786,-4.160992077928302
A2780,67156097,-2.4563073864206633,-1.210731042659951
FU-OV-1,136227924,3.2834953568281597,3.222167656354252
NCI-H1623,241158,4.3681147628536445,4.057333926953751
ONS-76,2828334,6.172523844471339,6.120328030265235
BxPC-3,11625818,4.084435736278963,4.4559695278586995
DMS 273,5281321,-3.764975659067455,-1.89860719404144
KMRC-1,3825829,4.43742858244417,4.140448594565743
JM-1,5280436,0.8051765864900793,2.454212583238336
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,2.810774002413342
MDA-MB-157,9927531,5.35009923211275,4.6637074867453245
OPM-2,56963564,0.1507827744052812,-0.301523620746581
JM-1,9825149,1.1101255190052433,1.6330747984762484
A4/Fukuda,136227924,1.9204852137512072,2.1919702872545543
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,1.1677470743245075
Panc 04.03,16065773,3.1082338307326687,2.6723080621143227
KMRC-1,148198,-3.0121915653316953,-3.380502722495496
NCI-H727,11612883,2.6691234813665226,2.588062279681143
A-673,25183872,-1.50300168442849,-1.3069098341931689
NCI-H292,5470400,0.7410873105484811,0.09394886364694889
SNU-61,24771867,2.3194270269791772,1.1193653809402082
ONS-76,2729026,2.9392891978845626,2.7746310491013833
NCI-H522,54618305,4.230012053256092,3.5488510052690856
MDA-MB-157,6918328,-1.4439105140240134,0.3648779037421515
SCC-9,11609586,3.4579622750703902,2.860553000666099
NCI-H2009,73707398,1.4628489872410333,1.5089256764414392
BT-549,613753,3.1113642662223913,3.2535613601163003
NCI-H522,11396600,3.374818989992459,3.443313901825627
A2780,227681,3.163289337051595,3.121898322160248
SNU-61,42642645,0.1547953205487765,0.6222372181863641
EFO-27,24753719,4.6250624916483405,4.3584373628973925
NCI-H522,1750826,-4.884358581349171,-1.5804181058373985
NCI-H460,3854666,3.1385110084048065,1.8916943639250383
Panc 04.03,16736978,2.069266987472695,1.471107462295647
KYSE-70,135875424,3.720063911223788,3.663724301585751
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,-0.44569970164333006
NCI-H727,4369359,4.470803757423574,4.1192935380891536
SNU-61,10296883,3.559313583941647,3.7356803975391166
MSTO-211H,24748573,5.719931334372704,2.2998898796576306
SNU-81,5479543,2.97701110816304,2.699530119620059
BT-549,2733526,4.582584043539932,3.801167686901039
A2780,135423438,1.4521240670524396,2.006206455663677
A-673,24772860,-3.1744597884682997,-2.090183900506725
G-401,15953870,2.2768915791068483,3.1147385322082375
DMS 273,5738263,3.533950076223639,3.122631186528583
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,-1.217996824775553
MSTO-211H,10385095,1.0224754227931234,1.34982867935953
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,1.617680139055922
EFO-27,25062766,1.510659268863457,2.120815800500935
FTC-133,11612883,4.310092339589411,3.008582267319962
MDA-MB-453,11455910,-0.0078824359576409,0.04612751744616455
FTC-133,23582824,1.291713189645836,0.6787168526928598
MSTO-211H,6918289,3.158366552983379,2.8527017998642834
CAL-51,9826308,0.5677925602140103,0.4741875775546868
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,-2.0050618975246595
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,1.5130900587382368
NCI-H292,25195348,2.925898223014509,3.367520102700948
NCI-H661,71466380,4.502023854991524,4.520469212795256
SNU-449,17755052,1.8812917370069304,2.319049288484724
SCC-9,11977753,0.680369597029185,-1.0826454672244534
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,3.152061643927683
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,3.9412714240869144
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,2.5210176843357184
OPM-2,56973724,2.552424788495835,1.8097753749716317
ONS-76,24785538,3.425081329750359,2.055480037558996
OVISE,6914657,-4.467384055269322,-3.6785173332184615
CA46,7326481,2.91557869092902,2.6126101220704436
SNU-61,445091,3.84586130327939,4.167060806380254
SNU-81,387447,-4.728664972971387,-3.9907903526961093
A4/Fukuda,613000,-0.1954730319333323,2.4946586367980625
JM-1,54143018,0.7319009489566454,-0.2684742764114982
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,-0.7906060749998564
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,-0.030760493470641234
NCI-H2009,11222830,1.732127254120576,1.725506633339473
Panc 04.03,25105715,3.6014191473601236,3.6138724562427655
BxPC-3,3038522,3.5132521338876352,2.8773347258371547
SBC-5,2945648,3.183732803518487,2.7114646364302093
SNU-449,6450551,3.816508101047544,2.9908246113184487
A2780,4261,0.5678575604143293,1.1128022919559848
JM-1,54639665,5.005029028557516,2.5354831742853112
MDA-MB-453,55508,3.100658329893645,3.2759135432487305
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,1.2733641646654943
OPM-2,71466578,1.093801721105574,3.025842785365411
DMS 273,219104,2.8685320291275276,3.20539116237419
MSTO-211H,36314,2.7056254754018,-1.2587561123688462
NCI-H661,135999136,1.375733620998009,3.765372861185954
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,3.3470563230161634
A4/Fukuda,387447,-5.631039688913266,-4.9169263617895345
ONS-76,65064,5.2757302482281005,4.8791387034817335
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,1.6052415036302223
LXF 289,613753,3.241655631161551,3.02024731504203
NCI-H661,25262965,-2.0298208680132253,-1.2399192602902642
LXF 289,6438330,5.338014468481796,2.526664175505834
HSC-4,51037431,1.5211622982639597,3.354465058338492
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,0.8647821481017308
A-673,613000,2.3658771635142877,2.4035260084971233
A4/Fukuda,135421197,1.440002399326734,1.4521506958149617
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,4.25013234671604
NCI-H522,322968,2.453472191773609,3.2817836631724675
JM-1,702558,3.1195416036187646,4.142648581247903
NCI-H1623,60700,-0.6326390393669364,0.2778449123575247
KYSE-70,71466578,3.801340757329347,4.716385194609982
OPM-2,969516,1.7213945625906069,2.438711714649518
FTC-133,71751553,4.47121108066688,4.430623009451185
HSC-4,4261,2.7283942469645424,1.914742990969348
DMS 273,60750,-2.8080851182888096,-2.984543318123089
BT-549,11955716,4.243153956403502,-0.8081744823541872
ONS-76,104842,-3.1760610756826826,-2.3133363407894234
JM-1,54619267,3.2762986321752656,3.582744354289511
NCI-H460,11427553,3.3912724357702873,2.8029936633589245
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.9009505736026748
KYSE-70,3503,4.330341802091645,2.4299291145777193
LoVo,6505803,-0.2027234925460443,-0.7115017180951747
A2780,123631,2.055120977987268,2.345677308067695
CA46,216345,3.098455032375494,2.5536420194648035
SBC-5,216345,4.3270666561224935,3.8463012383250446
SBC-5,104842,-4.617883126488141,-3.360145049428378
KYSE-70,3025944,3.9400169946897226,4.363828667151442
JM-1,16725315,3.055633956084052,3.489497057477471
KYSE-70,3385,2.7043091028991175,4.173286577573303
SNU-61,241158,3.885428513145571,4.015721966629945
Panc 04.03,44819697,-0.3269217472163675,0.2190666615775805
LOU-NH91,151289,1.7382502757713727,1.3749283190397998
SW1463,72193861,2.3780707386668563,1.1712782534669168
FU-OV-1,3081361,1.2672435670761582,2.475965691020511
NCI-H2171,5311,-0.0981787470707459,0.7515467648054249
OVISE,15983966,2.4746719809654474,-0.36483072593141164
CA46,56649450,3.397645307363617,2.651727122628261
G-401,135398516,1.567409789625541,1.8337523786378842
A4/Fukuda,285033,-4.063528792592557,-3.0853847854085723
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,-0.35041266267503474
SNU-81,2113511,5.998073078967423,5.520932145647119
SBC-5,984333,1.1242620116457585,0.750690252562372
DMS 273,31703,-1.0453531837534489,-0.9144136422197439
SNU-449,11955716,-1.9372940063200903,-0.9102638218076585
JM-1,156414,0.9517000986854224,1.1468617404795487
A-498,5746,0.9967598286589636,1.6314478538175659
CAL-51,168313016,5.819136604546001,4.791355965738799
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,-0.7030949056612082
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,3.656011997762817
DMS 273,285033,-4.2902604104934685,-2.6393100550974133
NCI-H1623,25227462,1.3835292391956049,0.47478011891983657
SNU-449,46199207,3.2102080061749665,3.2000640142891594
NCI-H727,54619267,4.766187279700058,3.9128591609582255
KYSE-70,2729026,2.877153539650856,2.506262199808937
JM-1,9866186,-1.392842627261666,0.179978578775308
CA46,9956119,2.2503821303322864,2.546572427679711
NCI-H1623,10302451,3.5735543079001553,3.434500764249163
NCI-H460,119607,4.735621464768821,5.42659845741658
LXF 289,36462,2.912637639845359,2.3268609535819467
HCC1143,208908,2.564266394778906,2.287739987792726
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,-2.6246828907834283
HSC-4,10296883,4.12801319058873,3.988352257287637
NCI-H460,44819697,0.8384181776379687,-0.1563245196296128
A-673,644241,3.265724898737132,1.758602400050619
SBC-5,55283,1.6476943611515316,2.405412559256107
CAL-51,60700,-0.6497243984818711,-0.4377569480169837
NCI-H460,44819697,0.8384181776379687,-0.1563245196296128
NCI-H460,2113511,6.407699041859446,5.719852236304224
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.4880814552906179
NCI-H146,44819697,-3.0409273944044672,-0.8167516814406273
CAL-51,2729026,2.5757432896171517,2.7158647412435717
OPM-2,25262965,-5.528707504919602,-2.478672430103947
BxPC-3,67156097,-2.0030489961064664,-0.6187051628505945
SNU-61,11455910,1.387165489844305,0.9464193650786767
MDA-MB-157,6252,-1.2956844965038024,1.2070767398888314
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,2.3050204298282453
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,1.9899188096495268
MSTO-211H,5284616,-7.533473618112548,2.6914731939765684
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.6884244658497193
NCI-H146,11609586,1.562173805318663,2.6126913228448756
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,2.3353163497671248
KMRC-1,9908783,5.060189279561186,5.091323242127906
OPM-2,3825829,3.9075204590636226,3.3622201975032477
FTC-133,439501,-1.0725688155870328,-1.7975982292874655
MDA-MB-157,73707398,-0.5856522541525173,1.3156641824199
YAPC,71466380,5.668462841036745,4.514637952008836
YAPC,81146,5.922853011724604,4.650239348636135
SNU-61,9935249,2.942554259952632,2.9493516306017393
FTC-133,72193861,2.4976681850124516,1.5846617651641675
NCI-H2171,3025944,4.816182739912449,3.9970812167246073
BT-549,6918638,1.3825585614023566,0.9080117714376089
A-673,24180125,1.1732098097274752,2.7528918821569746
KYSE-70,46907787,2.9670215892594793,2.043238595151608
NCI-H2171,54678924,2.405018759443171,1.1891175516039472
FU-OV-1,15547703,4.297867355017808,3.471108655568659
EFO-27,49846579,4.098108273885428,2.1327432829811492
HSC-4,24748573,1.230311327364621,2.185083409838135
BT-549,10427712,4.3521452258648505,4.436387985314276
EFO-27,126941,-4.256911665013358,-2.72604679920798
NCI-H2009,4096211,1.934112859371262,2.3458925233088492
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,4.875674037797728
NCI-H146,135999136,1.6477982136645704,3.269839600642301
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,3.5717893831264824
SNU-449,2746,3.928036011173348,3.2251746565039614
CAL-51,11228183,3.6770505489909007,2.0936953153028046
Panc 04.03,123631,3.678186856777378,2.4526945432085574
MDA-MB-453,6184667,2.451074325070958,2.8282502624670913
EFO-27,6438330,1.8682975687900552,2.444663177221425
NCI-H661,11497983,4.324872079299071,3.8632452089229603
Panc 04.03,637858,2.9634699724220783,2.387176985849398
SNU-61,168312962,1.49910092402229,1.8278812522391998
NCI-H522,25183872,-1.6150957585419312,-0.8559617708706893
A2780,6252,0.4918472463671758,0.032315550970037285
A-673,15547703,3.0802315016781843,2.738821233084684
NCI-H1623,36462,0.862958596391428,1.9678359509670298
MSTO-211H,44819697,0.327886174428457,-0.008266296439941829
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.4415697385959694
SNU-81,19582717,3.466001022974326,3.659134399143424
A2780,6610355,3.3735704633901973,4.170357785851267
SCC-9,119607,6.006958395758143,5.40945039193482
NCI-H146,11625818,3.4222174762792843,3.7296020831636425
CAL-51,11178236,-3.674192911743539,-3.329252323257188
NCI-H460,168312962,-1.8333752522095308,1.5109049331905382
NCI-H661,4788,4.879892558412017,5.5375649974825345
JM-1,4705,3.374089362448498,2.597038872838711
LoVo,3634881,2.800959668083557,3.3910952565833914
OPM-2,11178236,-3.008129792299995,-4.155689237447631
CA46,9884685,-1.0270691788705264,-0.5027667953114802
MDA-MB-453,44589607,2.562256212112598,2.495045680094174
SBC-5,54454,2.279469523172582,2.621155599995535
LoVo,5311,0.3380696500116906,1.4261085790518395
NOMO-1,100016,4.546215242968586,5.300421048890482
CAL-51,71304818,3.0248956992793565,2.4661636423203
HCC1143,216345,3.8986832350959792,3.9353936273889953
CAL-51,54618164,4.021329289838694,3.982322716212388
NCI-H292,135398516,1.6270415918019412,2.3016299054737255
HSC-4,71466445,6.061667629347064,4.179293436375903
BT-549,51039095,3.595187367514741,2.9248967327252275
MDA-MB-453,26596,-1.0726693130426117,-1.3112974137898126
CA46,4259181,0.0375174782651609,-0.6201715875534749
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,1.0233319155679848
SBC-5,9887053,2.384081187432928,3.5556043991473327
FTC-133,25154868,4.81278236826852,4.464243005980757
SNU-61,44202524,1.623676041505741,2.075389349850759
Panc 04.03,6914657,-3.724597953552904,-3.0875198132388477
EFO-27,445091,4.884678811382666,4.446988386534412
SCC-9,54619267,4.260733417129102,4.23140911743993
LOU-NH91,3815108,3.3787088400125422,3.09180781479707
NCI-H2171,135875424,2.950178944342904,3.4921292898482985
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,3.446388407837075
LOU-NH91,11404337,-0.9599092047687252,-0.19752690594014566
SBC-5,5746,-1.5208844717109098,0.8940608336597516
NCI-H460,135440466,3.295247648571462,2.2131158495023975
OPM-2,1242560,2.912152501304371,2.776944255456748
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,2.8916063160539864
BxPC-3,11364421,-1.186359589843585,-1.3710081561442622
NOMO-1,11626560,1.0628914473501356,0.6552862241545792
MDA-MB-157,5311281,2.9465431337253065,2.143858342492063
LoVo,753704,4.37626239298451,4.810487845034702
LoVo,1317464,3.6287749925486743,3.975932486209258
LoVo,11626560,0.8234069861143318,1.8784676870674664
SCC-9,60700,0.6764265945588348,-0.16102417104135658
YAPC,5351362,2.7486257978183812,1.5509028646384206
KYSE-70,24797083,1.8843278101436565,1.3367797603570009
LXF 289,65064,4.964411921317377,4.963056705989723
SNU-449,16736978,1.6431800441666105,1.6793980198751184
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,4.234608807367648
CAL-51,3062316,-2.5625958708444205,1.6280981881994077
Panc 04.03,49793307,-2.352687994078586,-2.599789659774999
MSTO-211H,10302451,2.2723798321327826,3.394027826029973
A-673,54619267,3.9525164677601015,3.7979292219876197
G-401,448949,1.8289326894340776,1.7822887120147204
SCC-9,15983966,-4.042628093805887,-0.9860079360872949
CA46,3854666,0.2733202158609283,0.8488481178116968
SBC-5,42642645,2.1700569257248734,0.7020467082679629
FTC-133,6184667,4.171777093513536,3.32225373898931
A-673,3543504,4.433549859321033,4.100382782481632
CAL-51,409805,3.8515087112009656,5.100272396978638
SNU-61,5287620,-1.5621550618200195,-2.249495316443921
BT-549,6610216,4.341228931549091,4.416099609418467
MDA-MB-453,44566777,-0.164341777615228,0.7968677530491313
CAL-51,219104,3.260140555917495,3.8042168150609736
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,-2.6455810039782275
A2780,65064,4.350950935999884,4.241280023712419
G-401,9803433,5.696660690430479,4.380411937796721
BT-549,11626560,2.6049019780447473,1.9192433699922065
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,4.362012729811934
A-673,107970,1.5652885370840817,2.0946892925889404
A-498,46199207,3.6222117747737057,3.3075525838349518
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,-2.000965443913894
BT-549,11364421,-5.683704390961643,-1.016101401905394
G-401,25195348,3.8836243061511215,2.745683930466169
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,2.8954331377757927
LoVo,24901704,1.9806347162028537,3.1742256558739173
NCI-H2009,11485656,2.228831542035607,2.41362730483108
NCI-H2171,1750826,-2.946975931831454,-1.544374664519529
MSTO-211H,5738263,2.0448017247583996,3.5067400703118516
SBC-5,2729026,3.0750341046070933,2.613385077269024
A-673,60700,-2.9578260017137437,-1.507389777035232
KMRC-1,216239,3.2937854483312172,2.2474576392854253
G-401,7251185,1.5631627066286176,2.1730396536173036
NCI-H522,568763,-0.6787143148403639,0.3889859246108176
MDA-MB-453,52912189,0.0253127265648339,2.071734294246866
NCI-H1623,637858,3.185553411157662,2.340383291060559
BxPC-3,65064,4.239552039257921,4.887505608871379
BxPC-3,44202524,1.2355479078044973,2.384838819600358
HCC1143,10231331,3.1675049490504943,1.9460841280855714
NCI-H727,4917,3.0740580007272125,3.060745227202021
NCI-H522,46907787,0.5375692456309028,1.6322875661629646
G-401,4261,0.8301994759372666,1.1169039254741318
HSC-4,46398810,3.0881815243810897,2.5389845258777335
NCI-H460,16722836,2.818869820371906,1.625477177477446
CAL-51,107985,-4.126908547019261,-3.419908643894641
EFO-27,445643,4.157223404562412,4.0509002652408395
NCI-H661,327653,3.5614910429728295,3.150023281041918
A2780,15547703,2.917961616739491,2.995357874668084
Panc 04.03,11222830,1.7267772277517466,1.7713178228920976
NCI-H727,445455,6.030056890362138,4.731045979966309
A-673,72199292,0.9360047714765588,1.189946062250642
DMS 273,2945648,3.171749675698132,2.5178280410874105
SCC-9,6917907,-5.592045136043938,-4.483552535647429
CAL-51,72193861,0.6423702350358801,1.4711900574016281
SBC-5,5281321,2.671163534426493,-1.3473792681769732
NCI-H2009,10231331,-1.9302715463885551,2.0722001275072937
SCC-9,3825829,4.24505295528646,4.1518741497530085
NCI-H661,702558,4.861012061293982,5.177293194104561
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,1.8028962210456756
MSTO-211H,451668,4.9569649646478515,1.6832992937646682
A2780,9908783,4.382006664554736,4.888965395779728
EFO-27,44566777,0.6667958565864378,0.761640710940694
SNU-449,11228183,3.721594588319689,2.548852562714433
MSTO-211H,322968,3.0218271531726897,3.9710422526032056
NCI-H522,135999136,4.552466214525868,3.320146206654211
BxPC-3,375860,-1.018881063070817,-0.06991440862256958
FTC-133,46398810,3.783858454202458,2.5480107280126156
LXF 289,446155,3.7142968943868073,2.6901379147985414
NCI-H146,54619267,2.4574193717136663,3.899120484134417
JM-1,400769,-1.2746733592438322,-1.2428735662831514
BT-549,5328940,1.7912058861852873,1.5996018814196282
NCI-H460,15547703,4.965379127843483,3.2488030651631585
JM-1,10026128,4.426440879951995,3.5251709699796434
LoVo,327653,2.9108064375514604,3.0426646193312434
HSC-4,5329102,2.7247882686097458,2.163421668726938
BxPC-3,5460769,-0.1362128387149436,2.3231517134868374
SNU-449,148124,1.515559327544478,-0.7913406553790192
KYSE-70,24951314,1.3178292218062186,1.0421846166340087
BT-549,11485656,2.9441987555380855,2.5724901887662877
CAL-51,9866186,1.45916914556855,0.7068343624199872
NOMO-1,5278396,3.0205756000124775,3.0837636493068556
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,1.2502401438816235
KMRC-1,42642645,1.142476115564406,1.0535409687055683
NCI-H460,100016,5.855223104671776,6.305654315006881
MDA-MB-157,25062766,0.4624374403471977,1.9063740324305007
MDA-MB-453,107970,2.0242856345207834,2.131253931920776
DMS 273,16741245,5.579276049340643,3.831942445918904
BxPC-3,3689413,-0.056748072256038,0.07576880326397833
KYSE-70,25126798,3.963979956832577,3.762508961331834
A-673,54678924,2.025744293137832,1.4769081148623764
HCC1143,25062766,2.2830484377909492,2.230034141551466
NCI-H2171,11625818,4.794880990749841,3.9046662884001204
MDA-MB-453,2729026,2.974469204821206,2.5433236317984846
G-401,9933475,0.0956350981602405,1.5979911943295955
NCI-H460,51039095,3.9314979002332535,2.8066255798206585
NCI-H522,219104,3.343081396349963,3.24903120611191
NCI-H661,56946209,-3.6194559692185018,-4.284275216842612
SNU-81,568763,0.5116878508289208,0.0701004513923922
A-673,67291369,2.4007963238191854,1.826375177023276
LoVo,3854666,1.417426416420887,2.1181959585727403
MSTO-211H,439501,-1.1644309958543906,-2.1622489808948813
SNU-449,285033,1.5882926770841097,-1.7388562775536056
CA46,6918878,-0.7300256707111569,0.7880746009820568
NCI-H146,71466445,0.6815814889300492,3.017684709402963
SBC-5,10385095,2.1758850118167077,1.2090458107980635
A-498,637858,3.4757595298108974,2.576808726944017
ONS-76,11964036,2.0748582848578865,1.3932441372607842
NCI-H727,16725315,4.353817237787042,4.5077370123734175
G-401,10427712,4.653472001336551,3.978051166378226
CA46,10127622,5.462644164632326,3.0281668499172905
SNU-449,25161177,4.378304661297746,4.372089149094191
MDA-MB-157,49766530,-2.405889714389838,-0.7169470935902058
FU-OV-1,23582824,0.4003812349581704,0.8705889733406909
FTC-133,24180719,5.041424864241871,3.5564056394384496
CA46,3689413,-3.563387503989764,-1.4597695338058625
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,1.732416648136733
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.4415697385959694
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,3.729527059530477
NCI-H522,6918638,0.2628749411775776,0.42002035601829035
EFO-27,10127622,7.049186817655218,4.3861040123996435
MDA-MB-157,400769,-0.9429856644264992,-0.7272891336293016
CAL-51,54618164,4.021329289838694,3.982322716212388
LOU-NH91,9935249,4.429052878520747,3.330791568385172
NCI-H727,49766530,1.5110740555461553,-0.1091231624254825
A-673,9926054,1.7717409858597033,1.7011243264859217
HCC1143,5351362,1.6023771560954885,1.5735238254750117
NOMO-1,54613361,-1.5441782746277026,-0.8205295937689173
JM-1,613000,2.2697515166000355,2.1081002532587196
CAL-51,49793307,-3.2015156477281193,-2.5037287775408545
NCI-H1623,1750826,-0.130863987039663,-1.2037931762286194
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,0.42665999375423214
NCI-H460,107970,2.752075604137296,2.2983871721902314
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,0.5295899743844009
CAL-51,46199207,3.548155956826357,3.2450782174229453
NCI-H2171,10074640,2.5219754676966435,2.953959244195992
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.3072724655351424
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,2.562893832354409
JM-1,11238147,1.2374439058156688,2.004948087210507
SNU-449,54678924,2.162306121493456,2.164952297938959
NCI-H522,3854666,0.0482767863302698,1.5298452579523902
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.3891979300431976
HSC-4,10427712,3.709601221495256,4.296334049348259
KMRC-1,10296883,4.079927671527966,3.958479094579918
A-673,46907787,1.1836850249017303,0.8157253887867901
NCI-H460,67156097,3.7191617083219097,-0.4165875877309654
Panc 04.03,11364421,2.200002813497647,-0.8217332532481761
A2780,57330099,3.934423580004946,4.171466721125167
KMRC-1,400769,0.144742351180573,-0.8324264261067615
LOU-NH91,25062766,1.8056251936091945,2.0939096920124625
NCI-H460,11175137,3.7005840280640374,2.6238976939793694
HSC-4,124202324,2.961748327308983,2.382375476178255
DMS 273,46191454,0.2871755056280096,1.2459362527024391
LoVo,23582824,-0.7966748622900964,0.8313910478327214
FU-OV-1,24785538,3.56375796516153,1.4752430857077992
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,2.737990192203562
CAL-51,216345,2.9520334452605637,3.9198824943093458
KYSE-70,11427553,3.0124804015996185,2.6191258826498394
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,2.5129257074205578
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,1.754231261229017
A2780,54618164,3.641335469190071,3.9533456408463876
SNU-61,2708,5.501133929338057,4.657915651410885
CAL-51,702558,3.5144984342436563,5.231888159967111
CAL-51,11175137,1.2330676481368064,2.588589259434792
OPM-2,119607,4.667002181538018,4.521332751635276
BxPC-3,4096211,0.9773140949236826,1.9319461427097193
NCI-H146,2749,0.7789788955457625,1.3553265444008766
LXF 289,16725315,3.2486511295045677,4.225024197325613
HCC1143,4261,1.976797651434544,1.8400656249590748
SNU-449,11152667,1.3844218204303944,-0.23842930684914637
CAL-51,52947716,-4.729660133739893,-0.9132080019516655
SBC-5,4477,-0.6853772163114386,0.3533829481032093
A4/Fukuda,44819697,-1.7397384839387715,-0.8769585573634338
NCI-H2009,54618771,-0.2233577251443086,1.2037359404006256
LOU-NH91,2733487,6.3296049393179485,6.223430187043833
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,2.7707705064682835
NCI-H146,89928392,0.6603214053079605,1.0554937249408187
SW1463,10231331,-1.1566445252598772,1.4769682082504005
MDA-MB-453,11977753,-1.828846421242697,-1.3947520592643212
HSC-4,445643,4.123722857917103,4.065310845526985
EFO-27,42642645,1.7670896576814532,1.094157731594103
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,1.9998621026184416
BxPC-3,5311281,3.739267965753581,2.4917542603858074
SBC-5,44185566,3.097813648169307,2.4558297125209223
LOU-NH91,5351362,1.6461408289790205,1.7936975026115187
EFO-27,50905018,5.404252445104634,4.705443353237378
MDA-MB-453,374536,3.68630764751743,2.0383483409131364
G-401,25262965,-3.9564581939856582,-1.7791397084948417
CA46,2749,1.009648399882346,0.8693144239541688
SW1463,387447,-4.88012723681038,-4.122078332311446
A4/Fukuda,8515,2.244185004641864,3.568817238350818
NCI-H1623,24901704,3.7829050158791064,3.1897173062966533
HCC1143,71680916,4.5741598898507565,4.777785497208663
YAPC,54143018,2.4773688492488892,0.39364175230571946
FU-OV-1,49793307,-0.2872221589202163,-2.4978536008825247
Panc 04.03,168312962,4.832441653848414,2.072733213278723
NCI-H292,11609586,2.9930145326420146,2.9130041585872464
NCI-H727,25150857,2.574637897952517,2.316359669263827
NCI-H292,6438330,2.681078996624105,2.6276261440493642
OPM-2,12003241,-2.9738714531294232,-1.664186711331566
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,2.754839643859413
NCI-H522,151289,0.0217168787144745,1.0064871536539801
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,-3.754794539817123
BT-549,11238147,3.2866911979765803,3.0748202703283103
OVISE,9866186,0.5630702781820192,1.0582234911621828
HSC-4,6918328,0.4827098957230251,0.22407828483179973
NCI-H2009,135411,0.2253946709705592,0.7114063116517109
JM-1,10385095,0.4126425157623973,0.8413920606016919
CA46,45279963,3.66447519946476,2.7107756535113587
A-673,44197249,4.247235211402652,3.1344292822520323
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,0.8136642042985458
NCI-H661,135440466,2.665416885593315,2.3947319471317194
G-401,168313016,4.483065775660181,4.466238371750788
BxPC-3,168313047,2.402437406788064,2.254596496003132
NCI-H661,2746,2.7828270451310786,3.2294204872416405
FU-OV-1,11612883,1.8669069183790803,3.0879745005191706
DMS 273,53232,2.0931635545137266,2.517782024181463
BxPC-3,9903786,2.126136875029704,2.8095603194582544
NCI-H661,11625818,4.41260734243293,4.424700047534139
NCI-H522,16659841,2.9113601324358287,3.5756728558120385
OVISE,53232,2.4849914286727426,3.212358370291908
EFO-27,135440466,3.806006891786582,2.431457039205782
SNU-449,5746,3.348109332475853,1.3762689580006857
CAL-51,969516,2.948027689121256,2.7410136603592514
FTC-133,11238147,4.273178384451577,3.1208652288094987
NCI-H522,24748573,1.6076101041751254,2.19302635422949
MDA-MB-453,46224516,2.0758190952131215,2.439341371055086
LXF 289,6918878,2.1668969721619833,2.7610391183582266
OPM-2,451668,-1.14063259637223,-0.45895106764494953
HCC1143,3689413,0.0716522323698814,-0.10144923313399523
SBC-5,135398744,6.447254342428179,6.331857247350212
CAL-51,227681,3.694103991631346,3.2268445436782884
CAL-51,5287620,-2.338247824560234,-1.8410179806364397
A2780,3062316,2.0817886994426704,1.3380443786920608
SNU-61,2858523,2.9582475566417195,2.984085821035095
SNU-61,54649381,3.9147762798202863,3.7764103803562903
A2780,10385095,0.5603604864283975,0.9326000345783834
MDA-MB-157,11152667,0.7570225590856333,-0.43404157402711196
ONS-76,400769,-0.3525004301248006,-0.5836427230259411
A-673,409805,3.491559756034339,4.30513609643784
SBC-5,10184653,2.5351322042771356,0.9043815627288907
NCI-H727,66577038,2.8647542032772604,3.0882620745195397
A-498,6505803,4.020571046679738,-0.23326937499564918
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,-3.4263988186734493
NCI-H522,2708,5.085998334781725,4.09904298016568
BT-549,45279963,4.047021813577569,3.819926402642441
LOU-NH91,25183872,2.2713164299079627,-0.80037386004769
FU-OV-1,24797083,1.8707999880079529,1.3247907894977382
SNU-449,44607530,1.456313243054954,1.9402523399376148
MSTO-211H,1566236,2.167071233614174,2.526301193659109
JM-1,24951314,0.1302219808330525,0.31997489728730527
EFO-27,53392493,1.9151019076026368,2.6850087355672736
FU-OV-1,16725315,4.930691545287574,4.39975258218602
NCI-H1623,12003241,-0.4868602659209724,-0.9318751284366013
SBC-5,148198,-1.371938553790338,-3.695123018019882
BxPC-3,17755052,0.5794893802598977,1.9242592128082308
SNU-61,11485656,2.115016827038527,2.1928359361571856
LXF 289,2729026,2.289348740995074,2.7186581812459916
MSTO-211H,654092,-1.1984807631004837,-0.23153954725774212
A-673,5291,3.269854942504113,3.370006106390067
LOU-NH91,4705,2.8449970854381945,3.1892455160416464
SBC-5,24753719,5.823724927288436,4.118908064826321
SNU-61,675434,4.254516948181055,4.377939235211787
A2780,5278396,2.562980728115376,3.165122993334491
DMS 273,122327,5.509571347430681,4.758030800199192
A-673,9884685,0.1604809562987641,0.26031581828847633
NCI-H1623,16722836,1.0817030477122866,1.5968927920673353
NCI-H661,67291369,1.7470049727917394,2.823236042882391
A4/Fukuda,135398516,0.099848878431286,1.6907416678060612
A-673,568763,-0.0608974572236531,0.10776138841534881
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,3.5493708990755146
SNU-81,11178236,-8.196337700198193,-3.1609976266714064
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,2.182739443179037
A4/Fukuda,46215462,1.453707580765341,1.4640117967174175
HSC-4,6252,1.1187983220422375,1.1558081479824496
HSC-4,3062316,-0.6194675763886993,0.8668185340089025
NCI-H1623,57330099,4.486652982197453,4.461164093617394
BxPC-3,23635314,-1.513116034089344,-1.9415885750698982
OPM-2,46943432,-1.735277326796896,0.9621682110430209
FTC-133,11175137,3.295108533345337,2.699821327335337
SNU-61,100016,6.106397388471953,6.028425684614413
MDA-MB-453,446155,5.408001660467943,2.714393913410819
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,2.3180195596834463
MSTO-211H,168313200,3.954855187852925,2.7805332037542767
LoVo,2729026,2.166128688763036,2.6198810288187726
FU-OV-1,73707398,1.0047751906041116,1.5306473990239726
LOU-NH91,44241473,5.33179348194517,5.089659315440953
YAPC,135440466,2.1529261418392807,2.1659268325919157
KMRC-1,568763,1.1483170277588293,0.5572355692602001
CAL-51,656346,0.8466306406200714,0.8315516414890672
MDA-MB-157,327653,1.3811083957143218,3.362673635552272
NCI-H460,107985,-2.632533954936978,-3.2589246522634796
NCI-H460,135875424,3.211754300989152,4.008210417507146
BT-549,119607,5.663531776682701,5.458324206401342
KYSE-70,4261,1.9447398866595849,1.82585088319207
CAL-51,44543605,3.919885801001582,4.1059119814129375
SCC-9,44566777,0.4714703461280546,0.8206941876136287
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.6922760600319333
EFO-27,10322450,4.618987367546035,4.166386204134894
LoVo,452548,-1.7762082467733018,0.5394927051369137
G-401,24821094,2.5559581237528097,2.719473115800129
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,-2.969472651340947
KYSE-70,135999136,5.194226724950964,4.054287529643307
NCI-H146,6438330,-0.4558524131736901,2.0000992610425716
BxPC-3,31703,-0.5929664629875476,-0.7580593375464514
Panc 04.03,5470400,0.9135030177256964,-0.4413344727270902
KYSE-70,25150857,2.5963104301055258,2.604098490808829
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,3.2095297173420705
A4/Fukuda,439501,-3.252400391503616,-2.3553065710031045
SBC-5,107985,-2.339881885950972,-3.1397480660612445
NCI-H146,25227462,0.2247724046939956,-0.8955240837268766
JM-1,44491742,3.590859136704876,3.7928616561278345
YAPC,6505803,-0.1975849276423945,-0.6814615031878045
MDA-MB-453,10113978,3.193218839681212,3.1260064453107463
A-673,16038120,-1.140194872712738,0.35672274953879923
FTC-133,675434,4.640800834602054,4.455737817764277
MDA-MB-157,439501,-3.062684000428755,-2.3339552813800664
SBC-5,10074640,3.660613951501144,2.9642394585530685
DMS 273,3689413,-1.7704206659692223,-1.0475473705230829
SCC-9,36462,2.4622585602605493,2.133478331727428
NCI-H1623,46843906,3.212648418277938,2.8087863697309206
NCI-H2009,676352,1.803439035619831,2.1675738658170767
CAL-51,387447,-3.720200693098244,-4.25338280150768
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,-0.6210325295034677
CAL-51,44632017,0.9975947899898204,1.195828165602503
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,-0.38931077522398516
DMS 273,9936388,3.4086707637717883,-1.7615144693881444
NCI-H1623,24180125,3.727544824819635,3.2885665309161136
NOMO-1,969516,2.327280884248625,2.3065681723273723
A4/Fukuda,1750826,-3.1003590099134284,-2.2505122538430644
Panc 04.03,5281321,2.674318568781228,-0.4670490576282468
FTC-133,176870,5.80195413779655,3.456214795988343
CAL-51,10113978,3.4506321601115397,3.261364112520309
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,2.371405349223542
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,0.20890398425450163
A2780,3385,2.4446535707127537,3.6600040791355655
DMS 273,45279963,3.8289869697511527,3.559576633967611
OPM-2,11609586,2.7966274513563496,1.6485131997639046
NCI-H1623,26596,-1.1542368606327895,-1.082290989318541
SW1463,5479543,1.0422897086412093,3.1467608548876997
SNU-449,53392493,3.0071956547718113,2.9211729243731424
Panc 04.03,11178236,-2.395899374087587,-3.5255602482864052
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,1.1541875151433971
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,2.5460289278478876
NCI-H460,9866186,0.4176494313944011,0.8782351738481003
FTC-133,53232,1.7186310962422595,2.330960131214007
BxPC-3,216345,4.279216843902863,4.075788987930889
A-673,10296883,3.758044639987347,3.7201334723168578
ONS-76,11178236,-3.26201925681368,-3.4562583414800088
CAL-51,25062766,1.9168321284868295,2.1492916727494698
NCI-H522,6852167,2.4506568165817777,2.3616225393326262
SNU-61,72193861,1.1230875557226898,0.973147291590423
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,1.3059064679377497
BxPC-3,3543504,4.240175882152398,4.3918197997945905
NCI-H661,73707438,4.487630336801632,4.059869863740156
OVISE,638278,1.1296919637825429,3.479577651936123
A4/Fukuda,36314,4.126705075384559,-1.789005343549048
SBC-5,10127622,7.037598772691409,3.1507623357377588
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,3.3704645298566347
BxPC-3,49766530,0.5943123243750338,-0.14748280114075793
LoVo,54143018,-0.354466194309244,0.1873305551773215
BT-549,44589607,2.161067974853105,3.0682320796597793
LOU-NH91,3136844,4.41334270983783,4.529508533788659
OPM-2,5311,-0.071810443528602,0.4719538661873743
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,1.306549788204226
HCC1143,676352,2.389016147507623,2.144505836278014
Panc 04.03,11657048,4.4356176445581,4.645439823550502
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.6986872225314371
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,-1.0626154507468817
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,1.7071305905180036
NCI-H1623,374536,0.6337427379168257,2.0314344780369344
SNU-61,3825829,4.102120147241808,3.867720240205506
DMS 273,56649450,3.5073695444545288,2.9137830835773757
CAL-51,24785538,0.7720267524795773,1.5454097429124658
OVISE,16038120,2.1825815777023965,0.943962203194519
EFO-27,6918328,-0.3264411901724555,0.2519628780818185
FTC-133,3025944,4.352563236352026,4.371644515875869
A-673,89183176,3.363943107585485,3.932104643853058
KYSE-70,123631,1.697265417228948,2.2709770333215586
MDA-MB-157,441298,1.9245422363016824,2.639170258528519
A-673,156422,4.078876073319714,3.856767263333269
BxPC-3,676352,2.25430531813019,2.276946066405092
HSC-4,25150857,3.233332545340528,2.6576322174981857
G-401,24856436,-0.0141865957174665,-0.33343915454883116
MSTO-211H,49793307,-4.316049670445352,-2.2366831637675113
OPM-2,11485656,1.3184852346481954,1.6698132633216962
HSC-4,208908,1.4999275809756432,1.9320104586162465
MDA-MB-453,54613361,-2.035930507333412,0.32578549235872084
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.847389785411761
EFO-27,44589607,3.0601109795549295,3.0276055604569514
SNU-61,44493528,4.287806417412906,4.265075970798415
G-401,11152667,0.9519757620011424,-0.930713954396022
NCI-H2009,5287620,-2.745575302534365,-2.0009931564495353
ONS-76,23725625,4.840348822045759,5.138653612148301
CAL-51,44620216,5.469091994130916,3.3016312414040834
NCI-H460,9903786,4.057661845653794,3.112269796672122
A-673,11214940,1.1675505170406824,1.6322128187598608
A-673,24964624,2.426022149354347,1.8939746292475141
BxPC-3,9866186,0.8001699279354296,0.9253856557280661
FTC-133,25062766,3.8237771334178903,2.1511096632237625
HSC-4,42642645,1.8060847122685193,1.0670555133506894
HSC-4,11178236,-3.2670379451965164,-3.295299157350249
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,1.208235101196055
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,3.3514296062023563
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,2.497865358083706
NOMO-1,46843906,1.7610241193794407,1.9825687771402989
NCI-H2171,6917907,-6.363958938419671,-4.678097720536356
DMS 273,11707110,5.189560989731051,-0.5055846400899413
LoVo,6918328,-0.3156299102516719,0.18712674978110416
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,3.3511245458909813
NCI-H2009,44632017,1.0717713653211387,1.7427134627817498
DMS 273,11626560,1.283315066012986,1.3813432777518997
MDA-MB-157,11317348,1.0421206228140214,2.6630304117545283
A2780,5311281,0.918852428114819,2.025294835803371
DMS 273,2113511,5.781557942421417,5.330315364753172
LOU-NH91,10184653,1.5324310696398793,1.583780507556884
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,2.345124353282523
Panc 04.03,73707398,1.757833710000806,1.5710483329706557
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,-0.6395640799639781
BxPC-3,11455910,2.77826122800999,1.0426148869974594
MDA-MB-453,11955716,-2.2213534191245303,-0.7102525145419449
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,0.8350790103758964
NCI-H661,3634881,2.923822089210327,3.2701238965843453
NCI-H460,5281672,4.99885948312363,4.525540651842518
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.4732036981041923
KYSE-70,4259181,-4.187670573846372,0.5128544095186651
BxPC-3,2756,5.8394588105914105,3.814575195668559
HCC1143,24901704,3.259585605807663,3.2707287356353265
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,1.9956955650564465
CAL-51,5470400,4.528848471588079,-0.5159625691783908
JM-1,10296883,2.092198976716966,3.259846632287818
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,-0.7279839296313753
NCI-H146,46199207,1.7925573568525552,2.949333859056899
OPM-2,448949,1.278414281383,1.4874717143856353
NCI-H146,216239,1.510222966819436,2.0191736666013096
HSC-4,9903786,4.262681016067309,2.9780654762045096
ONS-76,57330099,4.261013423315652,4.41583342149798
NCI-H522,148124,-6.241132033807486,-2.3790402206255066
SNU-449,156414,1.8120811787876097,2.029398918181298
NCI-H2171,2746,1.1013983502046127,2.1958798982646774
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,-0.4892938010085637
LXF 289,135398744,6.087135496005038,6.358599193648206
SNU-449,3689413,-2.168376107627999,0.07701020562044002
A4/Fukuda,5351362,0.320845740356061,1.1063336431676762
A4/Fukuda,446155,1.0805751863544764,2.3517908609555853
CA46,151289,0.6780663351050565,0.4453919622972316
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.5080652087512747
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.9198587526868747
NCI-H460,11625818,5.428588497019925,4.482410695197027
A2780,119182,-2.871948238792312,-1.4694754325749146
ONS-76,10385095,1.1655527010487017,1.2959621683776295
EFO-27,51037431,5.317639691280149,3.3752981222516065
A-673,72376,-3.645473298633041,-3.0464058743975118
MDA-MB-157,24748573,1.7707431454067368,2.3436529847363126
JM-1,6610355,3.6312795132079136,3.9951454158855335
EFO-27,44819697,-1.290536172530674,-0.5364775582521694
A2780,5702613,3.197014181878355,3.0179389411976696
A-498,25102847,3.3376740856950335,2.663614953742234
KMRC-1,3634881,3.321374403116886,3.4099644065836414
OPM-2,3081361,1.5210485339307265,1.93908055051772
LOU-NH91,3038522,4.554088179549466,3.105043437821599
SNU-61,216239,1.9834133881004128,2.1525685130980197
FU-OV-1,124202324,1.4335087059128786,2.7728448946859885
NCI-H292,72193861,2.2952018559260363,1.6891952245425517
MDA-MB-453,53495165,1.832682106227088,-0.12024530452259122
NCI-H2171,31703,-2.460746582121975,-1.2138570579525196
NCI-H460,2729026,3.0609463870825926,2.8010014925747067
SBC-5,9868037,1.591902673624677,3.003469230131955
LoVo,44632017,0.6073588127957028,1.2109326383143773
JM-1,25262965,-2.478831797463893,-2.331030045701523
SCC-9,148198,-2.735497552895971,-2.9483443772001836
CA46,89928392,0.0283947615438792,0.24203953550550422
OVISE,5566,3.518034595538079,3.1029988731668574
HSC-4,5278396,3.3910828172613128,3.6618247602427036
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,0.7136851216596224
KYSE-70,4788,5.890959200463747,5.67870382898716
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,2.0722454675550828
Panc 04.03,374536,2.376032280196277,2.850961958346969
NCI-H661,20959075,-3.3600823520668306,-2.8743776900946996
LXF 289,3543504,4.042070583449167,4.541297598847309
SNU-449,5287620,0.008240040829162,-1.9265010557731663
HCC1143,11719255,3.553533872223464,3.208201503941975
NOMO-1,54618164,3.731990472759892,3.7681585672719944
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.4216131740096118
NCI-H1623,5311,1.5946462199665867,1.562884232903936
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.1591388128820395
LOU-NH91,216468,5.562373540734892,3.3797867901471097
JM-1,9915743,0.8499678141273637,0.6801900032860015
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,1.8595448083636574
NOMO-1,107985,-4.118574275669005,-4.10052576282809
JM-1,135423438,1.5495237102322077,1.3668450240934027
A-673,24856436,-1.1403661815810562,-0.2393165227099451
CAL-51,5282054,3.552468823116285,3.589694460485228
CAL-51,11178236,-3.674192911743539,-3.329252323257188
G-401,6252,-0.6004387834343344,0.09091880740109957
KMRC-1,4261,3.216149224144429,1.6938310588075272
MSTO-211H,54454,-0.190602208325988,2.527636059325928
CAL-51,4917,3.122174268556499,3.020486362290577
HCC1143,54649381,3.828405406955801,3.8916575176344086
EFO-27,25262965,-3.442895730672298,-1.2894178540282468
NCI-H522,54626689,4.6269731577498066,4.541303460998258
KMRC-1,123631,2.4243478642730634,2.2917031162798467
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,-0.2566428433996406
MSTO-211H,6438330,1.6419113469823416,2.2690167867182915
CAL-51,446155,1.9002286289262065,2.570072964995485
MSTO-211H,25126798,3.885175037199499,3.8719532896656172
KYSE-70,54626689,6.762622459467938,4.640579895607768
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,-0.8045760415627775
CA46,4705,3.1649236354970154,2.8061681956693807
LOU-NH91,36314,-6.12634068503974,-0.12875594501239476
OPM-2,49766530,-3.767684481967312,-1.3368180341219371
NCI-H460,135411,0.3374737909082799,0.7627961125666617
NCI-H2009,6623618,3.0922058987418315,2.4741063588413392
KMRC-1,44185566,3.110367208302614,2.5725763078303014
Panc 04.03,9933475,2.3468691227324965,1.915873712462107
NCI-H146,25105715,3.2144396386290617,3.4076378888507746
SBC-5,25062766,3.305997596539037,2.05520509786283
G-401,11364421,-5.069536717957333,-3.383302628227678
OPM-2,1285940,4.143301448340403,3.4322323549938853
NCI-H661,46843906,3.609730466041,2.9376357757583866
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,1.823499972306497
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,2.370150652028235
ONS-76,656346,2.4725060186946974,0.9595511492412335
A-498,135421197,2.4500558267656873,2.49719804069487
YAPC,5280436,4.973863444979394,3.5065861730046857
NCI-H522,53481919,3.906372094667401,3.8641260576519367
CAL-51,448949,2.479839067238928,2.053403918136817
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,1.0680568386690061
NCI-H727,15953870,3.6175866373148713,3.5781779916482566
A4/Fukuda,4378219,1.9024946719152895,2.1873427885048304
ONS-76,374536,5.32668572402577,2.7693468261727396
HCC1143,387447,-2.8902460626215216,-4.071347470662763
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.3322990431836204
OPM-2,3543504,2.699241331915609,3.6913285016323862
G-401,54618305,4.431468655886698,3.6643154610437905
A2780,54649381,3.634529154077109,3.748287123627071
LXF 289,5287620,-2.3080718171081385,-1.859125384013286
YAPC,637858,2.16601707981449,2.102960574808811
NCI-H522,9915743,1.083108246388964,0.7028631422367237
KYSE-70,25183872,-0.2407157689495178,-0.42921101009972423
NCI-H522,56649450,4.1349782138767655,2.9490057249767174
OPM-2,52947716,0.8847701060718332,-3.4948765052210704
SBC-5,124202324,2.6085939591802307,2.224862578908768
DMS 273,2742550,3.72774264414297,3.6133913675030214
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,2.3806181646650146
NCI-H522,44491742,4.766943404170333,4.133784479618944
MSTO-211H,3503,2.7854032891391163,2.3805217993296113
FTC-133,10427712,4.710340548147587,4.238427893194966
SW1463,56946209,-2.6004240108086187,-4.074894099311936
KMRC-1,11178236,-3.5821993315226175,-3.88648540135606
NCI-H146,5281672,3.80713040102785,4.115082598484192
SBC-5,16038120,3.1431644252796835,0.8768157554287305
NCI-H522,421610,1.9391714098470076,3.1328169812061413
DMS 273,9866186,1.1265446059819233,0.530592692314795
SNU-61,11717001,3.914635952460324,4.041107355433743
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,1.1052296656621328
LOU-NH91,44137675,3.1585262513685612,3.7580181265481203
JM-1,5335621,3.4974928376934766,3.968837171015942
CAL-51,444795,5.053001195278548,4.531106295650337
SNU-81,68056272,2.81466177200511,3.377295788579186
MDA-MB-157,23582824,1.002360199735323,0.7904501992711549
CAL-51,44185566,1.8630594392382311,2.6056766097676176
MDA-MB-453,54618771,-0.4179555738274852,0.940139089679466
MDA-MB-157,16038120,1.7351596622267822,0.9499947191241279
OVISE,44589607,3.8530354372246394,2.7977478889533307
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,1.0539590490605582
NCI-H460,400769,-0.4007490431715684,-0.5687632648304863
SCC-9,5460769,4.655053652221148,2.74564132995051
MDA-MB-453,135398516,1.6443590350340722,1.7600504020846883
OPM-2,444795,4.04932788863876,3.5253924281571885
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.3786329115504006
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,0.8919391348152509
HSC-4,11656518,1.5757846986297326,2.218912227424595
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,-0.6696746377451452
G-401,3062316,1.3877203939609295,1.5123330655993952
SNU-61,16013152,3.3306050431250056,4.001469391354804
NCI-H292,4259181,-0.3596950747779806,0.5362289157971085
G-401,6918638,0.0373379560261908,-0.18412734234424577
NCI-H460,53232,3.485336782178725,2.879361460881407
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,-0.6692948064640195
HSC-4,262093,2.780665409693215,2.908522912265016
LoVo,100016,6.001395250082881,6.256935300789846
OVISE,2729026,3.0624747536258843,2.8480498129426404
SNU-449,46174525,4.694645250518289,4.6261315553892555
MDA-MB-453,25102847,3.185871702253412,2.211967037948368
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,3.3747430682227737
LoVo,208908,1.8298234127328137,2.1157971694741864
DMS 273,36462,2.158918041886743,1.2567015368989467
SCC-9,252682,6.244434841835944,6.495125567953348
CAL-51,3689413,0.5709426612715743,-0.09112811028047525
ONS-76,5328940,1.5304760606777814,1.7173776432020387
KYSE-70,46199207,3.0458734214111436,3.1400839968366374
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,1.0158243741785349
NCI-H727,16720766,2.0944103672723577,0.942042329251759
CAL-51,16741245,4.222373420591208,4.141716038473168
HSC-4,23939,4.494005895197972,4.393545419376105
LoVo,60700,-0.3967380120150421,-0.26896094270889886
MDA-MB-453,25262965,-0.03783703480807,-1.1817005362605044
A-498,374536,-1.3715174839162405,2.360589094130138
SNU-61,107970,2.0644711824277757,2.2288166908576432
G-401,702558,4.958816468985481,4.688632570068849
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,-0.7447356193305273
NOMO-1,16038120,-0.1786929053902652,0.3616266899862495
HSC-4,3543504,3.922868331711394,4.420871152593381
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,3.428514935154027
SNU-61,10410894,3.2150759349666176,3.018421416035494
JM-1,2746,0.8560843341026924,1.9611984517907606
NCI-H2009,15547703,2.9018345982556935,3.4125660417726995
A2780,246676,4.314588687253318,4.271827017227679
CA46,135398738,2.145043320547598,2.724317834666169
MDA-MB-157,55508,0.9028127001821934,3.538011106097544
Panc 04.03,71304818,2.709197405012258,2.698149943264772
MDA-MB-453,53301938,4.664434739240087,2.215579250886662
A-673,46843906,1.5511639515888018,2.297962147101259
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,1.156832307552039
MDA-MB-453,3543504,4.170014094465671,4.126821319856617
NCI-H2171,5470400,-1.4637445210918176,-0.6745576348661448
NCI-H292,25062766,1.6798511870535655,2.2356026499851125
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.4939651888468917
A4/Fukuda,16736978,-0.5754825114210159,0.6235809237654538
JM-1,2749,0.0460059123026362,0.6894811469887823
SCC-9,46215462,2.815249887965138,2.0583068416290358
SNU-61,24821094,2.5022209832597757,2.690479175220238
LXF 289,44493528,4.295099384269069,4.446091741224297
KYSE-70,54649381,4.140433754758901,3.6735289162055578
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,-0.5809818272179326
SNU-61,9826308,1.2155896819085543,0.2656595082445313
NCI-H522,49766530,-2.92412408259348,-0.8810826892999027
HCC1143,44493528,4.485488370266477,4.344148853284015
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,0.2570471568998799
CAL-51,3081361,1.780158758130264,2.4520782951507845
DMS 273,2746,1.8465116882146249,2.4335932386147685
HCC1143,5282054,3.2164949694146237,3.5391859288622505
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,-1.397244868093503
SBC-5,644241,3.9213876276885458,2.186461919440584
DMS 273,702558,5.649496210085508,4.956600703687153
NCI-H661,25183872,-0.013752841490686,-0.8027842800145925
NCI-H1623,71751553,5.091527890142487,4.5889940443087225
SNU-61,10322450,3.828611192492266,3.9092258591082873
YAPC,44589607,1.444383642816813,3.01849065719987
FTC-133,426756,4.37678677221598,4.729195037532251
DMS 273,25062766,2.819032107658894,1.7916652096763546
KYSE-70,375860,-0.042936769343065,0.0463044771971209
NCI-H292,6623618,2.2662127680014708,2.3198966320183216
A2780,3634881,2.2771511965432767,3.0037855360891093
FTC-133,11427553,5.52425857278767,2.751615610544383
FTC-133,613753,3.41594619216373,3.006535237022105
DMS 273,5978,-4.4169630962529896,-3.0386403564903266
MDA-MB-453,135398738,3.241714649843938,3.438642156868404
G-401,252682,7.482268639703102,6.388239427632918
CAL-51,126941,-2.448006630223804,-3.0877980458708794
KMRC-1,1716436,3.642710819139985,3.0766613132545255
KMRC-1,9967941,4.338887861114791,3.7631389307426404
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,2.206364604789495
A-673,16725315,4.562355532440761,3.7000304209303003
NCI-H661,54613361,-0.43407763491745,0.5315605515216218
NCI-H727,17755052,2.165535951118127,2.3221633765343785
LOU-NH91,4521392,4.279385220000522,4.365848881320914
NCI-H661,448949,1.832526735111792,2.1437455395986906
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,5.811960352431485
JM-1,24753719,1.6485500810507543,3.3999977345963384
CA46,42642645,0.1424242949920916,-0.29112723236017696
A2780,122327,3.970459431332868,4.707866198558775
LoVo,11609586,1.9215259939554383,2.8216657507918854
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,2.0567424239772425
Panc 04.03,6918328,0.7116207668770654,0.4792945566492889
YAPC,10302451,3.503177254309001,3.2794324489519573
Panc 04.03,262093,3.918875507815306,2.9704455491155874
Panc 04.03,4261,1.8035720705799856,2.2288748352053798
HCC1143,11238147,3.6259374679037943,2.8973333981801677
FU-OV-1,24951314,0.7779749033617789,1.3171925580833395
CA46,135440466,2.9995621349054007,1.6274088099682684
SNU-449,675434,6.334911868299287,4.5611963086299845
G-401,568763,-0.8413074079434755,0.05482872265487483
A4/Fukuda,421610,2.9916322722523425,2.8683451669797706
NCI-H727,11964036,1.415853516680377,1.4218279101371627
SBC-5,53232,3.018737473370281,2.6877508749915937
NCI-H1623,2746,3.1722069840164533,3.1857243943707103
A-673,25102847,1.6240664882379,1.9925535726657015
NCI-H146,71680916,3.9962882248297182,4.509110297185504
CA46,702558,3.0016875761250383,4.005764252350454
HSC-4,3465537,2.7025414883497443,2.464959262891572
SBC-5,15983966,-3.760719305706525,-1.0273218698687427
NCI-H661,10184653,-0.0970326303224196,1.3888195687869334
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,-2.3628998847936233
MDA-MB-453,3634881,3.217596499324366,3.2624155853256815
KMRC-1,54596558,4.448003654736506,4.331536287459548
SBC-5,6438330,2.801398037891768,2.207167695214541
DMS 273,11317348,1.436395200538785,1.919555480849536
MDA-MB-453,241158,3.8848602363142697,3.795223406733234
CA46,72376,-3.3789820311778764,-3.632566322162232
EFO-27,1242560,3.615097330539702,3.581389398473178
BxPC-3,51039095,2.7952547650191297,2.722159638735263
BxPC-3,71466380,5.524538311672043,4.407962279058466
A2780,49850262,3.28716577139928,3.2481814728567517
EFO-27,148124,2.931737870457193,-0.9435741605943341
DMS 273,65064,5.260786534928717,4.449596878694331
NCI-H727,5328940,1.5210077536616875,1.857972656730224
SBC-5,20959075,-3.707780876124786,-2.9454353787260397
LOU-NH91,5281321,-2.3527775967876097,-0.9045888851516172
OVISE,123631,2.580734449711204,2.11936670567872
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,2.085199224164241
OVISE,56946209,-1.506774361262591,-3.657329835292951
DMS 273,5282054,2.793045570742954,3.2253881271124243
SNU-449,11626560,2.613161578711923,1.8873046318730315
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,3.327109595332739
KYSE-70,11214940,1.7563649507227177,2.123933782542617
Panc 04.03,15953870,4.151399322633975,3.8409451541218327
LXF 289,16736978,1.6084503302226174,1.5836561433061815
MDA-MB-157,60700,-3.9633933148193066,-0.16628389219341033
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,2.3597344603104133
NCI-H522,11152667,0.761836671652074,-0.5422933029435781
SCC-9,1750826,-1.358939777918893,-1.1321369512270454
CAL-51,3854666,1.1494535123186709,1.972974760987867
CA46,11656518,1.817934601803022,0.4768700694390713
CA46,46843906,1.200591966763502,1.7475356369515227
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,0.3721923108633808
CA46,24772860,-2.6679944090404035,-2.813725522911123
G-401,24771867,0.701574094296253,1.1904763014320892
SBC-5,44202524,1.3408029920565403,2.3381034140548715
NCI-H2009,44507138,1.543580962147717,2.686957659118301
OPM-2,24748573,1.2641689672749945,0.9505855613105456
NCI-H661,3025986,-0.862198206140106,-1.0091737948792396
ONS-76,107970,2.339276188405755,2.3161683990311577
BxPC-3,54619267,3.7277591748612866,4.079978513716252
ONS-76,4917,3.1821597264511863,3.1372114295360767
NOMO-1,44493528,4.211717002525977,3.955306156779344
SNU-449,421610,4.477929285236737,3.2300789935846113
NCI-H460,4259181,-0.2054535095090753,0.33576814402451904
G-401,327653,2.827166761380022,2.89361761680843
SNU-449,10302451,2.626140201612578,3.4362204891440427
OPM-2,24964624,1.0133948666397414,1.2726959297630736
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,3.8148063350366708
SBC-5,441298,0.8643210359830038,2.5194798262515214
NCI-H727,44489367,5.9503570299169875,4.500357484929387
HSC-4,123631,0.7882754974693414,2.4112521544163745
ONS-76,24753719,3.8801096922841656,4.265216824026259
A2780,53495165,-2.5208465146636008,-0.6139079843088401
SCC-9,135411,1.0456929507985402,0.7443820272135219
A2780,6918878,0.724096247903148,1.8018958710554833
A-498,45279963,3.865048616527305,3.849737639521595
NCI-H522,51039095,-2.208127710853326,2.426308350787392
LoVo,5335621,4.644708398315867,4.580658188858134
HSC-4,46199207,3.2853086951025197,3.223089761334752
KMRC-1,45279963,3.811973271229391,3.6215964399498906
LXF 289,56946209,-4.292268406284497,-3.976228131534053
OPM-2,24775005,3.1759511003243532,3.0463855250968006
MDA-MB-453,11609586,2.797782394552202,2.645255677781423
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,2.3916997448019073
A2780,53481919,3.3933560170788355,3.6961950344929333
G-401,25150857,1.6513368879801875,2.2451617943175104
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.4939651888468917
G-401,126941,-1.029913917257394,-2.9643756120524847
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.883246367281688
MDA-MB-453,BRD-K55473186,2.6877336742225424,4.128420853438288
MSTO-211H,5311281,0.6318902138586533,2.223343855982697
CAL-51,44589607,2.4963130908502107,2.8999927787736577
KMRC-1,11234052,5.10610802043039,4.054249357851844
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,2.3082162362857583
HSC-4,5291,4.568554891244716,3.830027494328535
KYSE-70,3543504,4.273044270546896,4.337106441849503
NCI-H522,54618164,3.979913879048498,4.0838329560356765
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,3.4828479751522026
DMS 273,439501,-3.5888564067388633,-2.233647712183544
MDA-MB-453,122327,4.8881767020652775,4.6882185924696556
A2780,6918837,-3.827695834319955,-3.521331026464344
A4/Fukuda,44489675,3.3968348796203003,3.693601121472842
NCI-H522,25195348,4.252884841670477,3.0712134388938406
SNU-449,11404337,-0.5921655065432572,-0.06200593097409993
MSTO-211H,12003241,-2.79016034960529,-0.9798538773187139
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,2.8117339438425843
SNU-61,654092,-1.5451038120184588,-0.29935661587329854
NCI-H1623,4705,0.0935418442786881,3.0750755913766286
NCI-H460,3543504,4.388423548450019,4.389232450713719
NCI-H522,23635314,-4.582316729083318,-1.7840196069043706
LXF 289,6918837,-2.0130943060067454,-2.563066102781264
LoVo,31703,-2.470313869470646,-0.7983933035711266
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,0.5716129266984663
FU-OV-1,654092,-1.6613932676517214,-0.407510238666738
OPM-2,60750,-2.943046758118922,-3.4977659827622243
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,2.4457230159664585
A4/Fukuda,445643,2.2110077600401996,3.661875236941123
JM-1,25105715,3.1433974364296526,3.049673024996092
KYSE-70,9967941,5.193135802047497,3.7129972864844047
Panc 04.03,24748573,2.946919213932378,2.3422190548341364
MDA-MB-453,6918878,0.409116855324534,2.101976842034071
Panc 04.03,24901704,4.022965674422846,3.316465852865357
CAL-51,16736978,0.375988055286384,1.432504476632845
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,0.8933977012163177
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,2.8642346533157474
Panc 04.03,462382,1.207122186011881,0.5611386332637374
BxPC-3,568763,0.1839879990612418,0.6216491627458255
A4/Fukuda,11640390,-1.5428779369431247,2.876965333703891
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,3.08582753402351
NCI-H522,216239,1.926799438191183,2.203168416121198
G-401,53392493,1.8463111416757765,2.135769391530859
KMRC-1,241158,4.823138037217212,3.7018828626792573
A-498,5566,2.910612965628124,3.2192905835687924
SNU-61,17755052,2.932810476371255,1.625162612468069
HSC-4,49793307,-1.7279713732228117,-2.561968540699896
SW1463,49793307,-1.9541064611693424,-3.3194343551538723
LXF 289,11964036,0.5627528071719251,1.2923275810056831
FU-OV-1,11228183,2.3859582400300683,2.5073450548004046
EFO-27,5311,0.9089041307391243,1.7559819334038607
SNU-449,44819697,-1.6819344520854818,-0.23505264855029392
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,0.7438302914691066
A-498,168313307,4.423397924448837,3.264556552246586
NCI-H522,19582717,4.722348713472889,3.7320051000669974
FU-OV-1,9903786,2.8592788804010936,3.137834486462325
DMS 273,444795,4.3404236236698495,4.087437996939653
A2780,56946209,-4.674045280410088,-4.074858177529482
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,2.823798547117294
A4/Fukuda,3503,1.0521499831923595,1.7691645414775703
SBC-5,6918837,-2.402107568310104,-2.9056060253849667
YAPC,23582824,3.2647123156294855,0.7634643723404936
HSC-4,159324,3.192829599869501,2.821933759148382
ONS-76,54619238,4.4304444652836805,4.7040160395634025
G-401,11228183,5.702662541402335,1.2228749985284113
JM-1,44819697,-3.7816867530650535,-1.5115673694877512
SBC-5,54143018,-0.8844414516239579,0.6532270001542925
A4/Fukuda,44589607,1.1710928843495056,2.2721234412900944
ONS-76,44543605,3.8219566402137457,4.13638342639933
YAPC,15983966,2.0827072702810847,-0.34566458017298396
SBC-5,2749,1.818007095297154,1.8292937147749186
FU-OV-1,44487872,4.488734888040304,3.7673696595056354
EFO-27,44197249,3.884486906001317,3.8747298000383488
NCI-H2171,10385095,0.5588950968794439,0.907229430266392
LXF 289,5351362,2.37199640031851,1.6760052613698604
OPM-2,54618305,3.930022905522119,2.6177605031806648
NCI-H146,327653,2.704686127708374,2.9339206463067757
OVISE,11497983,4.4381003844097595,3.61086799147014
NCI-H522,11977753,-0.2877362686640902,-1.0840681803480439
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,0.9313531189685054
NCI-H522,11707110,3.8955176091352857,-0.07568612124721075
HSC-4,3676137,3.997252050059137,4.5543201341814035
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,1.4627961521334805
A2780,9840324,5.381878860524984,5.630533962417924
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,2.130448559831667
FU-OV-1,6917907,-4.405886494893828,-4.577729875758624
CAL-51,71304818,3.0248956992793565,2.4661636423203
FU-OV-1,51039095,3.5191953123451096,2.894215728758123
SNU-449,5470400,0.6313893315276518,-0.00558036268928072
MDA-MB-157,6438330,1.1379279588809148,2.3844799609175023
NCI-H727,969516,3.103754409621015,2.926210292568499
LOU-NH91,439501,-1.197324809082114,-1.821480583691616
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,0.4647959419920839
FTC-133,148124,-3.926787463073679,-1.8698360631468969
NCI-H146,24901704,3.4954665576646216,2.9663489782718178
NCI-H146,6505803,-0.3489025917214021,-0.24274254957686567
BT-549,44819697,3.658602858416661,-0.5534014086844448
Panc 04.03,5278396,4.260606427966062,3.742977590277018
G-401,11647372,0.0479330615057392,0.517749720441751
EFO-27,71466445,6.412452895571818,4.333941844619033
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.2756350182795309
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,2.5697488797235417
NOMO-1,1716436,2.6410194121109773,2.4692941214395088
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,-1.7652307223096173
SNU-61,46199207,3.1956978461436014,3.021310276841871
LXF 289,4261,1.4002862892534345,1.747585255379247
DMS 273,46843906,2.9019571008738763,2.4854451507111985
SCC-9,25150857,2.532575506870741,2.697573433378503
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,0.9601038407033
NCI-H727,24785538,-1.326987163467981,1.3191837744193793
NCI-H661,11404337,-0.0954545894437525,-0.2788607430819058
MSTO-211H,66577038,3.302731292752764,3.04451091335177
OVISE,126941,-1.5326684035544371,-2.0800780003783528
BT-549,44566777,1.3521548270810906,0.5382855486763851
A2780,3025986,-2.2950808421603983,-1.126018123775323
NCI-H727,16736978,4.598640955798025,1.6261103879725765
JM-1,6610216,3.7780643735318615,4.026360417371302
MDA-MB-453,168312962,-1.3854623993271444,1.5660804344978276
LoVo,2749,2.494181165729376,2.0651307844704436
OVISE,15547703,4.212246909591729,3.12898164912131
ONS-76,16736978,2.0849164003870877,1.5663402377336686
MDA-MB-453,1714884,2.9618056579194585,3.012505979683318
DMS 273,327653,3.1988672985426847,2.961074997723044
YAPC,2828334,6.193046978626199,6.246946117678777
CAL-51,10184653,1.4453250777347395,1.0964681013517288
Panc 04.03,9936388,2.385451093408398,0.10429990574240598
NCI-H2009,4477,0.2115452666376647,0.8691042645886314
A2780,322968,2.566344426002007,3.261416995903803
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,2.3804170940896574
EFO-27,216345,4.384346641524126,4.2152384917216335
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.8133181475398803
LOU-NH91,9956119,4.571782850484356,3.912800098606601
NCI-H661,1641662,2.9325574972427813,3.36423186360555
CA46,44493528,3.81061502276679,3.643251313126569
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,0.5624151692433451
A2780,11647372,-1.4335547211387447,0.760933453281825
SCC-9,176870,2.779248818408345,3.4330244071966796
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,0.33119177452931853
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,0.7683980668167455
NCI-H2009,25183872,2.394233803753281,-0.7845022893654096
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,3.0911028635431848
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.7553502364022098
NCI-H727,11222830,1.7878002384813196,1.6618951839161697
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,-0.4797980025682743
SCC-9,9823820,5.247901285797655,4.176354104854679
FTC-133,44462760,4.267925011817446,3.0336671438412153
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,4.99573981094021
DMS 273,54618164,3.989243888703328,3.9233656943037523
A-673,5470400,-1.9410984929514092,-0.6131782987517922
A4/Fukuda,56973724,1.7857996527787343,1.9628236594873858
NOMO-1,5311281,1.2143454060885572,1.6745369069715272
CA46,135423438,1.6657304721140649,0.8136120556747346
HCC1143,5287620,-1.5012475814925117,-1.5914773643930582
EFO-27,107970,2.9901836608736883,2.4489405336494636
EFO-27,7251185,1.6138148752584345,2.714042923307862
LoVo,11214940,1.900565531770479,2.0313988438771533
NCI-H2009,6450551,1.0382100121131883,2.99449273559382
LoVo,3081361,0.9226789940369008,2.559224096657029
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,4.377414555091578
Panc 04.03,2113511,7.412620584739622,5.836365530339016
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.3846633376360402
A2780,42642645,-1.071178701221225,0.44046238157169476
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,1.6177567214256559
G-401,72376,-2.6056367900842745,-2.761697747587342
NCI-H460,54618771,1.6853262233131374,0.8549385781964031
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,3.45352964385658
NCI-H1623,60750,-5.650217340343659,-1.221329848411778
BT-549,49766530,-1.005486623843658,-0.8376120660531647
NCI-H292,10184653,1.6188231902933972,1.332697957753202
NCI-H727,5282054,3.939726324876112,3.873642932200433
Panc 04.03,11485656,3.4698409381110435,2.458930677865192
NCI-H522,24772860,-1.6489481573528793,-1.8660826535761372
NOMO-1,136227331,3.913043208951298,3.8115814978828975
FU-OV-1,984333,0.3323688812243723,0.7948873572375876
LoVo,9911463,2.8816718818913176,3.9160899549081183
NCI-H661,6917907,-5.078778116905793,-4.471103712273481
SNU-81,25102847,1.5499571993593506,2.076662167257233
CAL-51,159324,3.1794720270506307,2.7575778862841434
A-673,122327,3.9666709409894527,4.449561436632659
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,4.541417277715002
KMRC-1,2858523,3.233729541186922,3.0785515221566055
LOU-NH91,9823820,5.384931157369051,4.2890654275924
NCI-H2171,5287969,-2.1635291246577286,-1.7913382072636506
A-673,426756,2.5032328390514365,4.3084687370852865
HSC-4,24964624,2.5086826728272538,2.4007448890410656
NCI-H1623,176870,0.1873243677029567,3.2677793100579686
KMRC-1,7251185,3.109058235493882,2.542944442008388
NCI-H727,6610216,4.563405769903236,4.290855954690141
BxPC-3,15983966,-3.8778410742282694,-0.4695106455601286
G-401,46843906,1.9398273455018735,2.4763541903839825
NCI-H661,126941,-5.16742432120375,-2.7866119921017476
FU-OV-1,5746,2.910322472492285,1.473326371607662
CAL-51,11609586,1.5077859423552509,2.925061419424372
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,1.564370259013131
NCI-H1623,23582824,0.0165284592292431,0.9803081164933303
SNU-449,31703,3.0847938162993707,-0.3053255928266042
A2780,4788,4.492604658524488,5.459006871904027
Panc 04.03,25102847,3.783052108341051,2.6219402710004824
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,3.1978808058306476
NCI-H522,5113032,5.82110442960573,4.7311152084447095
KYSE-70,16038120,2.0286855638164054,0.7994266481089448
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,3.135361486746614
JM-1,2828334,5.9839290329767945,5.650284498148448
G-401,16736978,0.7492323653316314,1.0091826421146421
CAL-51,107970,2.299284460939792,2.1649944601089652
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,2.4677521042957817
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,2.913722784629996
NCI-H460,51039095,3.9314979002332535,2.8066255798206585
MDA-MB-157,9903786,1.458865596348786,2.8426621454970604
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,2.1642996607721496
Panc 04.03,54678924,3.3151598744761626,2.2142290610515203
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,-0.22612579191518659
ONS-76,25195348,3.7356955751438754,3.1954193267514466
MSTO-211H,71466578,5.31450298723974,4.822675557903634
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,0.9519657057325049
LOU-NH91,10385095,0.9698085069900604,1.5723501833494935
FTC-133,24856436,2.183528137346661,0.08483502460326876
A2780,54613361,-2.0737031658574043,-0.0424501060348558
CAL-51,5311,1.4183219405835503,1.283762480623017
NCI-H522,51037431,4.989409718658752,3.2622528473206263
Panc 04.03,11647372,2.0191280123179824,1.1817727278866343
NCI-H727,327653,3.8552398443183193,3.2047542714696964
OPM-2,9884685,-0.7869928949425254,-0.012618607086426224
BT-549,676352,1.8104954024890367,2.238449640963837
CAL-51,46907787,3.297361866649883,1.9832431711801635
EFO-27,11494412,4.723849828867172,2.1962682536623763
A2780,60700,-2.20534635529039,-1.2232785884438588
A-673,5281321,-1.2857978730590742,-1.9863153542788599
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,1.2020750068942574
NCI-H661,6610216,4.875851858170822,4.300491383315943
NCI-H460,6917907,-4.956095121428261,-4.446561512940196
A4/Fukuda,5460769,3.0365194168079572,2.2390442592323936
BxPC-3,3025944,3.477531707151509,4.281723100090703
CAL-51,16065773,2.8749329306977853,2.4669256489456326
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.786584731312034
EFO-27,2874250,5.869363689503336,4.691105923832282
A-673,702558,2.7000584853196936,4.789473928350143
HCC1143,107985,-3.4652614368177432,-3.1562214711421457
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.1242554488570975
NCI-H522,3025986,-1.0139106356663683,-0.5915484284153402
NCI-H2171,439501,-3.0635131055453924,-2.2685805951542624
NCI-H522,444795,5.191031194563041,4.301757647200669
NCI-H661,53392493,2.28152765608909,2.4320272855219978
Panc 04.03,445643,3.9306423242452673,4.032474006985694
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,3.027678451571148
NCI-H292,25150857,2.3048085705836563,2.7474001916721544
NCI-H727,25126798,3.836281743476004,4.041594993853675
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,5.014729296185515
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,-0.8635244645859796
ONS-76,9887053,4.335145594020597,3.9017251995279802
OPM-2,675434,4.053836549963459,4.05949374127497
KMRC-1,16725315,5.238650021868635,4.347513875509
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,2.044154566570051
A4/Fukuda,151289,0.1986917338936865,0.6271581039110952
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,0.7321120888121639
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,0.8905176423506389
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,2.30495052130317
MDA-MB-453,56963564,1.2952259038449256,0.34759683355266774
NCI-H522,65064,5.303150406450188,4.5832275361081996
NCI-H2171,24772860,-3.209318985857815,-1.7503248406151952
KMRC-1,104842,1.0931359128213904,-2.2526314179903726
NCI-H460,16741245,2.175171044948558,3.8714602747926237
OVISE,4259181,0.909929291036465,0.4641141080108103
HSC-4,46191454,1.405754738797376,1.6579357089849622
KYSE-70,2749,2.2442090130660577,2.031137182976735
SNU-81,400769,-1.1944669265215293,-0.7993839966422418
NCI-H2009,6852167,1.9075911063810396,3.2577392157838703
SBC-5,241158,4.402731015442316,3.7368960497041104
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,0.8321373335138412
HSC-4,44185566,3.0805483382503844,2.5979144231563374
FU-OV-1,17755052,0.0450390211671309,1.9742352969466137
KMRC-1,53495165,5.726132279462146,0.7504118217886615
NCI-H146,6184667,1.5836777358218528,2.711413684400161
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,1.9692025541620595
HCC1143,55283,3.9101720152241226,2.860365486314438
OPM-2,71466445,2.165442844786418,2.5381677527793407
A2780,49867926,3.0666746223408157,4.040041382646013
LOU-NH91,17755052,2.4120102833965844,2.3597390013320294
MDA-MB-453,49867926,4.180155964726801,3.767583956783489
Panc 04.03,25183872,0.1973991794911014,-0.5344440054780103
CAL-51,9967941,3.511576456928413,3.7671039172205805
SBC-5,6852167,3.965917526242172,2.7506599503466465
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,-0.9794266746923577
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,2.717733271434708
NCI-H522,54596558,4.342696772784201,4.418776949305537
HSC-4,2733526,3.5101027459294425,3.7861518381699018
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,5.384262309558844
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.7488261556191154
MDA-MB-453,4477,-0.2020943624975227,0.47720444194899775
NCI-H2171,72193861,0.5955631718249997,0.22335223358662276
NCI-H292,2828334,6.458495810735601,6.193115377864802
ONS-76,7326481,1.79748139254514,3.1098540552565477
A-673,44607531,1.457749077960986,1.3443421907640425
NOMO-1,73707438,4.2876330596581305,3.7290819630637033
NCI-H460,60750,-0.8382921927225392,-2.317909985129624
NCI-H522,4259181,-0.2456063667287351,0.0910019171159647
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.7403444574091251
ONS-76,969516,2.910086136195903,2.8497821559509897
YAPC,49850262,3.6789282041181095,3.79585732813591
SNU-449,44491742,3.9284370838515903,4.234439018594942
MDA-MB-453,11485656,1.765591398344026,2.2362444902004865
NCI-H460,44607530,3.4043015144880444,1.997089354266659
OPM-2,56949517,5.349058842742104,3.8128856879613124
SBC-5,216239,1.5582588949606833,2.079195912123513
NCI-H661,219104,3.9372744940630646,3.761664680176122
NCI-H460,44484440,3.757520830720006,2.604445393276429
MDA-MB-453,44462760,5.00879187339522,2.6913632018741067
ONS-76,5281321,-1.2480266745690851,-1.1505987939292894
LOU-NH91,5566,3.288881685822646,3.0766484548276662
MSTO-211H,72193861,1.6065459514404858,1.877886896278619
NCI-H1623,16038120,-0.158474112921266,0.8382632594041346
BxPC-3,11238147,1.751681691561693,2.9156066295391736
YAPC,3025944,4.720838189364642,4.3316850367332504
SNU-61,1239801,4.195034605110225,3.7976231693180993
NCI-H522,11640390,4.472705990017258,3.396950272544662
OPM-2,11238147,3.2386204402735874,2.174008648540591
YAPC,16722836,1.8948218470527252,1.5854494553262974
MSTO-211H,4261,1.9115438043118669,1.8282459055330427
BxPC-3,24901704,3.2492386456059266,3.2489278614169694
A2780,2742550,2.799223861459344,3.660429392990946
LoVo,6918736,-4.296362304597629,-1.3924859600666468
NCI-H292,3854666,3.3764205876154074,2.2873360852043194
G-401,11222830,1.5347756238466792,1.2630624594165698
CAL-51,44620216,5.469091994130916,3.3016312414040834
NCI-H146,6918328,-4.616864565737749,-0.6809036154424742
SNU-449,100016,6.350050439021361,6.369086811958548
CAL-51,6438330,3.884194225982375,2.252951110840969
A4/Fukuda,451668,-0.3897468918932548,-0.4768161216385909
NOMO-1,135875424,3.068632733482165,3.3568126550590067
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,1.6855115435267565
MDA-MB-453,9907093,5.353373126975176,4.214469962543898
SNU-81,11404337,-1.7380856142345846,-0.6161068926114818
BT-549,3634881,2.142843752657143,3.3456610013180947
SW1463,6918837,-3.406571913442127,-2.8618639138000246
HSC-4,6610216,4.241818899552939,4.300600814605762
G-401,135421197,1.4306754302223277,1.6372748749851609
MSTO-211H,400769,-2.118881346037636,-0.5876961365591548
OPM-2,56946209,-6.715247823396851,-4.638055994561487
OPM-2,156414,0.898749748032719,0.8891241366636825
SCC-9,2708,5.420316309291021,5.184770406024219
BxPC-3,72376,-2.7426383250741786,-1.481565872228923
LXF 289,44607530,1.309750089611443,1.8043793121240128
A4/Fukuda,216468,0.7779788317268376,1.6637703190550779
ONS-76,9936388,2.029236983033262,0.20644291416534213
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,0.5781606835023312
A4/Fukuda,15953870,2.701018205920996,2.9724104590529317
A4/Fukuda,3825829,2.918538307685252,3.546721882361153
NCI-H522,1716436,2.601362471636894,2.715679619043155
NCI-H460,16725315,5.407057101640495,4.303404073440773
NCI-H661,969516,2.7370069869182996,2.829304906654433
SNU-449,9915743,1.6643053553641087,1.3634894528571613
NCI-H522,16219061,2.1788816492377054,2.8458570657042452
NCI-H1623,25126798,4.062693377799547,3.834309083174993
LoVo,46199207,2.62459096292295,3.1441344120604366
Panc 04.03,2126,5.406308275886939,4.596310157534422
NCI-H522,702558,5.065903257418961,4.825690809989919
NCI-H661,44489675,4.0470438340050086,4.050146248502542
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,5.026423898097019
CAL-51,11175137,1.2330676481368064,2.588589259434792
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,-0.31093895990510206
A-498,119607,5.756544485429512,5.3536564976042
CAL-51,89183176,3.8950338695454088,4.133886346963479
FTC-133,2828334,5.859070513237425,6.22037818408584
KMRC-1,135440466,2.425894917183188,2.246326812399592
NCI-H2009,36314,-5.253596358515139,-0.8621945535278498
G-401,11238147,2.0802759078276853,2.2885364957000798
NCI-H661,452548,0.003417557634082,0.08904423763437547
NCI-H292,5282054,4.085287507740134,3.9500221216996976
HCC1143,10385095,1.0799280769088206,1.4793192826143968
A4/Fukuda,11626560,-1.03034976821798,0.8857994034360229
FTC-133,65064,5.375666939367713,4.877990749209108
BT-549,753704,4.958873098850826,4.979070250037177
KYSE-70,46224516,2.993089177283032,2.393133345403811
CA46,11707110,2.876405562319207,-0.749545174129753
LXF 289,11609586,2.9430338892136354,3.065244596361468
KYSE-70,10296883,3.691258417269261,3.8965068110577046
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,-1.9403314312705924
DMS 273,67156097,-2.1294955352549,-1.0221029996197943
NCI-H2171,11955716,-2.5749004703466976,-1.4371142761118143
LOU-NH91,124202324,3.0671378719618283,2.507807322304017
A2780,135659046,3.385733838662662,3.4000690158880404
OPM-2,11427553,0.184758700497643,1.3121522247449666
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,3.247876948836681
OVISE,11427553,3.886061021243629,2.8318588677199847
A2780,24821094,2.7975033336102095,2.8367691379804008
LoVo,10410894,2.092646303934145,3.1561873871229036
CA46,327653,2.398308016277815,2.328466172252711
NCI-H522,135440466,2.851321997265629,2.2770667026904383
NCI-H661,9903786,4.646166413465223,3.1077552329425737
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,-3.220738675966907
CA46,11427553,1.0834968953052575,0.9646372025959762
Panc 04.03,6450551,3.8538949310121353,3.0866037272479367
A2780,644241,1.9281614760038184,1.9136556689886008
A2780,3815108,2.053113262637462,2.7278330001589044
NOMO-1,71466380,3.4384411266907295,3.7550565232128643
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,2.2781167544935617
A4/Fukuda,24821094,2.016569070962388,2.7838675034295632
LoVo,3503,2.2987332704820016,2.369790533424885
LXF 289,46398810,1.8383298322371264,2.7360142384091644
NCI-H146,42642645,1.3339409860624971,0.5565274391007743
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,-1.381045587385728
HCC1143,135984461,4.873829103860087,3.9387103102537275
LoVo,23725625,5.102020281972671,5.116787301749776
NCI-H2171,4477,0.0540600744484099,0.5402895851331159
Panc 04.03,24964624,3.127575767188385,2.5476975247159226
CA46,676352,1.5563040092860552,1.8789786063635554
ONS-76,135440466,2.234484066901876,2.3077576181574866
EFO-27,31703,1.037291503873681,-0.5679577978660029
MDA-MB-157,208908,2.741119640746793,2.4141720367066317
G-401,46191454,0.141864729037356,1.3764734657429716
LoVo,439501,-1.7683171506776545,-2.1584659658720846
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,3.101592781476979
A-498,36314,4.095863504824457,0.20628312614319902
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,0.31259258581954563
NCI-H727,9935249,3.73205967923935,3.144666767437696
KYSE-70,53392493,3.454381994737171,2.7116622997529753
HCC1143,11234052,5.229903952882612,4.313479969164646
CAL-51,4705,2.903463840875761,3.038791854989401
MDA-MB-157,56946209,-3.6171244608990905,-3.3178967488677955
LoVo,3689413,-0.0015328635235731,0.14221782373306355
NCI-H460,46199207,3.5033257005335163,3.4346953195919956
BxPC-3,135411,0.8341107494370649,0.7003606788893655
NCI-H727,46191454,2.1799448668848105,1.6227234499706968
OPM-2,25195348,0.9238255530721258,2.0779469940947415
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,1.1619364936650916
SNU-61,656346,0.8749051442535513,0.8753831593007323
JM-1,136227924,1.2038413750130548,2.236544483375215
SNU-449,49867930,4.864159132996777,4.9061548086188305
A2780,2733526,2.8794725769531997,3.7282984705296083
OVISE,23725625,5.908959950408421,5.100676363464569
BxPC-3,60700,-0.122761385712052,-0.1250259485080134
OPM-2,53495165,-4.146839218250571,-1.1519342949281448
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,0.7337962158118286
A-673,25227462,-5.829932006274449,-0.8356216391709808
KMRC-1,6918328,0.9635513821249304,0.04889482814202532
JM-1,89183176,3.1890961462334335,2.879726108952031
MSTO-211H,16038120,0.2471942161915729,0.9111437013593197
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,2.7579968729202857
ONS-76,6918878,5.0214366982824306,2.685736810169954
CA46,60750,-0.9269398092944348,-4.206813676550691
HCC1143,42642645,1.0566197638440329,0.911098810368078
OPM-2,3503,1.0860674816661569,1.8588427404793746
BxPC-3,11612883,2.2063280154469993,2.8122190866724015
NCI-H522,16065773,1.5488087432962436,2.4432718288396646
A-673,3634881,3.109333818891092,3.045091250332129
NCI-H2171,71466445,1.378191899492029,2.937570720358756
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,1.1429938489269356
NCI-H292,17755052,1.3393568867062529,1.96621643090138
NCI-H522,11427553,1.733163384028149,2.2039335362941923
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,1.2667886789672615
BT-549,24797083,1.6394182791354686,1.5521886839903394
OVISE,6438330,2.2515103089504818,2.3251003728619297
LXF 289,10410894,3.939992216810496,3.3256308279371103
EFO-27,60750,5.390319994108079,-1.4958420342616927
BT-549,400769,-1.1296625579443007,-0.6807395502580532
SCC-9,2742550,4.1692460597635135,4.112635816793185
JM-1,5281321,-3.43257780081901,-2.345515855458579
OVISE,24771867,1.656692666128474,2.213019841692373
SBC-5,3384730,0.0954837515635063,2.977669789381435
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,1.8982017380347609
A4/Fukuda,2749,1.141581020051295,1.1529216773382618
G-401,1716436,2.4290804430946547,2.5470890122690246
NCI-H2009,23635314,-2.363129056883172,-1.7660303190226245
SNU-449,3081361,2.056588488576824,2.6966022203229034
NCI-H522,969516,2.4900188230240485,2.59168774091435
MDA-MB-157,11626560,3.460415978238755,1.7198206383114611
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,3.5616793661655026
HSC-4,11719255,4.924721636143113,3.394798614393236
KYSE-70,17755052,0.9465092626724514,1.958345787486873
G-401,25062766,0.8725390828623283,1.7870771703056016
KMRC-1,4477,0.198014478122684,0.6248003785205236
SNU-81,44197249,-2.185783961489413,3.3515784102437776
A-673,10410894,2.502904420433103,3.1226174143034213
ONS-76,6914657,-4.101072641720643,-3.3308515742942095
MDA-MB-157,53495165,-1.8622859982145463,0.6825228625458393
Panc 04.03,72734382,5.165438336919353,4.676451922383209
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,-0.4714227405723354
CA46,613000,1.1767209163070167,2.1434598869435106
EFO-27,3503,2.721888959468924,2.459890626126367
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,1.2248319448603597
MSTO-211H,6917907,-6.416473568686441,-4.817656984402369
CAL-51,675434,4.354107922133551,4.350265788718306
CA46,5278396,3.312720557512005,3.094603860652273
FU-OV-1,9911463,4.1305925074662575,3.9544016278816554
DMS 273,5328940,1.9629216769229116,1.6180590595152406
LXF 289,54454,1.7599180903835134,2.789278780054197
A2780,446155,3.1527811730433366,2.4671584954264487
CA46,11222830,0.90552754986452,1.1946124306071426
MDA-MB-157,15547703,2.7177027433879912,3.3889019832948923
A-673,9915743,0.6829950735134661,1.0839564307620344
Panc 04.03,50905018,4.96616490546014,4.524826589330905
NCI-H146,50905018,3.857703749758686,4.155391433457214
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,1.023767931750112
CA46,148198,-5.7845042531785,-4.5323986754861805
BxPC-3,11427553,2.964396595429347,2.7023348308424056
JM-1,17755052,1.8568486472237824,1.304322613967794
MDA-MB-453,135875424,2.7753375231350104,3.5455540399322376
LoVo,52947716,-5.666189039665748,0.13007421544558395
SNU-81,3543504,4.205084802754879,4.222882142330039
CAL-51,9887053,4.486783389261201,3.901179156573244
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,-1.5689198515728842
FTC-133,6852167,4.78859095347106,2.7020493239181214
SBC-5,46907787,3.799315463541784,1.9430791044116729
SNU-449,6918638,1.2557717528626495,0.6944627202854714
NCI-H2171,6438330,1.125878118169246,1.5193383930705595
ONS-76,15953870,3.841628876209717,3.629480426378955
KYSE-70,44493528,4.735176242945038,4.25138517691077
BT-549,71751553,4.2471267374516435,4.642629851363328
NCI-H2171,46943432,3.4065574915710735,1.7476841761288475
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,3.1894607721634975
A4/Fukuda,135875424,2.943838777845953,3.3740621500920143
SCC-9,25154868,5.2906536290113975,4.518329112981658
A4/Fukuda,11964036,-0.0142982917472374,0.5317965981436602
NCI-H292,10302451,3.577296661602114,3.4038592327065538
A2780,135999136,1.5930192405329104,3.4382832175652993
NCI-H292,54618164,4.184972812062346,4.250760159642968
LXF 289,107985,-2.691798131563437,-3.3979183596452622
NCI-H522,44137675,3.8599044567005434,3.301271906198715
CAL-51,3503,3.2899889427654245,2.157960932048516
A2780,409805,4.989244714218352,4.506734267397474
HSC-4,71466380,3.6804948915169784,4.459040857920418
JM-1,6918638,-1.945896791217812,-0.5807235308883364
SNU-449,44566777,0.6479277578392284,0.9202530426107952
MSTO-211H,387447,-3.4382078488280063,-4.147174132996187
DMS 273,9915743,1.912374780622189,1.2387525130671513
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.5429402194697064
NCI-H661,16736978,1.5408428303752983,1.5342394653029627
MSTO-211H,44241473,3.911097970359605,4.99690823447113
NCI-H460,60700,-0.2314807684970784,-0.6143401748192265
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.8734818028818472
JM-1,227681,1.6891640861629382,2.4213927045042243
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,-0.036131644505565615
NCI-H661,656346,0.6919490200967222,0.8465549506867496
SW1463,5311,0.7635678260369684,1.138602470980421
NCI-H460,387447,-2.436463262555682,-3.97153333189371
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,1.205045983653287
HSC-4,9825149,2.985341504866837,1.9868073268636357
NCI-H727,25262965,0.7692581364380534,-0.9039058740180343
A2780,10077130,2.5506457702723786,3.139476484612583
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,1.8430927596182596
NCI-H661,136227924,2.7818959309662183,3.0370827683610555
SCC-9,446155,1.3937663931747788,2.743738244035328
BT-549,73707398,1.468839183930599,1.4846115757830063
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,2.3515919739844366
CAL-51,6623618,2.223133904662847,2.3942708550664094
LOU-NH91,327653,3.620861790086289,3.1588776288441367
BT-549,67291369,4.3793706620025095,3.100793492913387
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,-3.6549686695562436
NCI-H460,3025986,0.3909368316008428,-0.7698091451842511
Panc 04.03,11228183,3.2874901590346934,2.698435314175149
LoVo,25262965,-3.8912736240644694,-1.3291547121610932
SBC-5,73707398,1.6541333685248465,1.241561576837926
NCI-H661,89183176,4.289155461605826,4.369454591150363
G-401,44241473,4.28251451131172,4.685573740031351
BT-549,2746,3.8188337512891137,3.421439820387576
YAPC,25062766,2.237282024435701,2.1306040901906855
LXF 289,20959075,-2.4089188058085,-2.9557459250468616
SCC-9,53232,2.1606412524830017,2.9797419993861674
G-401,56649450,1.8227428945555348,2.9599376076314594
MSTO-211H,11222830,1.162959487763126,1.5796546923109225
JM-1,15953870,2.1778700018066144,2.8080335186917074
LoVo,15953870,2.9352023189332703,3.470784948222269
DMS 273,15953870,3.8128904638275216,3.223604978202543
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,0.4210901136056728
CAL-51,1750826,-0.4147302595408071,-1.0842371775077937
NCI-H522,9884685,0.1045560296672991,0.6484897059975494
HSC-4,327653,3.5197711195347434,3.1342940262033996
BxPC-3,6918328,-0.2318480121478282,0.32641769020808376
NCI-H661,10074640,2.974634579766932,3.2107038360765228
FTC-133,11178236,-4.398882676695501,-3.4580793294349172
CAL-51,6450551,1.9748462748620472,2.676774169656605
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,-1.4794090664038975
SCC-9,5978,-3.875351555062552,-2.0524753993638907
LOU-NH91,5311,1.697115177859265,1.6955033803999902
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,3.737256883493974
A4/Fukuda,49766530,-0.1813275565198268,-0.941432857196506
CA46,5978,-7.34958411963843,-3.7063534748165914
JM-1,15547703,2.5122126082355227,2.656853463681171
HSC-4,3038522,3.958216901800584,3.00682948884919
MDA-MB-453,24901704,3.2296574944609735,2.822963658718403
SCC-9,23635314,-1.650613607792241,-1.2953628868732567
KMRC-1,11612883,3.608500084904783,2.8219400202758407
OVISE,24772860,-1.0102375693918164,-1.2601823699644543
A2780,11626560,0.43489025720173,1.4356463111634372
MDA-MB-453,51037431,1.3361098813185686,3.16100310193365
HSC-4,4705,3.95336427523857,3.015168685255452
A4/Fukuda,24748573,1.3032837048402657,1.341009370797046
OPM-2,51039095,-2.6866952618976434,1.6373522468128505
KMRC-1,11609586,2.4412406506497155,2.8718293942669773
ONS-76,11609586,3.485979398565755,3.03301325906339
LoVo,12003241,-2.8621949377385465,-0.8467015299441151
DMS 273,241158,3.177272786345067,3.404127941374909
KYSE-70,20959075,-2.927604227069557,-2.955516221426609
SNU-61,16722836,1.3959733890222568,1.5554229909077726
SBC-5,89928392,2.3719311856170537,1.396262784208105
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.694916638558235
A-498,4261,1.667462132250413,2.4757701685396745
SNU-449,23725625,6.429990861305722,5.055889639631149
A2780,4259181,-1.27299012623329,0.08936730899503634
ONS-76,10127622,-2.1347139098699706,3.851111269355081
A2780,1641662,2.3828094640764412,3.2453541445428042
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,1.8452382310853452
Panc 04.03,9549297,5.2530677537073975,2.5000274235628215
MDA-MB-453,53481919,3.1180191774885735,3.719857613109438
JM-1,56963564,0.0249959117693502,-0.45609061860688604
HSC-4,11234052,4.4583786214563865,4.340181997766139
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,-0.6525592696491535
BxPC-3,119607,5.22613990212802,5.471305241860671
BxPC-3,5278396,2.866816315326302,3.4413131553942424
LOU-NH91,400769,-0.4518117512524929,-0.4392894141307952
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,-1.8980449788554885
FU-OV-1,16722836,-0.0099462763207794,1.7703292670677857
SNU-449,46907787,4.480861537403045,2.312990371506759
NCI-H292,24748573,1.9235457900331792,2.2203374826244375
NCI-H460,2113511,6.407699041859446,5.719852236304224
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,3.2979864621851744
NCI-H1623,46174525,4.205988468269685,4.427881640814341
NCI-H1623,6917907,-5.728045829659389,-4.368407260603777
MDA-MB-453,1641662,3.085427143962118,3.4627261023574443
NOMO-1,3854666,1.0231806307237967,0.921280993357376
SNU-449,24821094,1.9429996101140543,3.095432003742099
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,1.8659648729643672
Panc 04.03,216345,4.594435961426402,4.225814720311217
DMS 273,2708,4.711982190259564,4.151917391200779
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,1.342384993315069
A-673,11222830,1.3107049031534492,1.228140010765394
SCC-9,219104,4.323236898621614,4.146568024478425
KYSE-70,11455910,0.6771697782379181,0.6243787415799593
MSTO-211H,9915743,-1.0722844498490078,1.5600287502217502
HCC1143,3062316,0.306898118520016,1.1911713516182187
NCI-H460,11427553,3.3912724357702873,2.8029936633589245
NCI-H1623,675434,4.403585448845777,4.603306252913175
NCI-H1623,135928012,3.849713333151309,4.179963563181825
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.5006384638736794
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,2.011224453581136
KMRC-1,11222830,1.6210071273597368,1.7048661862867949
NCI-H661,44607530,1.6067743901515843,1.8042369398213074
HSC-4,24753719,5.996217074466553,4.324526273272406
NCI-H1623,44607530,0.6082825778474802,1.898521139739335
G-401,409805,3.720272745750916,4.44480960489666
MSTO-211H,24771867,-1.256499005348058,2.4309925986962586
LOU-NH91,100016,8.416108067142021,6.5724926026690325
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,-0.8796996843923199
MDA-MB-453,9911830,2.483477791354312,2.4233265263448143
MSTO-211H,216345,2.6222222224733702,4.013900619324229
A-673,5738263,2.33182798743241,3.0529946173268545
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,1.064515446434062
CAL-51,16038120,-0.248771562775031,0.7922144436763561
SNU-449,11222830,1.6348775900621026,1.5629645319324188
SBC-5,11656518,1.8588197700646856,1.7586644945124714
LoVo,637858,1.5179613366947162,2.0038098576154066
OPM-2,16065773,1.0643824527623371,2.081208568057134
LoVo,17759555,2.3197484044750905,3.4726555846764326
LoVo,23635314,-2.3980395881052723,-1.8460409728118503
OVISE,241158,2.9923875981017134,4.128834886096894
LXF 289,6918736,-2.4177135652368476,-0.7627244757702489
NCI-H727,24180125,3.0565666249941015,3.115547306524535
HCC1143,72193861,2.4539335535877607,1.554868067265695
LXF 289,17755052,1.3903450452706496,2.208482214615039
SNU-449,24797083,1.6612369643963127,1.440248552294855
A-673,9903786,1.5948741514342302,2.4395565997138524
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,-3.1178779200572233
SCC-9,3552672,2.2159119862051355,2.9185583586764166
G-401,9903786,2.8038927126182327,2.545865135707198
CAL-51,36314,1.3238047725901672,-0.6551402186146486
A2780,4917,2.608891014350475,3.105055058092292
BT-549,446155,2.043062772915461,2.7753718900710695
LOU-NH91,2828334,6.123728588021327,6.295932966701815
SCC-9,89928392,1.8759175792930969,1.7017373651637901
LXF 289,54613361,1.2100808209747431,0.3100184165583492
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,-0.4634744833949023
YAPC,4788,5.944205132488497,5.7108424380148515
NCI-H661,11485656,2.0326011859644075,2.2210741667446654
A4/Fukuda,56649450,0.8497740308893211,2.9030457194598456
JM-1,151289,0.6364544108799082,0.39326467702442647
SNU-449,1566236,1.8764566240908545,2.465029947968364
NCI-H522,11234052,4.642717967560772,3.883949646547382
MDA-MB-453,262093,2.6969191096415113,2.65788956062748
SNU-449,36314,1.881882754123643,-0.8453830388841486
FTC-133,3552672,1.929463221662531,2.7633575888936956
DMS 273,44202524,0.9824733163321672,2.0450310991882796
CAL-51,2708,4.939881356462198,4.738919758315712
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,-1.248454016963571
LOU-NH91,44507138,2.849532358816909,2.3931187634220565
A4/Fukuda,24856436,-2.105951383298443,-0.44133196102238414
EFO-27,9967941,3.205966960393555,3.867976868328965
NCI-H460,24964624,3.5490884182562565,2.40343075926338
A2780,71304818,1.3100858151797232,2.1847161942061444
LoVo,16065773,3.0239362353443195,2.4264365975624838
MDA-MB-157,19582717,3.2682056974125744,4.254910446688609
G-401,44607531,1.4405644617048554,1.2010280672065718
DMS 273,426756,5.171527401006451,4.306559023581391
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,2.01150763936739
A-673,3465537,3.0102553460613626,2.370574761102532
KYSE-70,135398744,6.338938630156892,6.362419284088437
NCI-H727,439501,-2.2848783314382133,-1.4873343564668389
EFO-27,1750826,-2.462449966677767,-1.3731777292806633
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,1.7611867045349925
NCI-H2171,15547703,3.4091207334536717,2.8624302329344378
BxPC-3,24753719,4.274594841538204,4.324313827155526
A2780,49846579,2.326369228321655,1.3779121709045663
KMRC-1,135398516,2.513650186922018,2.205700433697331
LXF 289,12001922,1.5738020993239468,1.852860595387746
OVISE,107985,-3.603598955800668,-3.2701221548611126
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.7405043297840073
MSTO-211H,51039095,-0.728954813106199,2.74944906291991
MDA-MB-453,24856436,0.153871218683687,0.04057868947652527
OVISE,12003241,-0.8183931153803442,-1.0184257436687647
JM-1,219104,1.4868441806857289,2.347585581847711
KMRC-1,24901704,3.4724240700357414,3.361359643738488
CAL-51,25105715,4.077363851334658,3.423408452549924
Panc 04.03,5284616,3.514498334257777,2.254250291436012
NCI-H2009,446155,3.3217785993510884,2.831875382444736
NCI-H1623,66577038,3.365380490578284,2.7556093347877764
NCI-H460,72193861,2.1658883750752844,1.5488037997232822
NCI-H522,17755052,3.243909986839396,1.886614281016859
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,4.634386604549113
LoVo,9936388,-7.372990206557469,-2.5410451414548656
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,1.2960752599192877
A2780,46907787,0.387414270491788,1.325275439278687
A-673,25150857,0.7583223763798244,2.135960641677417
KYSE-70,11175137,2.267736133904179,2.757636966341007
KYSE-70,6852167,2.2981101713941814,2.8504444073854915
SNU-61,3081361,2.723820700669796,2.198004322804815
NCI-H661,6252,2.9131036022991728,0.7622659982103721
NCI-H1623,9903786,3.0418604220511436,2.928859577368613
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.49385973308140385
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,0.9908951293454318
SNU-449,10322450,2.7236273289045942,4.050070279821372
LXF 289,4096211,2.4023988219433337,2.216802472930403
SNU-81,10026128,-0.7780702377310673,3.6633009284448117
KYSE-70,6610216,4.087252338732691,4.1163146922493095
MDA-MB-453,44607530,0.880863900568506,1.7409336595766722
NCI-H522,24978538,3.1859390482195216,0.0877545233736121
SBC-5,107970,3.247043743319875,2.293733967975318
DMS 273,969516,2.584462316279732,2.603073645858066
MDA-MB-453,5284616,0.7898078062241378,1.1278751351324936
A2780,16720766,0.7344228111589829,0.10164269148307509
OPM-2,25154868,3.783948059993976,3.9249280481480144
DMS 273,44493528,4.2569430545307725,4.236028819338422
MDA-MB-157,25022340,3.479219964634342,3.0988668059123268
LOU-NH91,15547703,3.808438680736899,3.2962613555899427
CA46,426756,4.77193452473935,3.7253761645168906
DMS 273,2858523,3.0502279484440233,2.8808779201141625
EFO-27,3676137,4.310046032716647,4.654120850280509
MDA-MB-157,3025986,-1.856662168016076,-0.614238279307436
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,-0.15055358974525707
LOU-NH91,44607531,1.3180545967249335,1.5040409191211208
G-401,46215462,1.5390133747858452,1.5868698972365838
OPM-2,7251185,0.5721351512480617,1.6991667492839386
CAL-51,15953870,3.220977372988981,3.658508408404919
YAPC,11964036,3.221056153642411,1.5629178615326658
BxPC-3,208908,2.4547812946400502,2.1401759075564133
MDA-MB-157,44589607,1.2787513073565453,2.8111437326352786
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,0.05561811441037072
NCI-H727,72193861,2.684204612264405,1.7254760126391242
MDA-MB-453,5287969,-1.436813958809434,-1.5577915403474543
NCI-H727,15983966,2.109759483394555,-1.2428157781592237
KMRC-1,216468,4.973373200756221,2.984461216294906
SNU-449,52912189,4.380826008996873,2.191941223785953
SCC-9,46174525,4.3512864598075645,4.563977599353214
A2780,3011155,5.55303778809739,3.406149881102176
SBC-5,135999136,5.333154079184271,4.000689083166609
YAPC,322968,3.8135092450764656,3.9731735542103825
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,1.350564843275475
NCI-H146,5328940,1.6811042727449883,1.6552362058753463
CAL-51,168313200,3.900876548563449,3.0493849078018944
DMS 273,1750826,-1.913269562568005,-1.963040201879706
A2780,54618305,3.781380565087532,3.7816405878522836
NOMO-1,9936388,-6.523282887173488,-4.06630134130402
NCI-H460,5282054,4.802373462225767,3.915825867641367
SBC-5,82146,3.3774942308101785,3.7523422523024186
NCI-H727,56946209,-2.7175198163763232,-3.8971006141254287
FTC-133,3062316,3.806169585149848,0.9619931793580351
A2780,9967941,1.4564169862408056,3.3635571272293094
DMS 273,5351362,1.0025978169272032,1.270915408631787
SCC-9,16038120,1.877705535955449,1.1650031084264325
NCI-H522,6917907,-6.015261010654924,-4.3413707110218835
CA46,4477,-0.2706834990523855,0.39829066065004864
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,3.2066725071848667
SNU-449,11178236,-2.056078636199096,-3.4232345759289022
SBC-5,5278396,3.3013936373431996,3.613164915678537
NCI-H1623,44493528,4.638812765070766,4.3846208800077315
NOMO-1,16720766,-1.891739380903732,-0.3606157814015976
G-401,2729026,2.5705443446476828,2.539234596349079
G-401,6917907,-5.905222634362146,-5.042472859016206
MDA-MB-453,2858523,2.664825786894245,2.9250947887667422
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.6315257149840274
LoVo,11427553,2.604805449600099,2.8299425548799326
G-401,11234052,3.7167035951130423,3.670275302923093
FU-OV-1,168312962,3.576057642182836,1.808081136958295
JM-1,11228183,-0.9199972643114134,-0.11889903798039793
ONS-76,65628,4.406189432641036,4.3673196093256115
Panc 04.03,11964036,1.4501208375942458,1.5046165195463528
YAPC,17759555,4.434513834785858,3.770019059062238
Panc 04.03,5311,1.931700632460216,1.6057976740029045
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,4.43344543351719
NOMO-1,49793307,-3.1091933140229,-3.953577550302511
MDA-MB-453,46174525,3.691895458218128,4.171582057741579
G-401,11977753,-3.640604480016117,-1.8949941597089899
A-673,16722836,0.9037523157925,1.4390044760208207
MDA-MB-453,5494449,3.8003034085581993,2.2477872510111623
NCI-H522,25150857,1.47132219158847,2.081208143695127
OPM-2,5311037,3.4844810711382936,3.1926501841811468
LXF 289,11152667,-0.4789950074309144,-0.3721602453968369
CAL-51,9911830,2.6702149728757343,2.428037364199702
KMRC-1,4378219,2.060133570967863,2.988827774351663
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.3607509709461822
CAL-51,156414,1.13799157004995,1.5790408906129902
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.5465558794338257
NCI-H727,89928392,1.7873251449620886,1.7322595056923307
KYSE-70,6918837,-2.6267197721971582,-2.580025326169753
JM-1,135928012,4.176764785732949,3.1014984561428594
NCI-H522,10427712,4.202859541756615,4.094578227623935
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,0.8693208987915382
CA46,5470400,3.727677755196873,-0.31997766394299426
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,-0.7464663869658961
EFO-27,9936388,3.039710224097925,-0.607785846054159
NCI-H292,54618771,0.019803014891406,1.0286693881333064
KYSE-70,25262965,-2.1035778811550836,-1.2866782052599726
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,3.35799724940815
MDA-MB-453,11656518,1.9818038641727111,1.5181323578337043
YAPC,5282054,4.005772938817316,3.7074127031406685
SNU-449,24180719,3.8016565421464072,3.7017252010633075
FU-OV-1,15983966,2.2280291717608947,-0.7964471014863979
SBC-5,11485656,2.2866280503579812,2.277643847692775
ONS-76,702558,5.821489397293988,5.2701525749887494
SCC-9,9911463,4.4493328300482995,3.970853489060391
HSC-4,72193861,2.788231918333871,1.5324698783473314
DMS 273,2126,4.20633218634453,4.596649208265933
OVISE,46199207,4.361349086507746,3.321035330378415
Panc 04.03,241158,4.444137488799797,4.2782651994502405
NCI-H460,654092,0.4612941847378306,-0.21045081657087883
A4/Fukuda,45279963,1.9027034071047564,3.000113406696112
NCI-H292,44259,1.4427392496176257,1.1027900556538928
FU-OV-1,17759555,4.190415677120393,3.7651557386803645
SNU-81,3634881,2.620060882721275,3.0838273320260243
NCI-H2009,107970,2.2954238398166344,2.365935794564363
LoVo,5278396,2.046108484267772,3.5786362828735627
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,0.2329046812038497
HCC1143,12003241,-0.0421467164139253,-0.7989879656942612
Panc 04.03,46926350,-3.8788763459733473,-3.987535301756777
A4/Fukuda,4578,3.815086457915261,4.092450745566556
CAL-51,9929138,6.421072450841616,5.6119446613368185
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,-0.48630924588903013
SNU-81,4259181,-0.3131255720640173,-0.20642917228453306
KYSE-70,675434,4.695192974207532,4.281463921295867
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,2.2805824822165914
A-673,135659046,3.595490040408381,3.4992711009389597
NCI-H522,4578,4.727447650100284,4.2574421787133385
DMS 273,54765302,4.301325739041371,3.900865968191921
A4/Fukuda,135440466,-0.9873079875011114,1.5054171554961868
LXF 289,24821094,2.4128137194258215,2.9648957339817668
NCI-H460,5746,0.0249012606464236,1.0398796324379411
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.4534458952328961
A-498,25062766,2.0793230877467166,2.218742937329217
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,2.7880878317183515
Panc 04.03,10127622,4.886231353649791,4.139263484273483
G-401,57330099,4.350194890812272,4.07704592467084
NCI-H1623,168312962,4.13769742192025,2.224649644112859
SBC-5,5566,3.1825236444892124,2.9939744363890846
Panc 04.03,9825149,3.055289787116955,2.3439337691436593
BT-549,11507802,2.533090965918468,1.5238022378229001
OPM-2,5951923,4.162321290800766,4.311733334391443
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,4.553852315965581
NOMO-1,9935249,2.770043096032674,2.1075872310305233
LOU-NH91,11640390,4.567382593568383,3.7899065609436833
MDA-MB-453,135440466,2.739035638886915,2.1665606759710196
HSC-4,644241,2.6183127396598262,2.454237339277342
MSTO-211H,17755052,-0.0733710656781619,2.2105537829020108
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,2.104310905986294
BxPC-3,5281321,-1.5422365883768068,-1.0352178047424012
MSTO-211H,9444,4.1850544738080915,4.128149350541695
LoVo,17755052,-0.1303127354802701,1.689603728067102
KMRC-1,44137675,2.117874577310701,3.2932578817926657
A4/Fukuda,9911463,2.417745886609146,3.447581338260855
MSTO-211H,3101542,4.302130070317232,3.6389020970666373
NCI-H146,426756,4.36191990335561,4.1341912001175425
Panc 04.03,44589607,3.8783822611027454,3.1219032602342462
G-401,24901704,2.2796887972749307,2.7084329525944315
MSTO-211H,285033,-3.2380358495287695,-1.9139709951546982
BxPC-3,452548,1.628130986083035,0.2680800633035836
SCC-9,9926054,1.898935947612019,2.0857131968988427
MSTO-211H,1750826,-4.930051018535606,-1.2602524825312598
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,0.2583935234970817
HSC-4,216345,4.5807127841732775,4.019066895307932
LOU-NH91,168312962,3.892175490150028,2.5813553406532237
MSTO-211H,53232,-0.5437095856797647,2.703799265805062
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,0.4138429652752464
EFO-27,5335621,6.264647611417884,4.660847158690027
CAL-51,1716436,3.275997904874087,3.0250883022713397
NCI-H460,53232,3.485336782178725,2.879361460881407
MDA-MB-157,54454,1.950382699789776,2.653259831786696
NCI-H292,44489367,4.492014578968512,4.48351981650963
KMRC-1,4521392,4.136909747869898,4.394773967148922
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,3.759942661359269
HSC-4,56649450,2.6853332826773144,3.2040372850892
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.4407265172170183
BT-549,9926054,1.9687680834705423,2.1307475724477856
SCC-9,9911830,2.3699428367857145,2.657462695256233
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.123124110549053
FU-OV-1,409805,4.026686349090877,5.237503482517524
BxPC-3,387447,-4.571753731996322,-4.094176806559038
CA46,44486219,3.6158388001945463,3.7176076970890195
EFO-27,135659046,3.7618075322397297,3.695489975265953
NCI-H661,104842,-3.978937701952532,-3.092697826291647
SBC-5,16741245,1.694771238369721,3.884848522978946
FU-OV-1,676352,2.7826635655764473,2.2198912987475725
CA46,969516,2.1845952347247306,2.0700959997019215
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,2.051368871307169
HCC1143,9825149,3.0211594258387486,2.0379778165541316
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,-0.12190205875049952
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.2691971961194677
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,2.7615247666862155
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,1.857161144385742
MDA-MB-453,676352,1.703646310562033,1.938305597367439
CAL-51,46191454,0.2698308836515951,1.7195007715916373
Panc 04.03,9823820,5.907522872650916,4.348540531561202
SNU-81,44259,0.6272555485824429,0.8090418324136741
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,2.5886455272409417
EFO-27,445455,4.405247459654703,4.668005409661557
BT-549,11152667,-0.4620191787747055,-0.518273359162305
HSC-4,23725625,4.12890848458229,5.304649947333059
BxPC-3,11640390,3.353927872983648,3.5710635242011346
HCC1143,216468,1.9778651637296407,3.3808740260349803
Panc 04.03,49766530,1.2448845141630578,0.056735684676847475
SCC-9,10427712,3.976850957625781,4.317060924353786
HCC1143,36462,4.303888689757339,2.3545175824064812
NCI-H460,262093,3.3627537421549314,3.021907142823777
SNU-61,56963564,0.6866306287041547,0.10605446086134407
SNU-449,2858523,3.0307383113048676,3.1471603167533275
KMRC-1,11214940,1.677559369833433,1.867590757531295
A2780,216239,1.3949646663017006,1.9108026907586797
MDA-MB-157,89183176,3.472749903375588,4.09260255611556
NCI-H146,11152667,-0.8780602169524299,-0.16611755258387137
NCI-H460,9956119,4.485375019847723,3.511248303287181
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.339395005751454
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,4.358873604396129
DMS 273,6450551,2.589238729256945,2.0326813509344155
NCI-H2171,5311281,0.8399284053106422,2.1594628445636843
SNU-81,23635314,-3.737654632526069,-1.8270013768344688
FTC-133,119182,-0.5312905210850081,-0.4857669852274011
A2780,656346,0.4231070640442763,0.6650651545862509
HSC-4,441298,2.8371907900438535,2.7389097468161263
MDA-MB-157,285033,-2.194765851649468,-1.5698769439734384
JM-1,73707398,-0.8556338999048841,0.3151149032322956
JM-1,6852167,1.3157742507093588,1.6869509352063061
A2780,11364421,-5.7057574677584295,-3.699921168036355
NCI-H522,54596490,4.410611853984333,4.594498035276609
NOMO-1,159324,1.6027654254866297,0.2928271084329057
A-673,107985,-4.827881226135439,-3.7691884419407007
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.9149065282869266
NCI-H661,5287620,-2.104840782561513,-1.7768755941080716
LOU-NH91,119182,4.180997641513534,-0.4954471705882533
SBC-5,10113978,4.162999994539472,3.0410545345687803
A-673,252682,5.861850244558702,6.399724242148665
NCI-H2171,5281321,-4.274427204887198,-1.7283720114149212
EFO-27,3854666,3.6632128701571194,2.420637185664867
A-498,25154868,5.700321852894753,4.603869103439285
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.2189634876722035
CAL-51,31703,-2.726607914110417,-1.0165853657026258
KMRC-1,9840324,5.892638074147807,5.835431745981114
BxPC-3,49850262,4.227475038244019,3.7215031845816626
JM-1,6450551,1.340572992486765,1.2633967419374523
KMRC-1,148124,2.1112012667960656,-0.8866866619468625
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,-0.9443741657676891
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,0.03613195606272623
NCI-H522,7326481,4.603358487226629,2.699449117302673
KMRC-1,3025944,4.220614757043024,4.241094130745443
EFO-27,9935249,3.352272124535396,3.4728288864607566
SNU-449,10296883,3.939630786750968,3.883457689456275
A-673,42611257,3.360985567795572,2.902084683569236
MDA-MB-453,156422,3.699160121301749,3.8111662054822317
A4/Fukuda,89928392,-0.3543848103605003,0.5588253120654102
SNU-449,10385095,1.0986031812390589,1.5437067322141313
HCC1143,6438330,1.6030228226948184,2.217422966837054
MDA-MB-453,3854666,1.8999840682298523,1.7915334357620794
SCC-9,46191454,1.8170261878735936,1.838238291335112
OPM-2,9825149,0.9763440152106764,1.5175572007870983
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,3.344781129441643
BxPC-3,25150857,2.298115585090939,2.4636052963951105
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,2.2922725550466967
NCI-H2171,25227462,0.3993487036849301,-1.17522773585223
JM-1,24748573,1.2692721555493711,1.7120272182244327
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,2.1497834055085265
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,-2.312719501819098
KYSE-70,5281321,-0.9979352327108848,-1.1854016654303092
NCI-H460,11507802,2.848054270429628,1.728193817468246
SCC-9,4259181,1.940043087837339,0.3953954823214992
ONS-76,135421197,2.4329108516652775,2.0850332547423225
CAL-51,52947716,-4.729660133739893,-0.9132080019516655
JM-1,123631,2.636256127990424,1.729791152092628
HCC1143,1641662,3.4150871228937563,3.581569896215082
NCI-H292,8515,4.694095877434875,4.153212638824565
SNU-449,71304818,1.9790204353457292,2.5426029315760403
A2780,5566,2.7251077604344696,2.916671839875402
EFO-27,82146,5.16738023752069,3.9720673107735984
NCI-H727,107985,-2.9799734550318204,-3.3840584124991073
CAL-51,446155,1.9002286289262065,2.570072964995485
SNU-61,4378219,2.193359587578685,2.632959462057029
NCI-H522,1641662,3.4912081270508293,3.246690928269337
FTC-133,44607530,3.0000417574370157,1.896288209217431
A-673,448949,0.8158812974066569,1.6923090127157667
LOU-NH91,20959075,-3.4746906487579494,-2.7641581102403068
SNU-449,5113032,5.017862259712187,4.781811213336136
NCI-H522,6450551,3.1458433056927295,1.892906872658744
SNU-449,16659841,4.200866251374559,4.150092112048226
NCI-H460,409805,5.4278006548731295,4.936793141607106
MSTO-211H,46943432,4.749068259324704,2.302473637504019
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,0.7459437830176214
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,1.0718464114884854
SCC-9,11455910,1.869884665357408,1.3050693636072475
Panc 04.03,613753,3.3040029053289772,3.3126259308114028
OPM-2,6918736,-1.006954953557461,-2.1797138292818805
A2780,3854666,-0.0414990172822217,1.4735339673283467
FTC-133,25183872,2.254027462535002,-0.5938217864533065
MDA-MB-157,387447,-4.079240132125457,-4.022244969697857
SNU-449,54618771,0.9697829427454708,1.1270476837427887
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.4738492456758172
MDA-MB-157,72376,-2.1484578807410553,-1.6044545627892308
SBC-5,5287620,-1.4097460130546278,-1.8548685137772236
FU-OV-1,54649381,4.3760479468817675,4.13027872336513
NCI-H2009,26596,-1.5885219134108934,-1.183832905976419
A-673,66577038,2.223533674143975,2.8822302188217037
SBC-5,6918878,2.928817535111611,2.520061100246011
OPM-2,11640390,0.8264429779628358,2.6360061764218834
NCI-H460,3503,2.4668231300278154,2.331171229245756
SBC-5,156422,4.2102641448485345,3.8090534795479067
ONS-76,216345,3.2166812322741043,3.8905084489803374
BT-549,15983966,-4.218963036377602,-0.7613616590887949
A4/Fukuda,3038522,1.5780319148667876,2.5950121233401866
BT-549,23582824,0.5256314804740283,1.0662617281602937
NCI-H146,2871966,-2.058689249756004,0.04421333790077573
OVISE,17755052,3.2346427318945263,2.2107725588756852
OVISE,44819697,-1.8576377458936848,-0.1947937829570775
SNU-449,46398810,3.267032406348896,2.710196149435518
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,3.1593461889486583
A2780,11228183,2.2113347222865123,1.231365974044128
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,1.805469997465515
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,-0.5137394070140336
SNU-81,46398810,0.3023493978041217,2.105574671500422
KYSE-70,11152667,0.5949086715112851,-0.4166681657590413
LoVo,73707386,4.416344333605744,3.1013662751755082
NCI-H522,5746,0.3558137383480795,0.20393136743865697
NCI-H460,135421197,3.2510260026522233,1.919990859222552
MDA-MB-453,11507802,1.551744908234443,1.606920057643185
A-673,4096211,1.8222389073608836,1.5012932296713866
NCI-H727,136227924,3.2179651731130585,2.906709912368978
NCI-H460,16065773,2.454458456288103,2.4782761607197794
SNU-61,24901704,3.3171528895384115,3.0693852716907006
NCI-H292,11612883,2.84187428422206,3.09866008599004
NCI-H2171,9907093,4.086146580877247,3.8649642511458957
NCI-H522,3634881,3.092168984490579,3.0527506829803563
G-401,9915743,0.7240748800691799,1.0535338344180631
SNU-61,46843906,2.645147040347038,2.8919865420157036
SNU-81,73707386,1.6277005390789234,2.8362843358791405
NCI-H1623,4261,0.4244365105903193,1.8733880830409466
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,2.528363976853951
OVISE,1750826,-3.1689535405206715,-0.9757547727840816
OVISE,25183872,-0.2641805795712313,-0.5757423010816344
MDA-MB-157,753704,5.007751734334353,4.971935259114209
CAL-51,54618771,0.0049145289548569,0.9994597724591153
NCI-H661,25195348,2.4001868352132445,3.2994745638524114
KMRC-1,3689413,-1.8207429228817171,-0.5179680034337281
HSC-4,650361,3.951915492066197,3.759566873721447
KYSE-70,10427712,2.9549225300897977,4.239948875612364
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,1.0173382050555555
OPM-2,11717001,3.8340096164502135,3.981145011625687
NCI-H727,11214940,2.165075102098245,2.352752699143511
KMRC-1,11404337,1.3121470144090095,-0.3833478771046922
MDA-MB-453,24951314,-0.4314694021522904,1.1142957922831682
SCC-9,135398516,3.38372398158662,2.2199354273101335
KMRC-1,11977753,-0.1874629547163491,-1.758228546247251
NCI-H2009,25062766,1.439977805675878,2.2855953365243002
NCI-H2171,6918638,-1.5146784294865197,-0.18699999386002733
Panc 04.03,3081361,3.5741960453568464,2.6833951924493067
BxPC-3,73707398,1.0061551215696194,1.2139360623803233
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,-1.2337457173709863
BT-549,11404337,-0.1293922368150601,-0.3260835587205066
SCC-9,5281321,1.285660121438517,-1.1842614663046052
SNU-81,104842,-4.044454085478647,-2.6364141542673445
CAL-51,6610216,4.7761200098267365,4.275514593589967
JM-1,9933475,1.5625695981291614,1.2693181962201758
NCI-H727,11485656,2.2939690780404423,2.124550486522514
A2780,426756,4.623757394028108,4.297506323703799
A2780,5311,0.5155233924036543,0.8717392382210428
NCI-H146,11707110,3.3128142773805176,-0.2650492563155528
MDA-MB-157,11977753,-1.6055696025393866,-1.8204168820729416
A4/Fukuda,11494412,-1.359408079628026,0.8410440974146145
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.1410252860902168
LoVo,11977753,-2.85765012298846,-1.4482210566166185
FU-OV-1,56963564,3.5833852081145836,0.9280709649815679
NOMO-1,375860,-0.5184264862355304,-0.49002209104272787
EFO-27,3136844,4.472321824110979,4.455053951034568
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,3.959594654787026
NCI-H292,168312962,3.5892294654935726,2.7583917324607508
CAL-51,44607530,2.3415901962162855,1.7661982642138188
EFO-27,2949965,3.1309950522818277,2.9045545179794305
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,3.337685818588244
A4/Fukuda,12001922,1.2276815023009988,1.4293912034311873
CAL-51,24951314,1.3730048574034712,1.3859975592381084
A4/Fukuda,135928012,2.23734461349398,3.5291408135835156
SNU-81,10127622,-3.2164123245129095,3.2039164216137035
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,1.7892189460064944
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,0.28334867005983316
OPM-2,122327,3.690232587907526,4.293240015709092
NCI-H522,5329102,1.9502496806074603,1.7951212295928767
NCI-H2171,9903786,1.7901794952315444,2.5679931723373834
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,-1.1976555934070465
YAPC,676352,2.46422610000008,2.1450835341959666
NCI-H292,44507138,1.692325111571909,2.796216050263697
SNU-449,2945648,2.540265867455936,3.041170872200332
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,-1.258417749164239
A-673,3136844,3.9161258830055736,3.9792833635772626
OPM-2,151289,0.8971834485048114,0.49610318781388996
LoVo,219104,3.1119995266948237,3.7636497530381012
NCI-H1623,9936388,-4.968103162812744,-1.2497737998287533
DMS 273,11485656,2.8704893197930272,2.0638656845825674
LoVo,73707398,0.5951327141059009,1.2507222519106842
NCI-H2009,135421197,1.5480281661357902,2.0015991383923017
NCI-H1623,409805,3.8984511674912943,4.797065097646192
CAL-51,1750826,-0.4147302595408071,-1.0842371775077937
MDA-MB-453,54143018,-0.7571444922765344,0.7387663426657909
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,-0.44942446953088366
HSC-4,54619267,4.093335991980471,4.1720775560495715
BxPC-3,4378219,2.0321108717651426,2.543903440913221
NCI-H292,5978,-1.7096488796134024,-2.084483218537531
A2780,71466380,3.7792629508428783,4.215983754971369
MSTO-211H,44589607,1.2735087838172758,2.7761899766796057
NOMO-1,54143018,-1.1216489579847602,-0.608762985977612
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,-0.5689487757092934
A-673,46174525,2.7075701285598375,3.8852272639341563
NCI-H661,3854666,2.0669995151297633,1.8477249097198019
NCI-H1623,322968,2.7878661836218863,3.706513282382352
Panc 04.03,52947716,3.0713971775620448,0.1098063885905634
DMS 273,9840324,6.645778367521572,5.769709757019291
NCI-H460,15547703,4.965379127843483,3.2488030651631585
FTC-133,11228183,0.2445093238012437,2.510138766276727
NCI-H522,9935249,3.002706281912375,3.0418675860331668
NOMO-1,6610216,4.0700997553747325,3.853686484613695
A4/Fukuda,46199207,1.9027513858957976,2.867328446415544
EFO-27,16659841,4.389988364450653,4.058796668187227
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,2.542339563086679
CA46,11977753,-4.21997551918338,-2.6303055649079123
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,1.5076308354263661
SBC-5,54613361,-1.7173374464522142,0.12926301249037075
MDA-MB-157,16065773,0.9216763205067852,2.5273380279007127
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,3.65082170244842
SNU-81,44137675,1.234825635215107,3.3916360095496607
OVISE,9929138,5.66720682434708,5.353355551598177
Panc 04.03,16725315,5.278537246983346,4.421566815891955
A4/Fukuda,6438330,0.8804707138455458,1.4627634198685522
NCI-H292,984333,1.6058463338689488,1.1347412878575873
NOMO-1,11396600,3.3888037624860674,2.678136468047541
SNU-81,24964624,0.6434241987426411,2.3605651988860137
BT-549,11964036,1.9997330886235436,1.6276280013784028
A-673,135411,0.3370419809316401,0.5387664777576127
NCI-H1623,10296883,4.489600285768525,3.824493184784066
NCI-H292,2733526,4.552154891253422,3.8244045114831873
YAPC,6914657,-3.2827547721856423,-3.741358400559634
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.7566367084671506
NCI-H2009,327653,3.1880644035572825,3.3042062608729696
CAL-51,3384730,2.4775948365465905,2.8254567032393454
FTC-133,3689413,-0.3036251064519336,-0.4086421774948139
MDA-MB-453,11964036,0.3676608059270313,1.2904289329091505
NCI-H2009,5281321,-2.3281539094269843,-1.33393103988437
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,2.271700734969305
LoVo,654092,0.3814222362545946,0.14475092671140813
MDA-MB-453,50905018,4.488581944485688,4.284953944567451
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,3.069976746692824
OPM-2,46215462,1.142494911690201,1.3872205611617232
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,2.0753216160497523
A4/Fukuda,5329102,0.822909221294871,1.5992488933738696
A4/Fukuda,11228183,1.827405863351363,1.0686686791709235
Panc 04.03,5460769,2.0457621674825224,2.7071778273544824
MDA-MB-157,9933475,1.5029335433067268,1.8994324700380638
A-673,12003241,-2.2168793422392103,-1.3423819516926778
NCI-H460,54618164,4.49670945938676,4.176265526937294
NCI-H292,11656518,2.099021496243428,2.242452526855871
SCC-9,51039095,3.242385267473305,2.936393487800114
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,4.284909518831448
SBC-5,3634881,3.763213110876527,3.35491413890352
SCC-9,984333,1.3591962563360305,1.0504249165062591
CAL-51,72193861,0.6423702350358801,1.4711900574016281
SNU-449,6610216,3.892858260461962,4.384245654330165
HCC1143,6918837,-2.8885170378203995,-2.205247280227796
DMS 273,10427712,3.7833762157010655,4.062047818707422
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,0.5412230246124424
LoVo,8515,2.0502092932288543,3.9260546698972507
ONS-76,5311281,3.0534152046102507,2.623214493084694
EFO-27,100016,6.711163327148508,6.394363870429674
A-498,6610216,4.284288503720797,4.391871900610139
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,-2.9223360107282623
G-401,71466578,3.958692091033976,3.9508584098160533
A2780,2749,1.2168739363641357,1.4372146707153797
LXF 289,23635314,-2.0420734326640253,-1.3199889370780895
LXF 289,24901704,2.332916050939017,3.4182550370804075
LoVo,9887053,2.8676927346989265,3.9381319186884354
OPM-2,6918837,-6.102124609605729,-4.402790289314537
NOMO-1,72734382,3.160209893803666,3.922261260675582
A2780,44507138,1.3155442648841038,2.0581194997428707
NCI-H661,9915743,-0.8538809858854721,1.3550206612874636
SW1463,168313047,-3.1836020137929246,2.293985620082333
SNU-81,55283,4.080745185244615,2.5033870284462925
YAPC,159324,3.323857793241652,2.884075331052976
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,4.172035840064288
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,2.572391753285633
A-673,31703,-3.778183583095139,-1.9289226515441598
OPM-2,439501,-4.648238189793765,-2.5317206538993813
A2780,452548,-4.864509732913544,-0.5645965475568575
CA46,71304818,1.9606514180280712,1.9638647516036445
LoVo,25150857,3.1045912764862056,2.29077712970139
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,2.5276249528868133
OVISE,446155,3.256033609420766,2.8732020449581364
SBC-5,54626689,4.608121703383126,4.590677915193024
DMS 273,11497983,-3.3171386440582467,2.7519107742414666
BT-549,46398810,3.037551805065761,2.699236846770304
KYSE-70,44819697,2.67312291481412,0.15613417391065693
DMS 273,10113978,3.3411401717417135,2.8748330274381533
YAPC,11178236,-2.1853000629740342,-3.4334408412584474
EFO-27,89928392,2.3405290602814586,1.8393798715512555
NCI-H727,3062316,3.1124899612632135,1.6789379620457867
MSTO-211H,9825149,1.7087798179810727,2.5557159757033183
OPM-2,25062766,1.526966504091227,1.557502729462048
LoVo,24797083,1.0858534416002044,1.2343776926688939
MDA-MB-157,11612883,1.9249665557248452,2.7929630143044735
MDA-MB-453,24978538,2.762094535978925,0.272869397172042
A-673,55283,2.8138583621562288,2.2038614677378563
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,3.662273685528044
OPM-2,11228183,2.227238978219669,0.6561011267505031
SNU-449,11640390,3.8548607423510384,3.5267382106365823
NCI-H522,5281321,-1.0736628447197911,-1.6338780029809672
NCI-H460,25126798,4.092385726400508,3.8341945499819015
JM-1,9887053,1.8224498727300744,2.4493142585217313
MDA-MB-453,3689413,0.605092083526794,-0.16198745471831072
BT-549,322968,4.038930181616003,4.120951029110492
G-401,969516,2.4612878169829067,2.649773253180686
FU-OV-1,10127622,2.361983631252389,4.3488528160921955
G-401,5738263,2.503403034491448,2.9585306303803467
MDA-MB-453,5328940,1.6011356292327752,1.689529271957232
HSC-4,25105715,3.6888708464756337,3.5212232442413693
G-401,5291,3.6897209629580616,3.352022485541927
SNU-81,148198,-1.0516438667772403,-3.3928596540294507
FU-OV-1,25183872,1.8271723160300688,-0.4302338396965352
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,2.0809349547276215
JM-1,9935249,0.9666917954448688,2.0222993481158973
JM-1,44607531,1.0390724505323097,1.3051341592869234
BT-549,5566,3.2694223641451887,3.1270622392164054
LXF 289,637858,2.285720521187594,2.036785147071627
SNU-81,56946209,-4.781557694686043,-3.6401643652751754
FU-OV-1,89928392,1.4286122200262183,1.602140111663826
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,-1.152692676944448
CAL-51,54618359,4.544084907505638,2.3980567939550674
LoVo,15983966,-3.091518031584947,-1.5154325151048982
CA46,5746,0.6077367646083516,-0.8170281496720496
CAL-51,2733487,8.211583338705053,5.899962001425714
NCI-H522,4705,3.8595388748644375,3.0031284105862865
A4/Fukuda,5284329,2.3119801528783244,2.9894968176621903
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,0.1825760373284297
OPM-2,6505803,-0.5489645461029444,-0.6945849021584745
NCI-H146,11955716,-2.61946993472624,-1.4718897094849615
Panc 04.03,19582717,5.125237161512837,4.447838888338497
LXF 289,9926054,2.043368643335034,2.1537467586398504
BT-549,136227924,3.266068806496957,2.9713500889423194
LOU-NH91,24901704,2.9181520482303585,3.535361117726497
A2780,11167602,1.1290528312474395,2.405740359172773
HCC1143,15983966,0.2074313732487278,-1.151546140822984
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.6000684617514784
JM-1,2871966,-2.1290689366468354,-0.5962975032307052
FU-OV-1,6852167,2.292876265150526,2.8457267558642347
MSTO-211H,31703,-2.679199045886266,-1.09308708159497
BxPC-3,5335621,4.830409945539455,4.566443051058477
SNU-81,6438330,3.0600940001891863,2.054466769519188
CAL-51,6918878,3.0110486558166274,2.5704462504340793
LXF 289,6610355,4.558728947318035,4.721724557212488
KYSE-70,12001922,1.7900886800743383,1.8480605003539634
BxPC-3,60168763,4.708123265391542,2.2506174348034076
CAL-51,44137675,3.485867182081199,3.2826184097885447
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,3.437426441531245
NCI-H460,216345,3.827300936034388,4.012494471998494
NCI-H522,15953870,3.615553645162116,3.3797014112806583
A-673,46199207,3.2534509529249176,3.0561427362945834
SCC-9,10127622,7.404435857651999,3.737640784025908
Panc 04.03,11977753,1.829262770264154,-1.5410907419424982
HCC1143,168313047,3.0210205197435935,2.225293147222455
EFO-27,3465537,3.52414234339403,2.7401912531440655
A-498,462382,4.566729065673536,0.9571451404968601
FTC-133,45279963,4.126382655862848,3.5413953889700633
G-401,71751553,4.092007605377758,4.169325562743336
MDA-MB-453,119607,3.891659451485504,4.992872401446678
MDA-MB-453,3384730,-0.7236289420344145,2.8519257163777105
SNU-61,6184667,2.8549853776409937,3.0404422079572866
NOMO-1,23635314,-2.3321691272104697,-2.734980950140442
SNU-81,54618164,-0.3986435357924686,4.035206456322635
NCI-H727,65064,3.1010913931031867,4.590550349284447
CAL-51,44607531,1.640429423812436,1.4147454226352836
CAL-51,72376,-2.938334648898351,-2.2275411574952564
NCI-H522,126941,-2.655181013676553,-3.11812226238078
ONS-76,3025944,4.431691617199171,4.358321168963623
NCI-H460,25154868,3.4600493825904564,4.427993920078481
FTC-133,71304818,3.18789827914798,2.5216993793865954
CAL-51,151289,0.6583498849401344,0.9222221183989285
LXF 289,11238147,3.4273419568352006,3.0088466118493047
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,4.242850818609113
KYSE-70,702558,6.39879445367054,5.026188429488154
CAL-51,124202324,2.033990287468598,2.4246092619449446
MSTO-211H,46907787,2.574686905184434,2.365975815915546
MSTO-211H,4521392,4.029667841571139,4.463189138418127
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,0.732675443846195
A2780,9549297,1.1491610880845489,2.1913832189297664
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,-0.31618051523421214
NCI-H2009,2729026,1.97459320968498,2.737375043084587
HSC-4,5311,1.8002123285320597,1.3949782336548506
YAPC,135398738,5.4751822545753415,4.131729626129299
Panc 04.03,285033,-1.1400173305697017,-1.8819301389977745
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,1.2266944119204795
A4/Fukuda,71466578,0.6387062903604859,3.001850275635223
CAL-51,135398738,4.757337519270393,4.340080474666886
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,3.386696987414814
A-498,24785538,3.3641680302296564,2.2658009898453084
HSC-4,452548,-1.2537746146037845,0.3144462370976157
NOMO-1,6918837,-4.687337521865761,-4.422986759254538
A2780,6505803,-1.803583295606165,-1.0582936625199022
YAPC,387447,-2.999100837413036,-4.067574454228431
NCI-H292,25183872,-0.4983801682636667,-0.512198633299883
NCI-H1623,44137675,2.921297693984664,3.5735982512493054
LoVo,46843906,2.381362357237743,2.9859938611820853
MDA-MB-157,5281321,-2.46264909171439,-1.2227975438375431
NCI-H292,44137675,3.1459685562862707,3.9123795661505394
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,1.4056142685662467
JM-1,5470400,3.917661049847631,-0.6781277321192499
NCI-H522,52912189,0.1662181985496506,1.5278301100539813
MDA-MB-157,15983966,-4.787780953616188,-1.350659336384056
CAL-51,10322450,3.881825194853649,3.8650217297966116
CAL-51,6918837,-3.0563476396929703,-2.7818790073396036
NCI-H661,54639126,4.507619035006863,4.055578243151643
NCI-H661,5311281,4.526772174839299,2.1357527849185454
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.0396402610124578
LXF 289,3025986,-0.453776319374568,-0.6885634376577099
Panc 04.03,25262965,-1.014076783670677,-1.2013321304647042
MDA-MB-453,5746,3.800897853250581,0.8824266108752724
SBC-5,15953870,3.487984127844562,3.375159797826496
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,2.3185671135010164
OVISE,3025986,-0.0395702470459638,-0.4792227370580312
FTC-133,5311,2.4215013743463647,1.5535348735373595
NCI-H2171,11485656,1.3701169509015756,1.9414172896216109
A4/Fukuda,5282054,2.418862118344995,3.0496401728234144
NCI-H1623,25102847,3.8675819706398418,2.518387588676066
OPM-2,984333,-0.0237710386013994,0.19590860280643896
FTC-133,387447,-3.6414317999651336,-3.701505000843595
BT-549,5311281,2.333978253730499,2.3384549913579127
OVISE,16720766,3.986904391501256,0.6230375898597988
NOMO-1,11612883,1.4996443311921075,2.0144417059079127
NCI-H146,5282054,2.6062567229872924,3.268978618364959
SBC-5,6917907,0.6114763356012877,-3.7208391405427097
NCI-H727,24951314,2.050368453430269,1.3809780985453575
MDA-MB-157,613753,2.6621381248494456,3.0036565276610436
JM-1,44486219,4.06629583721778,3.8417158011062758
CA46,285033,-4.358161131916293,-3.792136194511219
A-673,9952709,2.6406542482442545,2.858573261781925
BxPC-3,124202324,2.2278087185314694,2.3480845137856075
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.49385973308140385
A-673,6852167,1.8255345198368305,2.1183622637746287
NCI-H146,6610355,3.561762383324193,4.26067880175388
NOMO-1,46215462,1.6253213091786816,1.2241922650591988
CA46,439501,-3.521132637790176,-2.7883771835611815
KMRC-1,5329102,1.6227643750477536,1.9330055582283034
MDA-MB-453,568763,0.1355288059345826,0.37287845056244023
NCI-H2009,15953870,4.632669867834425,3.5937581683493405
G-401,16725315,3.2068580834321048,3.8545932801528857
SNU-81,25154868,4.054299809836995,4.330243420015601
SNU-61,2742550,3.576212598776706,3.5791847634631946
BxPC-3,44589607,1.722183316619471,2.9138796047399746
SNU-61,3025986,-0.1307165413786875,-0.8762878819891298
NCI-H1623,3062316,1.6941172744123574,1.3891513558733877
ONS-76,16115403,-5.005393778847352,-3.5177055883762374
LXF 289,12003241,-2.348837864712453,-0.4934939191306465
DMS 273,168313016,5.378851860414917,4.617754089874176
CA46,54765302,3.694944477545822,3.21041016177959
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,0.6611098657466592
A2780,10113978,1.7525717433500034,2.832778808977136
OVISE,9911463,4.4041109725525525,3.957995952154113
ONS-76,44589607,2.6985455021272573,2.8876484007302894
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,4.028181521933874
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.3465667681561515
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.0665603436946758
A2780,26596,-4.32263985415392,-1.5755312985949985
SNU-449,53481919,3.639889931386733,4.128864962505934
A-673,135875424,2.9734448822107886,3.623917783216951
A-673,49867926,4.049605811998934,4.092390353431923
MSTO-211H,16720766,-0.9979081980160748,0.4234296781868735
MDA-MB-157,24785538,1.324170410962965,1.6986422900025258
CAL-51,107970,2.299284460939792,2.1649944601089652
OVISE,11178236,-4.082767785475175,-3.1916755410956266
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,2.084345951769981
A4/Fukuda,25154868,2.544294393199085,4.055445502512456
CAL-51,46191454,0.2698308836515951,1.7195007715916373
NOMO-1,136227924,2.5449106490851263,2.3980112438924137
KMRC-1,24821094,3.705597482955712,2.7269365866383315
A2780,5282054,2.567919090275208,3.129924296425004
NCI-H2009,11404337,-0.0657811746758558,-0.10346853111511597
HSC-4,409805,5.399675964474335,4.8312239821826175
LoVo,24772860,-3.380615847351667,-1.8594127725065699
MDA-MB-453,54626689,4.438407624810902,4.478737936576485
G-401,104842,-3.837747012299513,-3.457703435905418
BT-549,135440466,3.2033555971359267,2.5187888172112523
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,-3.1893027874105284
NCI-H460,5280436,4.847067650781305,3.4862323230071577
NCI-H727,10385095,1.3903964913374658,1.3687153883865069
NCI-H727,262093,2.950291125725139,2.800916080666101
CA46,25227462,-5.088225796968986,-2.63237284617691
HCC1143,439501,-0.7374061663212956,-2.18817818579974
MSTO-211H,10113978,1.403014421240365,3.3509285941005347
SNU-449,72734382,5.7131640484247805,4.834650204447411
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,-0.5112743017679298
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,3.8643834240237966
BxPC-3,24772860,-3.1359973170310993,-1.8995728372202576
LoVo,5281321,-2.272723057934536,-1.3762644489057565
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,1.9779134357755037
MDA-MB-453,10427712,3.2513664008238874,3.9852494821168443
Panc 04.03,53495165,2.8699642151767746,0.847788256869523
FU-OV-1,54619267,4.302850520300199,3.998090223045487
MSTO-211H,24964624,0.1425074184859401,2.712521922145519
G-401,135875424,3.147536590476696,3.403091865932859
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,3.6175163815135214
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,2.6961763483913677
MDA-MB-157,9967941,1.858403940770751,3.7953186416581555
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,0.6669912778588103
NCI-H292,11497983,4.544493181272098,4.194058489916959
HSC-4,3011155,4.427149856421904,4.033771800425527
NCI-H1623,17755052,0.7357373094762232,1.8044466040025795
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,1.427890680090145
BxPC-3,5746,0.9856415477525818,0.879309858519341
OPM-2,24901704,1.9220236520558196,2.1426101954455303
MSTO-211H,2858523,3.0747353868294627,3.0714860292331267
BT-549,107970,2.9169966931039113,2.385546484064299
NCI-H292,135875424,4.14052752249008,4.083955171999394
LOU-NH91,107970,2.5070848864255093,2.23256876409423
MDA-MB-453,6918328,-2.060631340343386,-0.23000615958056134
KMRC-1,44566777,-0.0538941449270197,0.6521432089279764
HCC1143,17755052,1.15684078766818,1.9277036995946517
Panc 04.03,9956119,4.202347043107845,3.771180852385622
G-401,54613361,-0.5160099475891917,0.03972946640413607
NCI-H460,6918837,-0.9355989207233988,-2.331417697668112
SCC-9,10302451,2.205114392498864,3.2871487455341497
BT-549,24856436,0.2415814283223239,0.6943531740862725
Panc 04.03,25150857,3.139734816867742,2.591489389423507
A-498,9866186,-1.262750837313692,1.3240743340316008
SW1463,11497983,4.077621288565615,3.1524600686973043
LoVo,124202324,1.6089295836770297,2.30392181128123
JM-1,46215462,1.389060279673689,1.281355972564501
A-673,2729026,1.806074207860909,2.501600731495345
MSTO-211H,241158,2.290519528489604,4.03493855439756
A4/Fukuda,6917907,-6.123586781218294,-5.358524321907288
NCI-H460,11485656,2.6212830818798065,2.3818942504146587
A2780,135875424,2.703796648613349,3.5805730000805243
NCI-H292,10127622,7.746640801358069,4.163018663926614
DMS 273,9887053,1.8082863610482875,3.3212049573423097
EFO-27,426756,4.432789586131128,4.567485628372475
MDA-MB-453,2749,0.298775024907787,1.5435365727991632
NCI-H460,11222830,2.8861636193629323,1.6146162651679203
NCI-H460,119182,0.2489341964189734,-0.6981141563537198
MSTO-211H,676352,2.2606828184976955,2.0377845283174247
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.5260340822895355
SNU-81,16736978,0.587276282018702,1.1574999731345086
BxPC-3,10113978,2.7603674185652536,3.6747814789176902
SCC-9,6505803,-0.8932206272709824,-0.51038382741839
HSC-4,122327,4.034102983304833,4.7534132883963744
MDA-MB-157,107985,-3.8805729202788304,-3.1446096304709035
HCC1143,5566,3.096162587379626,3.194802656017001
BT-549,5738263,2.4683192628765753,3.509032390673172
A-498,3854666,2.914304878080617,2.6621327181428183
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,-0.5244085994113675
ONS-76,73707398,1.7098056225756528,1.32484812041409
A2780,10322450,2.9165978660974545,3.789142347188148
CA46,3062316,1.4079672687586804,-0.1546299420305565
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,2.524466203546988
BT-549,71466380,5.5332032048485065,4.635404678443534
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.203149078360403
KYSE-70,24180719,3.52071426185984,3.4860072145998204
BT-549,10385095,1.777553004720717,1.3448929558286946
JM-1,4259181,-0.0762731042787348,-0.61119058290756
BxPC-3,12003241,-1.7282705692868598,-1.0423360162087194
LXF 289,9840324,4.681234496405457,5.809915079750009
KYSE-70,17759555,3.816264723168541,3.480578838696525
NCI-H292,9911830,2.887423578139022,2.797723077916184
HSC-4,9840324,5.223554072523372,5.825610268346896
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,3.014379207969637
A2780,9915743,1.3754925129164983,0.9434415243714374
NCI-H2009,10302451,1.2105403110698565,3.261597614694523
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,1.3852149930102553
ONS-76,9935249,3.5330143946083874,3.053540611349068
BT-549,11427553,2.4752578658091524,2.771572863200127
G-401,148198,-4.717755806624399,-4.492103715224386
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.55028171481252
NCI-H460,5351362,3.0809857123464037,1.5265914241881149
BxPC-3,5978,-3.126756112961715,-1.9328485709645742
OPM-2,11396600,1.8817984525619431,2.879702147060714
A-673,5328940,0.9058407904985936,1.3559441912424968
LoVo,16720766,-0.1141862087465287,0.4188037842074126
LoVo,11404337,-0.8407014552816361,-0.27111384431852076
JM-1,11455910,-0.0097968256607179,0.10707418615481153
A2780,54686904,3.0280150906907206,3.3480921977762694
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,2.9469222622417233
SNU-449,9956119,3.198924280342594,3.7214240845357165
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,-2.2910013935656037
SNU-81,60700,-1.0304958014583914,-0.30304083939384785
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,1.9706768546476645
Panc 04.03,216468,3.559067681626077,3.4294392413340704
OVISE,46398810,3.0089868889673426,2.4365990379270595
MDA-MB-453,11494412,1.83607541398336,1.7649209241331625
NOMO-1,409805,3.6617718212828874,4.001514231270667
BT-549,25062766,0.9643791751629904,2.180219400050726
FTC-133,446155,0.3759987857405991,2.6192359437963955
KMRC-1,23635314,0.7760380281113136,-1.0165165123912565
SW1463,15953870,3.283482316204368,3.4689121650208663
LoVo,46943432,3.050109964187685,2.321083364839111
HSC-4,46907787,5.727789952108257,2.0357124592916613
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,1.2515985719390066
FTC-133,135440466,5.15132472260749,2.3150297728197393
SW1463,568763,0.7789022422759734,0.21015701660249023
JM-1,25150857,0.7748927856999902,1.838332004225224
A4/Fukuda,71304818,1.5363144884487692,2.013114416181762
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,-0.5789310619457789
NCI-H661,24785538,4.2805678056942,1.657365818350454
FTC-133,5282054,4.434007222498336,3.7937446315011045
A2780,613000,1.210736664046428,2.4392098639032924
SNU-449,6852167,2.6501635563943977,2.986578576413697
NCI-H1623,5280436,2.3425513929901043,3.111411147604028
SNU-61,11625818,5.738401007397874,4.286697146515137
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,2.9434656314366867
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,3.8183646753837803
G-401,11396600,3.403558125152034,3.243363431189053
LoVo,11396600,2.965288622606591,3.608594713064309
YAPC,5311,2.641039705119952,1.5821308733169106
HSC-4,168313047,3.0036663016787015,2.501068044812405
LXF 289,135440466,1.0541158239349229,2.129184415653631
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.8598001709966345
SW1463,16720766,2.9834843450585193,0.5092185399818715
Panc 04.03,2708,5.3340089352485816,5.083949425686404
MSTO-211H,11612883,1.8196539401694043,3.031901301861506
G-401,219104,1.9483296496250493,3.1127839564735167
OVISE,3854666,4.260793298508907,2.103410537236981
JM-1,327653,2.4402793258430786,2.550167391273059
SNU-449,984333,0.3609894515007521,0.9258290524336944
NCI-H146,40482356,6.02837292181762,3.010720708203104
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,2.046788004109276
HSC-4,9952709,2.643320259436509,3.1243373742343525
CA46,71680916,4.255070441315874,3.8621904045291036
MSTO-211H,119182,-3.3068023354733156,-1.2401224060502134
HSC-4,4788,5.270141450772874,5.7671879019645464
MDA-MB-453,11612883,2.003650622053601,2.5725488228198277
A-498,2729026,3.0720683032694827,2.7277244909070752
CAL-51,135659046,3.6035863494873137,3.7238976328540496
A-673,16736978,0.9204710311128564,1.0526833609965747
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.2190550250632024
G-401,5335621,4.041162639386401,4.395200817907761
NCI-H292,11647372,0.0082735983152987,1.237607172143171
NCI-H661,46191454,1.844409109204796,1.6066636314761158
NCI-H460,439501,-2.362377537788676,-2.0784926671765334
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.9566979595756226
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,0.25981963767467325
A4/Fukuda,5328940,-0.5379688872377596,1.203498766617389
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,4.356456911800901
LOU-NH91,25126798,3.943021506059378,3.972557611432773
CAL-51,56963564,0.4281851677964957,0.5454413741590582
Panc 04.03,24785538,2.964340727211602,2.0691745024379666
SNU-449,56963564,1.9660320048352,0.7595572456209381
SBC-5,156414,2.5142262290401516,1.090508734510084
FU-OV-1,46398810,1.7086224401878771,2.7597336198141447
MDA-MB-157,426756,4.156862898324412,4.443621877581613
G-401,4521392,4.161493335374481,4.265480104245045
OVISE,36462,4.611657944155446,2.2665844863301543
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,2.281592492413044
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,-1.3229555357114604
CAL-51,5351362,1.1872361858703535,1.3407051315654481
CAL-51,119182,-1.323881847361974,-0.7035449596779477
NCI-H522,24753719,5.009376195679754,4.111674468106434
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,3.5883442017309393
HCC1143,9915743,0.7364353129897024,0.8403565453610912
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,2.0809349547276215
NCI-H522,24889392,3.251100273050004,3.5772558365126135
LoVo,11178236,-1.6059359070935737,-3.104596981935292
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,3.741433643386857
CA46,23725625,5.582899861703026,3.2355445878895353
NCI-H460,25154868,3.4600493825904564,4.427993920078481
CAL-51,36462,0.7338920585832341,1.961540844283584
EFO-27,5281321,-1.9543223460886947,-1.3740006772097775
LXF 289,11612883,1.9814919247106189,3.1260572468646286
HCC1143,2828334,6.454192166435682,6.2805862980039615
A4/Fukuda,3854666,-0.0838776105349313,1.317307370293339
CA46,10322450,2.6264913036213606,3.2560159747971995
NCI-H2009,51039095,1.8360035457780568,2.764447764711203
BxPC-3,10231331,0.6961573218104748,1.5748196188581032
LOU-NH91,56649450,2.5557041031897705,3.775780245278654
G-401,216239,1.6826916037000108,1.5793652431009806
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.4853623347585705
HCC1143,5281321,0.7613054606946723,-0.8971739186791513
EFO-27,72376,-1.8608022629783372,-1.3774946528530427
NCI-H2171,19582717,3.772812394316534,3.5050785750414675
MDA-MB-453,10074640,2.421510718072182,2.939056659276417
G-401,11317348,2.32763680059041,1.6698309045902446
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,3.864751265497409
NCI-H146,2729026,1.2131739481587438,2.463906167150134
OPM-2,46907787,-3.368300500627006,-0.2350402233985226
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.971080566519515
KYSE-70,15547703,3.259406085484829,3.1534516841241316
NCI-H522,107985,-4.282222583037789,-3.4855079706407457
A4/Fukuda,9933475,1.717973727652582,1.5790869986785643
CAL-51,6505803,-1.1525670311484852,-0.6993899414930472
HCC1143,5329102,2.41968992927328,2.163372557970989
MDA-MB-453,46215462,2.7539180673476986,1.7893318405328233
LoVo,151289,0.7390860710542093,1.1726428195941532
SCC-9,10296883,4.238304408621306,4.024512747297116
LOU-NH91,54454,2.054793401572522,2.6799416673652012
A4/Fukuda,9884685,-2.10728676228506,-0.15558934394605628
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,-3.56064337827873
JM-1,11317348,1.0457451678280252,1.3052111401522923
MDA-MB-157,5287620,-1.8230093056434509,-1.7509667393851571
FU-OV-1,24821094,1.823018038350918,3.1057055406537057
Panc 04.03,15547703,3.067090198790942,3.2349186094867717
DMS 273,568763,0.8680081273298318,-0.08310010948473884
KMRC-1,16038120,1.697027615564608,0.788803789721685
A4/Fukuda,11214940,3.3298423014633585,1.5759189558961708
LoVo,168313016,4.599216339831628,4.849024862569914
JM-1,3011155,4.445867330482826,2.4668892937097824
NOMO-1,135411,-0.3073928829727976,-0.28737335193201763
A2780,24772860,-3.463956246093966,-2.0867944953471613
MSTO-211H,11625818,2.0984197145893853,4.390389909362808
FU-OV-1,219104,2.911303350256359,3.873824247711025
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,0.9710839201247932
SBC-5,49793307,2.0795512515040144,-2.6292534669955336
CA46,53232,2.437328600755792,2.5381848755908982
EFO-27,24901704,4.244323432217726,3.453326072289431
CA46,2746,0.9501634288999758,1.6600276019267326
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,1.9131105586467785
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,1.1185648321837385
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,1.1033111667973854
NCI-H661,9956119,3.313685900900753,3.6403395637137343
SW1463,44185566,1.4171512734588314,2.189318340817344
FU-OV-1,3384730,4.633609637548597,2.834251877983762
SW1463,3384730,2.9539510373394458,2.3654095677139146
MDA-MB-453,3825829,3.844348445708714,3.8905962803577037
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,0.37717634523064497
Panc 04.03,400769,-0.067858138339059,-0.49554441236236163
CAL-51,445643,4.334473435217703,4.0898398949300905
EFO-27,156414,2.3785601677308215,1.727038230447722
NCI-H2009,4259181,1.0344432117954978,0.4378794549119015
MSTO-211H,16722836,0.7655247341289007,1.6813246183992774
SNU-81,11364421,-4.012430935720713,-2.5747842817257993
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.279026694507863
A-673,2746,1.857945511282164,2.4692259445718294
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.5577028026621453
NCI-H460,135398516,4.13019906717736,2.0103644442600275
BT-549,25183872,-0.4430920052505824,-0.7189701314892099
JM-1,49846579,-3.8749150343559498,0.09356661632350048
NCI-H522,10127622,6.598645867237379,3.9640819199497583
OPM-2,446155,0.7744505725193765,2.4974464439864428
G-401,10296883,3.7583450228982342,3.674160415801065
DMS 273,1716436,3.74376938939547,2.6968932955277514
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,2.3602434410569235
NCI-H522,44566777,-0.9754694174653856,0.8545735462905434
MDA-MB-453,53393127,2.113910519669698,3.7482610393038804
FTC-133,49793307,1.1308238833509443,-2.1614981920116625
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,2.7611257429347775
A-673,135928012,2.926877088120134,3.868445975167047
NCI-H661,5280436,4.871704282803626,3.5511957168362303
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,-3.6078880556670527
JM-1,5282054,2.3244175489984573,2.7153314361098793
JM-1,9549297,1.5955396397117223,1.774976774999453
NCI-H460,11507802,2.848054270429628,1.728193817468246
A-673,387447,-4.940230504934896,-4.466814762359577
LoVo,89928392,0.5944678691764933,1.3906721344473596
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,1.1716683648483774
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,-1.1222373261775689
NCI-H2171,67156097,-2.093355563734418,-0.8901129129451258
CAL-51,9929138,6.421072450841616,5.6119446613368185
NCI-H522,11609586,2.3447481698139545,2.3719938506003118
JM-1,56946209,-6.537344033049601,-4.871462192344207
MSTO-211H,54649381,3.373909346349482,3.9250212293548965
A-673,4261,1.089626824326701,1.170505238156124
SNU-61,56649450,4.501229591303133,3.1527886804360308
EFO-27,5738263,4.449588569174732,3.6067441266770284
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,-1.8440763487901477
EFO-27,462382,1.6036436678954449,0.5870872885012655
BT-549,24180719,4.750015939259711,3.6339343635212176
HSC-4,73707398,0.9895931551524366,1.368158209079746
LXF 289,52912189,-0.1394416798850269,2.4503338037905826
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.9732368379660243
NCI-H2009,31703,-0.97323545782719,-0.8300122745486738
NCI-H2009,219104,3.953506929532588,4.030171684443776
A2780,11626927,5.568414170846121,3.010805725783495
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,-0.49643908444361123
Panc 04.03,4788,6.095957987809042,5.833205697540293
OPM-2,4259181,-0.0185783035827133,-0.24699274798761156
LOU-NH91,9915743,1.51930479588737,1.5637364713588573
G-401,2828334,5.836351566381613,5.880542733025017
LXF 289,3689413,0.4542816941401804,-0.19472421030065057
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,1.3590186690960726
SBC-5,119182,0.2964340092945935,-0.6627121596163411
JM-1,2729026,2.071801783442454,2.054731802828121
SNU-81,11214940,1.7135053171337324,1.8697101223000356
SBC-5,439501,-2.4874901722547977,-2.2788196688401587
OPM-2,46174525,3.627220507837432,3.4278169049032328
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,-0.3443542059450296
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,2.2879075346623994
NCI-H2009,3062316,-2.678423554108453,1.555348000429307
HSC-4,6438330,1.0116267584860468,2.544818870772014
A2780,1317464,4.304763369285543,3.832639569385176
G-401,3025944,3.816605103301755,4.093498258315144
NOMO-1,9915743,0.4758643096003905,0.4279902704314768
CAL-51,9877608,5.917079709597661,3.730207997485166
LoVo,71466380,3.017013363980257,4.612231484072785
HCC1143,53392493,2.60613854373917,2.4306062286893866
A-673,6918837,-5.129930095166698,-3.637272483963668
SNU-61,60700,1.2670278964841577,-0.26227567528611045
OVISE,6918837,-1.5846953199834826,-2.6458907987140896
NCI-H727,11609586,3.3120945172723917,3.116723297026655
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,3.679477339317452
NCI-H1623,5281672,4.562545083615407,4.716043122978851
NCI-H2009,6918328,-0.9509353973047906,0.15614802262557761
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,3.539533057048465
OVISE,16722836,2.434488476233433,1.7934385738910636
JM-1,10127622,5.153041805169496,2.9514309708462836
NCI-H1623,252682,6.46254793762087,6.610085725693576
JM-1,53392493,1.8440760854554048,1.814355955292651
MDA-MB-157,168312962,1.1798186112423137,2.3212464513658593
YAPC,44819697,-1.3460219164430964,-0.14309955410169892
KMRC-1,44607531,1.585622780528836,1.2237191168133832
NCI-H2171,6918878,0.0284372668850805,1.4441878112179591
MDA-MB-453,44607531,1.359301388322155,1.5782420692316002
ONS-76,11485656,2.5953354109263262,2.453268922299228
MDA-MB-157,135398516,1.565807276365399,2.4874879720011065
A2780,24753719,3.5545225878481745,4.009460071352711
NCI-H661,6918328,-0.1140400883450083,0.3193243171391409
JM-1,4578,4.1991230056704785,3.950589945170687
A4/Fukuda,9903786,0.7546004224414102,2.140761946870725
CAL-51,11485656,2.6541256228973773,2.355493020738484
NCI-H292,24964624,2.911439833663599,2.6144168607024585
NCI-H661,6918837,-3.3797686305940156,-3.043173780009561
EFO-27,71304818,3.2919872626583486,2.6518432298588057
MSTO-211H,4705,2.457156821386339,3.1252643048086113
DMS 273,107985,-4.548014092027974,-3.577475359076097
SNU-61,2729026,2.4451253635155106,2.5311998468839194
JM-1,60700,-2.9904484465209036,-2.2683248929555804
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,1.92103460346772
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,3.4615668602530594
SNU-449,24856436,4.072390930567189,0.6849657993901119
NCI-H460,159324,4.0462841352482855,3.1666653998775423
NCI-H2009,11175137,2.49599907102206,2.874798663689351
A-673,208908,1.851861192467165,2.163862141324651
BxPC-3,25183872,-1.12027566647844,-0.6558236219768818
EFO-27,5328940,2.731901822530229,1.896607614444333
HSC-4,135398516,2.2759469773851224,2.1191325524893485
HSC-4,11647372,1.1815136799972823,1.4631569808887703
CA46,16038120,1.1324791438314847,0.18925412052871388
MDA-MB-453,9868037,1.568237926564538,3.0418112173688514
A-673,446155,1.1478268834845686,2.6023903906912333
A2780,5479543,3.565203320915574,3.0804274522163966
MDA-MB-157,10322450,5.067042624032479,4.197408167228131
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.445286010511528
MDA-MB-157,9915743,0.9957990206413116,1.1272252063928607
A4/Fukuda,219104,2.2512696330904447,2.8085919580287766
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,3.2420744155219956
SBC-5,12001922,2.404615034975172,1.825100601422987
A-673,51037431,1.861905373589415,3.0826394603876635
A2780,637858,1.382423379201008,1.4742053366036934
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,1.714863869563731
A2780,9884685,-1.5939943621043984,0.2477867007925755
JM-1,5311,-0.0672732572458771,0.7234397626063449
CA46,15547703,2.518572103836232,2.4989554846713373
BxPC-3,54618164,4.016743819691475,4.070728223093887
BT-549,2749,3.5786970568950913,1.8624146539408648
SNU-81,73707398,1.1294477244846828,0.6843477033189541
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,-3.663452692393735
A-673,55508,3.3138750706926157,2.976816603424462
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,3.4505635232489116
MDA-MB-453,23725625,4.029710365908802,4.657225600922651
A4/Fukuda,4261,-0.9007526332595048,0.22543709429090877
NCI-H727,446155,4.65589483782911,3.0760268224026905
NCI-H1623,44486219,4.206804435599472,4.301679593024386
MDA-MB-453,441298,1.8295928982069447,2.7870004277081954
SNU-449,54454,2.520106415523585,2.547618034417568
A2780,387447,-4.368237522415053,-4.163352958006335
MSTO-211H,11152667,-3.5300772231011703,-0.40875722777492784
SNU-449,25195348,3.622170031481097,3.556578183679812
MDA-MB-157,322968,2.1225136411127545,4.046589602910412
A2780,168313200,1.7543183926879495,2.927051553337459
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.617203004771027
SNU-449,5329102,2.0099859216843075,2.3917147631185562
NCI-H2009,322968,4.70725114827159,4.068544479274499
KYSE-70,16722836,1.4327625680833322,1.7146281020235983
MDA-MB-157,11609586,1.0926317538630208,2.8234475094080778
FU-OV-1,10231331,3.398558944555642,2.117432409353214
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,3.247966697803524
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,-3.1106945070135845
LOU-NH91,11238147,4.007302405058718,3.113995513162202
LOU-NH91,49766530,0.361985362717411,-0.9245282001133852
YAPC,9444,4.346283036692295,4.126694686051771
NCI-H522,15547703,3.471643136947843,3.001573253033659
NCI-H522,375860,-0.630771500248647,-0.015235270897846742
CA46,119182,-4.388833865288787,-2.8740609190027038
OPM-2,10410894,2.9147321100270593,2.67654650781068
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,2.8916063160539864
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.1318021242925136
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,-5.238464068504684
NCI-H2171,4261,0.9024779156039784,0.6640173789300556
NCI-H1623,25262965,-3.228781743363827,-0.9917260982125127
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,-2.008763501282303
MSTO-211H,10427712,4.183883954719584,4.240152441053704
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.7502580952809081
A-498,9967941,4.3277437867326025,3.946152381195489
HCC1143,25183872,-1.001460572121427,-0.4856443072696118
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,1.6313645340988152
CAL-51,17755052,0.5283491907817935,1.700587810113369
SW1463,44137675,3.7114847318755806,3.4005154045049384
BT-549,5278396,3.375604766419473,3.7781238996876345
NCI-H292,3025986,-0.8794264876923694,-0.8762322767297336
NCI-H2171,3825829,3.727904622873516,3.555368688228117
EFO-27,327653,2.4330037956805133,3.1941000679282796
NCI-H460,637858,3.384702960830197,2.3169785344123848
G-401,5746,-1.2143401521495898,0.21323103578521377
A2780,5281321,-0.7497434400684011,-1.4526676740426077
NCI-H460,409805,5.4278006548731295,4.936793141607106
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,0.8348582866857995
SNU-81,11964036,-0.3940350311201446,1.209936010761166
OPM-2,53232,1.210133300080481,2.640527268790304
A-498,216468,3.41587450505901,3.584379824569607
LoVo,6852167,1.8421975016001388,2.8680450162727213
SNU-449,53325874,4.456238471946744,4.552474898363756
FU-OV-1,10296883,4.259179003182187,4.135867583724682
LoVo,3136844,3.7568853791466608,4.3578848434790824
HSC-4,637858,2.398043952194309,2.106017601993557
NCI-H522,9927531,4.749051096908956,4.437495223088401
MSTO-211H,53392493,1.8202473930982712,2.6973219194509257
Panc 04.03,11626560,2.20525660125161,2.092460012659812
EFO-27,11178236,-5.208504296414087,-3.4729372701526886
SBC-5,3503,1.24841833111282,2.230336689712975
G-401,11640390,2.8162749001609417,3.132907123121803
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,3.1486307517103898
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,3.1429759900046124
FTC-133,54454,1.7579296666098376,2.3230984377935866
MSTO-211H,54613361,-0.4311183648022992,0.5490711586643522
G-401,5282054,2.6200467258422235,3.156336207986225
NCI-H727,135440466,0.3181577925646752,2.1508445264953333
SCC-9,6852167,2.7106856908699255,2.7755119164952755
NCI-H2009,124202324,1.390796248932456,2.4626654212039014
SCC-9,54618771,0.4910288003516506,1.2059896280175186
A-673,9826308,0.1905391916215918,0.035680985529187165
KYSE-70,446155,3.830415114438346,2.946196587338824
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.1480225753447
CA46,10296883,3.259152671675197,3.086889226400045
NCI-H661,159324,2.633762936698375,2.761978475912032
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.5841813694239482
LXF 289,5328940,2.0490491787199687,1.8439810812759276
KYSE-70,400769,-0.6610715268602807,-0.6749732141293227
BxPC-3,9911463,3.950256717526944,4.082500469958674
MDA-MB-157,119607,5.813382396653367,5.34667683874522
NCI-H727,168312962,2.354698653601169,2.067823509273524
G-401,67156097,-1.3508759360204068,-1.2457589511349056
HSC-4,53232,3.536415160688875,2.710127284123507
BT-549,9866186,1.9395157417186848,1.0389360030549029
A2780,46174525,3.809782337657401,3.9773021633237122
NCI-H661,24797083,0.8737198077858661,1.3558298896071903
OPM-2,107970,1.3408908225452507,1.960046237851017
HCC1143,3038522,3.729990546362485,3.144899398809248
JM-1,5746,-1.3315669786621744,-0.8049137338732713
OPM-2,9935249,1.874633336412032,1.9330147469751486
A4/Fukuda,10302451,3.353566161735505,2.8622832570771966
SBC-5,1641662,2.7360117188732684,3.3259651328016577
CAL-51,25183872,-0.1080661998677032,-0.75399356475633
HCC1143,72734382,3.642829686089203,4.645254671270006
SCC-9,67156097,-0.5297515363076177,-0.4524695709618375
LOU-NH91,17759555,3.0310153631552295,3.7789411865687565
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.5348540210784927
FTC-133,6252,3.0791801983523297,1.1424589406236538
NCI-H146,10026128,3.971012402354388,3.614462926133438
HCC1143,327653,2.9245812810780745,2.9641618224298334
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,1.9436773052518697
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,-3.04406586378788
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,-0.895185720465401
A2780,71466445,2.121500658196736,3.432697378466522
FTC-133,11640390,4.129780643497309,3.5021996951352814
NCI-H661,66577038,3.3791675548307225,3.0773959985105908
A4/Fukuda,89183176,1.286008536767452,3.486189113286305
KYSE-70,49793307,-3.275020883815728,-2.990964250196823
NCI-H2171,36314,-6.271125424872196,-1.730167566901985
G-401,5351362,1.1066788885055705,1.2489855575422562
NOMO-1,44507138,0.557170216692965,1.3381032027355113
CAL-51,56649450,1.7310987503885624,3.206815719541477
MDA-MB-453,100016,6.0730906594859215,5.680417924496356
NCI-H1623,6852167,1.7873387390250663,2.8875391056321154
A-673,16659841,2.6132078541729404,3.368540673213152
OPM-2,67291369,1.773293288142809,1.1980068085520048
OVISE,374536,3.768512931442208,2.573126839840399
CAL-51,11238147,2.100409816322544,2.975395421640248
YAPC,11175137,3.2313352651289327,2.8809480280693345
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,0.5479251863946026
OVISE,10427712,4.5158462716299415,4.101734037761819
EFO-27,5351362,1.1790960486008195,1.5930939723902406
NCI-H292,6505803,0.1482155149138876,-0.2587291210629853
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,3.2314511247565663
DMS 273,71680916,4.789726238699708,4.440366872092022
CA46,10184653,1.13668363671425,0.5380432893199989
SBC-5,49867926,4.30527508614513,4.1103717288299615
LoVo,11238147,1.4038592423826672,2.623696267337414
MDA-MB-157,11427553,2.127814795485051,2.8269825917944864
SNU-61,11178236,-3.475859478717308,-3.0193350372228362
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,1.8409074431050643
FU-OV-1,11214940,1.6800576649286882,2.087793806017395
LoVo,9903786,0.6551100591729495,2.7615934568527876
NCI-H1623,135411,0.3784026464220375,0.9648434598319868
LoVo,3062316,-2.119304437973892,1.6538534264841018
NCI-H661,46174525,4.042428757819544,4.36037994151906
SBC-5,51037431,0.5420283127367359,3.3151395303272055
A-498,3689413,-0.327867250415736,-0.4176903796694182
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,2.6896082456795694
CAL-51,54649381,3.902782783768603,3.8747401587585686
A4/Fukuda,16038120,-3.113498344638628,0.158136733233399
A-673,135398516,1.4288802928040978,1.5424104281779074
NOMO-1,135398744,6.340708200805823,5.7840143445773595
KYSE-70,216468,2.031191966418552,2.782900226054886
A2780,67291369,1.1130592599106983,2.1309938753146747
NCI-H2009,654092,0.0283248260105453,-0.16261891649585222
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,1.6874809422433537
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,1.3982967131573891
SNU-61,11612883,3.050953505253589,2.755783101457242
SNU-61,5746,1.3298489283886064,0.8289995087881114
KYSE-70,124202324,2.186627813347476,2.1209557851505205
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,3.5120503515368076
BxPC-3,409805,3.7922849099240734,4.857338330203964
A4/Fukuda,3552672,1.9607713184754867,2.621381547490673
KYSE-70,9907093,3.6347338213446454,4.284717978338333
SNU-61,12003241,0.1572719330395487,-0.8965566438756281
HSC-4,322968,4.636798889333657,3.945108870842942
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,2.1929400884466848
CAL-51,16115403,-4.643171700082743,-3.93298047924476
LOU-NH91,2746,5.002248002286792,3.336065439975258
A2780,3543504,4.147653095225295,4.1721619759100825
NCI-H661,25126798,3.9237728184770946,3.8932516716080428
DMS 273,4521392,4.235410021964807,4.216045254738029
BxPC-3,49836020,-2.380895293574403,3.519360708483467
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,0.43086423893992576
OPM-2,3689413,-4.501811354570108,-1.062753956425613
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,3.1467839967216964
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,-1.4543362380587324
NCI-H460,5328940,3.322075361136407,1.8198840068168056
ONS-76,25126798,4.148768722347094,3.9817822039427835
OPM-2,57519531,1.419627244644159,1.4769203410660676
BxPC-3,20959075,-3.864209289368053,-2.989919698321267
OVISE,54618164,4.29678583267412,4.126163290135043
YAPC,10074640,3.068654585130056,3.257460493161314
BxPC-3,5287620,-2.837282092833542,-1.8979249681608141
SNU-81,24785538,-0.3807988804027284,1.0490211278801462
NCI-H292,5287620,-2.1513248285430997,-1.8726537377203227
NCI-H146,104842,-5.965892600420639,-3.408456976095442
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,2.237699539401255
KMRC-1,17755052,1.9475900469511016,2.14646502411691
NCI-H2171,24856436,-0.4096039036242957,-0.013378407277963592
NCI-H2009,11364421,-4.013811791110126,-1.3049961490096127
MDA-MB-157,5470400,0.4579153499304774,0.3636671415946012
HCC1143,51039095,3.6749130279746938,2.7132152725526133
G-401,11964036,0.0453230579510409,0.966989629870227
NOMO-1,1641662,3.174576963224712,2.813353265524488
MSTO-211H,25102847,1.842661618149511,2.512899518407015
A-673,9908783,4.713034696547774,4.746764779627472
BT-549,71680916,6.0821013857398745,4.821643214981948
JM-1,11719255,1.4438675590466743,2.1106967210417555
HSC-4,2874250,5.810325396532396,4.67697107555699
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,0.20621399717054076
NCI-H460,654092,0.4612941847378306,-0.21045081657087883
OPM-2,5328940,0.8145180628284293,1.1632248992023373
A4/Fukuda,44202524,1.0259860145116777,1.330615042081751
G-401,11213558,0.7886605378704363,1.4120993344570485
OVISE,135984461,1.6429740508824469,3.905737450918914
NOMO-1,11964036,-1.1045639043109698,0.24432194340819646
CA46,6184667,1.8666466805539537,2.3271119704695504
NCI-H460,9903786,4.057661845653794,3.112269796672122
BxPC-3,25102847,2.0998558206838913,2.347611296853374
SCC-9,5470400,0.9401931564199802,0.027276513394131383
ONS-76,5284329,2.36276815665719,3.678465465185841
DMS 273,25227462,-3.883072621079263,-1.0169156854703858
A-673,42642645,-0.8052568071576633,0.26852438657411914
A4/Fukuda,9549297,1.6255879909683784,1.7212883210728995
FU-OV-1,11427553,3.01783779671809,2.8494439750263676
SNU-61,5328940,1.147707594205283,1.5839080936173209
HSC-4,5281321,1.7816899121848235,-1.0401489321839401
KYSE-70,656346,0.9492660515895844,0.8614953508130392
NCI-H1623,72734382,4.853935764849827,4.7882753493521815
MSTO-211H,67156097,-3.635314822435898,-0.5927176894482894
MDA-MB-453,637858,1.2138352699902215,1.9761387947847135
CAL-51,56963564,0.4281851677964957,0.5454413741590582
A-673,10113978,2.507382463710335,2.9442096739685137
YAPC,2946601,6.339465197306548,1.9107463639376219
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,0.16931617979477726
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,3.09467387214485
HSC-4,65628,3.12205826618997,4.350591221703198
HCC1143,227681,3.1373347590378335,3.4046186515957824
A-673,53301938,4.3782771731899555,2.1567309187768244
G-401,66577038,2.320880294749871,2.8678342125842224
NCI-H661,9884685,0.1767392095869446,0.49496476274965523
SNU-449,6184667,3.7989058233577566,3.319673424646935
OPM-2,24951314,0.2222837933942169,0.7517335379701536
LXF 289,56963564,0.2991276479966406,0.46944042251453394
HCC1143,11364421,-2.85203888888326,-1.1739263290243789
NCI-H292,9936388,-1.1579069678838152,0.3838513275006418
G-401,10231331,2.894718734978725,1.680697210833114
CAL-51,89928392,1.068329558331595,1.4784426809628934
NCI-H2171,53392493,1.8740494203136608,2.1024072737958437
A-673,136227331,4.241984110268528,4.257659630473214
NCI-H727,11717001,2.7053596974758594,4.005325266337127
A2780,16219061,2.814782356526162,2.888350998657171
SCC-9,54454,3.1137155512464596,2.57438418454769
YAPC,12003241,-0.7644111057992425,-0.853443260388184
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.4407265172170183
SNU-81,5335621,4.181800470543683,4.2749856925500955
CAL-51,5329102,2.0492492410301484,2.1326742142937642
NCI-H146,10385095,0.6869778017915235,0.9502957916247691
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,2.6430249312130463
SCC-9,2113511,6.3303497429476625,5.477593862217674
ONS-76,2708,5.792421817961339,4.846915939114542
SNU-449,11485656,3.58452534173841,2.5635833954277043
A-673,46215462,1.2771489946566346,1.423429982148901
FTC-133,285033,-1.2963608176743802,-1.8669584628832814
SCC-9,6184667,3.279451062583292,3.040196677451295
NCI-H146,16722836,0.0677462505380894,1.2699431864518453
NCI-H661,44137675,3.7576040576240257,3.5253862900671895
NCI-H1623,11612883,1.5649574760969076,2.9489281237394254
LOU-NH91,3825829,4.327670981782257,4.1600990359119585
SCC-9,5287969,-2.1272191034883874,-1.6226625898619427
Panc 04.03,10410894,3.886544188244091,3.3500876142728093
NCI-H146,135398516,1.5035346569298091,2.0151719894356526
A-498,4096211,4.004902569915099,2.3205175782907146
OVISE,104842,-0.680714151991963,-2.5384232557734836
SCC-9,135440466,2.439160969941936,2.2153964107511
ONS-76,10322450,3.321198163736043,4.115001137996364
SNU-449,81146,6.119223793669881,4.765899158080746
JM-1,148124,-7.840698833354439,-3.5429303913454673
BT-549,5460769,6.35928800843138,3.1491455712730647
MDA-MB-157,969516,1.7670354115722269,2.8171158477708413
LXF 289,5278396,2.6487510770020104,3.6957271687795936
ONS-76,100016,6.019166856387977,6.23989676401278
A4/Fukuda,11707110,-3.666992219196893,-0.7542168729129081
JM-1,6438330,0.1685207017328377,1.1275255961981676
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,1.3949101413893725
BT-549,10074640,3.6929061121608577,3.2628957934619667
A4/Fukuda,46926350,-6.021657358635238,-4.674944818582534
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,0.8416885982369273
SNU-81,4917,2.3748179961814375,2.7797247335612
A4/Fukuda,119607,3.918640768426122,4.7155015044544415
HSC-4,613753,3.3632883902358715,3.155062279539618
DMS 273,135411,0.7219297948054574,0.45702911415335884
KMRC-1,46907787,3.729545872280723,1.8149017016130398
LXF 289,44489675,4.904101073680104,3.997781041805102
BxPC-3,6918736,-1.9181543280529496,-1.0945299609774195
KYSE-70,65064,5.1318583658275205,4.674569187641403
HSC-4,25062766,1.8609848482730849,2.153830535913166
SW1463,15983966,1.3055923116721375,-0.9005387230806329
HCC1143,11396600,3.529486359294858,3.6563766525113306
SCC-9,45279963,4.124125049817703,3.7435382961619843
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,-3.2632488848518455
NCI-H661,5113032,4.99918939361245,4.875783786750705
LXF 289,17759555,2.434653643868842,3.638642477184896
DMS 273,46926350,-4.333780789364997,-4.457528524522871
OPM-2,46224516,2.1207785622277373,1.9687990250814922
A4/Fukuda,9908783,4.281950187885367,4.838814557966317
A4/Fukuda,1716436,2.785785051354721,2.7969337926020152
KMRC-1,54454,2.958009627513852,2.5813927721410077
HSC-4,73707371,4.771220465805862,4.943845006763718
KYSE-70,9911830,3.1951659700149886,2.5980875186979886
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,-0.5659519213641423
HSC-4,16720766,-1.6245250648624636,0.501111476464324
OPM-2,11964036,0.2409704368173301,0.4922543362074524
LXF 289,3038522,4.104388560491244,3.153756905740654
A2780,49793307,-3.5064247630527494,-3.375748615465615
MDA-MB-157,12003241,-1.4339892472843776,-0.7939558724746983
MSTO-211H,53495165,-2.281905985837366,0.7589091218840113
MDA-MB-453,24797083,1.319210590833939,1.106133568043664
HSC-4,25126798,3.2488654911973196,3.928866702655036
BxPC-3,3854666,3.4835595653471167,2.199532763834278
HSC-4,176870,2.813832788377266,3.2153379063317775
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,-0.4839602793237839
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,0.645235636574784
YAPC,135398744,6.484368053683043,6.348114167586706
MDA-MB-453,51039095,2.709903892694302,2.440072224635873
CAL-51,24821094,3.2618915388877023,3.0878784473711245
NCI-H522,1239801,3.903810420887451,3.7048263993029047
KYSE-70,7251185,4.369311092923008,2.712992547805693
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.30400882588235
G-401,60750,-4.380742093252711,-3.208405199794858
YAPC,11404337,0.4717703732171429,-0.009375645919548745
MDA-MB-157,9826308,-1.0851482905673768,0.8567036433219539
MDA-MB-157,25262965,0.470934001928582,-0.8583361140562671
FU-OV-1,10427712,2.3896052276409887,4.312996796992853
CAL-51,285033,-2.914004430070481,-2.159509855151132
CA46,246676,4.699933053014099,3.9142314836934338
A-498,9926054,1.5026788619071982,2.230813204955669
LXF 289,44632017,2.313535350982782,1.728975161634415
NCI-H727,3689413,0.3749801507161196,-0.23068108769945428
SNU-449,1716436,3.0856052265463023,3.0750909125306576
LOU-NH91,24951314,1.380037957351277,1.4923093351328318
SNU-81,46191454,-1.5874627182763832,1.483784608618375
KMRC-1,119182,-0.1449504353389931,-1.115584987677802
NCI-H522,9823820,3.261618834820585,3.421265288740894
NCI-H460,11178236,-2.300904923417752,-3.4320367841100663
A2780,5738263,3.096886997462696,2.9801127733976425
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,2.9051888377988244
BT-549,5287969,-2.055370090828861,-1.7062178062219713
BT-549,11609586,2.735581966533724,3.1132733406513022
OPM-2,1317464,3.5924971065959244,3.4115321274086283
NCI-H146,54639701,4.038686865533554,3.6952104704524156
LOU-NH91,3384730,3.7773271912609623,3.243502207654282
YAPC,11152667,0.3482753398657929,-0.4628645420134783
SNU-449,702558,5.257858019653286,5.264108504269451
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,3.0741063658597714
FTC-133,6438330,2.249518605035186,2.481795025126132
NCI-H727,12001922,1.7281936629666887,1.776441146006459
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,3.1200993080479953
HSC-4,60750,-5.118377280037083,-1.949817512705843
SNU-61,1566236,1.9599867850180668,2.2965319097283667
NCI-H460,5282054,4.802373462225767,3.915825867641367
DMS 273,6610216,4.172124776089646,4.069584502316182
NCI-H727,6852167,3.356078560596427,3.0569496820416675
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.176235619049834
SNU-61,445455,4.539446073708065,4.51697204618754
DMS 273,3062316,3.60345807305724,1.4849939251030813
MDA-MB-157,9956119,2.310937024804907,3.65538347067713
OPM-2,135423438,0.9866001177758746,1.2087158518271652
Panc 04.03,16722836,2.845252730089092,1.7900722640003301
MDA-MB-453,9936388,0.6028011486270662,-2.7299161211332215
A-673,68056272,3.7833857366006094,3.2530898064781995
HCC1143,16722836,1.2433455264432278,1.4784184461792134
DMS 273,72193861,0.4647891664131632,0.8139840854903813
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,1.2169097636029926
Panc 04.03,11396600,3.73844061007523,3.610840190896202
NCI-H522,6505803,-3.5272214952237344,-0.5947090480107847
CA46,56963564,-0.0544830399645368,-0.3661930939693006
A-673,9825149,0.7138432506885886,1.8865534018164902
NCI-H1623,2871966,1.4286416314522286,0.41198678248287046
SNU-449,4096211,1.9400565485658428,2.428268897481681
CAL-51,44137675,3.485867182081199,3.2826184097885447
MDA-MB-157,375860,0.0174110406826079,-0.0960522362060931
MSTO-211H,327653,2.467891014920142,3.2012605221855397
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,0.9986905787965564
CA46,11178236,-6.883102305003874,-4.678091032187188
NCI-H661,5291,3.8370923902638063,3.7787302757815486
FTC-133,25262965,1.6757685209235111,-1.336304958297988
SNU-449,24771867,3.0453458349703793,2.813832428015287
HCC1143,9911830,2.6182666070844447,2.5333628965992223
SNU-61,44185566,2.430559307269213,2.0761435557555465
SNU-449,445091,4.4459202939225815,4.554159579764525
LXF 289,123631,1.612545473594554,2.506488864221683
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,4.237578865948973
SNU-61,637858,1.6436621136217924,1.8328714540950393
MSTO-211H,3025944,3.596075182431598,4.316406245194458
SNU-81,11612883,1.8877401103471,2.5428769571422736
A-673,52912189,-0.9448854486243604,1.2988939290490993
NCI-H727,613753,3.184500780825273,3.2573209318578007
BxPC-3,24856436,-0.8809901773698104,0.4319486717285643
SNU-61,3038522,3.6960216122526943,3.0188531759509774
KMRC-1,374536,2.325099751463231,2.164693847628714
CAL-51,54613361,0.2180057854442524,0.23737953451435984
CAL-51,10385095,1.0305027810027567,1.1271253544630369
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,4.0478743382532105
LXF 289,5281321,-2.4870532876216487,-1.2163419777715934
SNU-449,10184653,1.7910926490151993,1.4628172163356943
SNU-81,9887053,2.281153151762533,3.2679462145981995
KYSE-70,11485656,2.2230455690794404,2.2498057340734423
CAL-51,439501,-2.444412450902406,-2.3780948172560343
A4/Fukuda,72967,3.695839205584607,2.575336981381046
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,1.1048230400493042
BT-549,57519531,1.7866000969199525,2.3478983738722845
YAPC,9911830,4.0093640169179325,2.6346501478276267
KYSE-70,54143018,-0.2928055682999507,0.913423675599116
ONS-76,6852167,3.4771955261396252,2.8606220632542687
CA46,216468,1.7849524837603168,0.9168482049944612
KYSE-70,71304818,1.8226881659751617,2.2290356547135493
SNU-449,10427712,4.716616821408685,4.26701834838859
KYSE-70,11364421,-0.2598881855214042,-1.497924965188201
SCC-9,46199207,3.715699147831311,3.335450839924822
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,3.0335415629939932
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.3641718046663245
NCI-H522,45279963,2.975445810656792,3.4795570222949124
NCI-H727,44137675,3.902640688581202,3.6173465651025833
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.1435592512986386
CAL-51,3854666,1.1494535123186709,1.972974760987867
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,2.680828608488521
NCI-H2009,81146,6.16166931928307,4.663094597292226
LoVo,135440466,2.5900307411888357,2.2003417391190125
G-401,445455,4.8654155018395535,4.376475869784724
NCI-H1623,15547703,3.108106821400364,3.0895864245525413
SCC-9,322968,4.6886309532040435,4.102545535872053
MDA-MB-157,23635314,-3.347178711973772,-1.2222580675046224
CA46,49793307,-4.01311922110524,-4.253033035709526
CAL-51,53495165,0.3298774405260949,0.26570306937416666
SNU-449,54618164,4.194291334344069,4.173051334013955
LOU-NH91,11178236,-2.353397629942184,-3.662484321925695
A2780,5284616,-6.357248921927095,2.111120196543407
OVISE,11404337,1.793635825025173,-0.06543964143821311
HSC-4,216239,1.6239220207771676,2.2846378533523026
NCI-H1623,208908,0.8939149685214822,1.9399109481708465
NCI-H146,25161177,3.485806465133522,4.0607483828966835
YAPC,6918328,1.93910137978286,0.24493318860056384
EFO-27,3038522,3.6669358154068097,3.161826126963249
DMS 273,25262965,-3.6359475061731534,-1.7899800831342612
SNU-81,9803433,4.184314019267332,4.396200952053171
SBC-5,5351362,3.2358684618056164,1.4329968510437214
NCI-H661,9826308,-0.3578866099027624,0.4245500908901568
CA46,462382,0.6475442737717811,-0.05746502794771149
SNU-449,168313200,1.9091128501610053,3.0221761734323827
SBC-5,613753,3.3291324843640497,3.1974827407034594
HCC1143,24797083,1.671403596818138,1.4001137309316152
NCI-H522,11625818,5.118334572164132,4.2036545660725855
Panc 04.03,446155,2.4976903608369994,2.960531976808357
NOMO-1,2733487,3.664178503465112,5.702431968007416
CA46,11494412,-0.1540181126177876,0.2696267885538559
KMRC-1,168313200,3.9547474801247455,3.149454830367402
BT-549,12003241,-0.9663956127583828,-1.066799121541429
MDA-MB-453,53232,4.528141583720988,2.9552021200451213
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,4.343285180029713
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,1.96480266595772
BT-549,7251185,2.7032329014559555,2.7378538781972845
YAPC,72734382,4.459010686131963,4.828088794299217
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,0.42545475240181746
LoVo,10113978,1.9718639606113115,3.3357952794581043
G-401,9884685,-1.463173781220529,0.15832204360911922
NCI-H460,969516,4.1763077592827225,3.047592944064034
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.9557791658345667
NCI-H522,10302451,3.5044820085806645,3.29776673063796
SNU-61,10127622,0.6703048084308344,3.122368445933128
DMS 273,216239,1.7826696655906364,1.8935630947038953
NCI-H2171,24785538,-0.9958553447114444,0.6317007563678201
OPM-2,2945648,2.5610378238786367,2.153837859208738
JM-1,5278396,3.0111139094733987,2.7127577920090302
A-673,11625818,4.166556040788123,4.2066115876974495
MSTO-211H,23582824,0.616921606097025,0.9423541770049932
CAL-51,11977753,-3.094424679361229,-1.4524940229792187
OPM-2,55283,2.954343465689474,2.035327216480957
SCC-9,445091,4.9115801471194365,4.358931628114926
FTC-133,11609586,3.5175505098064113,2.8807724639971224
DMS 273,16065773,2.5819171284899873,2.4727936485824378
NCI-H661,16725315,3.2574493912109315,4.0211065429693065
ONS-76,3825829,4.014711164490238,4.119312908905265
NCI-H2009,613753,3.3208706433892483,3.307607735459735
OVISE,72376,-0.0680425204905225,-1.3519060322709706
Panc 04.03,1566236,3.6247050899799698,2.674672116534259
KMRC-1,10385095,1.0697515150450725,1.4122779657442086
MDA-MB-157,6918638,0.523436976846598,0.5678949970248331
SNU-61,10231331,-0.1396530061474971,1.1193375843471944
SBC-5,67156097,-2.1260485275267684,-0.6085262457488164
HCC1143,16720766,1.508740109375584,0.7783070207704245
SNU-449,5311281,1.2425771495660034,2.273949108301807
EFO-27,15547703,3.36481674718985,3.3743623397092914
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,4.226980881272258
HCC1143,71466445,2.406598865609875,3.853308359498837
HCC1143,11625818,4.1599423197543395,4.252714377916002
LoVo,67156097,-2.753278115102512,-1.001931988030347
NOMO-1,3385,1.8227638422939128,2.432522354731957
JM-1,11494412,0.2153546786296628,0.21868435501193478
SNU-449,3384730,4.130527031297823,3.292325454855282
KMRC-1,2871966,0.6996568641549454,0.46660582975529125
MDA-MB-157,2126,3.382661447598077,4.355060490680628
SBC-5,444795,4.741830288065925,4.470893452945192
CAL-51,135398516,1.449392214756173,2.230486421323652
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.2792727261955292
FTC-133,11626560,4.477282693511418,1.529069633237541
NCI-H2171,135411,0.036573209368321,0.32831352164181665
NCI-H522,5479543,3.719555600198391,3.153987901979929
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.3209674800314462
SNU-81,44494148,1.061827805146114,2.466602408116808
OVISE,119607,5.735286818250817,5.22719489523102
CA46,4578,4.451375135730711,4.087105055963971
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,2.0205182459273985
MDA-MB-453,148198,-6.384072425395857,-3.2798879907060385
CAL-51,44491742,5.152478206660974,4.21394541187538
G-401,6438330,1.230579919692557,1.7162755850335045
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,1.880508449870803
KMRC-1,2746,4.901784458568857,3.3053783799834333
SW1463,3025986,0.7137013515595916,-0.864096309471797
NCI-H727,54618164,4.079418853402711,3.9967524080778936
CA46,9907093,3.753589195065423,3.2745399009924148
CA46,1750826,-4.755590130007624,-3.0280231062886487
G-401,135411,0.5966957307940325,0.18402223914055585
NCI-H727,9825149,0.533141934304371,2.2972840758803814
NCI-H2009,168312962,3.455210391348572,2.2817154989532566
NCI-H522,25154868,4.970187113391964,4.444547166966921
HSC-4,3503,2.6271988960037502,2.327548829076767
SNU-449,54619267,4.584813130836932,4.16697935643113
CAL-51,44507138,2.6477043136390637,2.652070129004969
CAL-51,24753719,3.9981702522006257,4.204847648505427
SBC-5,16725315,4.9617798252058165,4.168107578587385
CAL-51,123631,2.4616591372530605,2.3390310985584675
A2780,56963564,-1.0587892817911606,0.08644562999792792
LoVo,119182,-3.2827225124554804,-1.028698739411832
A-498,3503,2.8872062971439436,2.409759683820769
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.6555437385612282
FU-OV-1,9915743,0.5010130642537969,1.302405909069179
LOU-NH91,6917907,-5.4115573726076125,-4.603865040335037
A4/Fukuda,322968,1.909418940393303,2.816394587390991
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,2.0256161565690163
HSC-4,54618164,4.183236352259565,4.214095102857737
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,1.0503027951540271
MSTO-211H,89928392,0.2675284607275224,1.6531839158746309
MSTO-211H,16741245,3.31564558456852,3.7629397022004154
FU-OV-1,969516,2.7898134338200093,2.8756050970958076
FTC-133,9840324,5.72186430729165,5.9586946683472055
FU-OV-1,2828334,6.23308188240882,6.112070592756944
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,-5.706096467137708
NCI-H146,25062766,0.9164062509537028,1.9017671470911162
MDA-MB-453,44197249,5.538441394278097,3.412437267421242
NCI-H292,25126798,3.8121795120859865,3.9419816242825783
NCI-H2009,49793307,-2.1832388254663746,-2.354756594779754
ONS-76,446155,1.9434822335598465,2.878818266038327
NCI-H460,613753,5.368273372553464,3.4244645739041846
NCI-H1623,375860,-0.2497324332058591,0.034852493236407434
NCI-H292,135440466,1.1809367948500966,2.299982939735799
DMS 273,24821094,3.2786522000090974,2.768121332111174
CA46,1566236,0.9666867201201066,1.3384532610724935
LXF 289,6914657,-2.1957863105134474,-3.136365719569146
BxPC-3,68056272,4.30573170491611,3.503041870547593
CA46,24856436,-0.7056093623802927,-0.6361328057133068
SCC-9,136227924,3.721677265331546,3.049303470275145
BT-549,5281672,6.431065394953252,4.806037421492993
KMRC-1,136227924,2.9529226708788734,3.2583038949535705
A2780,46224516,3.0956757820489966,2.0348837167985208
OPM-2,2871966,-0.6940984937409527,-0.7181663714124565
NCI-H522,44607530,1.256897748575463,1.8108725158221397
YAPC,135421197,1.6415717791988456,2.0212830034293727
Panc 04.03,11609586,3.1950022878003375,3.032909945634563
YAPC,285033,-1.734058118132599,-1.761463789226677
EFO-27,25161177,4.775691091389994,4.358125746196299
MDA-MB-453,285033,-3.584093663874095,-2.3040605676693904
YAPC,135398516,2.168624804585352,2.2483096086880088
BT-549,10184653,2.4120945582019098,1.2978319012236752
SNU-61,322968,3.1681402320576924,3.441391700653316
CAL-51,9911463,4.251278022142156,3.932871259779611
NCI-H661,119607,4.8407678671423975,5.251707927922309
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,-0.4108070638585612
CA46,16720766,0.453567173389679,-0.5377163055590833
CAL-51,11404337,-1.4033364127444676,-0.43758271569701335
SBC-5,9911463,4.310936662946409,3.7806697955258137
NCI-H727,2828334,5.890997909388885,6.154399117778041
JM-1,104842,-7.303088314363844,-4.572277904320058
NCI-H460,5335621,5.645903220513178,4.640005302887452
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,0.855692970535488
HSC-4,12003241,-0.0373048915881231,-1.1578278895869558
MDA-MB-157,53301938,4.15898814375023,2.373552330155038
MDA-MB-453,25150857,2.1104930677980964,2.263180899465403
HSC-4,25183872,-0.8460464512297751,-0.7230801190408819
CA46,46907787,-0.8110179268567884,-0.3074027442338839
LXF 289,5311,1.216776445363927,1.48814984211616
NOMO-1,6610355,3.932739350210071,4.0210418862385895
CAL-51,11222830,1.6762547521470548,1.5629625565612728
HSC-4,9915743,0.765957034876682,0.8469626570729301
SBC-5,72193861,-0.1091418694351138,1.694915182733722
NCI-H460,60700,-0.2314807684970784,-0.6143401748192265
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,-0.006161217150117024
SNU-449,2729026,2.998695944617882,2.6978768188092603
A-673,6914657,-9.096845778146204,-5.120386630562202
EFO-27,64971,3.389505323176025,2.9886834758237217
MDA-MB-157,44137675,2.4962707088889524,3.527970535077017
A-673,374536,-2.1767869041067462,1.8402019005955583
NCI-H522,24951314,1.0216385721244754,1.3170958789300056
JM-1,16038120,-0.8379540118722992,0.26886907754036093
SNU-449,25126798,3.9846076439311258,4.003036432534114
JM-1,9444,3.0857992205099616,3.546787006782836
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,2.389650217152747
A-673,327653,2.521292352419487,2.8286411695981553
MDA-MB-453,5470400,0.9814504444661803,-0.3885617735062151
KMRC-1,71751553,4.436686890494674,4.554584703822896
FU-OV-1,52947716,3.0881190342895626,-0.18433374079105802
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,3.0239299699276443
JM-1,3825829,3.3725964609251005,3.0258869897041634
G-401,6918328,-1.3062418496747916,-0.3097666677290847
OPM-2,136227331,3.7431952210756014,3.788729768814743
OVISE,5281321,-1.443802792924895,-1.021464139814858
CAL-51,6450551,1.9748462748620472,2.676774169656605
DMS 273,387447,-5.016212668564022,-4.485081721532003
OPM-2,5278396,3.463635489570463,3.300461900845018
ONS-76,445643,3.769289821936489,4.117212689820229
OVISE,676352,3.019558255819343,2.247990932648592
OPM-2,126941,-4.73900193491969,-2.8311291579551736
MDA-MB-453,11404337,-0.3002498088297632,-0.08605959462411313
NOMO-1,24797083,1.0415171353084307,1.0326039924688
NCI-H522,374536,3.894183139895475,1.8397660275301289
A-673,6252,-1.7615808961584718,-0.06325461872154893
LXF 289,9915743,1.5678711489122208,1.2587029378069832
DMS 273,72734382,4.203397510599988,4.150438715499974
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,3.2841085617366867
A4/Fukuda,BRD-K55473186,4.020373973875239,3.797487387988316
FU-OV-1,6505803,0.8019489696335256,-0.5065717154161118
NCI-H292,10074640,3.1247192788252134,3.358986905136561
A-673,3854666,0.8608139997201792,1.0920644084614661
EFO-27,637858,1.802850970746332,2.166849110166238
MSTO-211H,123631,1.7071024302486195,2.658078612423141
OPM-2,54619267,3.38914180731132,3.4284016485455497
SCC-9,11612883,3.4111633177056992,2.985800827672878
MSTO-211H,BRD-K55473186,4.0690738661382175,4.34442049361094
CA46,25154868,4.248651634430963,3.7759997699701717
LOU-NH91,6918837,-1.6936529516603684,-2.3295808161982436
OPM-2,9911830,2.101419447334853,1.8977238943016177
BT-549,6438330,1.5528656655176645,2.422743509576015
EFO-27,11647372,2.575313315468432,1.3697302528634794
SNU-61,568763,-0.2886838000487807,0.3941197457590305
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,2.7766301869648253
Panc 04.03,5282054,4.5317440773242925,3.964896726830432
YAPC,53232,3.166937959197618,2.905782165267035
SCC-9,44486219,3.972056382599232,4.164744505835999
NCI-H460,104842,-2.7771726159534773,-2.4765943107454422
BxPC-3,4788,5.831531206482249,5.706033006066559
KMRC-1,753704,4.9867166993089365,4.935227893016232
MDA-MB-157,71729975,1.9097389430207852,2.421900706471217
MDA-MB-157,46398810,3.5828771462995666,2.6103403242832384
ONS-76,42642645,1.3507577274785498,1.1607191264806525
EFO-27,9956119,4.364890218263242,3.808112086948172
SNU-61,49850262,3.504538311157692,3.4124948876043963
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,4.2281595982565126
MDA-MB-453,9967941,2.180105496017499,3.3643297393513665
OPM-2,409805,3.1459770002319023,4.027062626873485
BxPC-3,11214940,1.4945762019529478,2.1345468124096048
CAL-51,71466445,4.7818956768695715,4.109128178500797
YAPC,44137675,4.160217990140765,3.7256936425774385
A2780,3465537,2.6217509140821247,2.4624690581678474
SNU-449,135398744,6.632733291537939,6.332457186800647
A4/Fukuda,676352,1.592410759121419,1.8481992846471085
NCI-H522,5566,3.055916396278747,2.810247778934786
SBC-5,6252,1.1660150864515155,0.8767706067543515
NCI-H460,65064,5.803776096144955,5.091050790440381
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,0.7869236641107834
KMRC-1,60700,1.5998244644110848,-0.3444608219230829
MDA-MB-453,72734382,3.580352840578633,4.375969454089962
FTC-133,BRD-K55473186,4.331616686106064,4.14336188382301
NCI-H661,3062316,-1.6378145648450078,1.4859835879476975
NCI-H661,11977753,-1.2976183269776842,-1.7718824066197476
KYSE-70,4477,1.3887255745641551,0.7213746956009528
A2780,15953870,2.2934332620703457,3.360174376655729
SBC-5,44589607,3.2873586375678627,2.447262236786383
NCI-H2009,3634881,3.6058977960867233,3.3901731848660925
A2780,5951923,4.306994873236267,4.5167908477267185
HSC-4,11152667,-1.532358108136572,-0.4236330226035562
OVISE,3543504,4.513312782724499,4.286312523577182
CAL-51,676352,2.3367523995253454,1.947484348887964
LXF 289,100016,7.121965810949268,6.206066269828943
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.1298973345196985
KMRC-1,4096211,2.4789291220770053,2.2393537078584456
NCI-H522,2949965,1.5154466163896825,2.7862556972315593
G-401,613000,2.0341288465268397,2.4771604425764435
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,3.43951547295969
FU-OV-1,46907787,-0.0188806347407138,2.4456198613003095
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.459282089151403
NCI-H522,9926054,1.815484319665427,1.922945108029575
EFO-27,9866186,1.214213380462077,1.0997354873828054
DMS 273,446155,1.3230843960440628,2.6149165436393838
EFO-27,136227924,3.515702384882397,3.2182022025975012
NCI-H522,25161177,5.347457629837048,3.9819004645500415
BT-549,107985,-4.157404914346088,-3.1416434726258533
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,1.9895589771918478
CAL-51,984333,0.1261860025273146,0.7685078118294375
NCI-H2009,60700,0.1880080174398503,0.20470203096274567
CAL-51,135421197,1.6266864976107616,1.8637476799533197
MDA-MB-453,54619267,4.30313846005301,3.8584495108062784
NCI-H727,72376,-1.9917966726836325,-1.73082674751688
A4/Fukuda,54618771,0.259551202975953,0.3076576393540248
HCC1143,5280436,2.2824596389444567,3.53867448148775
FTC-133,168313200,3.883948141330694,2.88118305347324
LOU-NH91,11427553,1.5999683226177923,2.7834770075737407
LoVo,5287620,-2.196691557023958,-2.221064784951455
LOU-NH91,11222830,1.619786635706389,1.7202493782483348
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,0.24731138150774912
ONS-76,44507138,2.3475098717107685,2.485149900906522
EFO-27,12001922,2.6878207164132517,1.8882348956646982
HSC-4,25102847,2.881629074853979,2.587392028924395
A-673,4477,0.9527863024115504,0.6367117399820097
YAPC,119607,5.457421403002251,5.572918182915901
SNU-449,11364421,1.172419453845969,-1.2029296030351369
FTC-133,1566236,2.958331107997485,2.4191561719659576
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,2.9851409286778563
A2780,9956119,3.341179703016576,3.2194737417475845
A2780,421610,3.3194399172740296,3.017644026611391
MSTO-211H,11656518,-2.9147381038014095,2.2859136904501876
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,3.069378161096422
ONS-76,5282054,3.726244399490591,3.9089111873340863
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.3659109984086015
SNU-449,1750826,-2.5268598200751504,-0.9886575866645877
HSC-4,56949517,4.34052816497715,4.4231246266302175
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,0.4259895357676216
LXF 289,11175137,1.607203821415342,2.591819568269072
LoVo,400769,-0.9988261077541156,-0.8254211195222979
SNU-449,9823820,4.446865909721317,4.100110332742093
A2780,23582824,-1.3073183780043152,0.45341886580068286
LOU-NH91,24821094,3.1074025746804854,3.178041471223213
NCI-H2171,1566236,1.862945078393334,1.8887495621029708
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,0.027053392572936465
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,3.6092791799250836
LXF 289,3815108,3.5075214319549683,3.2426195327590053
SCC-9,6918638,0.4192666549800527,0.7730364791172398
LoVo,54626689,4.759845357486115,4.705637998819746
HSC-4,9956119,3.775946121479013,3.842945528903074
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,3.6480886533664894
JM-1,2708,2.6994993672471774,3.261636575993774
A2780,151289,-0.0035192392559562,0.6961764117919731
JM-1,135440466,2.1821804764998785,1.777358006120555
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.2340298397139737
SCC-9,100016,6.423023301160456,6.170517788818767
MDA-MB-453,24180125,2.9500133631526477,3.1956900205851726
MDA-MB-157,6610216,4.481014218943506,4.333686588847948
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,-0.3406404306250604
MDA-MB-157,216239,2.048111671637324,2.254824364875118
ONS-76,72376,-2.745447792813742,-1.5124368001686725
YAPC,56946209,-4.683971162846982,-3.8624509401405738
LXF 289,11977753,-2.1467130480879217,-1.4694427298595079
A-673,46926350,-6.171938943197618,-4.445018998106892
SNU-81,44490293,1.2258782245734428,-1.6724125323463743
A-673,3384730,1.4382839107098095,2.230117424934384
HSC-4,5328940,0.4436918358674775,1.6097436892471755
MDA-MB-453,15953870,2.92470748098227,3.3358719525996907
ONS-76,44487061,4.494085272908884,3.640823622087841
MSTO-211H,656346,1.1626228980727835,0.9197646170548155
NCI-H522,72376,-2.490005030905514,-2.237764549411582
A2780,2945648,2.954770875487345,2.6949010802064985
OPM-2,49867926,3.883283056469906,3.519761470891506
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,-1.6706203522689569
FU-OV-1,2729026,1.7636424043101242,2.824379133562124
A-673,5351362,0.6290025594893434,1.2512873961640576
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.8797390885143732
NOMO-1,3384730,0.781590014898287,1.413726955471188
A2780,753704,5.064252843259393,4.6991175418911375
LOU-NH91,104842,-1.007764649763801,-2.6174029906492104
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,3.5301168977081563
NCI-H661,135398738,5.197398941249139,4.182082773594034
OPM-2,11213558,0.5330056992590615,1.1385891163784287
SCC-9,216345,4.596520649168519,4.144435005677828
LXF 289,73707398,1.5723760999376108,1.4932208632728297
KYSE-70,148198,-2.193158047226166,-3.233766911547607
LoVo,5281672,4.34355838965171,4.626793000622981
NCI-H292,3081361,1.6323755734101046,2.569808718279922
NCI-H292,969516,2.7034021602074207,2.8913221811964704
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,3.6460452686613616
DMS 273,56963564,0.2331753873879126,0.10632147225038877
CAL-51,168313047,1.9592520089902103,2.4264068425419545
CA46,2949965,2.263314804434843,2.347596483141452
G-401,135423438,1.541142645334712,1.6362965766784796
OVISE,16741245,2.37455837119256,3.97468294909809
CA46,3634881,2.7183374991781903,2.560965007953251
HSC-4,11427553,3.1625220487182193,2.82744884634066
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,3.6178562263003418
G-401,168313200,3.793890782777564,2.6140932951183724
A-673,3689413,-2.493408888485536,-0.6999116455788836
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,0.99303644998984
A-673,3062316,1.882423163055416,1.423606150107319
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,2.5184234188887484
FU-OV-1,49766530,-1.0180111021842635,-0.5340612320552297
NCI-H1623,4259181,0.7011384719609343,0.5589236888341583
NOMO-1,11427553,1.1686106553832942,1.1577338089563352
JM-1,25102847,1.7356230100982195,1.9427953328212413
A2780,219104,2.8403974518726938,3.218318526928207
SBC-5,2113511,4.3346082595960045,5.440982146030166
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.4154501648073836
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.3839770612236704
BT-549,44607530,1.0072782741331217,2.0685795748799443
FTC-133,56946209,-2.082875590070058,-3.670204599313044
SBC-5,49766530,2.674414744921775,-1.1547698469073726
NCI-H727,1750826,-0.0055354600789778,-0.953290434152545
SNU-449,2749,2.680740017346485,2.145459028800288
YAPC,46843906,3.8406256643083214,3.2114390709775322
OVISE,3503,3.051689922997692,2.3521311864021914
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,-0.08904969998061896
A4/Fukuda,24901704,2.035809268681581,2.566297605171093
SNU-449,2949965,2.551789087127138,2.9879420545501567
MSTO-211H,65064,5.509158922836103,4.725874844047926
NCI-H460,753704,5.635234970240753,4.932309589067166
BT-549,9907093,5.687861442777729,4.415528901135085
SNU-449,89928392,1.7008506784074908,1.7804381691504827
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,1.943681285222178
LOU-NH91,675434,4.5447066201437325,4.68635793731892
CA46,5351362,0.7524287969492447,0.9005098577043344
BT-549,3025944,4.080638158593822,4.462716944421789
SW1463,57330099,3.693611547578868,4.308597211473133
HSC-4,16722836,1.7684769334825834,1.80536679079307
G-401,4096211,1.4243357241965535,1.7102627773271828
Panc 04.03,6610216,4.328711123736605,4.412024736384206
KMRC-1,5287620,-2.779883294896464,-2.1487461762741424
BxPC-3,119182,-1.1309049402050737,-1.1325704155782073
G-401,135999136,2.1711954992798987,3.163991056378366
KYSE-70,285033,-2.195981319752621,-1.9963613121677835
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,3.111649134814174
KYSE-70,44607531,3.0404164934883733,1.4426381123912864
SCC-9,6918878,3.402250236896725,2.954138638587797
MDA-MB-453,5282054,2.7696083041072237,3.4728996073330776
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,2.60006119581639
BxPC-3,57519531,2.3630144255947045,2.7800065176749387
NCI-H2171,56949517,4.289308734480345,4.029851655331552
Panc 04.03,54619267,4.1321899610425215,4.213738842118601
G-401,11485656,1.708547873036538,1.8589652333629154
A-673,6917907,-5.646852280462545,-5.252764355238841
NOMO-1,71304818,2.372593058500035,1.9232444917185305
MSTO-211H,11214940,0.3292815706978371,2.114693941209393
HSC-4,1750826,0.4564084690350189,-0.9801206043142838
HSC-4,426756,6.131320111521982,4.496853245137575
SCC-9,12001922,2.463166865850559,1.9121168691621993
CAL-51,656346,0.8466306406200714,0.8315516414890672
NCI-H661,49793307,-1.6947898398784864,-2.643357128983238
MSTO-211H,6450551,1.5186693992042568,2.899714208629655
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,1.3285437320362723
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,0.8259783785643794
NCI-H460,73707398,3.251551904382877,1.4471334818721542
CAL-51,168313016,5.819136604546001,4.791355965738799
NCI-H292,119607,5.8072644572840915,5.455561186763889
SNU-81,31703,-2.2099083949209715,-0.9334007804524324
A-673,11719255,3.0296971336672627,3.0316157364762484
HSC-4,9911830,2.7717739782698563,2.76252456852771
CAL-51,44589607,2.4963130908502107,2.8999927787736577
FU-OV-1,24180125,2.037807307003979,3.0656620818340086
EFO-27,3634881,3.530057446917586,3.40155246646776
MSTO-211H,25262965,-3.426128826799908,-1.0516550125832942
LOU-NH91,3543504,4.266458043071255,4.601816008714977
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,0.7347684737465094
NCI-H2171,23582824,0.048802245172864,0.26678802928089423
SCC-9,11507802,1.3688807961315366,1.7463381697804854
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,3.6192768954674746
CAL-51,65628,4.560195683913681,4.362256895897461
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,3.5190370146554617
CA46,6505803,0.7805822725654986,-1.264059777301625
KYSE-70,327653,3.7336437717951103,2.990072682514553
NCI-H2171,11494412,-0.1110474347644453,0.9100060179294135
LXF 289,6918328,-0.239589445073231,0.21659019210719105
CAL-51,24951314,1.3730048574034712,1.3859975592381084
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,3.4077565294688013
A4/Fukuda,2858523,2.415383768636832,2.9250498675378394
NCI-H522,753704,4.098243268802601,4.793811948307165
A4/Fukuda,11625818,2.700159842549232,3.4922138461970023
MDA-MB-157,2949965,2.5406478696331587,2.8059388839328623
ONS-76,409805,3.962852167855045,4.912952880176971
NCI-H146,439501,-3.5641402563292393,-2.3293575396307684
CAL-51,24856436,-0.3083697359271743,0.46200682279083866
SBC-5,31703,-1.5086983052531706,-0.8980258110451382
NCI-H522,10184653,0.5663226513641079,1.029191761307413
NCI-H522,135421197,1.9700795220087195,1.6358356317962373
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,-0.7635177281740287
NCI-H1623,46398810,3.5623335184860196,2.631681117513314
A-673,216468,-1.1121166448103192,1.6270131137241515
BxPC-3,2708,4.650566781622339,5.12130879936289
SNU-81,6184667,-0.6614889419446587,3.103689880731723
NOMO-1,168312962,2.6221164331885003,0.309270017196312
MDA-MB-453,16720766,-0.5495005772629474,0.16511844195402436
NCI-H522,9956119,4.024745164263863,3.4287818223832818
NCI-H1623,135440466,0.8012621152288821,2.29650553162855
CA46,3025944,4.264528242833472,3.5904733398078696
CAL-51,71466380,3.802692276073616,4.556494915262842
Panc 04.03,11656518,3.295682085422899,2.1075329976396566
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,1.2050189506311189
LOU-NH91,16720766,0.888730139062919,0.6908261941933048
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,2.5716568173883187
JM-1,57519531,1.1574190263295916,1.6508342511683651
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.1480225753447
MSTO-211H,148198,-2.180219295506665,-2.806381448977102
SCC-9,4521392,4.43257578464979,4.429923248770212
FTC-133,2746,3.487652314498242,3.1076207186225844
LoVo,44819697,3.398153390084315,-0.6467236716532715
Panc 04.03,122327,5.490637645011104,4.821001579757455
BxPC-3,25154868,5.007679584209566,4.560328854744185
NCI-H661,3503,2.324538290067321,2.1418451774167666
NCI-H727,54618771,2.7901712320729333,1.174142138061062
A2780,10302451,4.067201499125142,3.059501780969307
A4/Fukuda,5281321,-4.090150251628595,-1.804762643566473
Panc 04.03,24771867,4.398084543376112,2.57287362839448
CA46,241158,1.6221144264981358,2.4162684640314054
SBC-5,26596,-2.1907470722084414,-1.4507607622147114
A-498,11625818,3.6553151033235904,4.7196601106978315
G-401,9911830,0.6760173642929876,2.0955285308348333
CA46,123631,1.9024335998312112,2.073400370829187
LoVo,104842,-3.39586805089817,-2.6660604094839666
OPM-2,5479543,3.226492982806864,2.346343483836
HCC1143,6623618,3.4930934009716226,2.4242933988261015
NCI-H2009,46199207,3.041674504763304,3.294440372921793
NCI-H661,49766530,1.1318827683023138,-0.5295783758211525
CAL-51,1641662,3.5457804017420744,3.325216583901737
ONS-76,44819697,-0.7397391051726983,0.048501944560929225
BxPC-3,57330099,4.21152658046839,4.473302228419045
MSTO-211H,3038522,3.865174160499475,3.1365735044713987
LXF 289,71466380,3.888647536265504,4.807545597926844
CA46,5479543,2.004846411807367,2.230770207925502
OPM-2,9907093,3.786753386665246,3.6511449664548525
NCI-H522,54613361,-1.014694822148615,0.14141222796974132
NCI-H2171,25195348,2.4042641753284872,2.8992559377814597
LOU-NH91,9911463,4.226439837654448,3.9410775965516818
JM-1,6918736,-2.112176013423493,-2.080895312983576
OPM-2,89183176,2.1177805080987633,2.9032784341956246
OPM-2,135875424,2.796643273298537,3.511386338188993
HCC1143,24964624,2.836653438175677,2.5495998133757087
DMS 273,44566777,1.254196350489733,0.3829730756856178
NCI-H522,49867926,4.17523654199276,3.9626634007940864
LoVo,72193861,-0.0557430791680942,1.5789382174261828
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.3953898325545806
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.576917175109839
SNU-61,374536,-1.8297483787291275,1.9888333560379774
CA46,44566777,-1.0409480025289963,0.0874324195200553
JM-1,54613361,-0.7111924625528845,-0.7826662573897596
LoVo,25154868,3.829103546750207,4.429315837072164
A4/Fukuda,15547703,2.4441609561923547,2.794973264428382
KMRC-1,10074640,3.6694615069556886,3.133085386593749
NCI-H2171,2729026,2.1337054337121466,2.268846181069666
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,-0.17568221881195314
HCC1143,68056272,4.744387863321378,3.575042532029317
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,1.0157803447439324
NCI-H2009,44607531,0.9822487023795796,1.5067160496222467
KYSE-70,89183176,4.766828638924323,3.852569057268162
SBC-5,25154868,3.0138435145006155,4.41273110000989
A-498,11719255,3.5352993104723245,3.5463529930941053
SCC-9,208908,2.838235608451249,2.1766724954799876
SW1463,2126,3.781949624288532,4.313214423595707
SBC-5,5311,0.7694897344457827,1.2721764101072717
BxPC-3,11609586,2.766108761160721,2.8209124353358317
CA46,71466380,3.212448709653588,3.5453210812385754
FTC-133,25126798,4.495223588633032,3.6433474791099814
JM-1,44632017,0.8586744690995054,0.6045418197144143
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,0.7654328121206163
SNU-449,4917,3.4001304631059965,3.1834111028318124
JM-1,135984461,1.552881480804892,2.9058173260414724
NCI-H2009,969516,2.7623608328977314,3.142226470328591
SCC-9,104842,-1.437225086828998,-2.5253878169126347
CAL-51,73707398,0.7053044464230985,1.218137864881192
KMRC-1,67156097,2.0694443843024173,-0.259700743325589
SNU-449,135411,1.1071215925884743,0.9253881448176193
A4/Fukuda,72376,-3.4342601152101473,-3.141963362857233
CAL-51,54619238,5.308906879487735,4.6823938227646815
SBC-5,5282054,4.370273963099393,3.657147650256974
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,2.9801532441399514
OVISE,5328940,2.3935755372069676,1.78991878417973
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,4.48771285828645
A2780,24779724,4.3340331177123765,4.013864652708649
A-673,400769,-0.9976419565742564,-0.6999810528517482
MDA-MB-453,3081361,2.1431734647577496,2.3913960947691466
A4/Fukuda,123631,1.573225246333458,2.079395091768005
A-498,46224516,5.193995490382977,2.6762915377228973
CA46,5738263,2.2696720462337456,2.726570213057657
DMS 273,16722836,2.1308156944151833,1.709448026617067
KYSE-70,119607,5.065055719995064,5.128441709725151
MDA-MB-157,637858,0.0650158223638603,2.230499891106315
KMRC-1,24180125,3.3952911821821052,3.2488135322799763
A4/Fukuda,9935249,-4.132944592984893,2.430704981731861
A4/Fukuda,9915743,-0.3554458205966057,0.780034332668984
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,-3.9239562129667003
FU-OV-1,11222830,1.8946229471337992,1.681245050719299
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,2.3936688879134276
NCI-H522,24775005,3.057250054087749,4.1411700786959065
NCI-H522,15983966,4.053677978120726,-1.6192830288160545
DMS 273,25102847,1.54508352242066,2.208422812626759
A4/Fukuda,44543605,3.1271044447490235,3.780059975764084
CAL-51,44507138,2.6477043136390637,2.652070129004969
SNU-61,16725315,5.215969195263621,4.386923521156762
EFO-27,448949,1.7491267397814168,2.0661042529976243
A-673,5280436,1.8974559090481808,2.95463317712168
MDA-MB-453,24779724,5.606505141806212,4.2882202632104205
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,3.0703184740556764
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,-0.6331133935637214
NCI-H522,216345,3.499198551341706,3.4955655329150574
BT-549,25022340,3.398199457605664,3.10193486662561
SCC-9,23725625,6.300420686237622,5.190664507784461
MSTO-211H,54619267,2.133098694540018,3.7563630135230257
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,0.9797686151780332
A-498,148198,-1.0809020747576437,-2.609590737738932
SNU-449,10127622,5.039458046327855,3.8281745776545177
CAL-51,1641662,3.5457804017420744,3.325216583901737
MDA-MB-453,5291,3.622613892398656,3.466602216127934
A-673,168312962,-0.712468254461992,1.2708250184017094
SNU-61,52912189,0.4386789975034979,1.6746540628079793
LXF 289,2828334,5.402872149224608,6.351171009336688
BxPC-3,374536,3.0351492595764347,2.460621008976623
EFO-27,9825149,3.71226874457915,2.129820665747744
NCI-H727,216345,4.166745514794161,4.0027948905954585
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.5163120479719694
A2780,156414,1.0391092981452308,0.9912059753654222
BxPC-3,11647372,-0.5523773269560157,1.053804814676903
NOMO-1,10296883,3.647443685498321,3.1739825523641656
LOU-NH91,60750,2.5426597160889823,-1.7030756640709706
NCI-H460,16038120,2.547350732010626,0.934375547365962
ONS-76,123631,2.7486777230854176,2.461545989379572
OVISE,9903786,4.69480560533159,3.193616790106648
HSC-4,168312962,-1.5337410071263893,2.5443591589058876
NOMO-1,421610,4.35383474826381,2.629072094117161
NCI-H661,4917,2.840246866325883,3.0222312659299995
LXF 289,3634881,3.11935208210029,3.290101571014251
EFO-27,9911830,3.273850069923984,2.5660086391423977
A2780,46215462,1.4920420325768875,1.5173015334459767
MSTO-211H,11234052,3.0252233847843515,4.157994028884926
NCI-H522,2842253,4.095670069869479,4.934441807863131
A-673,3385,3.2869772752619033,3.7607353016931033
MSTO-211H,46398810,1.7478948810000858,2.634483217497313
ONS-76,49850262,3.849158291733923,3.771524287040839
MDA-MB-157,11507802,-0.5781039838427031,1.7659079691854196
A2780,24978538,0.9309197302054482,0.45949426648848735
BxPC-3,24180719,3.164671730334926,3.377461007961094
NCI-H146,676352,1.7139908333138,2.0528800448213262
A-673,82146,3.820966427179324,3.495155505836043
NCI-H2009,46174525,3.5250507211438107,4.573130990789158
EFO-27,10302451,6.465018307145316,3.690027608501579
A-673,135984461,3.9402009784769745,3.282838609170975
HCC1143,4521392,4.180219407268625,4.368848641379505
A2780,5351362,1.3372825777001471,1.301237326373717
EFO-27,10296883,4.235346466258499,4.09357382658893
SNU-61,25150857,2.1451887473522295,2.4814824032656593
LXF 289,25150857,2.4132050810476,2.6114577547046496
KYSE-70,135440466,2.892957215680813,2.267866843376671
MDA-MB-453,11222830,1.1155100991132725,1.4677983139410344
A2780,6918289,-5.622064624678881,2.2295481491527775
OPM-2,445455,3.93427157933256,3.9723691370990246
EFO-27,15953870,3.8448280803188233,3.7639394623642324
A4/Fukuda,4917,1.915641979161103,2.696261215641558
YAPC,44185566,2.6271326170179248,2.6147729494494705
SNU-449,3634881,3.3285371967859128,3.4398813141401483
OPM-2,44566777,-0.9514063433103236,0.42764981147452713
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,-4.130871559618899
MDA-MB-157,4259181,-0.4671059045276012,0.33191908303427786
SNU-81,11656518,-0.0512259493867009,1.047862437796573
NCI-H522,11494412,-0.7022253688217924,1.283218421263949
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,2.907664025224008
CA46,24180719,4.114109141176105,3.1134998581306674
MDA-MB-157,82146,3.0360891700929984,3.8097706709867123
G-401,23635314,-3.865618451368766,-1.9854580072215635
LoVo,42642645,0.0146125142547242,0.901042315576272
HSC-4,9826308,3.3704185574061456,0.666734918142374
NCI-H292,176870,4.643600229240446,3.5019507971389547
ONS-76,44202524,1.6130278410730936,2.531032825880483
KYSE-70,9911463,3.4914249269651307,3.8222344125568877
NCI-H146,24779724,4.32606530761132,3.606612351455381
LoVo,44493528,4.114958638118981,4.269252612823539
CAL-51,44486219,4.943814728636009,4.2627517862385504
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,2.2822935878888613
MDA-MB-453,8515,4.14044832994183,3.8724280573185923
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,-0.21591681432445345
FTC-133,56963564,0.7376209226585526,0.32640235871953593
MDA-MB-157,11494412,-1.4760508995443156,1.7844222454505339
SNU-449,4261,2.5462586921108197,1.9930426774496661
MSTO-211H,984333,0.926178476056404,0.9118703180907352
SCC-9,1641662,3.777884166860496,3.4864224850776298
HSC-4,2949965,3.8536489984175097,2.7664910782618026
NCI-H2009,5566,2.98031688083636,3.081883671537621
HCC1143,16741245,3.781249389530293,4.056589362624478
CA46,67156097,-2.616833441535583,-2.3641874147863247
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,3.4948792059181204
G-401,55283,4.120501166008349,2.205528966251081
A-673,11977753,-4.8378783477247875,-1.5736805471601258
BT-549,637858,2.0216713295762614,2.348276361964515
MDA-MB-453,5287620,-1.4808110009700917,-1.917108165919219
BxPC-3,46907787,0.03250860780982,1.965406114031474
NCI-H661,44819697,-3.610310878099198,-0.5667275139163478
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,3.4626750543215286
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,2.72822721908545
BxPC-3,46191454,0.7426288337003383,1.608912800340494
MDA-MB-453,322968,3.088283756332906,3.1168632626008552
NCI-H1623,16736978,1.234327001570643,1.6002720828665533
KYSE-70,1641662,3.490090790744947,3.511798947411634
A2780,5470400,5.365026906170319,-0.2561560715787888
NCI-H522,23582824,0.9084599252004664,0.7132628306263672
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,4.019973758772248
MDA-MB-157,23725625,0.2462467633250468,4.983734724917232
SNU-61,44632017,1.0979359106396418,1.1127359314666934
ONS-76,8515,4.109060881613791,3.9480658098791808
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,3.1291304588545414
HSC-4,54626689,4.284935050666877,4.782433881064288
SCC-9,42642645,1.380036396261508,1.0850623282078629
LOU-NH91,9866186,2.5706791809917258,1.1695480258950754
MDA-MB-453,3552672,1.8646445353613752,2.699734193144516
LXF 289,11507802,1.7765111516543377,1.6207960161423687
KYSE-70,107985,-3.298359335305578,-3.4165178736418884
G-401,53325874,4.831157164763357,4.228463225955087
NCI-H460,5746,0.0249012606464236,1.0398796324379411
MSTO-211H,11213558,-0.8326933060339966,2.126745595729968
KYSE-70,56963564,0.3897414986371327,0.5951173370100941
FU-OV-1,11485656,3.4521578130267336,2.4050051271842645
A4/Fukuda,56963564,-0.5107551488404702,-0.10946522396366616
A-498,51039095,3.6847311434926535,3.039261493179741
BxPC-3,44486219,3.8860987116797703,4.384499521612864
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,0.42755832543972916
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,1.4611072539303804
HSC-4,44819697,-1.3561318696958864,-0.010583763072439412
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,3.7438410247516414
A2780,148198,-4.120801514793353,-4.443803361647035
YAPC,36462,2.246335150310725,2.1840113930612772
NCI-H460,10184653,3.574651577310896,1.0831655507961038
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.6408005637398504
LOU-NH91,54678924,3.1162234647683205,2.1375136001675856
ONS-76,11214940,1.2536021206371053,2.0599376041087316
SCC-9,9907093,4.490912734248418,4.323273555254696
NCI-H661,11964036,1.3116184134954847,1.40757125740003
CAL-51,135411,0.595745817277345,0.6096299393256638
EFO-27,613753,3.260816470325069,3.105234894539024
A-673,73707398,-0.4228078892765429,0.887886270127431
YAPC,25262965,-0.9761970914901598,-0.9968365599698794
LXF 289,31703,0.1888440469000175,-0.6584882177106851
A-673,44486219,3.969252294689724,4.185037987390921
HCC1143,135875424,3.1375636080090925,3.9926169659182076
NCI-H661,241158,4.406370209729512,3.798568573078593
A-673,17755052,1.3895683648511998,1.3328395663463832
LXF 289,4788,5.213081732847737,5.739654715831603
NCI-H522,5738263,2.340773324031017,3.1151132951115317
SCC-9,4788,5.928282303581182,5.79297119393193
JM-1,46843906,0.1108259550663182,1.5888216628352325
CAL-51,9967941,3.511576456928413,3.7671039172205805
Panc 04.03,5746,1.7282227653726634,1.3623555356556603
JM-1,444795,2.4559914793227597,3.334190625041095
A2780,25183872,-0.9660294253312856,-1.2351916151612052
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.5009855751469605
A-498,12001922,2.3665933531109564,2.0751786847336766
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,2.9695915998948346
NCI-H460,3384730,3.247736649900264,2.6785479501452447
NCI-H292,9884685,1.805947993429832,1.1606721490928311
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,3.6782304382022546
NCI-H2009,25126798,3.423512143516965,4.002627397546767
A-673,67156097,-2.6530750558799268,-1.7136284909886836
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,1.0018408817169382
NCI-H1623,11364421,1.5638784569997608,-0.5134448634936731
OVISE,65064,5.3042455172619345,4.7223615808592765
CAL-51,11485656,2.6541256228973773,2.355493020738484
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,1.0827732943906376
G-401,135984461,4.271777659576195,3.6020015430102297
A2780,11960529,3.87105656281655,3.9100321228814043
OVISE,168312962,-1.1497759256084987,2.0815468414100518
SNU-449,25062766,2.0173338536366776,2.21672036914913
CA46,44462760,4.878030903037556,2.4977552393781774
SNU-449,126941,-4.267074342641938,-2.4675446526636247
BxPC-3,55283,0.3092833280624811,2.270836675424336
MDA-MB-453,2708,5.180783048838842,4.7132834603369025
EFO-27,441298,3.357031616162376,2.698882630004638
A-673,25195348,4.457358631051988,2.55879134218484
OPM-2,285033,-4.309653599496783,-3.1657454467624717
FTC-133,156414,2.701071854154092,1.2909997381332394
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,-0.1869405042073366
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,0.5760307608245911
SNU-449,219104,4.193064059209751,4.091831717867574
SNU-61,387447,-3.847354855280633,-4.4200098980278435
ONS-76,89928392,2.125505613903981,1.592916726321607
DMS 273,10296883,4.130929131041443,3.5959786276531536
SCC-9,71466380,4.753733846444339,4.730854758131802
CAL-51,11234052,5.18044926966805,4.121492762049893
FTC-133,135875424,4.265925786122884,4.094818403782656
NCI-H292,135398738,5.91070825601545,4.268979039390259
NCI-H2009,24785538,-2.0037312151285462,1.7413088021383283
KMRC-1,5281321,-2.040334048066586,-1.0671472132723927
OPM-2,9926054,1.8132463747821628,1.651554937539217
NOMO-1,44607530,2.1799605259844914,1.5363762899852347
BxPC-3,104842,-2.6661298782325265,-2.736859698571265
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,1.3926659110444155
A-498,1716436,3.6890609174990057,3.119833073770556
NCI-H522,252682,6.061888172888063,6.313785720452391
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,4.002827623388916
CAL-51,409805,3.8515087112009656,5.100272396978638
SNU-449,676352,1.7938896042567478,2.2310939782843335
NOMO-1,72193861,0.7304873005319745,0.5736324860729378
FU-OV-1,5566,3.32118213388136,3.0224769820737425
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,1.847960083617659
CAL-51,5291,4.8235616489491635,3.8410765407675935
NCI-H1623,73707398,1.8898657972875643,1.6077991976680732
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,1.1805709457357858
A2780,54619267,2.083839750794981,3.933600194948284
A4/Fukuda,25150857,1.0832866246256998,1.8283493106138986
SCC-9,25195348,3.9019221273063858,3.4194757452297737
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,4.239216152764733
NCI-H2009,20959075,-3.4439076637996076,-2.939877403277198
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.5938388459018977
YAPC,135875424,4.215334227700636,3.922627107471998
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,3.0548130701563467
LOU-NH91,2708,7.798658787946165,5.114836298562006
MDA-MB-157,54613361,-1.9100924648361528,0.27659483022860815
YAPC,613753,3.436227254149273,3.345943789177641
G-401,26596,-1.5666727843222663,-1.5036698652542178
A2780,124202324,1.685811695923782,2.2322818243582256
BT-549,52912189,4.655826026030035,2.4259681922704543
OPM-2,6438330,0.5735051923287856,1.0355891118560507
ONS-76,49766530,-0.8397126534273769,-0.7861175073713562
A-673,24180719,3.918829940752815,3.376195377324815
A-673,72734382,3.862779655203366,4.175364589074809
JM-1,46926350,-6.131969810114727,-4.7164363217346645
A-498,216239,2.9738940537308203,2.3398907971354466
NOMO-1,54618771,-0.7336388686704796,0.15331258427331879
A4/Fukuda,25126798,3.529395374343333,3.2499431694854377
NCI-H522,16013152,4.870026952980287,3.945339099447365
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.312000124086821
ONS-76,6918328,0.1573953751573411,0.05615968393550706
LOU-NH91,1566236,3.241690914019502,2.651572191039192
HCC1143,2858523,3.0390361797055276,2.9955251661287123
BT-549,71304818,3.5849392152335713,2.4254080691093636
MDA-MB-453,49867930,4.991198207309722,4.542233942434323
LOU-NH91,4261,2.7247094190978007,1.8845943044687383
NCI-H522,52947716,2.6251827866590385,-0.9690873805592504
NCI-H661,6852167,3.3441449371697205,2.789062192899282
NCI-H292,16736978,2.16203795839555,1.4822922198686335
SNU-449,637858,2.172600125936458,2.1482761308055616
SBC-5,16720766,-1.9276845300945755,0.2645161233514276
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.8795454463376882
NCI-H661,2828334,5.966055284777512,6.129830526774389
EFO-27,9884685,1.4230112837032636,1.098338043677053
OPM-2,25227462,-6.0467342682230445,-2.8480761975394357
A-673,3038522,2.0400506341720237,2.6369539072337522
HSC-4,54686904,4.85379149564711,3.9753250919996583
A4/Fukuda,969516,2.117405484631732,2.5793488132758675
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.9536248762048507
LOU-NH91,6610216,4.701575628194421,4.443178643232184
NCI-H661,24856436,-1.6135015308236011,0.648302153428102
LoVo,6252,1.008875569338637,1.0722370401443628
CAL-51,5281672,3.9430830045045857,4.586831180900338
YAPC,25183872,-0.4840811687838853,-0.5857547491832236
NCI-H2171,11222830,1.3474519729527985,1.4924636685528574
SBC-5,16722836,3.112579400078665,1.4948881529727265
FU-OV-1,3689413,-2.180005064661593,-0.43229961900594577
JM-1,6914657,-7.803103466538306,-5.3161486481812155
A4/Fukuda,11222830,1.361211164053787,1.1493188079810561
OPM-2,24180719,3.7347961717129383,3.2381846068756692
A2780,50905018,3.503420862443992,4.247800099203748
LXF 289,168313016,5.746715572468322,5.039680649486562
MDA-MB-453,2874250,4.390759253530558,4.27630174085261
NCI-H146,3543504,3.2112662755133616,4.061145012721372
MSTO-211H,9956119,3.2798548332341246,3.458124282623393
NOMO-1,11152667,-1.8753376491976492,-1.9083580145906947
NCI-H292,241158,3.585722962787503,4.09967737067878
SCC-9,52912189,3.371588298050412,2.467352324417422
A-673,15983966,-8.138595470092604,-2.546121808502685
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,-0.4624087205054967
NCI-H146,5287969,-2.632266530811145,-1.964848966351322
A4/Fukuda,44632017,0.3391160528514481,0.8407719578890878
CA46,1242560,2.637858421223904,2.7084340256139
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,2.1486783477087545
NCI-H727,10184653,0.8809089143232124,1.4042600443033086
MSTO-211H,6918736,-4.031815262851263,-1.3828543475238544
Panc 04.03,54454,4.748257983656133,2.706388103758175
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,-0.7497130396996087
SNU-449,6918328,2.053547134624907,0.45983507591579326
A4/Fukuda,262093,3.0357368226896178,1.8373183732432095
ONS-76,6918837,-2.636307015456442,-2.48682182371479
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,-2.7742178030269264
ONS-76,107985,-3.307412021608342,-3.256907894419574
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,3.220378814522393
OPM-2,42642645,-0.4905470491794313,0.09143590569787875
FTC-133,16722836,3.262117509304611,1.7922951667658569
SNU-449,123631,2.9179285945779183,2.367840318308115
OPM-2,644241,1.6900050339542656,1.2744150469775062
HSC-4,1242560,3.572222416741055,3.482498202982739
NCI-H292,123631,3.5457837677726833,2.490878500458802
HSC-4,2842253,4.76622062087716,5.411254628538114
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,4.221742567931472
Panc 04.03,3689413,0.3957464459941977,0.11324003715332803
NCI-H460,135398516,4.13019906717736,2.0103644442600275
NCI-H460,5311,2.161812802665503,1.5811973360498663
SNU-61,11238147,3.2212717665721375,2.711344498460414
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,0.8177284300308214
HCC1143,44607531,1.4024247683472026,1.48942619718669
NCI-H727,5351362,1.1476230363651536,1.590997264590124
KMRC-1,6852167,3.0099217565414693,2.8946086980231946
MDA-MB-157,5311,0.9088479539093504,1.6933329126827104
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,3.9704588764976636
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,2.0790806537982003
SNU-449,3025944,4.153676005178765,4.352358317162925
A-673,23635314,-4.460908555858267,-2.181861533206742
JM-1,5351362,0.3312371174067021,0.7931021399922882
DMS 273,24901704,3.9468378622372264,2.977683281033796
MDA-MB-453,9911463,3.8683390626627454,3.6310004764667094
OVISE,60700,1.357326318980797,0.24180159313823255
FTC-133,448949,3.317946341403347,2.0858650695646643
LoVo,5566,2.507145044552918,3.0057639066874575
DMS 273,9967941,3.979035067958665,3.3457465916178717
LOU-NH91,16038120,-0.2213795856096394,1.2423143425917778
NCI-H1623,11977753,-1.4500330036408269,-1.5305786617453996
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,0.42282486383758183
NCI-H460,31703,-0.6563705559837907,-0.6495689038173424
A-673,9866186,-0.4052980916556575,0.45185594102214355
OVISE,31703,0.0982732174518241,-0.6952771499784499
HCC1143,124202324,1.6321362493528402,2.604302446557122
G-401,4705,3.1032512954578415,3.170337316513726
NOMO-1,3025986,-1.4139862297409005,-1.876112893034532
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.7249408569195495
NOMO-1,148198,-5.33573798573566,-4.173293299745403
A2780,9907093,2.8643649893432106,4.032002023527385
HSC-4,44607531,1.5153971496977892,1.25159131177719
LXF 289,2746,3.190299829163617,3.1859755245827497
MDA-MB-453,4261,0.3032353935433951,1.3855385220634266
BxPC-3,656346,-0.1234429100103727,1.1240516301368957
Panc 04.03,BRD-K55473186,5.259619810258457,4.3333598531201725
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,0.6734934718681036
CAL-51,3385,3.064238699960593,4.220660201991997
BT-549,675434,4.287026263227802,4.615916871856319
LOU-NH91,9868037,3.6278868560603574,3.305394479657565
G-401,400769,-0.955062013548762,-0.8362368323127578
SNU-449,44185566,2.80206906512974,2.754265663472668
DMS 273,613753,3.2268993277161524,3.024607539406864
FTC-133,9911830,2.8814152307979946,2.5595496948449594
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,2.251665150383854
FTC-133,462382,1.2436445575195818,0.38066404574730944
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,2.6776405987494094
NOMO-1,9884685,0.4754269892492985,-0.03796190424191057
FU-OV-1,44589607,2.6910555486326397,3.148355018452436
CA46,11228183,3.2150932794291975,0.337101513138817
G-401,24797083,1.4378353960151609,1.052660744036137
OPM-2,4705,3.10353547990691,2.800814155427681
SCC-9,49766530,0.4117706354329887,-0.3469130576976285
DMS 273,44819697,-0.9932488797546292,-0.7665704259867819
NCI-H661,56963564,-1.1338494929069671,0.6928695561999416
NCI-H727,25154868,4.680199730171404,4.443778357519496
MDA-MB-453,56649450,1.3470223737131497,2.820818478464271
CAL-51,54678924,3.225490994604415,1.8842182285837674
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,1.3820182514072794
NCI-H522,56963564,-0.3134921987801757,0.4009729231194109
JM-1,10322450,2.576608882705072,3.3001033737112566
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,0.6274174026495238
A-673,24748573,1.962021648564739,1.7722800285791154
LoVo,24785538,0.3940436885335026,1.5835738100872299
NCI-H292,135421197,1.1571557888211337,2.059752146895038
SCC-9,19582717,4.601399638975327,4.217525952456791
NCI-H2009,5311281,-0.1357038590739554,2.493731733470711
BT-549,24951314,1.7605147679012945,1.5328829678193117
CAL-51,10302451,1.350542324147247,3.1413239225797587
HCC1143,10127622,3.54698748679943,4.291591567657589
NCI-H460,44589607,4.73035444754351,3.021707849796042
LXF 289,10113978,1.6721223719755247,3.2376221630966278
YAPC,5566,3.1204203259985044,3.164513270045032
NCI-H522,135423438,2.202740699610144,1.8264534444441027
MDA-MB-453,5280436,1.8692407341233208,2.9741581712600382
BxPC-3,400769,-1.094495387384235,-0.6420722680275177
MDA-MB-453,57330099,4.336922942952946,4.276689743972247
DMS 273,24964624,-0.4885915334424611,1.7937813585923583
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.8524862284387316
A2780,11964036,-0.2399638951327319,0.8532678416472617
BxPC-3,56963564,-0.5407215297938537,0.383744956287499
A-673,9907093,4.212541297476806,3.9840056020800687
EFO-27,11427553,3.591439679350591,2.8950037035442477
MDA-MB-453,439501,-3.002845657836036,-2.1712573039902963
LOU-NH91,11485656,3.2972382499502935,2.597736580707051
MDA-MB-453,25161177,4.057301598200359,4.095040785322874
NCI-H460,54143018,2.5592633032091956,0.7766102757375056
MDA-MB-453,53325874,4.468628295310174,4.232349676809102
CAL-51,71466380,3.802692276073616,4.556494915262842
NCI-H1623,4788,5.98570816019398,5.681750999696298
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,2.185666425692477
Panc 04.03,11707110,4.882480457753906,0.7804503603210455
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,2.6920818484130375
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,1.8563026870993864
SNU-61,285033,-2.2323165928541746,-2.038446227096417
A2780,25150857,2.724824774969284,2.1748217070000626
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,-0.17762833186618732
SW1463,36314,3.0951531870893523,-0.6370342994866972
A2780,2858523,2.134868506415456,2.8715124193574257
NCI-H460,3825829,4.446795399525052,3.9992936812346613
A2780,1750826,-0.9954774428329844,-1.743091706734714
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,3.4419802476210606
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,2.525396688601914
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.179523413792478
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,0.3616593904431902
MSTO-211H,107985,-3.699787970340743,-3.5928517898005747
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,1.0034089878203842
DMS 273,10302451,4.121656528900648,3.239699401197534
CAL-51,262093,2.862241975448649,2.9068023717790883
DMS 273,4261,-0.2104746005525494,0.7410078759952935
MDA-MB-453,148124,-4.8335014079709975,-0.44863065030517846
G-401,11178236,-6.653209761704985,-3.671359110162832
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,2.6147157444363107
MDA-MB-157,262093,2.565616950913742,2.9403951131184116
MSTO-211H,9868037,1.9157833543052896,3.386520015990724
HSC-4,5280436,3.1415705358429884,3.4089570543528747
MSTO-211H,10231331,1.7809441814393978,2.270039579954327
NCI-H2171,969516,2.758162928931276,2.588376079816655
HCC1143,10184653,0.277782870066905,1.1257196867790074
A-673,4788,5.851137286094999,5.284969180981691
OVISE,11364421,1.999223974612241,-0.8331599669190416
NCI-H661,44202524,1.2385989199848235,2.633136542849212
NCI-H460,3062316,3.704520183651484,1.4796203259031002
NCI-H1623,44607531,0.8047036576600745,1.4622365299395406
OPM-2,9956119,3.674575368535915,2.6490384870618255
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,3.5760095102645177
NCI-H146,54618305,4.054654997899016,3.725951091774515
OPM-2,11507802,0.0988268127526858,0.9996082060108141
CAL-51,10385095,1.0305027810027567,1.1271253544630369
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.732533649088864
A-673,71466380,3.8107210551169577,4.22654755792832
A-673,10427712,3.6867963290416346,4.080343350436251
DMS 273,56946209,-5.704769625352934,-3.8088129670318303
A2780,53301938,-5.924783673466769,2.399215728568428
MDA-MB-453,3025944,3.940846865776467,4.10379503136206
NCI-H146,9840324,5.546223512080725,5.59478408676867
HCC1143,3815108,2.289037887638348,3.056723714309234
NCI-H460,11625818,5.428588497019925,4.482410695197027
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,4.980245132240738
SNU-61,123631,1.7897165257078365,2.0855584498332735
HCC1143,73707398,0.6963565440176983,1.4585240165585593
FU-OV-1,24964624,0.6948307959675745,2.487210095235697
BxPC-3,89928392,1.339609071089843,1.7252331112499464
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,2.9938584337238208
NCI-H661,46398810,2.545394900571619,2.6759590436791725
NCI-H661,17755052,1.4228000150725233,2.026607438858934
CAL-51,10427712,4.2973287072996085,4.262980995399781
NCI-H661,208908,1.9265593878348335,2.2642325813741593
LXF 289,71466578,4.726723075051965,4.787152230248227
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,1.8580803670304664
KMRC-1,46224516,3.1277122869876064,2.4648749217427537
JM-1,2113511,3.632981632735763,4.587757372083911
LOU-NH91,2113511,6.175446639496144,5.582661693019033
A4/Fukuda,6918837,-6.1208599704470865,-4.377380897187938
FU-OV-1,11640390,5.4167064390474335,3.742646376493304
SBC-5,44607531,2.697205944866836,1.4522664730232941
OVISE,71304818,3.3064642565645572,2.376768745097337
OPM-2,11152667,-1.3080541002664456,-1.8279486242348073
NCI-H146,3552672,1.604439194031644,2.3900742609240573
CAL-51,12001922,2.008779489179369,1.8965426011618067
SBC-5,969516,3.68635139774897,2.813713250438566
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,0.40921484780329354
CA46,53495165,-3.0280125025934495,-1.8450708468830885
SW1463,60750,0.1610513612263897,-2.1193406866630724
FU-OV-1,46215462,1.830231092617303,2.109095619657248
ONS-76,49793307,-2.5280436252167733,-2.2603680836309046
NOMO-1,11404337,-0.1001889231988697,-1.148769377870219
SW1463,123631,0.5150504925697384,2.3127114792658983
A2780,44819697,-3.3662473846109333,-0.9464451383541437
A-673,44491742,3.844993574977925,4.103554090779436
NOMO-1,5280436,3.413613220161409,2.476251967463049
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,3.931004230030231
BxPC-3,2858523,2.8297817429760945,2.9013862755866033
A2780,445091,3.798794327077476,4.373703937466478
OPM-2,11647372,1.2733466761832082,0.20674763398391524
CA46,71751553,4.222934016329145,3.8597718581443456
G-401,44486219,4.1772416968228505,4.224988378040142
NCI-H522,9826308,0.3930789830124517,0.33561422772042887
CAL-51,5566,3.271951139375183,3.170011342046573
G-401,89183176,4.003742825914683,4.066401395528683
NOMO-1,12003241,-0.5951695723430065,-1.8704900848674
MDA-MB-157,2708,2.34132544783096,5.0131819155757515
YAPC,10410894,3.466680540940763,3.306245457295256
HCC1143,65064,3.71051637258464,4.5627566168448155
EFO-27,2746,3.149760082978987,3.369061829026717
LoVo,216468,2.992200557668688,2.726439884893018
DMS 273,3025944,4.590997145359233,4.153579508759897
NCI-H661,15983966,-5.492856258402122,-1.2744445234928188
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,3.336533468780428
CAL-51,2708,4.939881356462198,4.738919758315712
HCC1143,11175137,3.393081010308343,2.6329455447149552
CA46,42611257,2.680269393096826,2.5126731695705606
ONS-76,68056272,2.9147642388168675,3.5333283734938536
Panc 04.03,2871966,2.8539977368648275,0.629735378257329
CAL-51,25062766,1.9168321284868295,2.1492916727494698
FU-OV-1,52912189,0.1271866873311006,1.9400573463530038
EFO-27,73707371,4.965139584704115,5.19130108588189
SNU-449,24951314,2.758293516562198,1.3543110008301864
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,0.5122742457906286
A4/Fukuda,135999136,4.178898868342667,3.1270212951562133
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,0.9599305783778179
HSC-4,119182,0.0150561689419209,-0.5476165401598495
LXF 289,68056272,4.660756431297166,3.5241270468168624
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,1.7298611511391977
SNU-61,31703,0.3335579072308824,-0.7744346080201179
SCC-9,9915743,1.0040050158500469,1.1003328205342198
NCI-H460,446155,3.79922347841428,2.827826013709023
MSTO-211H,51037431,1.7350128995421004,3.112160388775982
OPM-2,73707438,4.146852269482474,3.9881976850330165
MDA-MB-453,9926054,1.6596725660557576,1.9840646871360426
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,3.6224377590590002
MDA-MB-157,126941,-4.13859012935224,-2.771343610571955
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,-1.3934039444408786
MDA-MB-453,24785538,3.5897722779252383,1.6096764012424924
JM-1,24978538,0.0218307924501431,-0.8952673256347643
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,4.257784852175225
DMS 273,3503,1.4004718919159695,2.0818656010241066
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,0.9313531189685054
NCI-H2009,9926054,2.181635437582939,2.0235932157317715
KYSE-70,23725625,6.518030965677853,4.8101423867222515
CA46,2729026,2.6315261399645755,2.077818413450313
OPM-2,135398516,1.2750707316498222,1.7202106740860887
SNU-449,42642645,1.3579889941817174,1.1535769078832383
HCC1143,25126798,4.15297730422149,3.891897177501698
KMRC-1,9933475,1.7755712843428362,1.6107001374676386
G-401,12003241,-2.103305079214356,-1.0867426407798817
A-498,5113032,5.384850868352965,4.746986213487341
NCI-H2009,6918736,-2.2815319513344896,-0.9621819245475303
NCI-H292,11455910,1.285235050416197,1.185876324375214
NOMO-1,24889392,4.281820029392572,1.6620379726389154
HSC-4,4259181,1.301377168384764,0.5344392185866244
NCI-H2171,73707371,5.940029655461802,4.2858084690396065
A-498,5329102,2.2449182254359843,2.3775972603602376
JM-1,51037431,4.238886241129638,2.6253786821235714
A-673,56973724,1.675633920325915,2.2575956388792258
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,0.8609998491742848
MDA-MB-157,136227331,3.870321503168366,4.40288888930651
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,-2.3491135391328495
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.7193578470824418
OPM-2,7326481,2.643641332780412,2.354419106801389
NCI-H146,135423438,2.8528911509997137,1.8611151388606564
BT-549,36314,1.6954100357352504,-0.03828284792560693
A2780,11717001,3.193837101204412,4.124297970706328
NCI-H2171,136227924,2.167829841056951,2.7386851741577227
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,2.132844113713738
NCI-H460,11152667,1.2005763717636435,-0.31084114860852874
JM-1,462382,-0.3688196944858197,-0.07155471962342683
SNU-61,262093,2.836545473910542,2.6849502788415567
FU-OV-1,10385095,1.480245925499038,1.2537703011436883
SCC-9,72193861,2.3270498811162508,1.5138631129482494
NCI-H661,1242560,4.217168015363727,3.3979541521524976
CAL-51,984333,0.1261860025273146,0.7685078118294375
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,-0.6293811041675689
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,-1.1533055791217963
BT-549,374536,3.1184462544943363,2.4750322275590424
NCI-H1623,11640390,0.1271923003977441,3.2400217838922596
HSC-4,387447,-4.060952426407354,-4.173880399537291
MDA-MB-157,5311037,2.9595373739718087,3.4074790383885296
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.3758480387257197
YAPC,3543504,4.3832051547821855,4.572952985683039
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,-0.46137402372960523
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.7250029555660984
NCI-H1623,9866186,-0.0100221274837169,1.0169874881527086
SNU-449,4788,5.842775682236554,5.717357197926506
Panc 04.03,5287620,-2.39349186702993,-2.0352231925143354
MDA-MB-157,11717001,3.389932991765854,4.305997541046244
NCI-H2009,216468,1.7077485468094884,3.505918955442319
HSC-4,24821094,3.2038955653523713,2.898751214852451
A-673,4578,4.214026417190043,4.331850158543141
KMRC-1,135875424,5.075329697898493,3.842621444184658
G-401,11612883,1.6387860096052431,2.4888294254318057
HSC-4,156422,5.249929789072156,4.217491274307971
NCI-H522,2742550,2.7952007563166203,3.685453693583979
NCI-H522,400769,-0.9806645547005408,-0.7481312133880752
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,3.604282941837511
NCI-H661,46199207,2.8133245189521054,3.195402136493468
A2780,10184653,1.3482388837291208,0.933735014113947
SCC-9,24856436,1.519847806890015,0.494493008116999
NCI-H460,2729026,3.0609463870825926,2.8010014925747067
LXF 289,11222830,2.2114905387790755,1.67018705191259
KMRC-1,46215462,1.6205494448376236,2.1066280743328822
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,-0.5848499793399555
OPM-2,421610,2.2409150931042072,2.808767998011391
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,1.7248061400610022
CAL-51,119607,5.291790266428237,5.180241495031896
CAL-51,24753719,3.9981702522006257,4.204847648505427
KMRC-1,25154868,5.3943697684741805,4.36216427803577
Panc 04.03,89928392,1.6805018731496522,1.672103799612824
SNU-61,25126798,4.129245799651812,3.9218371851173845
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,1.6571169903984058
HSC-4,11977753,4.574500022269399,-1.3355604725267096
NCI-H727,4477,0.5438785176620984,0.7103429044840661
CA46,5335621,3.676802077981384,3.98246320259379
JM-1,322968,1.8634300837521185,2.4067361415582464
CAL-51,46907787,3.297361866649883,1.9832431711801635
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,-0.7976448544549412
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,4.971762968857172
NCI-H522,53495165,-1.820766752755188,-0.43027171003309633
MSTO-211H,11626560,1.3885064506517848,2.0941895337664955
SBC-5,262093,2.1741934315953726,2.6635353882588517
MSTO-211H,52912189,3.1066961080068123,2.2621015045861115
HSC-4,568763,1.3764913265299208,0.7195424733121141
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,0.8066471038640479
DMS 273,25195348,3.734209419300899,2.8761927858618463
Panc 04.03,5951923,4.37213064077745,4.67953399895842
FU-OV-1,439501,-0.5556149973103641,-1.9646645427304625
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,1.9931609556325154
LXF 289,168313047,4.113002678801054,2.3121136633939092
SCC-9,67291369,5.015060977849177,2.260388209009408
OPM-2,5351362,0.2459388559982981,1.284205002455592
FTC-133,11485656,4.087051585535102,2.3768317007492357
HSC-4,46843906,4.814917111969106,3.095730904484632
CA46,51039095,1.651262767418978,2.148368253201153
NCI-H522,2945648,3.0823392214986343,2.690740614776199
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,2.765211498041361
YAPC,9911463,3.901904463732921,4.021916712970784
DMS 273,11977753,-2.475673354763999,-1.5088342467925815
SNU-449,46191454,5.774811831739998,2.0609435077717335
NCI-H661,25062766,2.1967321973268294,2.169862661202795
A-498,53301938,4.241910990361246,2.9350525616005654
Panc 04.03,10302451,3.874200048588579,3.2464253521973006
A-673,16065773,1.4559751864460968,2.2318797019245427
NCI-H1623,135398516,1.607867961646436,2.039167950661638
FTC-133,60700,-2.7194012548196,-0.15937417346244323
NCI-H661,3384730,1.2254103498827775,3.0471572955305164
SCC-9,168313200,4.072126418899639,3.109430708702091
OPM-2,25150857,1.3601106429565517,1.8109220518114661
NCI-H292,3385,4.509781783210997,4.693796922663672
NOMO-1,227681,3.177880686522457,2.7439960362241753
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,2.6146187673497066
OPM-2,46191454,-0.9534482392265864,0.22193101639230353
NCI-H522,3081361,1.6470006965888542,2.1050812453642997
CA46,374536,0.6029387131655304,0.7021329744108669
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,3.2050460164157384
DMS 273,4705,3.496116762813734,3.0294405736271854
A4/Fukuda,17755052,-0.6813796549781841,1.4362479477811942
SNU-81,24180125,-1.7131691030529954,2.7694941045561694
Panc 04.03,969516,3.706271998961216,3.0522162854844384
CAL-51,15547703,3.503799403292956,3.0992363403741017
NCI-H460,24951314,1.96669984187411,1.353488495114353
SBC-5,446155,1.3486611419477716,2.8708828528056647
Panc 04.03,6184667,3.768891848670565,3.344628329964739
MDA-MB-157,4096211,2.1957324566584715,2.2013286804216206
CAL-51,15983966,-4.387912760170627,-1.778709749136486
NCI-H2171,49793307,-5.547674326636965,-3.723171031842931
MDA-MB-453,31703,-1.1483878700266144,-0.9820727826605254
KMRC-1,24785538,2.687509195601708,1.9112923090922296
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,1.4320408031887566
FU-OV-1,54618164,4.603510021761196,4.178886820591998
YAPC,5287620,-1.8729921135671632,-1.8162264529445045
NCI-H661,16065773,2.6852778174065435,2.4102366140824514
CA46,5329102,1.3169898780971163,1.4084023486764392
OVISE,66577038,3.7859124338920065,2.9664914123465334
LOU-NH91,57519531,4.764819520424852,2.7551627116079613
LOU-NH91,448949,2.461672905148464,2.067861673239806
LXF 289,10427712,4.0701965709145504,4.41686567611188
CAL-51,9915743,1.1260994347217144,0.6387051658033669
NCI-H2009,11609586,4.059888202416809,3.2287546011581556
SBC-5,60700,-1.8327808511007615,-0.29593675886605547
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,-1.1137611186163547
OVISE,24951314,2.5954730551837386,1.3262611872386916
KMRC-1,66577038,2.9827052655036206,2.925027824856077
LXF 289,36314,1.2391029615263165,-0.9326725585940526
NCI-H292,44607531,0.4181911293940362,1.5188386803381673
KYSE-70,219104,3.9271840577372705,3.929126180102645
NCI-H460,71304818,2.359856693071434,2.489323630607738
SNU-81,4477,1.0310003158688126,0.8007407495043151
A2780,1716436,1.933630716197044,2.731746965279437
LOU-NH91,11964036,1.2476019563081622,1.476886763665192
SBC-5,9936388,-5.234314033557506,-2.250589660576068
KMRC-1,24964624,2.351358467802262,2.5482453494257826
MSTO-211H,73707438,4.334782721865043,4.235748426361597
MDA-MB-453,73707438,3.778137609083601,3.939185227972077
EFO-27,49793307,-1.9052761294403429,-2.1961308087711493
G-401,71680916,4.434691555895244,4.322564178184384
MSTO-211H,3634881,2.531877742135044,3.4096372282841565
NCI-H292,42642645,0.8145779285410705,1.0017529828100016
OPM-2,168313200,1.8002020874491595,2.695856713934718
NCI-H2009,53232,2.115043522086945,3.0414752726878795
SNU-449,9825149,2.659052538489635,2.3364048303105465
CAL-51,25105715,4.077363851334658,3.423408452549924
MDA-MB-157,53232,1.9030895496471385,2.7021626268697356
NCI-H727,2708,6.607150814967448,4.967065494050446
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.7970650439160616
NCI-H1623,44632017,1.5464636141196502,1.5788979750158498
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,0.7387954627506877
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,3.3504019239451783
SCC-9,3689413,-0.5284639903905319,-0.2300765345677794
NCI-H460,23725625,5.666756485817308,5.264822921025353
NCI-H460,100016,5.855223104671776,6.305654315006881
NCI-H2009,24771867,-1.6305331500245923,2.4395902456523246
SBC-5,9952709,3.0525329755213466,3.0453095832489283
SNU-449,5566,3.0151612646695822,3.1059553787735417
NOMO-1,9926054,1.6113291347040215,1.4672506804735308
EFO-27,11404337,1.0583908830182924,-0.07221442815076604
A2780,54626689,3.943205764450006,4.386141665473713
A4/Fukuda,168313200,2.9572494196719723,2.8018925084933852
LoVo,5460769,-2.1468642890382412,2.4473240033906576
NCI-H661,25102847,2.378632231655901,2.5151600365337208
A4/Fukuda,9866186,-0.2462641713744652,0.33210818140258697
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,3.4607727450786645
KYSE-70,36314,1.2189527676950276,-0.6982651119745446
BT-549,2828334,6.061535937537666,6.207770747542338
NOMO-1,25262965,-2.043358942198166,-2.0148122344826844
LXF 289,25195348,5.284501520866742,3.5214498878709066
CA46,451668,2.285623139838705,-0.6811344971929547
SNU-61,24856436,-0.371488374536367,-0.08938107971024774
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.6627132825938242
SCC-9,44137675,3.491154886377157,3.7178314455981836
BT-549,151289,0.9825598768305964,1.344601356485812
JM-1,49836020,4.6064946369246025,3.024770085772792
YAPC,54618771,0.5686030675412354,0.9140225405769982
SCC-9,24772860,-2.0717241396099473,-1.544297536872398
A-673,10385095,1.0544598585596625,0.957641211497052
SNU-449,216468,4.54901774756382,3.383178840224409
SNU-61,67291369,4.2845115751683736,2.2187808466775745
FU-OV-1,5291,4.051520848138153,3.8315641775490032
LoVo,12001922,1.64420677630862,1.9146838383073665
NCI-H661,3815108,3.885074716587427,3.162247818550253
JM-1,374536,-1.2279479926310035,0.7092105025169805
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,4.903438688260332
NOMO-1,4788,5.067002306940809,5.259302472939496
SNU-61,24748573,1.6967337473161408,2.03652117456854
BxPC-3,16720766,0.4925277259578197,0.556892729273508
EFO-27,46215462,2.714023108610326,2.061244658231921
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,0.6155077895864551
SCC-9,31703,-1.2436349312067534,-0.7641544506104074
A2780,5335621,4.014990109441054,4.525137115461412
EFO-27,4917,3.7917867214450096,3.2583285105930537
A2780,9926054,1.5482217772077662,1.883727547291681
A4/Fukuda,3689413,-1.7998697854540155,-1.1214606097849855
OPM-2,6610216,3.8953919440086575,3.888650831001335
NCI-H522,6918328,0.2751454024017333,-0.07391834715580506
LoVo,60750,-4.161283305326802,-2.1160470135914577
LXF 289,15547703,4.3915240757493565,3.2457139622620343
HSC-4,55283,3.529343210540244,2.920960853345051
MDA-MB-453,6436223,-6.0469700747965325,-3.5692822979123604
OVISE,54619267,4.300185321056238,4.043949883960101
CA46,12001922,1.4868064190708767,1.2608744925482656
SNU-61,53392493,2.2959575452819543,2.327611183238
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,-1.7493836548250488
G-401,44137675,2.141460704144857,3.1799599093553166
NOMO-1,9825149,1.4944850939332062,1.515589596744445
CAL-51,4788,6.061217822513647,5.520846344796992
HSC-4,119607,3.948608575005578,5.4433392686591935
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,-0.10061061396477519
LXF 289,4477,1.125394938272502,0.5334171214256584
JM-1,11657048,4.676495506604394,3.711214241834387
G-401,10302451,3.1015289114526774,2.9301954889780033
HCC1143,31703,-0.2055424786168501,-0.822710295260535
HCC1143,374536,1.384467639208202,2.092393216382522
Panc 04.03,10184653,2.983159460505767,1.1807449075303147
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,1.893564056240981
MDA-MB-453,9915743,0.2126089191242519,-0.11279604043539328
HCC1143,4477,1.746819852748151,0.7080980616360278
LoVo,44486219,3.9526381308541025,4.326508992657347
ONS-76,135875424,3.856833286433643,4.167387247029011
SCC-9,24797083,1.144476664186746,1.3486563067360118
OPM-2,4096211,1.0315429789467454,1.0945135503441856
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,2.0483983650114994
SNU-81,25262965,-1.8265758424412304,-1.2876455190318727
KYSE-70,44137675,3.4677446622108925,3.5211276690383717
NCI-H1623,3854666,1.505587442259218,2.167161368773524
HSC-4,10385095,0.4573663196580717,1.4061255114193907
EFO-27,107985,-2.474640150808475,-3.2372518160688255
NCI-H2009,6610216,3.953101400309774,4.34448408135894
SNU-61,135421197,1.1046098427392648,1.571932557686701
HCC1143,4259181,-0.4991941409006941,0.22412774890737314
BxPC-3,16038120,0.5924635925282854,1.0135097927781398
NCI-H661,135875424,2.4725937826628006,3.672149599144512
SCC-9,9866186,1.319539660579235,1.0155495904694154
LXF 289,24964624,1.3940062455599875,2.571426106525704
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,0.9973879673467512
HCC1143,6610216,3.638345017281011,4.43177373621854
G-401,2949965,1.5385484234582818,2.6864066618374687
BxPC-3,49793307,-3.2953922214008697,-2.6463831214759956
A4/Fukuda,5287969,-2.571307610380136,-2.1048657328018257
A-673,6184667,1.935989865778159,2.8871465453720746
NCI-H2171,24821094,2.9775477594317743,2.9589502990364247
NCI-H2009,67156097,-1.7347724318553324,-0.4142759836228042
A4/Fukuda,409805,3.596796639089143,4.058244550866021
JM-1,5738263,2.278112606764228,2.484771811842422
SBC-5,2828334,5.980106592077389,6.067783630969925
BxPC-3,107985,-2.51349631829315,-3.616169361274784
G-401,11427553,1.555705840809683,2.012364286953253
G-401,10113978,1.710663554595952,2.9121055258900275
NCI-H661,16013152,4.678017706607999,4.21493767781227
A4/Fukuda,11497983,-1.0595923666648657,1.8060732496185559
NCI-H522,10296883,3.751667506317718,3.7240372590736173
HCC1143,6610355,4.569348514461763,4.64697672694192
SCC-9,56946209,-4.978704692275232,-3.666032310519278
LOU-NH91,54613361,0.2217026048603205,0.26104359236269126
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,0.719711315383956
G-401,42642645,-0.5846467586678221,-0.0182347985230739
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.6260173189261977
NCI-H727,5287620,-1.579053209750056,-2.0721090461027187
FTC-133,16038120,2.9212616737408896,1.016134424791245
SCC-9,11626560,2.4253223939520976,1.8766276641565653
Panc 04.03,2742550,4.347188786942969,3.9737189074719224
OPM-2,15547703,2.634316496996711,2.70246701171493
NCI-H522,10074640,3.1231046963753686,2.7542073217827787
HSC-4,2945648,2.59041604505869,2.9555099333995365
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,1.29004222013477
MSTO-211H,10127622,2.776094640706434,3.78962163808221
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,2.1314388898361223
NCI-H661,2858523,3.1395656938248124,3.110516055802092
A-673,56946209,-5.889509916794497,-3.957877276295995
CAL-51,44185566,1.8630594392382311,2.6056766097676176
YAPC,51039095,2.046611375354791,2.672293876602583
OPM-2,4261,-0.9911458583810344,0.39206894373253853
BT-549,969516,2.601131538014171,3.001503426541047
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,2.5988250622245688
A-498,55508,4.21947279006693,3.4976578692395814
SNU-449,71466380,4.63195087543953,4.594896878263881
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,3.8307975037232147
A-673,11707110,3.906892758790242,-0.36964041801405556
NCI-H460,54649381,4.173104904963283,3.847518467664959
KYSE-70,5282054,4.279196842795529,3.405993261635366
G-401,119607,4.5837417334889885,4.804546364308987
YAPC,24856436,1.898811352025064,0.20232604300842985
CAL-51,5460769,1.3780575552768597,2.5483904719721377
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,-2.518639994869991
CA46,400769,-1.5476292313826252,-1.4687465872607526
SNU-449,19582717,4.423938746946012,4.170563571101123
KMRC-1,46191454,1.86757619496812,1.5747029701613864
MDA-MB-453,45279963,3.011106079512325,3.3966484523314375
BT-549,25150857,2.011062957026122,2.5824706421712875
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,-0.8132161252105378
NCI-H2009,135999136,4.285465393980956,4.221789810584511
LXF 289,984333,0.880488465949386,1.0876299414210309
NCI-H146,11238147,0.964491846183422,2.7591369353771373
Panc 04.03,5287969,-1.8253556910298991,-1.6848277580579596
NCI-H292,654092,0.1209701484650686,-0.16479236134282316
MDA-MB-453,9927531,3.885109165752666,4.337304857566975
NCI-H522,44819697,-2.38793523497331,-0.6870736027029204
LOU-NH91,11364421,-1.522672653311712,-1.074466002600487
NOMO-1,4477,1.0767445259598296,0.582013516933365
LoVo,148198,-1.1147075342847712,-3.297633071913946
SBC-5,54619267,3.782844847718682,3.865152242855268
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,3.445749591690786
NCI-H2171,46224516,1.006764214935909,1.7485823086483168
SNU-61,55283,2.411692675664504,2.5469072165389632
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.765006637023469
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,0.8343463415842707
G-401,135398738,4.751845538055463,3.4313044731185145
A2780,24889392,2.5877097444926265,3.546669722232518
CAL-51,3081361,1.780158758130264,2.4520782951507845
MSTO-211H,3025986,-0.6925850648320051,-0.9783027165550897
NCI-H1623,10231331,4.737119210946733,2.056703809921341
LXF 289,60750,-4.482846219959503,-1.4622889487988817
JM-1,19582717,1.6871405928140415,3.1017408614390263
MDA-MB-453,24775005,1.4926368241852035,4.139447717063792
JM-1,10074640,2.5195149680920657,2.5130132858471566
A-673,2749,0.4791921848862392,1.3650606340686868
ONS-76,9911463,3.87028315643254,3.9339335273084477
A2780,3136844,3.626688956130205,4.04101840929397
LOU-NH91,2945648,3.130856585594597,3.018234038912739
NCI-H146,52912189,0.5266703058361273,1.2824336335544129
A2780,156422,3.602973007130472,3.9074869470556326
LXF 289,969516,2.6399649875984355,3.0637556321092343
NCI-H146,25154868,-1.0719819424572428,3.9244669959340954
YAPC,1641662,3.645861677961698,3.598690494848693
LOU-NH91,136227331,3.865245001267085,4.337425889370199
YAPC,46224516,2.408657893134071,2.63017459694614
JM-1,46199207,1.915427322474508,2.3488399580170656
G-401,54618164,3.8592700204433807,3.9184926070209953
A-673,53232,1.7702469915903785,2.8415695796612455
SBC-5,6918289,2.991753308414544,2.493166376860039
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,2.022355092776909
NCI-H522,24797083,1.396487413816628,1.1916891453201186
YAPC,11238147,2.574935183805209,2.9262282027907953
BT-549,9444,3.939814284899288,4.2475911794412875
NCI-H460,11364421,0.3566052665939138,-2.5729977121496947
LXF 289,23582824,0.8647594683412683,0.8471078990057012
FTC-133,89928392,1.8077600838169707,1.5253203770702768
NCI-H661,15547703,3.600649740500543,3.1434702026615566
JM-1,8515,3.19981027650634,3.1213605802087763
LXF 289,25102847,1.656353256373218,2.104775374504645
NCI-H1623,11626560,2.1087636260711333,1.7899025021205888
NOMO-1,2729026,1.9247353379999697,2.486378769761635
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,2.276795458677417
OPM-2,60700,-1.448416790812607,-2.0711818391166785
NCI-H292,9825149,1.7347241761388297,2.398547456417228
KMRC-1,6918878,5.2070030404450485,2.5247872795762647
SBC-5,4259181,0.3536055110585087,0.1616837048755616
KMRC-1,71466578,5.804397104747809,4.042148241083729
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.2954829828782408
SCC-9,54596490,5.620994411748341,4.949058678422741
MSTO-211H,42642645,-0.4763575861779333,1.1479412386149497
DMS 273,4378219,3.0463884183789336,2.3706138510979717
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,-1.2743351603400437
MDA-MB-453,11626560,2.2881538301476696,1.734173532111078
BT-549,46215462,1.7261150757919093,2.172583640989446
SNU-449,45279963,4.011305658965759,3.9630971722882795
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,4.186869237508248
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,2.160345704710062
A-673,10302451,3.0176041071951345,3.062377792104154
CAL-51,5280436,3.749440064194485,3.2983886301345704
OPM-2,23582824,0.3145394278485406,0.5950755037719153
JM-1,5287620,-0.1298713463901946,-1.9691392635530385
MDA-MB-157,3503,1.1658051797362206,2.3006814670058744
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,2.0546501299213396
SNU-61,16741245,4.568608723382813,3.799760769704986
SNU-449,54626689,4.585589968636992,4.693195204824768
G-401,49867930,6.047675909857249,4.409638806308777
HCC1143,46199207,3.122692827276537,3.274437782575535
OPM-2,445643,3.4082912819673536,3.749153071105677
DMS 273,54618771,0.8675837195237585,0.43112971234001923
NCI-H1623,71304818,2.8160491805212615,2.3803660581160573
MDA-MB-157,16659841,3.727147143419768,3.8171370020883324
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,0.6927583026769797
MDA-MB-453,1750826,0.6003684780059517,-0.9331999135540359
NCI-H1623,5281321,-0.5392861044239732,-0.9731410983701145
MDA-MB-453,613753,2.5060803116052357,3.084130192961802
MDA-MB-453,2871966,-0.7610622755396385,0.044647696097142246
MSTO-211H,5281321,-2.386258436411726,-1.7180126590663016
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,3.2054736721038175
FU-OV-1,44137675,3.1043101525841377,3.8260678746536296
NCI-H2171,285033,-3.2427052076981693,-3.149191131533166
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,0.4339270729751503
NCI-H727,5311,2.2708816030438816,1.4412335250301185
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,-0.6682611436158752
A2780,5746,0.8697095475366516,0.15884344516617996
NCI-H2171,53232,2.7429596689347875,3.0381908604824623
EFO-27,5291,4.106816055599409,3.8658585316514715
MDA-MB-453,9933475,1.6213532539721074,1.8601959273158286
OPM-2,5281321,-3.721370442971226,-2.0457996964769674
SBC-5,25183872,-1.21590268467039,-0.9816780180757299
SBC-5,452548,-1.978558467437607,0.26763539679960524
NCI-H522,5351362,1.1598735323390523,1.53144951402488
MSTO-211H,3552672,1.7334798735784387,2.8757953998789345
A2780,10427712,3.0744297357135557,4.009096303566757
LOU-NH91,409805,5.248055334811583,4.821140373191196
JM-1,5460769,0.6255065324989537,1.8891363651796487
NCI-H292,9967941,4.033073764451828,3.785228575352183
NCI-H727,16038120,-0.1646423801756905,0.8556987040022783
NCI-H460,16038120,2.547350732010626,0.934375547365962
LXF 289,241158,4.717778097263283,4.049236631733628
OPM-2,46398810,1.9487214127979129,1.84751196681091
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,1.2225487220038205
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,2.0168805863578836
CAL-51,9884685,-0.2528326244590672,0.5598065932660156
LoVo,44607531,1.302221694572025,1.513337415546606
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5199297940942892
MSTO-211H,56963564,1.234327129960966,0.8849340783262241
MDA-MB-453,73707398,1.1537227860078607,1.1627297879895475
BxPC-3,5329102,1.9407746673909456,1.896229355601921
HSC-4,5287620,-1.917371788332746,-2.0940806949351356
FTC-133,11152667,-0.4786534736280033,-0.29449484773429363
NCI-H146,9935249,1.0600603569941576,2.1954040496480896
YAPC,2729026,2.7496252904978293,2.806554619601348
SNU-449,71751553,4.402646349497825,4.532861982259603
HCC1143,9926054,1.808099247882512,1.9941888280551316
Panc 04.03,448949,2.534760210414342,2.2817190959426736
NCI-H661,5566,3.151274839096282,3.1840499904561206
FTC-133,6610355,5.440540243356366,4.572181682191093
JM-1,16741245,4.187666128361383,3.439645256816549
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,1.5069804552227735
LXF 289,107970,2.2922723928752307,2.3843945693630033
Panc 04.03,54626689,4.659724899973851,4.7107066468376475
MSTO-211H,16736978,0.1439838744803616,1.7167761159214194
MDA-MB-453,151289,1.613318506724072,1.2403092247115486
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.732533649088864
CA46,6918638,-2.155597959241919,-0.714962175463571
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,3.098608109423619
A4/Fukuda,53495165,-3.058270414187161,-1.1398421193153303
DMS 273,135984461,4.327877942465965,3.8456181339627675
OPM-2,89928392,0.3187576395153793,0.35132343619132816
NCI-H1623,10385095,1.1256497169747182,1.4998685466280164
ONS-76,11717001,3.327449083785458,4.322066674471257
LoVo,6610216,4.332472846182503,4.361858894203476
NCI-H292,16722836,1.3558361632896196,1.870749879964482
MSTO-211H,135440466,1.110539790918092,2.5047260708240664
BxPC-3,9868037,2.7194108471732243,3.143994956235465
CA46,2874250,4.668483912698598,4.034478677499545
MSTO-211H,11238147,2.1702387480753393,2.9683689513108478
JM-1,44607530,1.0639194271383936,1.3862096400291046
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.5804321038040257
ONS-76,2749,5.1102698724547375,1.9762511768572524
CAL-51,36462,0.7338920585832341,1.961540844283584
CAL-51,6610216,4.7761200098267365,4.275514593589967
KYSE-70,3062316,0.8461927752800795,0.8463521898739107
LOU-NH91,285033,0.7293222441785373,-1.3273466632983826
A2780,11485656,1.5628347007454235,2.0414121031084504
A-673,26596,-3.820628112159822,-1.6592861325186286
KYSE-70,44632017,1.4611535882953923,1.3136754908567019
NCI-H2171,702558,3.801125308495619,4.543181635835338
MSTO-211H,23635314,-1.96294908215212,-1.3319848557663854
SNU-81,5746,1.2061469752663514,0.44069931182474287
KMRC-1,4788,5.9167994505540475,5.700524940363367
CAL-51,15983966,-4.387912760170627,-1.778709749136486
CA46,49867930,4.292641096024632,3.7588106712983573
HSC-4,11455910,0.337268703123225,0.9267268783351246
YAPC,5281672,4.680001258160183,4.664359492939142
SBC-5,5978,-3.632907311761228,-1.981874291718776
NCI-H460,3825829,4.446795399525052,3.9992936812346613
MDA-MB-157,9444,2.0478202605503206,4.133327994544054
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,0.2575797958013566
SBC-5,46191454,2.9096163569547,1.6338484989375985
CA46,644241,2.374325583681648,1.0373905435584658
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,3.253512915120342
FTC-133,252682,6.679184103041344,6.6269567445051045
SCC-9,56649450,2.7319907342568275,3.1228852207620434
CA46,5311,-0.1889513685103653,0.24661936134086512
OVISE,9967941,3.747669270164806,3.734160047623922
KMRC-1,5328940,2.3844062156656256,1.727524758261974
NCI-H146,9825149,1.1795040286889695,2.0345200724617403
SNU-81,445091,-0.9408785363266468,4.140848353875571
FU-OV-1,6610216,4.742914927321441,4.493240665170657
A2780,56949517,4.37203598237815,4.196557183623874
EFO-27,119607,5.664089470896734,5.481624985687833
ONS-76,57519531,2.0495811593793105,2.616493727266587
MDA-MB-157,42642645,0.4106458170856017,1.0342188774710706
CA46,135421197,1.13174100448049,1.2930807564502629
LOU-NH91,11719255,2.9529273796726394,3.5386570791648033
A-673,9967941,2.0264988474191377,3.2375529596820685
A-673,23582824,0.2073680927392712,0.4909908948622305
CAL-51,374536,3.1977545561189347,2.363016659873971
SNU-449,5311,2.373513113952619,1.7925520468498406
SCC-9,11178236,-3.8920346249942264,-3.349258567214816
SNU-61,71680916,4.248107596602719,4.826912249473958
BT-549,4578,4.840393866327907,4.662437460058957
JM-1,56973724,1.572059771180543,1.9164528083491408
BT-549,6184667,4.320802676068414,3.149014903302537
OPM-2,6918878,0.2719026340750923,0.8424109820205845
HSC-4,9967941,3.0274642479334215,3.577126074892769
G-401,6610355,3.5029306645068696,4.123701777558292
Panc 04.03,1750826,0.308709425359425,-0.7705721184355485
KYSE-70,6610355,4.961596413135767,4.542743924346667
A-673,24775005,3.310963685757038,3.8100416975905778
SNU-81,208908,2.232815974371363,1.8291223336776832
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,0.6720745287770168
NCI-H727,3543504,4.299187359877464,4.417988894358391
SCC-9,11152667,-0.1233430086603879,-0.5396790227841344
A2780,208908,2.5004436475537974,2.166778741397163
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,-0.3441675002207532
A4/Fukuda,44607531,1.1783204907000706,1.0081443037520395
ONS-76,54649381,4.0197495944656465,4.036196313897699
A4/Fukuda,31703,-2.1013190360416147,-1.9543416083462468
EFO-27,46398810,2.9967281863964867,2.722516034026317
JM-1,119182,-5.01139227406357,-2.5038558873392587
NCI-H2171,25183872,-2.065345244597309,-0.9641541446557835
SCC-9,53392493,3.3396857977581917,2.6292925258054702
ONS-76,44259,0.6373390659589321,1.1190198045162143
NCI-H661,72376,-3.040643961037913,-2.038098533521148
KYSE-70,11609586,2.827625452517046,2.6396266013521346
NCI-H727,3025944,4.64192894764355,4.305272476569299
NCI-H460,262093,3.3627537421549314,3.021907142823777
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,2.949593407133934
NCI-H292,11396600,3.7365966834404225,3.7361112375452596
OPM-2,11626560,0.8852338363333486,0.5309502352678526
MDA-MB-453,24772860,-3.354356853525474,-1.9265757611059615
BxPC-3,168312962,2.7485538585474547,1.9023125943225523
KMRC-1,46199207,3.449143967158838,3.1653481496653852
MDA-MB-157,2729026,3.2437974205657816,2.693214827947793
LoVo,4259181,0.2045859597859785,0.28247235169176776
KYSE-70,5329102,1.9375891375175784,2.0437540058148453
EFO-27,3025944,4.337116030950391,4.325185304673375
EFO-27,2742550,4.50908635993052,4.107739043377477
A2780,6610216,3.3472253004646593,4.196049597053399
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,-3.114012201915951
EFO-27,24856436,4.205894943099943,0.5589243903245639
Panc 04.03,9444,4.565679465533194,4.238153524009508
ONS-76,72193861,2.0006819721723197,1.8367892848378804
MSTO-211H,445643,1.8400808237063873,4.130282545717896
CAL-51,8515,3.5852991976047863,3.978322847947786
OVISE,25150857,3.4132003431569524,2.5191326549271738
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,-0.18293527141750424
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,0.46166322395888754
OVISE,5746,2.6308159153246047,1.2882302885767336
A4/Fukuda,168313016,2.0147776130358253,4.302381172616468
LOU-NH91,54686904,4.160622905506427,4.025151398576304
LOU-NH91,8515,5.2113767400480775,4.040913375803818
NCI-H727,73707398,1.5620380856857303,1.4045078427631466
OPM-2,16722836,0.349034656527362,1.0564915507920896
NCI-H2009,119607,5.663513162505294,5.60578946706571
G-401,11707110,-1.5866495763270043,-0.005098731659203524
SCC-9,439501,-2.6581193485563737,-2.209797250443963
NCI-H2171,4259181,0.2390230285316857,-0.2837650977879308
MDA-MB-157,45279963,1.9862312593637983,3.7858051200473546
LXF 289,6610216,3.700752852024682,4.307051825104843
NCI-H2009,9936388,-6.076047204085024,-0.9556666284067498
ONS-76,11612883,3.1090836160489417,3.013473895795184
SNU-61,969516,2.346236032939849,2.636690143141857
HCC1143,3025986,-1.3091092061734078,-0.7234785497127936
NCI-H146,46398810,1.4219775291726766,2.3007361903252037
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,2.8685969313706026
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,-1.609223458079359
HSC-4,9887053,4.087399127765092,4.097055071631559
JM-1,11178236,-8.647638887964375,-4.662487344099699
LOU-NH91,24856436,2.045063798311017,0.7888543741465266
JM-1,4477,0.6485766089343484,0.2431772714531336
MDA-MB-157,31703,-2.5361356877609142,-0.8462472209063656
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,3.4291016806703545
NCI-H661,54619267,3.8937949591354486,4.135356704671069
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,0.8665195282581436
CAL-51,135398516,1.449392214756173,2.230486421323652
CA46,4917,3.2539126844885757,2.5327256369113904
A-673,4705,3.2416788332737454,2.7998597152700837
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,2.5533588901116415
NCI-H661,107985,-3.0533673433660393,-3.3550217535899445
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,-1.978891274926655
NCI-H727,322968,3.201201930682186,3.8528488473712756
MDA-MB-453,9823820,3.844639760703811,3.205671780670622
CAL-51,44202524,1.5528850010053556,2.252428021737213
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,2.60966611798863
NCI-H522,216468,3.814024876197808,2.200471366442947
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.6056786042884723
FTC-133,46191454,4.521976640758756,1.792888078807146
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,-2.003825828934902
NCI-H460,3385,3.2657114863965573,4.647240408916707
SBC-5,4917,3.6947166304022465,3.0402169060303597
SNU-449,241158,4.010766929552104,3.951563979932759
SBC-5,676352,1.191452976157089,1.9290115236273566
FU-OV-1,11626560,1.6217924510760422,2.020349865835698
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,1.8851449270267508
JM-1,23635314,-4.012358401321602,-3.210849930664123
MSTO-211H,24978538,-1.489482683206989,0.7340511755272096
A-673,6438330,1.8412388803722883,1.684721650879239
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,2.362523628479303
SNU-449,11719255,4.899085715446655,3.513331149769662
SBC-5,3025986,0.415316224839701,-0.9701161963847161
YAPC,439501,-1.3344819600707327,-1.9006567281936713
NCI-H292,25262965,-1.3774761624707286,-1.398282501580567
OVISE,4261,2.633875372862392,1.8858606954784543
SCC-9,24951314,2.365472705935838,1.4191093624369175
CAL-51,57519531,1.893237876741888,2.4553757370779303
SNU-449,4521392,4.287622659497221,4.264191286585443
SNU-61,136227924,2.341371828887226,2.7695304691937697
HCC1143,24772860,-1.4749293698634824,-1.3989372186930868
BT-549,11178236,-2.7962989267365828,-3.700188167538762
G-401,322968,2.2957138552590264,3.1267782148369694
DMS 273,322968,3.714238246037839,3.213090847497927
NCI-H460,135875424,3.211754300989152,4.008210417507146
SNU-449,8515,3.796953450261519,4.1715419924142205
EFO-27,3689413,-2.375877948841856,-0.07442434220341913
SBC-5,46224516,4.445568719663603,2.229154451121591
SCC-9,285033,-1.0227924755741569,-1.8378980363005233
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.2268033964416338
YAPC,6610216,4.2275333940091215,4.390999781899659
DMS 273,26596,-2.1961333269229173,-2.077689402824576
NCI-H460,15953870,5.00315267734786,3.671920198968586
JM-1,16065773,2.0826903108024646,2.1099763816819115
CA46,5280436,1.6785665289286047,2.3611828957792196
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,0.7695274595453507
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,0.1563000335299668
NCI-H522,40482356,5.076444098213918,3.2278164889577514
SNU-449,72193861,2.670314458690751,1.8297886120345594
A-673,44185566,1.862123250313604,1.9628882563915107
MSTO-211H,6623618,1.8328237574963773,2.258893032524175
NCI-H661,9868037,2.6835007144938032,3.302459585131306
NCI-H522,9903786,3.9217135447784783,2.7392033349884897
A2780,2828334,5.5086207374667175,5.949463356095929
FTC-133,9887053,4.335569761437092,4.407201210348278
Panc 04.03,3503,2.292907505320521,2.603647453195147
A-498,126941,-2.1438583463370495,-2.3877025362071156
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,0.15657348951634603
OPM-2,2130404,2.9720984033823896,2.6340027492754468
HCC1143,10427712,3.6655746579836497,4.418089115523088
EFO-27,148198,-4.612142049540045,-3.4833078264403086
MSTO-211H,25195348,2.7607409792089186,3.3612549716902067
NCI-H460,11455910,1.4134750909778395,1.0418964190018558
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,3.6001779932839697
NCI-H727,11640390,0.8742840152576016,3.4068956031902333
EFO-27,51039095,3.8168650627357903,2.971111746635261
OPM-2,148198,-4.827513159673032,-3.7711711130617114
CAL-51,10113978,3.4506321601115397,3.261364112520309
NCI-H2009,71304818,2.93523377765095,2.483208796315668
A4/Fukuda,24772860,-3.4983689572797307,-2.3458682181980173
NCI-H460,6918837,-0.9355989207233988,-2.331417697668112
MDA-MB-453,3503,1.4691071846699333,2.041603481368607
EFO-27,135398516,1.6834680726831996,2.2835308373291157
A2780,19582717,2.5113952618702102,3.707716086218682
SNU-61,6918289,4.130324820008196,2.347257842737302
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,-1.0081831968809178
MDA-MB-157,448949,1.9498713128669924,2.0837331005971684
NCI-H727,675434,4.719754403481023,4.330004310685729
KMRC-1,11152667,-0.0604913513883814,-0.20377402546439666
ONS-76,9926054,2.5108803232151304,1.974090140507591
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,-0.6141712032140151
CAL-51,44491742,5.152478206660974,4.21394541187538
NCI-H1623,5278396,3.5068270087169022,3.523461919090086
DMS 273,3634881,3.2856933751991844,3.142858793275301
NCI-H146,23582824,-0.1302486758765051,0.5793691942657984
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,4.796069381440142
A-673,11175137,1.5552265537901524,1.9370409750623394
A-673,4378219,1.9880690032317576,2.3408154979538875
NCI-H661,5460769,1.0320957244219937,3.047712104524509
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,3.8334293431105055
NCI-H146,2746,0.8652413173737366,2.6544813983675453
NCI-H1623,11955716,5.690110889982477,-1.2236736060861535
JM-1,46224516,0.3128269384104456,1.6582323362045672
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,-3.645472447637183
A2780,11317348,0.9115498056774632,1.8099180843888738
NCI-H661,9911830,2.711917815790479,2.432316580183612
CAL-51,44202524,1.5528850010053556,2.252428021737213
BT-549,4096211,1.216432091282546,2.4692253996818594
FTC-133,6918328,0.7944971797491694,0.153056500775186
CAL-51,9911830,2.6702149728757343,2.428037364199702
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.365093974692348
NCI-H146,BRD-K55473186,3.591565624419444,3.9306395421366744
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,-0.8241075577051907
SNU-81,16720766,0.0913844680975832,0.24321822227483966
LOU-NH91,46215462,2.06389335978863,1.990531319485745
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.4704127786281742
CAL-51,5978,-2.6819752982341463,-2.3390755785305095
CAL-51,5278396,3.885366261927898,3.505272086201306
HSC-4,4477,1.1301199037714704,0.5848156489763094
HSC-4,25195348,4.125902627491381,3.484180769068723
NCI-H661,227681,4.255095664751994,3.475620889220919
NCI-H292,24951314,1.8411912809473163,1.539853054828607
NCI-H522,3543504,4.389197316233122,4.168173729080212
NCI-H460,452548,0.6919333948360032,0.4077021440789671
SNU-61,25105715,3.603411279706935,3.4586583583170394
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,-0.5392715072623874
SW1463,11175137,3.4916395483032256,2.6097608775808827
SBC-5,6914657,-3.351925471283153,-4.070666282221011
JM-1,65064,5.210865559450395,3.812531359973221
OPM-2,9967941,3.958466181768741,3.254129102160798
KMRC-1,969516,2.336566526495707,2.8668480479140133
MSTO-211H,15983966,-3.5322347663594016,-1.330135083170766
OPM-2,9952709,2.422518614873216,2.6148757800568667
NOMO-1,16741245,4.369418152152245,3.1811204295812896
DMS 273,16659841,4.479005871158747,3.513543898581174
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.664404930605975
JM-1,46398810,2.06860116520361,1.6550465681412938
NCI-H661,12003241,-1.8871798966926587,-1.0397454544569193
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,-5.146173828552489
FU-OV-1,10184653,3.943218547538411,1.2565681059260505
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,3.8041625995679924
OPM-2,156422,3.8836640353636382,3.2352062777020074
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,0.9176736983650788
SNU-449,56649450,3.812927022122559,3.8504891436440043
CAL-51,119607,5.291790266428237,5.180241495031896
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,3.4304280341413294
BT-549,148124,3.591112191677911,-1.320261143479161
A2780,216468,0.3493873836888674,1.7974535129602562
MDA-MB-453,176870,4.531738011413092,3.3596236305296587
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,-2.583176760337114
LXF 289,24180125,2.8590757937383517,3.2615159302594012
G-401,4259181,0.5796012369716917,-0.036510069366686604
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,4.482656178921896
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,-0.3398471384245028
JM-1,54618305,4.117087010604098,3.5991489817013194
NCI-H522,16736978,1.523319728114192,1.4804907805982797
NCI-H522,36462,3.1215227661343925,1.5199113043681405
HSC-4,400769,-0.948607557046086,-0.6438778086280135
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,1.950543952247293
YAPC,20959075,1.1991758721406616,-2.896886813364105
A-498,5328940,1.8314953095149151,1.9085530512899316
YAPC,9915743,1.8269757962027744,0.914050857067898
SNU-81,54613361,-2.01246069716893,-0.07043898400817818
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,-2.003607454136349
OPM-2,1716436,2.6292767753294437,2.633535777889751
Panc 04.03,3025986,-1.5275729109481309,-0.9858763592788126
NCI-H661,25150857,2.764254958619497,2.3782582646231383
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,2.441109202649923
LOU-NH91,5746,1.403252091596802,1.5118504075517025
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,1.6951660334111398
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,2.618354713752382
NCI-H146,135398738,5.0513404057578155,3.555612009265926
MDA-MB-453,25227462,0.3575965628816619,-0.26919288582856565
NCI-H460,2858523,3.1665522277325575,2.95864646934669
SNU-449,9866186,1.4050575476777012,0.951684563817368
CAL-51,54686904,4.850424917483252,3.756315688828634
LoVo,53392493,2.4765619401689154,2.5023978170847743
LXF 289,24951314,1.0119406639366386,1.434324937074379
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,2.1927822993687283
NCI-H1623,5329102,1.790138577011996,2.114917548381
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,2.169799561103099
NCI-H292,3815108,3.432884993584308,3.3213609023471133
OPM-2,400769,-3.2268127368380215,-1.3000161088816156
MDA-MB-157,9823820,1.002295209558588,3.851659984110652
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,2.9838901175579866
YAPC,135999136,4.461108174764027,4.206276150119303
A-498,71680916,6.416494665581045,4.913825280846619
BT-549,252682,5.865498031558929,6.522647958194923
NCI-H522,2130404,2.4549438882602463,3.3143316203284354
BT-549,60750,3.345812478570961,-1.5847002306169025
A2780,55508,1.942124594025635,3.1082795452038368
BT-549,3136844,5.53345832245052,4.203481768638047
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,-1.987336287134908
NCI-H522,135398516,2.766899162932887,1.9704600382883999
Panc 04.03,45279963,4.427260741974604,3.8455455415879585
MDA-MB-157,107970,2.1200224507121868,2.295531393739551
DMS 273,24180719,3.915275581303962,3.6180299825815982
Panc 04.03,71680916,5.172010716636655,5.010357285649458
DMS 273,44632017,0.8019003224742934,1.0689673486665268
NCI-H292,5311281,4.174884455345005,2.421261582334102
NCI-H2171,9549297,1.2348443580878434,2.1597886486904083
NCI-H661,135398516,2.0112722508641525,2.133167329975822
A4/Fukuda,6918328,-3.9252329494253586,-1.3454871022133568
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,2.3063533526010627
A-673,5284616,-2.8220877865693996,1.6371125577592056
A-498,11222830,1.898532346529896,1.8294315982978722
SNU-81,44589607,-1.0723208776906596,2.377173453187506
SCC-9,54596558,4.378159430294897,4.433601209380382
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,-0.2125989609393718
OPM-2,56649450,1.6365959554779024,2.410635075735763
JM-1,2945648,1.8231052373320176,2.2257886073945916
Panc 04.03,6852167,3.6951209581653743,3.1173815330758416
OPM-2,5311281,1.024044758253736,1.7822041226639715
SCC-9,9967941,4.677287493278682,3.88470751596588
CAL-51,11609586,1.5077859423552509,2.925061419424372
SNU-61,9911463,3.407728451470452,3.713447215906757
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,2.6878069734626937
KMRC-1,72193861,2.923138623905541,1.7611538499921318
SCC-9,168313016,4.940700460648117,4.910631990206598
NCI-H1623,46215462,1.70222177248337,1.933963191806148
MDA-MB-157,6505803,-0.678815881739905,-0.2300952850353757
A-673,25062766,1.5933001652207863,1.7920598859417276
NCI-H522,148198,-5.538025476960186,-3.997509977251365
KMRC-1,11625818,4.222506706272698,4.2654435251372504
LoVo,10074640,2.9851259451828476,3.1888511313517767
NCI-H1623,12001922,2.89915315578861,1.8072938418503173
NCI-H460,107970,2.752075604137296,2.2983871721902314
HSC-4,10322450,4.749470049467763,4.128662160205568
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,-0.36687186740055056
CAL-51,65628,4.560195683913681,4.362256895897461
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,3.4634180006176725
SCC-9,2746,3.644005246156997,3.131023087723205
JM-1,107985,-4.195149425063274,-4.121846854520055
NCI-H146,119607,3.9951566487227823,5.0434087671235455
JM-1,44566777,-1.1129943275867182,0.16366045813800792
SBC-5,11167602,1.6319389998554443,2.4887477542327945
LOU-NH91,9936388,-6.294191236399446,-0.009799465365199392
SNU-61,135875424,3.609444893060012,3.8215824017521705
NCI-H292,6917907,-6.008612763335491,-4.626308754004248
G-401,19582717,3.4233639988307623,3.6324409068790224
LXF 289,46174525,4.3838011857350585,4.46557112575509
SW1463,10184653,-0.9517511422842978,1.3255151101836504
SCC-9,7251185,3.4755501931610486,2.8029444698538692
OPM-2,4788,3.799883557086963,5.218710999371527
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,3.678193433981193
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,0.25715532493004206
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,-0.025090493395661103
NCI-H460,387447,-2.436463262555682,-3.97153333189371
NCI-H522,3465537,1.2201304719285595,2.3820483900451386
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,2.0050711577806353
OVISE,11228183,1.089434907795814,2.60450202015679
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,0.8052620236527236
NOMO-1,10410894,2.884775843935945,2.6334759873825764
NCI-H522,3062316,1.3416096793720445,1.6237696416813359
NCI-H522,5328940,1.3898569828081493,1.6273491993296005
OVISE,6917907,-2.8614664806523975,-3.9493371836769797
DMS 273,53392493,1.951320459884087,2.121063537076602
BxPC-3,44259,0.1590720374324279,1.0950100708732302
CAL-51,17755052,0.5283491907817935,1.700587810113369
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,2.7285703482180166
NCI-H661,676352,2.2217693895783115,2.020595924609887
LXF 289,452548,0.2436004430663324,0.46823606990369315
LoVo,6438330,1.2087527750724023,2.215514888372676
OPM-2,16736978,1.1906517256258733,0.798112354794648
DMS 273,89928392,1.202164769006387,1.071836625759616
CA46,3543504,2.8823298921776717,3.6077343720232693
SBC-5,11427553,4.187017651849035,2.618445922806706
CAL-51,67156097,-2.385254348530768,-0.8665341171217982
FTC-133,23725625,5.526585624025884,5.08884312174874
BT-549,25227462,1.1552638438270102,0.5385007580792904
SNU-81,374536,-2.2172994025671877,1.6406671378260291
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,-0.9343306258787537
BT-549,65064,5.372588334008338,4.867371948671053
NOMO-1,135398738,0.7085728369009435,2.2178876298712136
A-673,44566777,0.6818018070798556,0.68496202964354
OVISE,42642645,1.7980918591344808,0.8910876377594054
CA46,637858,0.8997823848237061,0.9576709380409385
NCI-H292,9877608,5.923265260718527,3.9033789449048664
DMS 273,11964036,0.5570994002779035,1.212719492579848
FTC-133,44137675,6.176024086140045,3.707718634370697
BxPC-3,9926054,1.7603137158224154,1.7516868819667228
DMS 273,5311,0.3077166337368,1.0047207453449603
SNU-61,36314,2.631499046696298,-0.5835795451764457
EFO-27,6917907,-5.745836009999857,-4.551920952688951
OPM-2,11455910,0.7503761469114726,0.34184092441315866
NCI-H1623,24785538,-1.341558176424811,1.6803167344097525
SNU-449,462382,1.3667681892704822,0.6613612713365145
G-401,8515,3.316277000480566,3.510269938946933
SNU-449,25102847,2.813788740655036,2.3682955549673865
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,1.802170520245066
ONS-76,11404337,-0.4259392266769182,-0.18210423401469392
KMRC-1,49766530,-0.1675164065777726,-1.3379661769198876
HSC-4,24785538,3.772420906085344,1.6717453504369206
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,5.38730613957679
KYSE-70,73707398,2.029692143461395,1.5451567920427038
NCI-H1623,2729026,3.210868522276231,2.6707939695589413
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,2.238544934154329
FTC-133,56649450,4.4227260509908275,3.3145299987186307
NCI-H727,3815108,3.498449156165097,2.972095065157438
FU-OV-1,448949,2.8154029654914137,2.102561224509087
FU-OV-1,168313200,1.721890351327649,3.055864598527727
HSC-4,107985,-2.2656284906222144,-3.225878199410471
NCI-H2009,44241473,6.22803294537171,5.255817868294909
CAL-51,46843906,2.776329873296567,3.120332662330938
NCI-H1623,56946209,-3.1229213094171895,-3.5831067103685648
FU-OV-1,3825829,3.720797122696784,4.1641285986807
LXF 289,10385095,0.5776298837700374,1.447521306128649
KMRC-1,4259181,1.968851453570829,0.2417169901158114
G-401,11494412,0.2825252149996007,1.1771287056722282
KYSE-70,6918878,2.8589087884624673,2.4995088944928536
CA46,44185566,1.786162700750641,1.3413522683105603
LoVo,54618164,3.038824107117225,4.131415359538265
NOMO-1,16722836,0.125485002235246,0.8143897455318218
A4/Fukuda,44486219,1.5854911698245977,4.074395180271135
LOU-NH91,10127622,4.686411868973226,4.081272808958651
KMRC-1,387447,-4.945508167403058,-3.823451917261703
NCI-H146,54618164,3.6762408834701423,3.6751356246747053
KMRC-1,5351362,3.133883590343709,1.4741533707863033
NCI-H2171,54765302,2.983840848305476,3.4134370797026268
KMRC-1,16013152,4.7431155582488325,4.129599450466165
SNU-61,71304818,2.3861681407496125,2.273635265416212
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.4029522312393201
SW1463,2708,3.597321448088185,4.659976924169992
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,0.05795791030746729
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.8457683605469852
SBC-5,445643,4.051401497201939,4.042171318278737
A4/Fukuda,241158,1.407426277414268,2.7014796582861034
NOMO-1,6852167,1.234836949550939,1.7323294000057772
A-673,9887053,2.3565868011684956,3.0270483588114825
SNU-61,6450551,3.0035817833604783,2.305099609355376
OPM-2,24771867,-0.0082042750480303,0.09405997475968401
NOMO-1,11507802,1.1250810428603863,0.9851104037871251
CAL-51,2828334,6.190580852669228,6.06779687985793
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,3.1690394681900256
KMRC-1,44489675,3.6404436921550607,4.1330408167311905
FU-OV-1,23725625,5.156277829802871,4.941852545671453
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,-1.1828601057620247
OVISE,439501,-2.343202219776273,-1.9458993157748625
CAL-51,5281321,-0.4656602142962174,-1.4335792765038502
DMS 273,151289,0.7083247440682101,0.8408085916318697
MSTO-211H,9903786,1.212702371904443,3.079731345303639
LXF 289,135421197,2.6553019911408056,1.8013872430519862
NCI-H146,24771867,1.252264036368602,0.782185932411151
CAL-51,136227924,2.079284078064279,2.8190144872465113
NCI-H522,3689413,-4.273368850016072,-0.5186496136144686
NCI-H460,46907787,4.3372157131836255,2.390426398434677
NCI-H146,25183872,-1.3449770735764903,-0.8008596747691292
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.448777718411779
CAL-51,9887053,4.486783389261201,3.901179156573244
NCI-H460,107985,-2.632533954936978,-3.2589246522634796
YAPC,65064,4.247853222703643,4.858890525750871
SCC-9,9884685,0.522968392230544,1.0256119010901201
SNU-61,6852167,3.859693430343892,2.5389211415628488
NCI-H292,400769,-0.4441855968341354,-0.5012243743248225
EFO-27,24748573,3.2354879524418347,2.357930942766826
CA46,65628,4.372814936384242,3.4453424657991234
NOMO-1,1750826,-5.797741098147838,-2.8499732463148058
LOU-NH91,135440466,0.9387697781897782,2.407636989269948
MSTO-211H,11427553,1.7459714847796464,2.7211270804576553
SNU-61,9903786,2.1391845181717373,2.4915953084254445
JM-1,9952709,2.333856130884211,2.5616200068601347
YAPC,44507138,4.423761616669373,2.5113822485035406
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,1.3127614504846559
NCI-H727,10231331,-2.105430518957453,1.9424200320147886
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,-1.2004223060309684
LoVo,6610355,3.962139785065475,4.45853795056207
LOU-NH91,16065773,1.5129164046929433,2.7616488849360827
NCI-H292,51039095,2.62578521626359,3.0328259499888777
NCI-H2009,135398516,3.792403018557381,2.6582329678977565
Panc 04.03,44566777,0.5187219827219705,0.995091414100732
NOMO-1,285033,-2.4289999699368923,-3.3093936265638915
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,-0.7178628440023169
KYSE-70,51039095,3.5490987853947247,2.844883460699462
NCI-H460,36462,3.103581216464206,2.143747409134056
MDA-MB-157,216345,3.882260039310166,3.944552661220023
NCI-H522,104842,-1.8805759610000512,-3.3360412403284765
FU-OV-1,72376,-3.2802123060842283,-1.4473405017052943
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.7323827106750402
NCI-H661,5978,-4.21717720873681,-2.260220356000834
A-498,54619267,3.764771843303345,4.2365273716784335
SCC-9,53495165,0.7472636588137463,0.17987097731059315
MSTO-211H,9823820,1.3460489687603958,4.070861235577292
EFO-27,11222830,1.8018026478898377,1.6987562090391841
JM-1,11612883,1.345048153552996,1.8843450452104655
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,1.9547496692182762
EFO-27,12003241,-1.7336155023360622,-0.7165298791267751
SNU-449,969516,2.7263398794742972,2.9658578767175943
NCI-H146,4259181,0.4591034911128469,-0.03381904679608945
NOMO-1,24901704,1.738276567126731,1.8945677157004812
BxPC-3,54619238,5.160880582862859,4.707809199909083
SBC-5,654092,0.9915803206550192,-0.330355442698469
MDA-MB-453,71751553,4.5545018888168185,4.314303967346959
MDA-MB-157,5978,-4.802538048228265,-1.8459058078019863
CAL-51,24964624,1.6704816041215405,2.3181525184540037
LOU-NH91,5280436,5.173335280456015,3.6578505180325385
EFO-27,53481919,4.175905541374054,4.145209318968918
ONS-76,6610216,4.821554065133985,4.356768639502508
JM-1,53495165,-3.850144918627292,-1.4747740141499797
YAPC,16065773,2.864044457230109,2.4667853335228536
SNU-449,51039095,3.650396552732121,3.033965448934259
NCI-H661,71466445,2.1620252686029646,4.0513599566737275
A4/Fukuda,984333,-0.4165614363108865,0.30002523054306207
JM-1,4096211,0.9764948319580444,0.832325368872156
SNU-449,44197249,4.950419501644914,3.833885593069292
NCI-H460,11178236,-2.300904923417752,-3.4320367841100663
MDA-MB-453,12001922,1.470906003655458,1.8835039438821095
NCI-H460,44620216,3.8133491956675902,3.415627305268606
A-673,119182,-1.0392852637873304,-1.8911117144435132
NCI-H727,11178236,-2.542459533585497,-3.5842590110237555
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,2.8733037543754865
A4/Fukuda,753704,3.7176461109746897,4.416413926058546
SW1463,168312962,2.678519281942756,1.7589005165874667
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,-1.0043030733536582
OPM-2,227681,1.827584998281281,3.0039929297618913
HCC1143,3081361,2.3254724072420316,2.31209037312285
CAL-51,44607531,1.640429423812436,1.4147454226352836
HCC1143,322968,3.187805633465504,3.7308088463973093
FTC-133,9911463,4.36756965003986,4.087146919064865
SNU-61,159324,1.5880493113453718,2.071744854251237
NCI-H2171,5738263,2.6832104272478188,2.961237250523944
CA46,49867926,4.142181337076857,3.545071219346479
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,2.268468985703559
HSC-4,44589607,3.345116081225748,2.884588536238036
EFO-27,11485656,3.240498776862908,2.3652047522199364
SNU-81,23725625,1.2739024793065858,4.666221409725973
A4/Fukuda,9911830,0.8865121451383732,2.073663136013697
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.7763846543489128
NCI-H292,9866186,0.3072921576740348,1.0378230595911537
NCI-H460,54143018,2.5592633032091956,0.7766102757375056
A2780,4378219,4.7769256594107254,2.4325658304113773
NCI-H1623,44566777,3.7111231324950102,0.9552080047564027
CAL-51,10074640,3.192334769578339,3.2703613608042144
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,4.757584259208565
CAL-51,60700,-0.6497243984818711,-0.4377569480169837
HCC1143,12001922,1.8011931254041345,1.7545056845778284
NCI-H727,638278,3.5555642892396744,3.4107571847792344
LOU-NH91,72376,-0.6247816475402558,-1.3853538798775034
EFO-27,4578,4.426476303141277,4.603351261840911
HCC1143,119607,4.074424413991316,5.282144337638263
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,0.9394180723483836
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,0.4204003600419203
NCI-H727,159324,3.364651085509472,3.0034786862561482
NCI-H1623,5287620,-2.020641279124402,-1.9519156338580772
CAL-51,4261,2.4552246887350417,1.5958424989423228
JM-1,3543504,2.821603823672808,3.823522632755386
SNU-81,11497983,2.4691665919847514,2.145693341209747
G-401,5113032,4.898905985161468,4.629978097433453
MDA-MB-157,52912189,4.238554807379722,2.018563873344479
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.192040117614214
KYSE-70,10410894,6.372300696648814,3.412292150233513
LXF 289,54618164,3.0378434141224617,4.276153876604735
SNU-61,11214940,-0.337645985307237,1.685930591252408
ONS-76,11364421,-0.3098764345335473,-1.3929005458403758
KYSE-70,5978,-0.772629381148284,-1.8674021436056418
Panc 04.03,53232,3.444660782403792,3.1317055097325923
FTC-133,46926350,-4.117104249862265,-3.925071929160054
